diff --git a/obi.owl b/obi.owl
index 77e77a99..edd0ac72 100755
--- a/obi.owl
+++ b/obi.owl
@@ -13,7 +13,7 @@
xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#"
xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#">
-
+
en
Ontology for Biomedical Investigations
Advisors for this project come from the IFOMIS group, Saarbruecken and from the Co-ODE group in Manchester
@@ -80,7 +80,7 @@
http://creativecommons.org/licenses/by/4.0/
Ontology for Biomedical Investigations
Please cite the OBI consortium http://purl.obolibrary.org/obo/obi where traditional citation is called for. However it is adequate that individual terms be attributed simply by use of the identifying PURL for the term, in projects that refer to them.
- 2022-07-11
+ 2022-12-14
@@ -2239,7 +2239,10 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
has performer
- performer relation covers the need to report on who performed a planned processed. it has to cover processes done by People or Devices (such as a robot controlled by software WF management system)
+ A relation between a planned process and a continuant where the continuant can be a person, organization or device (such as a robot controlled by software workflow management system) that performs the planned process.
+ OBI
+ OBI
+ The 'has performer' relation covers the need to report on who performed a planned processed. It has to cover processes done by People or Devices (such as a robot controlled by software WF management system).
has performer
@@ -2690,6 +2693,18 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+
+
+
+
+ A relation between a material entity (such as a cell) and a process, in which the material entity has the ability to carry out the process.
+ has function realized in
+ capable of
+
+
+
+
@@ -4258,6 +4273,7 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
BFO 2 Reference: Material entities (continuants) can preserve their identity even while gaining and losing material parts. Continuants are contrasted with occurrents, which unfold themselves in successive temporal parts or phases [60
BFO 2 Reference: Object, Fiat Object Part and Object Aggregate are not intended to be exhaustive of Material Entity. Users are invited to propose new subcategories of Material Entity.
BFO 2 Reference: ‘Matter’ is intended to encompass both mass and energy (we will address the ontological treatment of portions of energy in a later version of BFO). A portion of matter is anything that includes elementary particles among its proper or improper parts: quarks and leptons, including electrons, as the smallest particles thus far discovered; baryons (including protons and neutrons) at a higher level of granularity; atoms and molecules at still higher levels, forming the cells, organs, organisms and other material entities studied by biologists, the portions of rock studied by geologists, the fossils studied by paleontologists, and so on.Material entities are three-dimensional entities (entities extended in three spatial dimensions), as contrasted with the processes in which they participate, which are four-dimensional entities (entities extended also along the dimension of time).According to the FMA, material entities may have immaterial entities as parts – including the entities identified below as sites; for example the interior (or ‘lumen’) of your small intestine is a part of your body. BFO 2.0 embodies a decision to follow the FMA here.
+
A material entity is an independent continuant that has some portion of matter as proper or improper continuant part. (axiom label in BFO2 Reference: [019-002])
@@ -6243,12 +6259,10 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
cell
- cell
PMID:18089833.Cancer Res. 2007 Dec 15;67(24):12018-25. "...Epithelial cells were harvested from histologically confirmed adenocarcinomas .."
A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.
cell
- cell
@@ -6453,7 +6467,6 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
B cell
A lymphocyte of B lineage that is capable of B cell mediated immunity.
- A lymphocyte of B lineage with the phenotype CD19-positive, CD20-positive, and capable of B cell mediated immunity.
B cell
@@ -6477,11 +6490,9 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
neuron
- neuron
The basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.
neuron
- neuron
@@ -6738,6 +6749,18 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+
+
+
+ malignant cell
+ A neoplastic cell that is capable of entering a surrounding tissue
+
+ malignant cell
+
+
+
+
@@ -6786,6 +6809,19 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+
+
+
+
+ peripheral blood mononuclear cell
+ A leukocyte with a single non-segmented nucleus in the mature form found in the circulatory pool of blood.
+
+ peripheral blood mononuclear cell
+
+
+
+
@@ -6880,10 +6916,10 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
- transcription, RNA-templated
- The cellular synthesis of RNA on a template of RNA.
+ RNA-templated transcription
+ The synthesis of an RNA transcript from an RNA template.
- transcription, RNA-templated
+ RNA-templated transcription
@@ -7101,6 +7137,18 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+
+
+
+ L-iditol 2-dehydrogenase activity
+ Catalysis of the reaction: L-iditol + NAD+ = L-sorbose + NADH + H+.
+
+ L-iditol 2-dehydrogenase activity
+
+
+
+
@@ -7125,6 +7173,90 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+
+
+
+ acyl-CoA oxidase activity
+ Catalysis of the reaction: acyl-CoA + O2 = trans-2,3-dehydroacyl-CoA + hydrogen peroxide.
+
+ acyl-CoA oxidase activity
+
+
+
+
+
+
+
+
+ L-alanine:2-oxoglutarate aminotransferase activity
+ Catalysis of the reaction: 2-oxoglutarate + L-alanine = L-glutamate + pyruvate.
+
+ L-alanine:2-oxoglutarate aminotransferase activity
+
+
+
+
+
+
+
+
+ alkaline phosphatase activity
+ Catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.
+
+ alkaline phosphatase activity
+
+
+
+
+
+
+
+
+ L-aspartate:2-oxoglutarate aminotransferase activity
+ Catalysis of the reaction: L-aspartate + 2-oxoglutarate = oxaloacetate + L-glutamate.
+
+ L-aspartate:2-oxoglutarate aminotransferase activity
+
+
+
+
+
+
+
+
+ cholinesterase activity
+ Catalysis of the reaction: an acylcholine + H2O = choline + a carboxylic acid anion.
+
+ cholinesterase activity
+
+
+
+
+
+
+
+
+ creatine kinase activity
+ Catalysis of the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+).
+
+ creatine kinase activity
+
+
+
+
+
+
+
+
+ glutamate dehydrogenase [NAD(P)+] activity
+ Catalysis of the reaction: L-glutamate + H2O + NAD(P)+ = 2-oxoglutarate + NH3 + NAD(P)H + H+.
+
+ glutamate dehydrogenase [NAD(P)+] activity
+
+
+
+
@@ -7137,6 +7269,42 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+
+
+
+ isocitrate dehydrogenase [NAD(P)+] activity
+ Catalysis of the reaction: isocitrate + NAD(P)+ = 2-oxoglutarate + CO2 + NAD(P)H.
+
+ isocitrate dehydrogenase [NAD(P)+] activity
+
+
+
+
+
+
+
+
+ lactate dehydrogenase activity
+ Catalysis of the reaction: lactate + NAD+ = H+ + NADH + pyruvate.
+
+ lactate dehydrogenase activity
+
+
+
+
+
+
+
+
+ ribonuclease activity
+ Catalysis of the hydrolysis of phosphodiester bonds in chains of RNA.
+
+ ribonuclease activity
+
+
+
+
@@ -7330,6 +7498,18 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+
+
+
+ 5'-nucleotidase activity
+ Catalysis of the reaction: a 5'-ribonucleotide + H2O = a ribonucleoside + phosphate.
+
+ 5'-nucleotidase activity
+
+
+
+
@@ -7390,6 +7570,18 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+
+
+
+ galactosidase activity
+ Catalysis of the hydrolysis of galactosyl compounds, substances containing a group derived from a cyclic form of galactose or a galactose derivative.
+
+ galactosidase activity
+
+
+
+
@@ -7402,6 +7594,30 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+
+
+
+ amylase activity
+ Catalysis of the hydrolysis of amylose or an amylose derivative.
+
+ amylase activity
+
+
+
+
+
+
+
+
+ beta-N-acetylglucosaminidase activity
+ Catalysis of the hydrolysis of terminal non-reducing N-acetyl-D-glucosamine residues in N-acetyl-beta-D-glucosaminides.
+
+ beta-N-acetylglucosaminidase activity
+
+
+
+
@@ -8351,6 +8567,18 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+
+
+
+ D-glutamyltransferase activity
+ Catalysis of the reaction: L(or D)-glutamine + D-glutamyl-peptide = NH3 + 5-glutamyl-D-glutamyl-peptide.
+
+ D-glutamyltransferase activity
+
+
+
+
@@ -12799,10 +13027,23 @@ No imports
+
+
+
+
+ Metazoa
+ metazoans
+ multicellular animals
+
+ Metazoa
+
+
+
+
-
+
Bilateria
Bilateria
@@ -12935,7 +13176,6 @@ No imports
Caenorhabditis elegans
- roundworm
Caenorhabditis elegans
@@ -13075,7 +13315,6 @@ No imports
Homo sapiens
human
human being
- man
Homo sapiens
@@ -16253,7 +16492,7 @@ for now.
-
+
@@ -18474,12 +18713,12 @@ that has_part some material entity is a material entity. If we add as equivalent
- intra cellular electrophysiology recording assay
+ intracellular electrophysiology recording assay
- An electrophysiology recording assay where the recording location of the electrode is intracellular
+ An electrophysiology assay where the recording location of the electrode is intracellular.
Frank Gibson
Frank Gibson
- intra cellular electrophysiology recording assay
+ intracellular electrophysiology recording assay
@@ -18621,7 +18860,7 @@ that has_part some material entity is a material entity. If we add as equivalent
extracellular electrophysiology recording assay
The recording of a spike train in the caudate nucleus of a monkey where the electrodes are extra cellular, i.e. not in the neuron
- An electrophysiology recording assay where the recording location of the electrode is extracellular
+ An electrophysiology assay where the recording location of the electrode is extracellular.
Frank Gibson
Helen Parkinson
Frank Gibson
@@ -21646,6 +21885,15 @@ Eur J Cancer. 2009 Jan;45(1):74-81. PMID: 19008094
+
+
+
+
+
+
+
+
+
@@ -23746,7 +23994,7 @@ http://sourceforge.net/p/obi/obi-terms/716/
-
+
@@ -23807,7 +24055,7 @@ http://sourceforge.net/p/obi/obi-terms/716/
pathogen challenge
- A pathogen challenge is the administration of a live pathogenic organism to a host
+ The administration of a live pathogenic organism to a host.
pathogen challenge
@@ -25239,12 +25487,16 @@ http://en.wikipedia.org/wiki/Survival_rate
-
- transcription factor binding site
+
+ obsolete transcription factor binding site
SO:0000235
- PLace_holder for sequence ontology term
- transcription factor binding site
+
+ PLace_holder for sequence ontology term
+ https://github.com/obi-ontology/obi/issues/1553
+
+ obsolete transcription factor binding site
+ true
@@ -26523,7 +26775,7 @@ placeholder
record of missing knowledge
A statement in a journal article indicating that the age of a patient at the onset of disease is not known. A statement indicating that the weight of a mouse was not measured.
- a information content entity created to indicate that information about something is not available to the person recording it.
+ An information content entity created to indicate that information about something is not available to the person recording it.
This class should probably end up in IAO. It could be further breaken down to indicate different kinds of lack of knowledge, e.g. inability to determine something vs. no attempt made to determine something vs. no informatino available if it was even attempted to determine something. The design pattern should be generalizable. 'unknown sex' is the first example, and needed immediately.
Bjoern Peters
@@ -35260,31 +35512,9 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
efficacy of epitope intervention experiment
- An assay that tests if inducing an epitope specific immune response in an organism has an effect, such as the ability to prevent, treat or excarbate diseases in the organism.
+ An assay that tests if inducing an epitope specific immune response in an organism has an effect, such as the ability to prevent, treat or exacerbate diseases in the organism.
Bjoern Peters
efficacy of in vivo intervention
efficacy of epitope intervention experiment
@@ -35378,7 +35608,7 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
An epitope protection experiment in which the ability of the epitope to protect the host from developing tumors is assessed.
Bjoern Peters
- tumor burden after challenge
+ protection from tumor challenge
epitope protection from tumor challenge experiment
@@ -35444,7 +35674,7 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
An epitope protection from infectious challenge experiment in which the readout is a reduction in the presence of pathogens in the host compared to controls.
Bjoern Peters
- pathogen urden after infectious challenge
+ burden after infectious challenge
epitope protection from infectious challenge experiment based on pathogen burden
@@ -36646,13 +36876,47 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -36660,13 +36924,13 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
- biological activity assay measuring epitope specific helper T cell enhancement of a B cell mediated immune response
+ in vivo assay measuring epitope specific helper T cell enhancement of a B cell mediated immune response
A T cell epitope specific helper activity assay that detects the ability of a T cell epitope to enhance an antibody response.
IEDB
IEDB
- antibody help|biological activity
- biological activity assay measuring epitope specific helper T cell enhancement of a B cell mediated immune response
+ antibody help|in vivo assay
+ in vivo assay measuring epitope specific helper T cell enhancement of a B cell mediated immune response
@@ -37193,13 +37457,13 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
- detection of specific nucleic acids with complementary probes assay measuring epitope specific tumor necrosis factor production by T cells
+ detection of specific nucleic acids with complementary probes assay measuring epitope specific tumor necrosis factor alpha production by T cells
- A detection of specific nucleic acid polymers with complementary probes that detects tumor necrosis factor production by T cells.
+ A detection of specific nucleic acid polymers with complementary probes that detects tumor necrosis factor alpha production by T cells.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
TNFa release|RNA/DNA detection
- detection of specific nucleic acids with complementary probes assay measuring epitope specific tumor necrosis factor production by T cells
+ detection of specific nucleic acids with complementary probes assay measuring epitope specific tumor necrosis factor alpha production by T cells
@@ -37915,13 +38179,47 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -37929,13 +38227,13 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
- biological activity assay measuring epitope specific helper T cell enhancement of a T cell mediated immune response
+ in vivo assay measuring epitope specific helper T cell enhancement of a T cell mediated immune response
A T cell epitope specific helper activity assay that detects the ability of a T cell epitope to enhance a T cell response.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
- T cell help|biological activity
- biological activity assay measuring epitope specific helper T cell enhancement of a T cell mediated immune response
+ T cell help|in vivo assay
+ in vivo assay measuring epitope specific helper T cell enhancement of a T cell mediated immune response
@@ -39999,16 +40297,24 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -40016,7 +40322,22 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -40024,6 +40345,7 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
+
in vivo assay measuring T cell epitope specific tolerance induction
An efficacy of T cell epitope intervention experiment that uses a tolerance induction intervention experiment.
@@ -40826,19 +41148,54 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo skin test assay measuring T cell epitope specific type IV hypersensitivity
@@ -41023,13 +41380,13 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
- cytometric bead array assay measuring epitope specific tumor necrosis factor production by T cells
+ cytometric bead array assay measuring epitope specific tumor necrosis factor alpha production by T cells
- A cytometric bead array assay that detects tumor necrosis factor production by T cells.
+ A cytometric bead array assay that detects tumor necrosis factor alpha production by T cells.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
TNFa release|cytometric bead array
- cytometric bead array assay measuring epitope specific tumor necrosis factor production by T cells
+ cytometric bead array assay measuring epitope specific tumor necrosis factor alpha production by T cells
@@ -42302,25 +42659,59 @@ http://en.wikipedia.org/wiki/Strain_%28biology%29
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring epitope specific T cell killing
- A T cell epitope specific killing assay that uses an in vivo cell mediated cell killing assay.
+ An in vivo cell killing assay that measures the killing of antigen presenting cells (APC) by T cells whose TCR recognizes an epitope presented by the APC.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
cytotoxicity|in vivo assay
@@ -42902,14 +43293,40 @@ pat1-114/pat1-114 ade6-M210/ade6-M216 h+/h+ (cells are diploid)
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
- biological activity assay measuring epitope specific T cell activation
+ assay measuring epitope specific T cell activation
A T cell epitope dependent biological activity assay that detects T cell activation.
IEDB
IEDB
activation|biological activity
- biological activity assay measuring epitope specific T cell activation
+ assay measuring epitope specific T cell activation
@@ -43202,13 +43619,13 @@ pat1-114/pat1-114 ade6-M210/ade6-M216 h+/h+ (cells are diploid)
- assay measuring epitope specific tumor necrosis factor production by T cells
+ assay measuring epitope specific tumor necrosis factor alpha production by T cells
- An assay of epitope specific tumor necrosis factor superfamily cytokine production by T cells that detects tumor necrosis factor production.
+ An assay of epitope specific tumor necrosis factor alpha production by T cells that detects tumor necrosis factor production.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
TNFa release|biological activity
- assay measuring epitope specific tumor necrosis factor production by T cells
+ assay measuring epitope specific tumor necrosis factor alpha production by T cells
@@ -44177,15 +44594,15 @@ http://svitsrv25.epfl.ch/R-doc/library/qvalue.html
-
- cell culture analyte detection bioassay measuring epitope specific tumor necrosis factor production by T cells
+
+ cell culture analyte detection bioassay measuring epitope specific tumor necrosis factor alpha production by T cells
- A reporter cell line analyte detection bioassay that detects tumor necrosis factor production by T cells.
+ A reporter cell line analyte detection bioassay that detects tumor necrosis factor alpha production by T cells.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
TNFa release|bioassay
- cell culture analyte detection bioassay measuring epitope specific tumor necrosis factor production by T cells
+ cell culture analyte detection bioassay measuring epitope specific tumor necrosis factor alpha production by T cells
@@ -44695,21 +45112,49 @@ http://svitsrv25.epfl.ch/R-doc/library/qvalue.html
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring T cell epitope specific disease exacerbation
@@ -44855,33 +45300,65 @@ http://svitsrv25.epfl.ch/R-doc/library/qvalue.html
-
+
+
+
+
+
+
+
+
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
-
+
+
+
+
+
+
+
+
+
+
+
+
-
- in vivo assay measuring T cell epitope specific protection from tumor challenge
+
+
+ in vivo assay measuring T cell epitope specific protection after tumor burden challenge
- A T cell epitope in vivo intervention experiment that uses a epitope protection experiment based on tumor burden.
+ An in vivo assay measuring T cell epitope specific protection from tumor challenge using tumor burden.
IEDB
IEDB
tumor burden after challenge|in vivo assay
- in vivo assay measuring T cell epitope specific protection from tumor challenge
+ in vivo assay measuring T cell epitope specific protection after tumor burden challenge
@@ -44906,39 +45383,61 @@ http://svitsrv25.epfl.ch/R-doc/library/qvalue.html
-
+
+
+
+
+
+
+
+
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
-
-
-
+
+
+
-
-
+
+
-
-
+
+
-
+
+
in vivo assay measuring T cell epitope specific protection from infectious challenge based on pathogen burden
- A T cell epitope in vivo intervention experiment that uses a epitope protection experiment based on pathogen burden.
+ An in vivo assay measuring T cell epitope specific protection from pathogen challenge using pathogen burden.
IEDB
IEDB
pathogen burden after challenge|in vivo assay
@@ -45203,29 +45702,56 @@ http://svitsrv25.epfl.ch/R-doc/library/qvalue.html
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
- biological activity assay measuring T cell epitope specific in vivo activity
+ assay measuring T cell epitope specific in vivo activity
A T cell epitope dependent biological activity determination assay that uses an in vivo intervention experiment.
IEDB
IEDB
in vivo activity|biological activity
- biological activity assay measuring T cell epitope specific in vivo activity
+ assay measuring T cell epitope specific in vivo activity
@@ -45419,25 +45945,72 @@ http://svitsrv25.epfl.ch/R-doc/library/qvalue.html
-
+
+
+
+
+
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
+
in vivo assay measuring T cell epitope specific protection based on survival
- A T cell epitope in vivo intervention experiment that uses a epitope protection experiment based on survival.
+ An in vivo assay measuring T cell epitope specific protection from other challenge using survival.
IEDB
IEDB
survival from challenge|in vivo assay
@@ -45544,27 +46117,61 @@ http://svitsrv25.epfl.ch/R-doc/library/qvalue.html
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
- biological activity assay measuring epitope specific T cell helper activity
+
+ in vivo assay measuring epitope specific T cell helper activity
A T cell epitope dependent biological activity assay that detects the ability of epitope specific helper T cells to enhance either B cell or T cell adaptive immune response function.
IEDB
IEDB
- helper response|biological activity
- biological activity assay measuring epitope specific T cell helper activity
+ helper response|in vivo assay
+ in vivo assay measuring epitope specific T cell helper activity
@@ -45946,21 +46553,53 @@ http://svitsrv25.epfl.ch/R-doc/library/qvalue.html
-
+
+
+
+
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring T cell epitope specific treatment of disease
@@ -51047,13 +51686,37 @@ https://sourceforge.net/tracker/?func=detail&aid=3483338&group_id=177891
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
+
+
+
+
+
@@ -51061,13 +51724,13 @@ https://sourceforge.net/tracker/?func=detail&aid=3483338&group_id=177891
- biological activity assay measuring epitope specific Ig-mediated histamine release
+ assay measuring epitope specific Ig-mediated histamine release
- A B cell epitope specific activation of additional immune response in vitro assay that detects histamine release.
+ A B cell epitope specific activation of additional immune response assay that detects histamine release in vitro.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
histamine release|biological activity
- biological activity assay measuring epitope specific Ig-mediated histamine release
+ assay measuring epitope specific Ig-mediated histamine release
@@ -51082,18 +51745,28 @@ https://sourceforge.net/tracker/?func=detail&aid=3483338&group_id=177891
-
+
+
+
+
+
+
+
+
+
+
+
- biological activity assay measuring epitope specific immunoglobulin-mediated antigen activation
+ assay measuring epitope specific immunoglobulin-mediated antigen activation
A B cell epitope dependent biological activity determination assay that detects antigen activation.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
antigen activation|biological activity
- biological activity assay measuring epitope specific immunoglobulin-mediated antigen activation
+ assay measuring epitope specific immunoglobulin-mediated antigen activation
@@ -51104,13 +51777,37 @@ https://sourceforge.net/tracker/?func=detail&aid=3483338&group_id=177891
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
+
+
+
+
+
@@ -51118,13 +51815,13 @@ https://sourceforge.net/tracker/?func=detail&aid=3483338&group_id=177891
- biological activity assay measuring epitope specific complement-dependent cytotoxicity
+ assay measuring epitope specific complement-dependent cytotoxicity
- A B cell epitope specific activation of additional immune response in vitro assay that detects complement-dependent cytotoxicity.
+ A B cell epitope specific activation of additional immune response assay that detects complement-dependent cytotoxicity in vitro .
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
complement-dependent cytotoxicity|biological activity
- biological activity assay measuring epitope specific complement-dependent cytotoxicity
+ assay measuring epitope specific complement-dependent cytotoxicity
@@ -51135,13 +51832,37 @@ https://sourceforge.net/tracker/?func=detail&aid=3483338&group_id=177891
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -51149,13 +51870,13 @@ https://sourceforge.net/tracker/?func=detail&aid=3483338&group_id=177891
- biological activity assay measuring epitope specific antibody-dependent cellular cytotoxicity
+ assay measuring epitope specific antibody-dependent cellular cytotoxicity
- A B cell epitope specific activation of additional immune response in vitro assay that detects antibody-dependent cellular cytotoxicity.
+ A B cell epitope specific activation of additional immune response assay that detects antibody-dependent cellular cytotoxicity in vitro.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
antibody-dependent cellular cytotoxicity|biological activity
- biological activity assay measuring epitope specific antibody-dependent cellular cytotoxicity
+ assay measuring epitope specific antibody-dependent cellular cytotoxicity
@@ -51163,30 +51884,35 @@ https://sourceforge.net/tracker/?func=detail&aid=3483338&group_id=177891
-
-
-
-
+
+
+
+
+
-
+
-
-
-
-
+
+
+
+
+
+
+
+
+
-
-
-
-
- biological activity assay measuring epitope specific immunoglobulin-mediated neutralization
+
+
+
+ assay measuring epitope specific immunoglobulin-mediated neutralization
A B cell epitope dependent biological activity determination assay that detects neutralization of the antigen.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
neutralization |biological activity
- biological activity assay measuring epitope specific immunoglobulin-mediated neutralization
+ assay measuring epitope specific immunoglobulin-mediated neutralization
@@ -51197,13 +51923,37 @@ https://sourceforge.net/tracker/?func=detail&aid=3483338&group_id=177891
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
+
+
+
+
+
@@ -51211,13 +51961,13 @@ https://sourceforge.net/tracker/?func=detail&aid=3483338&group_id=177891
- biological activity assay measuring epitope specific opsonization
+ assay measuring epitope specific opsonization
- A B cell epitope specific activation of additional immune response in vitro assay that detects opsonization.
+ A B cell epitope specific activation of additional immune response assay that detects opsonization in vitro .
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
opsonization|biological activity
- biological activity assay measuring epitope specific opsonization
+ assay measuring epitope specific opsonization
@@ -53146,17 +53896,47 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -53177,16 +53957,24 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -53194,13 +53982,29 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring B cell epitope specific tolerance induction
@@ -53219,16 +54023,24 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -53236,13 +54048,29 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring B cell epitope specific induction of hypersensitivity
@@ -53261,13 +54089,37 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
+
+
+
+
+
@@ -53275,13 +54127,13 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
- biological activity assay measuring epitope specific immune complex formation
+ assay measuring epitope specific immune complex formation
- A B cell epitope specific activation of additional immune response in vitro assay that detects agglutination.
+ A B cell epitope specific activation of additional immune response assay that detects agglutination in vitro.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
agglutination|biological activity
- biological activity assay measuring epitope specific immune complex formation
+ assay measuring epitope specific immune complex formation
@@ -53289,23 +54141,75 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring B cell epitope specific protection based on survival
- A B cell epitope in vivo intervention experiment that uses a epitope protection experiment based on survival.
+ An in vivo assay measuring B cell epitope specific protection from other challenge using survival.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
survival from challenge|in vivo assay
@@ -53320,21 +54224,53 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
-
+
+
+
+
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring B cell epitope specific treatment of disease
@@ -53353,29 +54289,56 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
- biological activity assay measuring B cell epitope specific in vivo activity
+ assay measuring B cell epitope specific in vivo activity
A B cell epitope dependent biological activity determination assay that uses an in vivo intervention experiment.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
in vivo activity|biological activity
- biological activity assay measuring B cell epitope specific in vivo activity
+ assay measuring B cell epitope specific in vivo activity
@@ -53644,30 +54607,49 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
-
-
-
-
-
+
+
+
+
-
+
-
-
+
+
+
+
+
+
+
-
-
-
- biological activity assay measuring epitope specific activation of additional immune response in vitro
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ assay measuring epitope specific activation of additional immune response in vitro
A B cell epitope dependent biological activity determination assay that detects secondary in vitro activity.
IEDB
IEDB
secondary in vitro activity|biological activity
- biological activity assay measuring epitope specific activation of additional immune response in vitro
+ assay measuring epitope specific activation of additional immune response in vitro
@@ -53692,13 +54674,29 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
- biological activity assay measuring epitope specific antigen inhibition of antibody activity
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ assay measuring epitope specific antigen inhibition of antibody activity
A B cell epitope dependent biological activity determination assay that detects inhibition of the antibody's activity by the antigen.
IEDB
IEDB
antibody activity inhibition|biological activity
- biological activity assay measuring epitope specific antigen inhibition of antibody activity
+ assay measuring epitope specific antigen inhibition of antibody activity
@@ -53839,21 +54837,49 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring B cell epitope specific protection from challenge
@@ -53872,21 +54898,49 @@ https://sourceforge.net/tracker/?func=detail&aid=3512891&group_id=177891
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring B cell epitope specific disease exacerbation
@@ -59980,7 +61034,7 @@ Concluding that a gene is upregulated in a tissue sample based on the band inten
-
+
@@ -60046,6 +61100,17 @@ Concluding that a gene is upregulated in a tissue sample based on the band inten
+
+
+
+
+
+
+
+
+
+
+
@@ -65882,7 +66947,7 @@ Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries.
-
+
@@ -66007,7 +67072,7 @@ Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries.
-
+
@@ -66851,39 +67916,64 @@ Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring B cell epitope specific protection from infectious challenge based on pathogen burden
- A B cell epitope in vivo intervention experiment that uses a epitope protection experiment based on pathogen burden.
+ An in vivo assay measuring B cell epitope specific protection from pathogen challenge using pathogen burden.
IEDB
IEDB
pathogen burden after challenge|in vivo assay
@@ -66895,33 +67985,68 @@ Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- in vivo assay measuring B cell epitope specific protection from tumor challenge
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific protection after tumor burden challenge
- A B cell epitope in vivo intervention experiment that uses a epitope protection experiment based on tumor burden.
+ An in vivo assay measuring B cell epitope specific protection from tumor challenge using tumor burden.
IEDB
IEDB
tumor burden after challenge|in vivo assay
- in vivo assay measuring B cell epitope specific protection from tumor challenge
+ in vivo assay measuring B cell epitope specific protection after tumor burden challenge
@@ -67301,25 +68426,48 @@ Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries.
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vitro assay measuring epitope specific T cell killing
- A T cell epitope specific killing assay that uses an in vitro cell killing assay.
+ An in vitro cell killing assay that measures the killing of antigen presenting cells (APC) by T cells whose TCR recognizes an epitope presented by the APC.
IEDB
IEDB
cytotoxicity|in vitro assay
@@ -67628,16 +68776,48 @@ Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries.
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -67659,6 +68839,46 @@ Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries.
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vitro assay measuring epitope specific proliferation of T cells
@@ -67712,21 +68932,49 @@ Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries.
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring T cell epitope specific protection from challenge
@@ -67743,13 +68991,45 @@ Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries.
- in vitro assay measuring T cell epitope specific suppression
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ assay measuring T cell epitope specific suppression in vitro
T cell epitope dependent biological activity assay that detects suppression of an in vitro response.
PERSON:Randi Vita, James Overton, Bjoern Peters
IEDB
suppression|in vitro assay
- in vitro assay measuring T cell epitope specific suppression
+ assay measuring T cell epitope specific suppression in vitro
@@ -68206,25 +69486,48 @@ Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries.
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
carboxyfluorescein succinimidyl ester staining assay measuring epitope specific proliferation of T cells
- A T cell epitope specific proliferation assay performed on cells in vitro that uses a CFSE assay.
+ A CFSE assay that detects T cell epitope specific proliferation in vitro.
IEDB
IEDB
proliferation|CFSE
@@ -72642,7 +73945,7 @@ https://www.doi.org/
exposure to environmental and workplace carcinogens history
- A information content entity that indicates the exposure of an individual to carcinogens in the workplace or environment.
+ An information content entity that indicates the exposure of an individual to carcinogens in the workplace or environment.
Chris Stoeckert, Helena Ellis
OBIB
NCI BBRB
@@ -73657,7 +74960,7 @@ https://www.doi.org/
An inclusion criterion that is based on fitting within the defined characteristics of a population based study design.
Chris Stoeckert, Mathias Brochhausen
MIABIS 2.0
- 920
+ https://github.com/obi-ontology/obi/issues/920
MIABIS 2.0
defined population inclusion criterion
@@ -75826,7 +77129,7 @@ https://www.doi.org/
An inclusion criterion that defines and states an age bracket which, if met, makes an entity suitable for a given task or participation in a given process.
Mathias Brochhausen
- #839
+ https://github.com/obi-ontology/obi/issues/839
age group inclusion criterion
@@ -75867,7 +77170,7 @@ https://www.doi.org/
An inclusion criterion that defines and states a a set of medications, which, if used by an entity, makes that entity suitable for a given task or participation in a given process.
Mathias Brochhausen
- #840
+ https://github.com/obi-ontology/obi/issues/840
use of medication inclusion criterion
@@ -77462,16 +78765,47 @@ https://www.doi.org/
-
+
+
+
+
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -77496,18 +78830,56 @@ https://www.doi.org/
-
+
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -77530,18 +78902,56 @@ https://www.doi.org/
-
+
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -77564,16 +78974,47 @@ https://www.doi.org/
-
+
+
+
+
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -77598,16 +79039,47 @@ https://www.doi.org/
-
+
+
+
+
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -77629,10 +79101,72 @@ https://www.doi.org/
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring T cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific T cells based on pathogen burden
- A T cell epitope in vivo intervention experiment that uses a epitope protection experiment based on pathogen burden after adoptive transfer of epitope specfic T cells.
+ An in vivo assay measuring T cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific antibodies or B cells using pathogen burden.
IEDB
IEDB
pathogen burden after challenge after adoptive transfer|in vivo assay
@@ -77644,10 +79178,72 @@ https://www.doi.org/
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring B cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on pathogen burden
- A B cell epitope in vivo intervention experiment that uses a epitope protection experiment based on pathogen burden after adoptive transfer of epitope specific antibodies or B cells.
+ An in vivo assay measuring B cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific antibodies or B cells using pathogen burden.
IEDB
IEDB
pathogen burden after challenge after adoptive transfer|in vivo assay
@@ -77659,33 +79255,87 @@ https://www.doi.org/
-
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
-
-
-
-
- in vivo assay measuring T cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific T cells based on survival
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring T cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific T cells based on survival
- A T cell epitope in vivo intervention experiment that uses a epitope protection experiment based on survival after adoptive transfer of epitope specfic T cells.
+ An in vivo assay measuring T cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific T cells using survival.
IEDB
IEDB
- survival from challenge after adoptive transfer|in vivo assay
- in vivo assay measuring T cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific T cells based on survival
+ survival from other challenge after adoptive transfer|in vivo assay
+ in vivo assay measuring T cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific T cells based on survival
@@ -77693,32 +79343,87 @@ https://www.doi.org/
-
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
-
-
-
- in vivo assay measuring B cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on survival
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on survival
- A B cell epitope in vivo intervention experiment that uses a epitope protection experiment based on survival after adoptive transfer of epitope specific antibodies or B cells.
+ An in vivo assay measuring B cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific antibodies or B cells using survival.
IEDB
IEDB
- survival from challenge after adoptive transfer|in vivo assay
- in vivo assay measuring B cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on survival
+ survival from other challenge after adoptive transfer|in vivo assay
+ in vivo assay measuring B cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on survival
@@ -77726,14 +79431,76 @@ https://www.doi.org/
-
- in vivo assay measuring T cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring T cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific T cells based on tumor burden
- A T cell epitope in vivo intervention experiment that uses a epitope protection experiment based on tumor burden after adoptive transfer of epitope specfic T cells.
+ An in vivo assay measuring T cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific T cells using tumor burden.
IEDB
IEDB
tumor burden after challenge after adoptive transfer|in vivo assay
- in vivo assay measuring T cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific T cells
+ in vivo assay measuring T cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific T cells based on tumor burden
@@ -77741,14 +79508,76 @@ https://www.doi.org/
-
- in vivo assay measuring B cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific antibodies or B cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on tumor burden
- A B cell epitope in vivo intervention experiment that uses a epitope protection experiment based on tumor burden after adoptive transfer of epitope specific antibodies or B cells.
+ An in vivo assay measuring B cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific antibodies or B cells using tumor burden.
IEDB
IEDB
tumor burden after challenge after adoptive transfer|in vivo assay
- in vivo assay measuring B cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific antibodies or B cells
+ in vivo assay measuring B cell epitope specific protection from challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on tumor burden
@@ -77759,21 +79588,58 @@ https://www.doi.org/
-
+
+
+
+
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring T cell epitope specific tolerance induction resulting from the adoptive transfer of epitope specific T cells
@@ -77792,21 +79658,58 @@ https://www.doi.org/
-
+
+
+
+
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring B cell epitope specific tolerance induction resulting from the adoptive transfer of epitope specific antibodies or B cells
@@ -78371,19 +80274,62 @@ https://www.doi.org/
-
-
-
-
-
-
+
+
+
+
-
-
+
+
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo assay measuring B cell epitope specific induction of hypersensitivity resulting from the adoptive transfer of epitope specific antibodies or B cells
An efficacy of B cell epitope intervention experiment that detects a hypersensitivity response by monitoring skin reactions after adoptive transfer of epitope specific antibodies or B cells.
@@ -78398,19 +80344,62 @@ https://www.doi.org/
-
-
-
-
-
-
+
+
+
+
-
-
+
+
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
in vivo skin test assay measuring T cell epitope specific type IV hypersensitivity resulting from the adoptive transfer of epitope specific T cells
An efficacy of T cell epitope intervention experiment that detects epitope specific type IV hypersensitivity after adoptive transfer of epitope specfic T cells.
@@ -78428,16 +80417,28 @@ https://www.doi.org/
-
+
+
+
+
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -78445,7 +80446,22 @@ https://www.doi.org/
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -78468,26 +80484,69 @@ https://www.doi.org/
-
-
-
-
-
-
+
+
+
+
-
-
+
+
-
-
-
- biological activity assay measuring epitope specific helper T cell enhancement of a B cell mediated immune response resulting from the adoptive transfer of epitope specific T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ assay measuring epitope specific helper T cell enhancement of a B cell mediated immune response resulting from the adoptive transfer of epitope specific T cells
A T cell epitope specific helper activity assay that detects the ability of a T cell epitope to enhance an antibody response after adoptive transfer of epitope specfic T cells.
IEDB
IEDB
- antibody help after adoptive transfer|biological activity
- biological activity assay measuring epitope specific helper T cell enhancement of a B cell mediated immune response resulting from the adoptive transfer of epitope specific T cells
+ antibody help after adoptive transfer|in vivo assay
+ assay measuring epitope specific helper T cell enhancement of a B cell mediated immune response resulting from the adoptive transfer of epitope specific T cells
@@ -78495,26 +80554,69 @@ https://www.doi.org/
-
-
-
-
-
-
+
+
+
+
-
-
+
+
-
-
-
- biological activity assay measuring epitope specific helper T cell enhancement of a T cell mediated immune response resulting from the adoptive transfer of epitope specific T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ assay measuring epitope specific helper T cell enhancement of a T cell mediated immune response resulting from the adoptive transfer of epitope specific T cells
A T cell epitope specific helper activity assay that detects the ability of a T cell epitope to enhance a T cell response after adoptive transfer of epitope specfic T cells.
IEDB
IEDB
- T cell help after adoptive transfer|biological activity
- biological activity assay measuring epitope specific helper T cell enhancement of a T cell mediated immune response resulting from the adoptive transfer of epitope specific T cells
+ T cell help after adoptive transfer|in vivo assay
+ assay measuring epitope specific helper T cell enhancement of a T cell mediated immune response resulting from the adoptive transfer of epitope specific T cells
@@ -78525,16 +80627,28 @@ https://www.doi.org/
-
+
+
+
+
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -78542,7 +80656,22 @@ https://www.doi.org/
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -78553,7 +80682,7 @@ https://www.doi.org/
in vivo assay measuring epitope specific T cell killing resulting from the adoptive transfer of epitope specific T cells
- A T cell epitope specific killing assay that uses an in vivo cell mediated cell killing assay after adoptive transfer of epitope specfic T cells.
+ An in vivo cell killing assay that detects the killing of an antigen presenting cell (APC) by a T cell whose TCR recognizes an epitope presented by the APC after adoptive transfer of epitope specific T cells.
IEDB
IEDB
cytotoxicity after adoptive transfer|in vivo assay
@@ -78656,13 +80785,56 @@ https://www.doi.org/
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
-
-
-
-
-
in vivo assay measuring a T cell epitope specific response after adoptive transfer of epitope specific T cells
An efficacy of T cell epitope intervention experiment that is performed after adoptive transfer of epitope specfic T cells.
@@ -78677,13 +80849,56 @@ https://www.doi.org/
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
-
-
-
-
-
in vivo assay measuring a B cell epitope specific response after adoptive transfer of epitope specific antibodies or B cells
An efficacy of B cell epitope intervention experiment that is performed after adoptive transfer of epitope specific antibodies or B cells.
@@ -78701,16 +80916,47 @@ https://www.doi.org/
-
+
+
+
+
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -82484,7 +84730,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
catheter
- A catheter left inside the body, either temporarily or permanently, may be referred to as an "indwelling catheter".
+ A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter.
A device which is a flexible tube inserted into a body and which enables transfer of fluids into or out of a body.
https://orcid.org/0000-0002-8844-9165
@@ -83069,13 +85315,13 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
- Mosquito Magnet trap
+ Mosquito Magnet Pro trap
An arthropod trap that is powered by propane and is designed to emit a combination of carbon dioxide, heat, water, and oct-1-en-3-ol attractants while simultaneously using suction to trap arthropods.
John Judkins
IRO:0000022
https://github.com/obi-ontology/obi/issues/1217
- Mosquito Magnet trap
+ Mosquito Magnet Pro trap
@@ -83264,7 +85510,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
A study design where the selection of the individuals that are included into the study are intended to be representative of all individuals in the a priori defined specific population and is done at the population level or among the population groups, generally to find the cause, incidence or spread of the disease or to see the response to the treatment, nutrition or environment.
Chris Stoeckert
https://link.springer.com/referenceworkentry/10.1007%2F978-1-4419-1005-9_45, EFO_0001430 population based design
- #1090
+ https://github.com/obi-ontology/obi/issues/1090
population based design
@@ -90621,7 +92867,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
blood microbiology datum
- An organism identification assay that is the specified output of a blood microbiology assay.
+ An organism identification datum that is the specified output of a blood microbiology assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1428
@@ -90663,7 +92909,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
feces microbiology datum
- An organism identification assay that is the specified output of a feces microbiology assay.
+ An organism identification datum that is the specified output of a feces microbiology assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1428
@@ -90705,7 +92951,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
urine microbiology datum
- An organism identification assay that is the specified output of a urine microbiology assay.
+ An organism identification datum that is the specified output of a urine microbiology assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1428
@@ -90747,7 +92993,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
induced sputum microbiology datum
- An organism identification assay that is the specified output of an induced sputum microbiology assay.
+ An organism identification datum that is the specified output of an induced sputum microbiology assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1428
@@ -90789,7 +93035,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
cerebrospinal fluid microbiology datum
- An organism identification assay that is the specified output of a cerebrospinal fluid microbiology assay.
+ An organism identification datum that is the specified output of a cerebrospinal fluid microbiology assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1428
@@ -90810,7 +93056,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
endotracheal aspirate assay datum
- An organism identification assay that is the specified output of an endotracheal aspirate assay.
+ An organism identification datum that is the specified output of an endotracheal aspirate assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1428
@@ -90831,7 +93077,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
endotracheal tube aspirate microbiology datum
- An organism identification assay that is the specified output of an endotracheal tube aspirate microbiology assay.
+ An organism identification datum that is the specified output of an endotracheal tube aspirate microbiology assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1428
@@ -90852,7 +93098,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
lung microbiology datum
- An organism identification assay that is the specified output of a lung microbiology assay.
+ An organism identification datum that is the specified output of a lung microbiology assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1428
@@ -90873,7 +93119,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
nasopharyngeal or oropharyngeal swab microbiology datum
- An organism identification assay that is the specified output of a nasopharyngeal or oropharyngeal swab microbiology assay.
+ An organism identification datum that is the specified output of a nasopharyngeal or oropharyngeal swab microbiology assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1428
@@ -90894,7 +93140,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
pleural fluid microbiology datum
- An organism identification assay that is the specified output of a pleural fluid microbiology assay.
+ An organism identification datum that is the specified output of a pleural fluid microbiology assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1428
@@ -90915,7 +93161,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
umbilical cord blood assay datum
- An organism identification assay that is the specified output of an umbilical cord blood assay.
+ An organism identification datum that is the specified output of an umbilical cord blood assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1428
@@ -90936,7 +93182,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
umbilical cord blood microbiology datum
- An organism identification assay that is the specified output of an umbilical cord blood microbiology assay.
+ An organism identification datum that is the specified output of an umbilical cord blood microbiology assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1428
@@ -92755,13 +95001,15 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
-
+
assay kit
Glutathione S-Transferase (GST) Assay Kit: https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/101/301/cs0410bul.pdf
- A processed material that consists of reagents and devices that enable the performance of a specific type of assay, which could, in addition, require specific instruments not included in the kit.
+ A device that consists of reagents and devices that enable the performance of a specific type of assay, which could, in addition, require specific instruments not included in the kit.
John Judkins
OBI, VEuPathDB
+ https://github.com/obi-ontology/obi/issues/1456
+ VEuPathDB
assay kit
@@ -92983,7 +95231,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
placental blood microbiology datum
- An organism identification assay that is the specified output of a placental blood microbiology assay.
+ An organism identification datum that is the specified output of a placental blood microbiology assay.
John Judkins
VEuPathDB
https://github.com/obi-ontology/obi/issues/1297
@@ -93013,766 +95261,3882 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
-
+
-
-
- injection function
-
- The function of a device realized when administering a substance in vivo, applied particularly to the forcible insertion of a liquid or gas by means of a syringe, pump, etc.
- PERSON: Alan Ruttenberg
- PERSON: Melanie Courtot
- adapted from WEB: http://www.dictionary.net/injection
- injection function
+
+
+ synaptosome preparation process
+
+ A material component separation process where a synaptic terminal is isolated from a neuron by mild homogenization of nervous tissue under isotonic conditions and subsequent fractionation using differential and density gradient centrifugation.
+ Michelle Giglio
+ Suvarna Nadendla
+ url:https://en.wikipedia.org/wiki/Synaptosome
+ CFDE-GlyGen
+ synaptosome preparation process
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- Epstein Barr virus transformed B cell
- PMID: 8777380. Expression of thyroid peroxidase in EBV-transformed B cell lines using adenovirus.Thyroid. 1996 Feb;6(1):23-8.
+
+
+
+
+
+
+
+
+ Illumina HiSeq 1500
- A material entity which results from viral transformation process using EBV as transformation agent when applied to B-cell entity
- PERSON: Susanna Sansone
- GROUP: OBI Biomaterial Branch
- Epstein Barr virus transformed B cell
+ A DNA sequencer which is manufactured by the Illumina corporation, with a single flow cell. Built upon sequencing by synthesis technology, the machine employs dual surface imaging and offers two high-output options and one rapid-run option.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ HiSeq 1500
+ https://jp.support.illumina.com/content/dam/illumina-support/documents/documentation/system_documentation/hiseq1500/hiseq-1500-system-guide-15035788-03.pdf
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Illumina HiSeq 1500
-
+
-
-
- chimera
+
+
+
+
+
+
+
+
+ NextSeq 550
- An organism which contains cells or tissues with a different genotype
- PERSON: Helen Parkinson
- GROUP: OBI
- chimera
+ A DNA sequencer manufactured by the Illumina corporation, which provides the increased flexibility of microarray scanning in addition to sequencing.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ https://www.illumina.com/systems/sequencing-platforms/nextseq.html
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ NextSeq 550
-
+
-
-
- obsolete_anatomical entity
- Tissue, organ, system, sperm, blood or body location (arm).
-
- An anatomical entity is a material entity that is part of a multicellular organism, and which is large enough so that it forms an identifiable structure in the organism. Specifically, it excludes granular parts of the organism, such as atoms, molecules, cells, which can be removed from the organism without affecting it. It is defined as the union of 'multi-tissue structure', 'body substance' and 'portion of tissue'
- Bjoern Peters
- Philippe Rocca-Serra
- Tina Boussard
- MO
-
- obsolete_anatomical entity
- true
+
+
+
+
+
+
+
+
+ Agilent-026655 Whole Mouse Genome Microarray 4x44K v2
+
+ A DNA microarray manufactured with Agilent 60-mer SurePrint Technology .The SurePrint G3 Mouse Gene Expression 4x44K v2 Microarray provide full coverage of the mouse transcriptome using the latest annotation databases, including long non-coding RNA(lncRNA). Each glass slide is formatted with four high-definition 44K arrays.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ https://www.agilent.com/cs/library/brochures/IBS-231%20genomics%20catalog%20mech%20FINAL.pdf
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Agilent-026655 Whole Mouse Genome Microarray 4x44K v2
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
-
-
-
-
-
-
-
-
-
-
-
-
+
+
- blood plasma specimen
- PMID: 18217225.Sex Transm Dis. 2008 Jan;35(1):55-60. Review.Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings.
+ Agilent-030493 SurePrint G3 Mouse Exon 4x180K Microarray
- a material entity which corresponds to the liquid component of blood, in which the blood cells are suspended.
- 03/21/2010: BP, blood plasma is defined as the output of certain separation processes, so this is in the domain of OBI, not FMA.
- PERSON: Maura Gasparetto
- PERSON: Melanie Courtot
- PERSON: Philippe Rocca-Serra
- plasma
- WEB: http://en.wikipedia.org/wiki/Blood_plasma
- blood plasma specimen
+ A DNA microarray manufactured with Agilent 60-mer SurePrint Technology for studying exon-level gene expression changes. The SurePrint G3 Mouse Exon 4x180K Microarray include probes targeting individual exons. Each glass slide formatted with four 180K arrays.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ https://www.agilent.com/cs/library/brochures/5990-6928en_lo.pdf
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Agilent-030493 SurePrint G3 Mouse Exon 4x180K Microarray
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
-
-
+
+
- blood serum specimen
- PMID: 18229666.Adv Med Sci. 2007;52 Suppl 1:204-6.Antioxidant activity of blood serum and saliva in patients with periodontal disease treated due to epilepsy.
+ Agilent-074809 SurePrint G3 Mouse GE v2 8x60K Microarray
- A material entity which derives from blood and corresponds to blood plasma without fibrinogen or the other clotting factors.
- PERSON: Maura Gasparetto
- PERSON: Melanie Courtot
- PERSON: Philippe Rocca-Serra
- WEB: http://en.wikipedia.org/wiki/Blood_plasma
- blood serum specimen
+ A DNA microarray manufactured with Agilent 60-mer SurePrint technology which provides comprehensive coverage of genes and transcripts using the latest annotation databases. The SurePrint G3 Mouse Gene Expression 8x60K v2 Microarray features complete coverage of established RefSeq coding transcripts (NM) from the latest build and updated long non-coding RNA (lncRNA) content to ensure relevant research.Each glass slide formatted with eight high-definition 60K arrays.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ https://www.agilent.com/cs/library/usermanuals/public/G4140-90050_GeneExpression_TwoColor_6.9.pdf
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Agilent-074809 SurePrint G3 Mouse GE v2 8x60K Microarray
-
+
-
-
-
-
-
-
-
-
-
-
-
-
- organism
- animal
- fungus
- plant
- virus
-
- A material entity that is an individual living system, such as animal, plant, bacteria or virus, that is capable of replicating or reproducing, growth and maintenance in the right environment. An organism may be unicellular or made up, like humans, of many billions of cells divided into specialized tissues and organs.
- 10/21/09: This is a placeholder term, that should ideally be imported from the NCBI taxonomy, but the high level hierarchy there does not suit our needs (includes plasmids and 'other organisms')
- 13-02-2009:
-OBI doesn't take position as to when an organism starts or ends being an organism - e.g. sperm, foetus.
-This issue is outside the scope of OBI.
- GROUP: OBI Biomaterial Branch
- WEB: http://en.wikipedia.org/wiki/Organism
- organism
+
+
+
+
+
+
+
+
+ Affymetrix Mouse Genome 430 2.0 Array
+
+ A DNA microarray manufactured by Affymetrix, which includes complete coverage of the GeneChip Mouse Expression Set 430, for analysis of over 39,000 transcripts and variants from more than 34,000 well-characterized mouse genes and UniGene clusters, on a single array. The sequences for this array were selected from GenBank™, dbEST, and RefSeq., and sequence clusters cretaed from the UniGene database.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ GeneChip Mouse Genome 430 2.0 Array
+ https://www.thermofisher.com/order/catalog/product/900497
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Affymetrix Mouse Genome 430 2.0 Array
-
+
-
-
- obsolete_immortal cell
- a single Hela cell
+
+
+
+
+
+
+
+
+ Affymetrix Mouse Genome 430A 2.0 Array
- a cell derived from a multicellular organism that has the potential to replicate indefinitely
- PERSON: Bjoern Peters
- GROUP: OBI Biomaterial Branch
-
- obsolete_immortal cell
- true
+ A DNA microarray manufactured by Affymetrix for gene expression analysis focusing on approximately 14,000 well-characterized genes in the transcribed mouse genome using single-array cartridge. Sequences used in the design of the array were selected from GenBank™, dbEST, and RefSeq. The sequence clusters were created from the UniGene database.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ GeneChip Mouse Genome 430A 2.0 Array
+ https://www.thermofisher.com/order/catalog/product/900500TS?SID=srch-srp-900500TS
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Affymetrix Mouse Genome 430A 2.0 Array
-
+
-
-
- obsolete_fragment derived from protein
- the peptide with sequence SIINFEKL, which is eluted from a cell expressing hen egg lysozyme
-
- A material entity which is derived from a protein
- PERSON: Bjoern Peters
- GROUP: IEDB
-
- obsolete_fragment derived from protein
- true
+
+
+
+
+
+
+
+
+ Affymetrix Mouse Gene 1.0 ST Array
+
+ A DNA microarray manufactured by Affymetrix, which is a whole-transcript array that includes probes to measure both messenger (mRNA) and long intergenic non-coding RNA transcripts (lincRNA). This whole-transcript array design provides a complete expression profile of mRNA as well as the intermediary lincRNA transcripts that impact the mRNA expression profile.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ GeneChip Mouse Gene 1.0 ST Array
+ https://www.thermofisher.com/order/catalog/product/901168
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Affymetrix Mouse Gene 1.0 ST Array
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
-
-
+
+
- phosphate buffered saline solution
- PMID: 16279733.Dent Mater J. 2005 Sep;24(3):414-21.PBS buffer solutions with different pH values can change porosity of DNA-chitosan complexes.
-
- Phosphate buffered saline (abbreviated PBS) is a buffer solution commonly used in biochemistry. It is a salty solution containing sodium chloride, sodium phosphate and in some preparations potassium chloride and potassium phosphate. The buffer helps to maintain a constant pH. The concentration usually matches the human body (isotonic).
- PERSON: Melanie Courtot
- PERSON: Philippe Rocca-Serra
- PERSON: Tina Boussard
- PBS buffer
- WEB: http://en.wikipedia.org/wiki/Phosphate_buffered_saline
- phosphate buffered saline solution
+ Affymetrix Mouse Gene 2.1 ST Array
+
+ A DNA microarray manufactured by Affymetrix, which is a whole-transcript array that includes probes to measure both messenger (mRNA) and long intergenic non-coding RNA transcripts (lincRNA).To supplement the lincRNA data contained in RefSeq, we used sequence and transcript data from lncRNA db.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ GeneChip Mouse Gene 2.1 ST Array
+ https://www.thermofisher.com/document-connect/document-connect.html?url=https%3A%2F%2Fassets.thermofisher.com%2FTFS-Assets%2FLSG%2Fbrochures%2Fmouse_gene_array_datasheet.pdf
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Affymetrix Mouse Gene 2.1 ST Array
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
- specimen
- Biobanking of blood taken and stored in a freezer for potential future investigations stores specimen.
-
- A material entity that has the specimen role.
- Note: definition is in specimen creation objective which is defined as an objective to obtain and store a material entity for potential use as an input during an investigation.
- PERSON: James Malone
- PERSON: Philippe Rocca-Serra
- GROUP: OBI Biomaterial Branch
-
- specimen
+
+
+
+
+
+
+
+
+ Affymetrix Rhesus Macaque Genome Array
+
+ A DNA microarray manufactured by Affymetrix,which is a single-labeled high-density oligonucleotide array, designed to study gene expression in the rhesus animal model and to interrogate rhesus transcripts orthologous to the 3' end of human transcripts. The array consists of over 52,000 probe sets representing more than 20,000 genes, and several relevant viral organisms for studying host-disease immune response.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ GeneChip Rhesus Macaque Genome Array
+ https://www.thermofisher.com/document-connect/document-connect.html?url=https%3A%2F%2Fassets.thermofisher.com%2FTFS-Assets%2FLSG%2Fmanuals%2FMAN0017705_702023_RhesusArray_PI.pdf
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Affymetrix Rhesus Macaque Genome Array
-
+
-
-
- obsolete_cell line cell
+
+
+
+
+
+
+
+
+ Affymetrix Human Transcriptome Array 2.0
- A material entity that represents generations of a primary culture.
- PERSON: Susanna Sansone
- GROUP: OBI Biomaterial Branch
-
- obsolete_cell line cell
- true
+ A DNA microarray manufactured by Affymetrix, to go beyond gene-level expression profiling to accurately detect all known transcript isoforms produced by a gene. The array design covers >245,000 coding transcripts, >40,000 non-coding transcripts and >339,000 probe sets covering exon-exon junctions, thus ensuring uniform coverage of the transcriptome.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ GeneChip Human Transcriptome Array 2.0
+ https://www.thermofisher.com/document-connect/document-connect.html?url=https%3A%2F%2Fassets.thermofisher.com%2FTFS-Assets%2FLSG%2Fbrochures%2Fhta_array_2_0_datasheet.pdf
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Affymetrix Human Transcriptome Array 2.0
-
+
-
-
- obsolete_immortal cell line culture
+
+
+
+
+
+
+
+
+ Affymetrix Human Genome U219 Array
- A cell line that is expected to be capable of indefinite propagation in an vitro culture.
- PERSON:Matthew Brush
- immortal cell line sample
- permanent cell line
- PERSON:Matthew Brush
-
-
- obsolete_immortal cell line culture
- true
+ A DNA microarray manufactured by Affymetrix, which comprises more than 530,000 probes covering more than 36,000 transcripts and variants, which represent more than 20,000 genes mapped through RefSeq or via UniGene annotation. Sequences used in the design of the array were selected from the RefSeq version 36, UniGene database 219, and full-length human mRNAs from GenBank™.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ Applied Biosystems GeneChip PrimeView Human Gene Expression Array
+ https://www.thermofisher.com/document-connect/document-connect.html?url=https%3A%2F%2Fassets.thermofisher.com%2FTFS-Assets%2FLSG%2Fmanuals%2FMAN0017681_703036_GeneChipPrimeViewArray_PI.pdf
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Affymetrix Human Genome U219 Array
-
+
-
-
-
-
-
-
-
-
+
+
-
-
+
+
- xenograft
- Human xenotransplantation (e.g. from pig to human) offers a potential treatment for end-stage organ failure, a significant health problem in parts of the industrialized world
+ Affymetrix Human Gene 2.0 ST Array
- A material entity which results from the transplantation of living cells, tissues or organs from on organism of one species to an organism of another species.
- PERSON: Melanie Courtot
- PERSON: Philippe Rocca-Serra
- xenotransplant
- WEB: http://en.wikipedia.org/wiki/Xenograft
- xenograft
+ A DNA microarray manufactured by Affymetrix, which provides the most accurate, sensitive, and comprehensive measurement of protein coding (mRNA) and long intergenic non-coding RNA (lincRNA) transcripts. The array design covers >33,500 coding transcripts and >11,000 lincRNA transcripts thus enabling researchers to understand whole-transcriptome gene expression at the gene and exon levels, which allows the study of transcript variants and alternative splicing events.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ GeneChip Human Gene 2.0 ST Array
+ https://www.thermofisher.com/document-connect/document-connect.html?url=https%3A%2F%2Fassets.thermofisher.com%2FTFS-Assets%2FLSG%2Fbrochures%2Fhugene_2_st_datasheet.pdf
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Affymetrix Human Gene 2.0 ST Array
-
+
-
-
-
-
-
-
-
-
+
+
-
-
+
+
+ Affymetrix Clariom S Assay, Human
+
+ A DNA microarray manufactured by Affymetrix, to obtain a gene-level view of the human transcriptome. The assay design covers >20,000 well-annotated genes, providing researchers with the ability to perform gene-level expression profiling studies, to identify expression biomarkers , and to quickly assess changes in key genes and pathways.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ https://www.thermofisher.com/order/catalog/product/902926#1_1
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Affymetrix Clariom S Assay, Human
+
+
+
+
+
+
+
+
-
-
+
+
- cultured cell population
- A cultured cell population applied in an experiment: "293 cells expressing TrkA were serum-starved for 18 hours and then neurotrophins were added for 10 min before cell harvest." (Lee, Ramee, et al. "Regulation of cell survival by secreted proneurotrophins." Science 294.5548 (2001): 1945-1948).
-
-A cultured cell population maintained in vitro: "Rat cortical neurons from 15 day embryos are grown in dissociated cell culture and maintained in vitro for 8–12 weeks" (Dichter, Marc A. "Rat cortical neurons in cell culture: culture methods, cell morphology, electrophysiology, and synapse formation." Brain Research 149.2 (1978): 279-293).
+ Affymetrix Clariom S Assay, Mouse
- A processed material comprised of a collection of cultured cells that has been continuously maintained together in culture and shares a common propagation history.
- 2013-6-5 MHB: This OBI class was formerly called 'cell culture', but label changed and definition updated following CLO alignment efforts in spring 2013, during which the intent of this class was clarified to refer to portions of a culture or line rather than a complete cell culture or line.
- PERSON:Matthew Brush
- cell culture sample
- PERSON:Matthew Brush
- The extent of a 'cultured cell population' is restricted only in that all cell members must share a propagation history (ie be derived through a common lineage of passages from an initial culture). In being defined in this way, this class can be used to refer to the populations that researchers actually use in the practice of science - ie are the inputs to culturing, experimentation, and sharing. The cells in such populations will be a relatively uniform population as they have experienced similar selective pressures due to their continuous co-propagation. And this population will also have a single passage number, again owing to their common passaging history. Cultured cell populations represent only a collection of cells (ie do not include media, culture dishes, etc), and include populations of cultured unicellular organisms or cultured multicellular organism cells. They can exist under active culture, stored in a quiescent state for future use, or applied experimentally.
- cultured cell population
+ A DNA microarray manufactured by Affymetrix, to obtain a gene-level view of the mouse transcriptome. The assay design covers >20,000 well-annotated genes, providing researchers with the ability to perform gene-level expression profiling studies, to identify expression biomarkers, and to quickly assess changes in key genes and pathways.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ https://www.thermofisher.com/order/catalog/product/902931?SID=srch-srp-902931,
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Affymetrix Clariom S Assay, Mouse
-
+
-
-
+
+
-
-
+
+
+ Illumina HumanHT-12 V4.0 expression beadchip
+
+ An Illumina BeadChip which employs direct-hybridization assay, for whole-genome expression profiling and expression-based quantitative trait loci (eQTL) studies. This BeadChip contains 12 arrays, each featuring more than 48,000 probes, targeting more than 31,000 annotated genes, providing genome-wide coverage of well-characterized genes, gene candidates, and splice variants.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ https://www.illumina.com/documents/products/technotes/technote_humanht_12_imputation.pdf
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Illumina HumanHT-12 V4.0 expression beadchip
+
+
+
+
+
+
+
+
-
-
+
+
+ Illumina MouseRef-8 v2.0 beadchip
+
+ An Illumina BeadChip which employs direct-hybridization assay, for whole-genome expression profiling in the mouse.This Beadchip contains 8 microarrays, featuring more than 25,000 probes per array, derived from the NCBI RefSeq database and supplemented with MEEBO and RIKEN FANTOM2 content.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ https://support.illumina.com/content/dam/illumina-support/documents/documentation/chemistry_documentation/arraykits/whole-genome-gene-expression/WGGEX_Direct_Hybridization_Assay_Guide_11322355_A.pdf, https://www.illumina.com/documents/products/datasheets/datasheet_gene_exp_analysis.pdf
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Illumina MouseRef-8 v2.0 beadchip
+
+
+
+
+
+
+
+
-
- 0
-
+
+
- primary cultured cell population
- Spleen cells put directly into culture; Cold storage of biopsies from wild endangered native Chilean species in field conditions and subsequent isolation of primary culture cell lines. In Vitro Cell Dev Biol Anim. 2008 Jul 2. PMID: 18594934
- cells that have been isolated from some organismal source, expanded in culture, but not undergone a complete passaging (ie are still in culture, or have been lifted from culture and frozen in aliquots for future use)
+ Affymetrix Mouse Exon Junction Array
- A cultured cell population comprised of cells expanded directly from living tissue prior to being passaged.
-
-
- 2013-6-5 MHB: This OBI class was formerly called 'primary cell culture', but label changed and definition updated following CLO alignment work. Previous definition: 'a primary cell culture is a cell culture where the cells derive from a fresh tissue source.'
- PERSON:Matthew Brush
- primary cell culture
- primary cell culture sample
- PERSON:Matthew Brush
- primary cultured cell population
+ A DNA microarray manufactured by Affymetrix, used to identify exon-exon junctions associated with alternate splice variants in the mouse transcriptome.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ https://academic.oup.com/bioinformatics/article/26/2/268/209989
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Affymetrix Mouse Exon Junction Array
-
-
-
-
-
-
- 0
-
-
-
- consider if we really want to be so strict here . . . ie maybe we we say that they have not been output from an 'establishing cell line' process, but in some cases a passage or two may be allowed for a primary culture. the establishing of a line requires some procedss that attains a degree of homogeneity in the culture.
-
-
+
-
-
- obsolete_cell line
- A split of HeLa cells in active culture, or stored in frozen aliquots. Populations of HEK 293 cells used in experiments such as those documented in Changes in ultrastructure and endogenous ionic channels activity during culture of HEK 293 cell line. Eur J Pharmacol. 2007 Jul 12;567(1-2):10-8. PMID: 17482592.
- He, Tong-Chuan, et al. Identification of c-MYC as a target of the APC pathway. Science 281.5382 (1998): 1509-1512. - To evaluate the transcriptional effects of APC, we studied a human colorectal cancer cell line (HT29-APC) containing a zinc-inducible APC gene and a control cell line (HT29–β-Gal) containing an analogous inducible lacZ gene. Note that common usage in the literature is often of the form a human colorectal cancer cell line, as seen above. But such references to studies in a line refer to the fact that discrete populations of cells that are input into culturing or experiments, not an entire lineage of cells. It is these discrete populations that we refer to as 'cell lines'.
+
+
+
+
+
+
+
+
+ Affymetrix Human Exon Junction Array
- A secondary cultured cell population that represents a genetically stable and homogenous population of cultured cells that shares a common propagation history (ie has been successively passaged together in culture).
- PERSON:Matthew Brush
- cell line sample
- OBI-CLO Alignment Working Group (Spring 2013)
-
-
- obsolete_cell line
- true
+ A DNA microarray manufactured by Affymetrix, used to identify exon-exon junctions associated with alternate splice variants in the human transcriptome.
+ Jain Aluvathingal
+ Michelle Giglio
+ Suvarna Nadendla
+ https://academic.oup.com/bioinformatics/article/26/2/268/209989
+ https://github.com/obi-ontology/obi/issues/1546
+ gEAR
+ Affymetrix Human Exon Junction Array
-
+
-
-
- cultured clonal cell population
- cell cut
-Stem cell functions assessed in clonal culture. Soc Gen Physiol Ser. 1988;43:39-45. Review. PMID: 3077557
+
+
+ administering substance in vivo to cause disease
- A cultured cell population comprised of cells which can all be traced back to a single ancestor cell, and which therefore can be treated as identical.
- PERSON: Susanna Sansone
- PERSON:Matthew Brush
- clonal cell culture sample
- GROUP: OBI Biomaterial Branch
- cultured clonal cell population
+ An administration of substance in vivo with the intention to induce disease in the organism.
+ IEDB
+ IEDB
+ administering substance in vivo to cause disease
-
+
-
-
- screening library
- PMID: 15615535.J Med Chem. 2004 Dec 30;47(27):6864-74.A screening library for peptide activated G-protein coupled receptors. 1. The test set. [cdna_library, phage display library]
-
- a screening library is a collection of materials engineered to identify qualities of a subset of its members during a screening process?
- PRS: 22-02-2008: while working on definition of cDNA library and looking at current example of usage, a screening library should be a defined class -> any material library which has input_role in a screening protocol application
-change biomaterial to material in definition
- PERSON: Bjoern Peters
- GROUP: IEDB
- 7/13/09: Need to clarify if this meets reagent role definition
- screening library
+
+
+ administering substance in vivo to reduce or prevent disease
+
+ An administration of substance in vivo with the intention to reduce the symptoms of or prevent development of a disease in the organism.
+ IEDB
+ IEDB
+ administering substance in vivo to reduce or prevent disease
-
+
-
-
+
+
+
-
+
-
+
+
+
+
+
-
-
-
- synthetic peptide
- the synthesized peptide SIINFEKL which also occurs in hen-egg lysozyme
+
+ peripheral blood mononuclear cell specimen
- a synthetic peptide is an material entity which is artificially engineered and results from the synthesis of a chain of amino acids which may also be found in natural protein and be identical in sequence to a protein fragment
- changed from synthetic polypeptide to peptide, to get rid of the restriction of having more than 10 amino acids (required by Chebi).
- Bjoern Peters
- IEDB
- PRS:22-02-2008: a chebi entity which has output role in a synthesis protocol application
- original term: protein fragment split into synthetic polypeptide and fragment derived from protein
-DS: Is this synthetic an oxymoron to the biomaterial?
- synthetic peptide
+ A processed specimen that is extracted from whole blood using gradient centrifugation that separates the blood into a layer of peripheral blood mononuclear cells under the top layer of plasma. It contains lymphocytes, monocytes or macrophages that are critical components in the immune system.
+ Chris Stoeckert
+ Jie Zheng
+ PBMC specimen
+ http://en.wikipedia.org/wiki/Peripheral_blood_mononuclear_cell
+ peripheral blood mononuclear cell specimen
-
+
-
-
+
+
-
+
-
-
-
-
+
+
+
+
+
+
+
-
-
-
-
-
-
- organ section
- A liver slice used in a perfusion experiment.
-Thyroidectomy during laryngectomy for advanced laryngeal carcinoma--whole organ section study with long-term functional evaluation. Clin Otolaryngol Allied Sci. 1995 Apr;20(2):145-9. PMID: 7634521
-
- A processed material which derives from an organ and results from a process of dissection or histological sample preparation a portion(formerly an organ section is portion of an organ removed from the context of the organ)
- PERSON: Helen Parkinson
- PERSON: Philippe Rocca-Serra
- GROUP: CEBS
- GROUP: OBI Biomaterial Branch
- organ section
+ mid-upper arm circumference datum
+
+ A length measurement datum that is the specified output of an assay measuring the length around an upper arm, taken midway along the upper arm.
+ The Mother and Child Health and Education Trust
+ mid-upper arm circumference datum
-
+
-
-
+
+
-
-
+
+
+ antigen specific antibodies assay datum
+
+ A data item that is the specified output of an antigen specific antibodies assay.
+ John Judkins ORCID:0000-0001-6595-0902
+ VEuPathDB
+ https://github.com/obi-ontology/obi/issues/1526
+ antigen specific antibodies assay datum
+
+
+
+
+
+
+
+
+
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
- bronchial alveolar lavage
- solution containing lung derived T cells, eosinophils, and TNFa.
+ antigen specific antibodies in blood assay
- Group of biomaterials present in the bronchial aveolar space of an organism which are collected through lavage including the reagents used to for the lavage process, organisms, cells, and cellular secretions present in the bronchial aveolar space.
- PERSON: Bjoern Peters
- BAL
- GROUP: IEDB
- bronchial alveolar lavage
+ An antigen specific antibodies assay that has a blood specimen as evaluant.
+ John Judkins ORCID:0000-0001-6595-0902
+ VEuPathDB
+ https://github.com/obi-ontology/obi/issues/1526
+ VEuPathDB
+ antigen specific antibodies in blood assay
-
+
-
-
- obsolete_polymer
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ antigen specific antibodies in milk assay
- A macromolecule is a molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.
- James Malone
- Philippe Rocca-Serra
- TERM: CHEBI:33839
-
- obsolete_polymer
- true
+ An antigen specific antibodies assay that has a milk specimen as evaluant.
+ John Judkins ORCID:0000-0001-6595-0902
+ VEuPathDB
+ https://github.com/obi-ontology/obi/issues/1526
+ VEuPathDB
+ antigen specific antibodies in milk assay
-
+
-
-
+
+
-
-
+
+
- glucose in solution
- Glucose present in blood
-
- A scattered aggregate of glucose molecules in a liquid
- PERSON: Jie Zheng
- glucose molecules
- glucose in solution
+ antigen specific antibodies in blood assay datum
+
+ An antigen specific antibodies assay datum that is the specified output of an antigen specific antibodies in blood assay.
+ John Judkins ORCID:0000-0001-6595-0902
+ VEuPathDB
+ https://github.com/obi-ontology/obi/issues/1526
+ antigen specific antibodies in blood assay datum
-
+
-
-
+
+
+
-
-
+
+
-
-
+
+ antigen specific antibodies in milk assay datum
+
+ An antigen specific antibodies assay datum that is the specified output of an antigen specific antibodies in milk assay.
+ John Judkins ORCID:0000-0001-6595-0902
+ VEuPathDB
+ https://github.com/obi-ontology/obi/issues/1526
+ antigen specific antibodies in milk assay datum
+
+
+
+
+
+
+
+
-
+
-
-
-
-
-
-
-
-
-
-
-
-
+
+
-
-
-
-
-
-
-
- data transformation
- The application of a clustering protocol to microarray data or the application of a statistical testing method on a primary data set to determine a p-value.
-
- A planned process that produces output data from input data.
- Elisabetta Manduchi
- Helen Parkinson
- James Malone
- Melanie Courtot
- Philippe Rocca-Serra
- Richard Scheuermann
- Ryan Brinkman
- Tina Hernandez-Boussard
- data analysis
- data processing
- Branch editors
-
- data transformation
+ enzymatic activity level assay
+
+ An assay in which the level of catalytic activity of an enzyme is determined.
+ James A. Overton
+ enzymatic activity level assay
-
+
-
-
-
-
-
+
+
+
-
+
+
+
+
+
+
+
+
+
+
+
+ 5'-nucleotidase activity level assay
+
+ An enzymatic activity level assay that measures the activity of 5'-nucleotidase in a sample.
+ James A. Overton
+ 5'-nucleotidase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ alanine aminotransferase activity level assay
+
+ An enzymatic activity level assay that measures the activity of alanine aminotransferase in a sample.
+ James A. Overton
+ alanine aminotransferase activity level assay
+
+
+
+
+
+
+
+
+
+
+
-
-
+
+
+
+
+
+
+
-
-
-
-
-
-
-
- geometric mean calculation
+
+
+ alkaline phosphatase activity level assay
+ An enzymatic activity level assay that measures the activity of alkaline phosphatase in a sample.
+ James A. Overton
+ alkaline phosphatase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ amylase activity level assay
+
+ An enzymatic activity level assay that measures the activity of amylase in a sample.
+ James A. Overton
+ amylase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ aspartate aminotransferase activity level assay
+
+ An enzymatic activity level assay that measures the activity of aspartate aminotransferase in a sample.
+ James A. Overton
+ aspartate aminotransferase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ cholinesterase activity level assay
+
+ An enzymatic activity level assay that measures the activity of cholinesterase in a sample.
+ James A. Overton
+ cholinesterase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ creatine kinase activity level assay
+
+ An enzymatic activity level assay that measures the activity of creatine kinase in a sample.
+ James A. Overton
+ creatine kinase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ gamma-glutamyltransferase activity level assay
+
+ An enzymatic activity level assay that measures the activity of gamma-glutamyltransferase in a sample.
+ James A. Overton
+ gamma-glutamyltransferase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ glutamate dehydrogenase activity level assay
+
+ An enzymatic activity level assay that measures the activity of glutamate dehydrogenase in a sample.
+ James A. Overton
+ glutamate dehydrogenase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ isocitrate dehydrogenase activity level assay
+
+ An enzymatic activity level assay that measures the activity of isocitrate dehydrogenase in a sample.
+ James A. Overton
+ isocitrate dehydrogenase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ lactate dehydrogenase activity level assay
+
+ An enzymatic activity level assay that measures the activity of lactate dehydrogenase in a sample.
+ James A. Overton
+ lactate dehydrogenase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ sorbitol dehydrogenase activity level assay
+
+ An enzymatic activity level assay that measures the activity of sorbitol dehydrogenase in a sample.
+ James A. Overton
+ sorbitol dehydrogenase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ acyl-CoA oxidase activity level assay
+
+ An enzymatic activity level assay that measures the activity of Acyl-CoA oxidase in a sample.
+ James A. Overton
+ acyl-CoA oxidase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ N-acetyl-beta-glucosaminidase activity level assay
+
+ An enzymatic activity level assay that measures the activity of N-acetyl-beta-glucosaminidase in a sample.
+ James A. Overton
+ N-acetyl-beta-glucosaminidase activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ ribonuclease activity level assay
+
+ An enzymatic activity level assay that measures the activity of ribonuclease in a sample.
+ James A. Overton
+ ribonuclease activity level assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ galactosidase activity level assay
+
+ An enzymatic activity level assay that measures the activity of galactosidase in a sample.
+ James A. Overton
+ galactosidase activity level assay
+
+
+
+
+
+
+
+
+ Mosquito Magnet Liberty Plus trap
+
+ An arthropod trap that is designed to emit a combination of carbon dioxide, heat, water, and oct-1-en-3-ol attractants while simultaneously using suction to trap arthropods. This trap has the same design as the Mosquito Magnet Pro trap but is smaller, is more lightweight, and uses a main line electricity supply instead of propane to power itself. Both use propane to produce the arthropod attractor.
+ VEuPathDB
+ https://github.com/obi-ontology/obi/issues/1523
+ Mosquito Magnet Liberty Plus trap
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ tumor challenge
+
+ The administration of a malignant cell to a host.
+ Hector Guzman-Orozco
+ IEDB
+ tumor challenge
+
+
+
+
+
+
+
+
+ in vivo challenge
+
+ The administration of a challenge to a live host.
+ Hector Guzman-Orozco
+ IEDB
+ in vivo challenge
+
+
+
+
+
+
+
+
+ epitope protection from infectious challenge experiment based on survival
+
+ An epitope protection from infectious challenge experiment that determines the success of the epitope intervention based on increased survival of the host compared to controls.
+ Hector Guzman-Orozco
+ survival after infectious challenge
+ IEDB
+ https://github.com/obi-ontology/obi/issues/1594
+ epitope protection from infectious challenge experiment based on survival
+
+
+
+
+
+
+
+
+ epitope protection from tumor challenge experiment based on burden
+
+ An epitope protection from tumor challenge experiment in which the readout is a reduction in the presence of malignant cells in the host compared to controls.
+ Hector Guzman-Orozco
+ burden after tumor challenge
+ IEDB
+ https://github.com/obi-ontology/obi/issues/1594
+ epitope protection from tumor challenge experiment based on burden
+
+
+
+
+
+
+
+
+ epitope protection from tumor challenge experiment based on survival
+
+ An epitope protection from tumor challenge experiment that determines the success of the epitope intervention based on increased survival of the host compared to controls.
+ Hector Guzman-Orozco
+ survival after tumor challenge
+ IEDB
+ https://github.com/obi-ontology/obi/issues/1594
+ epitope protection from tumor challenge experiment based on survival
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring T cell epitope specific protection from pathogen challenge
+
+ An in vivo assay measuring T cell epitope specific protection from pathogen challenge.
+ IEDB
+ IEDB
+ protection from pathogen challenge|in vivo assay
+ in vivo assay measuring T cell epitope specific protection from pathogen challenge
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring T cell epitope specific protection from tumor challenge
+
+ An in vivo assay measuring T cell epitope specific protection from tumor challenge.
+ IEDB
+ IEDB
+ protection from tumor challenge|in vivo assay
+ in vivo assay measuring T cell epitope specific protection from tumor challenge
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring T cell epitope specific protection from other challenge
+
+ An in vivo assay measuring T cell epitope specific protection from a challenge other than pathogen, infection, or tumor.
+ IEDB
+ IEDB
+ protection from other challenge|in vivo assay
+ in vivo assay measuring T cell epitope specific protection from other challenge
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring T cell epitope specific survival after tumor challenge
+
+ An in vivo assay measuring T cell epitope specific protection from tumor challenge using survival.
+ IEDB
+ IEDB
+ survival from tumor challenge|in vivo assay
+ in vivo assay measuring T cell epitope specific survival after tumor challenge
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring T cell epitope specific survival after pathogen challenge
+
+ An in vivo assay measuring T cell epitope specific protection from pathogen challenge using survival.
+ IEDB
+ IEDB
+ survival from pathogen challenge|in vivo assay
+ in vivo assay measuring T cell epitope specific survival after pathogen challenge
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific protection from pathogen challenge
+
+ An in vivo assay measuring B cell epitope specific protection from pathogen challenge.
+ IEDB
+ IEDB
+ protection from pathogen challenge|in vivo assay
+ in vivo assay measuring B cell epitope specific protection from pathogen challenge
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific protection from tumor challenge
+
+ An in vivo assay measuring B cell epitope specific protection from tumor challenge.
+ IEDB
+ IEDB
+ protection from tumor challenge|in vivo assay
+ in vivo assay measuring B cell epitope specific protection from tumor challenge
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific protection from other challenge
+
+ An in vivo assay measuring B cell epitope specific protection from a challenge other than pathogen, infection, or tumor.
+ IEDB
+ IEDB
+ protection from other challenge|in vivo assay
+ in vivo assay measuring B cell epitope specific protection from other challenge
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific survival after pathogen challenge
+
+ An in vivo assay measuring B cell epitope specific protection from pathogen challenge using survival.
+ IEDB
+ IEDB
+ survival from pathogen challenge|in vivo assay
+ in vivo assay measuring B cell epitope specific survival after pathogen challenge
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific survival after tumor challenge
+
+ An in vivo assay measuring B cell epitope specific protection from tumor challenge using survival.
+ IEDB
+ IEDB
+ survival from tumor challenge|in vivo assay
+ in vivo assay measuring B cell epitope specific survival after tumor challenge
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring T cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific T cells
+
+ An in vivo assay measuring a T cell epitope specific protection from a pathogen challenge after adoptive transfer of epitope specific antibodies or B cells.
+ IEDB
+ IEDB
+ protection from pathogen challenge after adoptive transfer|in vivo assay
+ in vivo assay measuring T cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring T cell epitope specific pathogen protection from challenge resulting from the adoptive transfer of epitope specific T cells based on survival
+
+ An in vivo assay measuring T cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific T cells using survival.
+ IEDB
+ IEDB
+ survival after pathogen challenge after adoptive transfer|in vivo assay
+ in vivo assay measuring T cell epitope specific pathogen protection from challenge resulting from the adoptive transfer of epitope specific T cells based on survival
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring T cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific T cells
+
+ An in vivo assay measuring a T cell epitope specific protection from a tumor challenge after adoptive transfer of epitope specific T cells.
+ IEDB
+ IEDB
+ protection from tumor challenge after adoptive transfer|in vivo assay
+ in vivo assay measuring T cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring T cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific T cells based on survival
+
+ An in vivo assay measuring T cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific T cells using survival.
+ IEDB
+ IEDB
+ survival after tumor challenge after adoptive transfer|in vivo assay
+ in vivo assay measuring T cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific T cells based on survival
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring T cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific T cells
+
+ An in vivo assay measuring a T cell epitope specific protection from other challenge after adoptive transfer of epitope specific T cells.
+ IEDB
+ IEDB
+ protection from other challenge after adoptive transfer|in vivo assay
+ in vivo assay measuring T cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific antibodies or B cells
+
+ An in vivo assay measuring a B cell epitope specific protection from a pathogen challenge after adoptive transfer of epitope specific antibodies or B cells.
+ IEDB
+ IEDB
+ protection from pathogen challenge after adoptive transfer|in vivo assay
+ in vivo assay measuring B cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific antibodies or B cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific pathogen protection from challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on survival
+
+ An in vivo assay measuring B cell epitope specific protection from pathogen challenge resulting from the adoptive transfer of epitope specific antibodies or B cells using survival.
+ IEDB
+ IEDB
+ survival after pathogen challenge after adoptive transfer|in vivo assay
+ in vivo assay measuring B cell epitope specific pathogen protection from challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on survival
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific antibodies or B cells
+
+ An in vivo assay measuring a B cell epitope specific protection from a tumor challenge after adoptive transfer of epitope specific antibodies or B cells.
+ IEDB
+ IEDB
+ protection from tumor challenge after adoptive transfer|in vivo assay
+ in vivo assay measuring B cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific antibodies or B cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on survival
+
+ An in vivo assay measuring B cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific antibodies or B cells using survival.
+ IEDB
+ IEDB
+ survival after tumor challenge after adoptive transfer|in vivo assay
+ in vivo assay measuring B cell epitope specific protection from tumor challenge resulting from the adoptive transfer of epitope specific antibodies or B cells based on survival
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ in vivo assay measuring B cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific antibodies or B cells
+
+ An in vivo assay measuring a B cell epitope specific protection from other challenge after adoptive transfer of epitope specific antibodies or B cells.
+ IEDB
+ IEDB
+ protection from other challenge after adoptive transfer|in vivo assay
+ in vivo assay measuring B cell epitope specific protection from other challenge resulting from the adoptive transfer of epitope specific antibodies or B cells
+
+
+
+
+
+
+
+
+ Gram stain assay
+
+ An organism identification assay that identifies bacteria based on the differential retention of a crystal violet-iodine complex within the cell wall.
+ Gram-positive bacteria retain the violet stain whereas gram-negative bacteria do not.
+ John Judkins ORCID:0000-0001-6595-0902
+ American Heritage Medical Dictionary
+ NCI
+ https://github.com/obi-ontology/obi/issues/1603
+ Gram stain assay
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ cow-baited arthropod trap
+
+ A resting arthropod trap that consists of a tent inside which an adult cow is tethered to the ground, in order to attract arthropods and collect those that rest on the interior walls of the tent.
+ John Judkins ORCID:0000-0001-6595-0902
+ Sarah Kelly
+ https://github.com/obi-ontology/obi/issues/1602
+ cow-baited arthropod trap
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ lymph specimen
+
+ A specimen that is derived from a portion of lymph collected from an organism.
+ John Judkins ORCID:0000-0001-6595-0902
+ VEuPathDB
+ lymph specimen
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ digestive tract specimen
+
+ A specimen that is derived from part of a digestive tract.
+ John Judkins ORCID:0000-0001-6595-0902
+ VEuPathDB
+ digestive tract specimen
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ assay measuring epitope specific interleukin-25 production by T cells
+
+ A T cell epitope specific cytokine production assay that detects interleukin-25 production by T cells.
+ IEDB
+ IEDB
+ IL-25 release|biological activity
+ assay measuring epitope specific interleukin-25 production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-25 production by T cells
+
+ A detection of specific nucleic acid polymers with complementary probes that detects interleukin-25 production by T cells.
+ IEDB
+ IEDB
+ IL-25 release|RNA/DNA detection
+ detection of specific nucleic acids with complementary probes assay measuring epitope specific interleukin-25 production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ intracellular cytokine staining assay measuring epitope specific interleukin-25 production by T cells
+
+ A flow cytometry assay that detects interleukin-25 production by T cells.
+ IEDB
+ IEDB
+ IL-25 release|ICS
+ intracellular cytokine staining assay measuring epitope specific interleukin-25 production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ ELISA measuring epitope specific interleukin-25 production by T cells
+
+ An enzyme-linked immunosorbent assay that detects interleukin-25 production by T cells.
+ IEDB
+ IEDB
+ IL-25 release|ELISA
+ ELISA measuring epitope specific interleukin-25 production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ cell culture analyte detection bioassay measuring epitope specific tumor necrosis factor superfamily cytokine production by T cells
+
+ A reporter cell line analyte detection bioassay that detects tumor necrosis factor superfamily cytokine production by T cells.
+ IEDB
+ IEDB
+ TNF release|bioassay
+ cell culture analyte detection bioassay measuring epitope specific tumor necrosis factor superfamily cytokine production by T cells
+
+
+
+
+
+
+
+
+ injection function
+
+ The function of a device realized when administering a substance in vivo, applied particularly to the forcible insertion of a liquid or gas by means of a syringe, pump, etc.
+ PERSON: Alan Ruttenberg
+ PERSON: Melanie Courtot
+ adapted from WEB: http://www.dictionary.net/injection
+ injection function
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ Epstein Barr virus transformed B cell
+ PMID: 8777380. Expression of thyroid peroxidase in EBV-transformed B cell lines using adenovirus.Thyroid. 1996 Feb;6(1):23-8.
+
+ A material entity which results from viral transformation process using EBV as transformation agent when applied to B-cell entity
+ PERSON: Susanna Sansone
+ GROUP: OBI Biomaterial Branch
+ Epstein Barr virus transformed B cell
+
+
+
+
+
+
+
+
+ chimera
+
+ An organism which contains cells or tissues with a different genotype
+ PERSON: Helen Parkinson
+ GROUP: OBI
+ chimera
+
+
+
+
+
+
+
+
+ obsolete_anatomical entity
+ Tissue, organ, system, sperm, blood or body location (arm).
+
+ An anatomical entity is a material entity that is part of a multicellular organism, and which is large enough so that it forms an identifiable structure in the organism. Specifically, it excludes granular parts of the organism, such as atoms, molecules, cells, which can be removed from the organism without affecting it. It is defined as the union of 'multi-tissue structure', 'body substance' and 'portion of tissue'
+ Bjoern Peters
+ Philippe Rocca-Serra
+ Tina Boussard
+ MO
+
+ obsolete_anatomical entity
+ true
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ blood plasma specimen
+ PMID: 18217225.Sex Transm Dis. 2008 Jan;35(1):55-60. Review.Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings.
+
+ a material entity which corresponds to the liquid component of blood, in which the blood cells are suspended.
+ 03/21/2010: BP, blood plasma is defined as the output of certain separation processes, so this is in the domain of OBI, not FMA.
+ PERSON: Maura Gasparetto
+ PERSON: Melanie Courtot
+ PERSON: Philippe Rocca-Serra
+ plasma
+ WEB: http://en.wikipedia.org/wiki/Blood_plasma
+ blood plasma specimen
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ blood serum specimen
+ PMID: 18229666.Adv Med Sci. 2007;52 Suppl 1:204-6.Antioxidant activity of blood serum and saliva in patients with periodontal disease treated due to epilepsy.
+
+ A material entity which derives from blood and corresponds to blood plasma without fibrinogen or the other clotting factors.
+ PERSON: Maura Gasparetto
+ PERSON: Melanie Courtot
+ PERSON: Philippe Rocca-Serra
+ WEB: http://en.wikipedia.org/wiki/Blood_plasma
+ blood serum specimen
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ organism
+ animal
+ fungus
+ plant
+ virus
+
+ A material entity that is an individual living system, such as animal, plant, bacteria or virus, that is capable of replicating or reproducing, growth and maintenance in the right environment. An organism may be unicellular or made up, like humans, of many billions of cells divided into specialized tissues and organs.
+ 10/21/09: This is a placeholder term, that should ideally be imported from the NCBI taxonomy, but the high level hierarchy there does not suit our needs (includes plasmids and 'other organisms')
+ 13-02-2009:
+OBI doesn't take position as to when an organism starts or ends being an organism - e.g. sperm, foetus.
+This issue is outside the scope of OBI.
+ GROUP: OBI Biomaterial Branch
+ WEB: http://en.wikipedia.org/wiki/Organism
+ organism
+
+
+
+
+
+
+
+
+ obsolete_immortal cell
+ a single Hela cell
+
+ a cell derived from a multicellular organism that has the potential to replicate indefinitely
+ PERSON: Bjoern Peters
+ GROUP: OBI Biomaterial Branch
+
+ obsolete_immortal cell
+ true
+
+
+
+
+
+
+
+
+ obsolete_fragment derived from protein
+ the peptide with sequence SIINFEKL, which is eluted from a cell expressing hen egg lysozyme
+
+ A material entity which is derived from a protein
+ PERSON: Bjoern Peters
+ GROUP: IEDB
+
+ obsolete_fragment derived from protein
+ true
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ phosphate buffered saline solution
+ PMID: 16279733.Dent Mater J. 2005 Sep;24(3):414-21.PBS buffer solutions with different pH values can change porosity of DNA-chitosan complexes.
+
+ Phosphate buffered saline (abbreviated PBS) is a buffer solution commonly used in biochemistry. It is a salty solution containing sodium chloride, sodium phosphate and in some preparations potassium chloride and potassium phosphate. The buffer helps to maintain a constant pH. The concentration usually matches the human body (isotonic).
+ PERSON: Melanie Courtot
+ PERSON: Philippe Rocca-Serra
+ PERSON: Tina Boussard
+ PBS buffer
+ WEB: http://en.wikipedia.org/wiki/Phosphate_buffered_saline
+ phosphate buffered saline solution
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ specimen
+ Biobanking of blood taken and stored in a freezer for potential future investigations stores specimen.
+
+ A material entity that has the specimen role.
+ Note: definition is in specimen creation objective which is defined as an objective to obtain and store a material entity for potential use as an input during an investigation.
+ PERSON: James Malone
+ PERSON: Philippe Rocca-Serra
+ GROUP: OBI Biomaterial Branch
+
+ specimen
+
+
+
+
+
+
+
+
+ obsolete_cell line cell
+
+ A material entity that represents generations of a primary culture.
+ PERSON: Susanna Sansone
+ GROUP: OBI Biomaterial Branch
+
+ obsolete_cell line cell
+ true
+
+
+
+
+
+
+
+
+ obsolete_immortal cell line culture
+
+ A cell line that is expected to be capable of indefinite propagation in an vitro culture.
+ PERSON:Matthew Brush
+ immortal cell line sample
+ permanent cell line
+ PERSON:Matthew Brush
+
+
+ obsolete_immortal cell line culture
+ true
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ xenograft
+ Human xenotransplantation (e.g. from pig to human) offers a potential treatment for end-stage organ failure, a significant health problem in parts of the industrialized world
+
+ A material entity which results from the transplantation of living cells, tissues or organs from on organism of one species to an organism of another species.
+ PERSON: Melanie Courtot
+ PERSON: Philippe Rocca-Serra
+ xenotransplant
+ WEB: http://en.wikipedia.org/wiki/Xenograft
+ xenograft
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ cultured cell population
+ A cultured cell population applied in an experiment: "293 cells expressing TrkA were serum-starved for 18 hours and then neurotrophins were added for 10 min before cell harvest." (Lee, Ramee, et al. "Regulation of cell survival by secreted proneurotrophins." Science 294.5548 (2001): 1945-1948).
+
+A cultured cell population maintained in vitro: "Rat cortical neurons from 15 day embryos are grown in dissociated cell culture and maintained in vitro for 8–12 weeks" (Dichter, Marc A. "Rat cortical neurons in cell culture: culture methods, cell morphology, electrophysiology, and synapse formation." Brain Research 149.2 (1978): 279-293).
+
+ A processed material comprised of a collection of cultured cells that has been continuously maintained together in culture and shares a common propagation history.
+ 2013-6-5 MHB: This OBI class was formerly called 'cell culture', but label changed and definition updated following CLO alignment efforts in spring 2013, during which the intent of this class was clarified to refer to portions of a culture or line rather than a complete cell culture or line.
+ PERSON:Matthew Brush
+ cell culture sample
+ PERSON:Matthew Brush
+ The extent of a 'cultured cell population' is restricted only in that all cell members must share a propagation history (ie be derived through a common lineage of passages from an initial culture). In being defined in this way, this class can be used to refer to the populations that researchers actually use in the practice of science - ie are the inputs to culturing, experimentation, and sharing. The cells in such populations will be a relatively uniform population as they have experienced similar selective pressures due to their continuous co-propagation. And this population will also have a single passage number, again owing to their common passaging history. Cultured cell populations represent only a collection of cells (ie do not include media, culture dishes, etc), and include populations of cultured unicellular organisms or cultured multicellular organism cells. They can exist under active culture, stored in a quiescent state for future use, or applied experimentally.
+ cultured cell population
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ 0
+
+
+
+ primary cultured cell population
+ Spleen cells put directly into culture; Cold storage of biopsies from wild endangered native Chilean species in field conditions and subsequent isolation of primary culture cell lines. In Vitro Cell Dev Biol Anim. 2008 Jul 2. PMID: 18594934
+ cells that have been isolated from some organismal source, expanded in culture, but not undergone a complete passaging (ie are still in culture, or have been lifted from culture and frozen in aliquots for future use)
+
+ A cultured cell population comprised of cells expanded directly from living tissue prior to being passaged.
+
+
+ 2013-6-5 MHB: This OBI class was formerly called 'primary cell culture', but label changed and definition updated following CLO alignment work. Previous definition: 'a primary cell culture is a cell culture where the cells derive from a fresh tissue source.'
+ PERSON:Matthew Brush
+ primary cell culture
+ primary cell culture sample
+ PERSON:Matthew Brush
+ primary cultured cell population
+
+
+
+
+
+
+
+ 0
+
+
+
+ consider if we really want to be so strict here . . . ie maybe we we say that they have not been output from an 'establishing cell line' process, but in some cases a passage or two may be allowed for a primary culture. the establishing of a line requires some procedss that attains a degree of homogeneity in the culture.
+
+
+
+
+
+
+
+
+ obsolete_cell line
+ A split of HeLa cells in active culture, or stored in frozen aliquots. Populations of HEK 293 cells used in experiments such as those documented in Changes in ultrastructure and endogenous ionic channels activity during culture of HEK 293 cell line. Eur J Pharmacol. 2007 Jul 12;567(1-2):10-8. PMID: 17482592.
+ He, Tong-Chuan, et al. Identification of c-MYC as a target of the APC pathway. Science 281.5382 (1998): 1509-1512. - To evaluate the transcriptional effects of APC, we studied a human colorectal cancer cell line (HT29-APC) containing a zinc-inducible APC gene and a control cell line (HT29–β-Gal) containing an analogous inducible lacZ gene. Note that common usage in the literature is often of the form a human colorectal cancer cell line, as seen above. But such references to studies in a line refer to the fact that discrete populations of cells that are input into culturing or experiments, not an entire lineage of cells. It is these discrete populations that we refer to as 'cell lines'.
+
+ A secondary cultured cell population that represents a genetically stable and homogenous population of cultured cells that shares a common propagation history (ie has been successively passaged together in culture).
+ PERSON:Matthew Brush
+ cell line sample
+ OBI-CLO Alignment Working Group (Spring 2013)
+
+
+ obsolete_cell line
+ true
+
+
+
+
+
+
+
+
+ cultured clonal cell population
+ cell cut
+Stem cell functions assessed in clonal culture. Soc Gen Physiol Ser. 1988;43:39-45. Review. PMID: 3077557
+
+ A cultured cell population comprised of cells which can all be traced back to a single ancestor cell, and which therefore can be treated as identical.
+ PERSON: Susanna Sansone
+ PERSON:Matthew Brush
+ clonal cell culture sample
+ GROUP: OBI Biomaterial Branch
+ cultured clonal cell population
+
+
+
+
+
+
+
+
+ screening library
+ PMID: 15615535.J Med Chem. 2004 Dec 30;47(27):6864-74.A screening library for peptide activated G-protein coupled receptors. 1. The test set. [cdna_library, phage display library]
+
+ a screening library is a collection of materials engineered to identify qualities of a subset of its members during a screening process?
+ PRS: 22-02-2008: while working on definition of cDNA library and looking at current example of usage, a screening library should be a defined class -> any material library which has input_role in a screening protocol application
+change biomaterial to material in definition
+ PERSON: Bjoern Peters
+ GROUP: IEDB
+ 7/13/09: Need to clarify if this meets reagent role definition
+ screening library
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ synthetic peptide
+ the synthesized peptide SIINFEKL which also occurs in hen-egg lysozyme
+
+ a synthetic peptide is an material entity which is artificially engineered and results from the synthesis of a chain of amino acids which may also be found in natural protein and be identical in sequence to a protein fragment
+ changed from synthetic polypeptide to peptide, to get rid of the restriction of having more than 10 amino acids (required by Chebi).
+ Bjoern Peters
+ IEDB
+ PRS:22-02-2008: a chebi entity which has output role in a synthesis protocol application
+ original term: protein fragment split into synthetic polypeptide and fragment derived from protein
+DS: Is this synthetic an oxymoron to the biomaterial?
+ synthetic peptide
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ organ section
+ A liver slice used in a perfusion experiment.
+Thyroidectomy during laryngectomy for advanced laryngeal carcinoma--whole organ section study with long-term functional evaluation. Clin Otolaryngol Allied Sci. 1995 Apr;20(2):145-9. PMID: 7634521
+
+ A processed material which derives from an organ and results from a process of dissection or histological sample preparation a portion(formerly an organ section is portion of an organ removed from the context of the organ)
+ PERSON: Helen Parkinson
+ PERSON: Philippe Rocca-Serra
+ GROUP: CEBS
+ GROUP: OBI Biomaterial Branch
+ organ section
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ bronchial alveolar lavage
+ solution containing lung derived T cells, eosinophils, and TNFa.
+
+ Group of biomaterials present in the bronchial aveolar space of an organism which are collected through lavage including the reagents used to for the lavage process, organisms, cells, and cellular secretions present in the bronchial aveolar space.
+ PERSON: Bjoern Peters
+ BAL
+ GROUP: IEDB
+ bronchial alveolar lavage
+
+
+
+
+
+
+
+
+ obsolete_polymer
+
+ A macromolecule is a molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.
+ James Malone
+ Philippe Rocca-Serra
+ TERM: CHEBI:33839
+
+ obsolete_polymer
+ true
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ glucose in solution
+ Glucose present in blood
+
+ A scattered aggregate of glucose molecules in a liquid
+ PERSON: Jie Zheng
+ glucose molecules
+ glucose in solution
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ data transformation
+ The application of a clustering protocol to microarray data or the application of a statistical testing method on a primary data set to determine a p-value.
+
+ A planned process that produces output data from input data.
+ Elisabetta Manduchi
+ Helen Parkinson
+ James Malone
+ Melanie Courtot
+ Philippe Rocca-Serra
+ Richard Scheuermann
+ Ryan Brinkman
+ Tina Hernandez-Boussard
+ data analysis
+ data processing
+ Branch editors
+
+ data transformation
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ geometric mean calculation
+
+ A data transformation in which the mean is calculated by taking the nth root of the product of all of the observations in a data (n being the number of all observations).
Mathias Brochhausen
PERSON: Mathias Brochhausen
A geometric mean calculation is a descriptive statistics calculation in which the mean is calculated by taking the nth root of the product of all of the observations in a data (n being the number of all observations).
@@ -98206,7 +103570,7 @@ J Insect Physiol. 1998 May;44(5-6):525-528. PMID: 12770172
curated information
PMID: 17344875: A curated compendium of phosphorylation motifs.Nat Biotechnol. 2007 Mar;25(3):285-6.
- A information content entity that has undergone a digital curation performed by a curator for accuracy checks and compliance with curation requirements. Information which has been assessed for accuracy by domain experts.
+ An information content entity that has undergone a digital curation performed by a curator for accuracy checks and compliance with curation requirements. Information which has been assessed for accuracy by domain experts.
2009-11-10 Bjoern Peters. Need to check if this was intended. overlap with 'edited information', and has the same logical restrictions.
2010-01-31 Philippe Rocca-Serra: restriction now changed to be the output of a digital curation process + reflected in example of usage and reference
Person:Bjoern Peters
@@ -106587,38 +111951,38 @@ MHB 3-5-13: Need to review axiom on this class in light of clarification that it
-
-
-
-
-
-
-
-
-
-
-
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
- biological activity assay measuring epitope specific T cell killing
+ assay measuring epitope specific T cell killing
A T cell epitope dependent biological activity assay that detects the killing of an antigen presenting cell (APC) by a T cell whose TCR recognizes an epitope presented by the APC.
IEDB
IEDB
cytotoxicity|biological activity
- biological activity assay measuring epitope specific T cell killing
+ assay measuring epitope specific T cell killing
@@ -106629,24 +111993,23 @@ MHB 3-5-13: Need to review axiom on this class in light of clarification that it
-
-
-
-
-
-
-
-
-
-
-
-
+
-
+
+
+
+
+
+
+
+
+
+
+
@@ -106654,13 +112017,13 @@ MHB 3-5-13: Need to review axiom on this class in light of clarification that it
- biological activity assay measuring epitope specific proliferation of T cells
+ assay measuring epitope specific proliferation of T cells
A T cell epitope dependent biological activity assay that detects T cell proliferation.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
proliferation|biological activity
- biological activity assay measuring epitope specific proliferation of T cells
+ assay measuring epitope specific proliferation of T cells
@@ -106686,25 +112049,48 @@ MHB 3-5-13: Need to review axiom on this class in light of clarification that it
-
+
-
+
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
51 chromium assay measuring epitope specific T cell killing
- A T cell epitope specific killing assay performed in vitro that uses a chromium release assay.
+ A chromium release assay that detects the killing of an antigen presenting cell (APC) by a T cell whose TCR recognizes an epitope presented by the APC.
IEDB
IEDB
cytotoxicity|51 chromium
@@ -106912,13 +112298,13 @@ MHB 3-5-13: Need to review axiom on this class in light of clarification that it
- ELISA measuring epitope specific tumor necrosis factor production by T cells
+ ELISA measuring epitope specific tumor necrosis factor alpha production by T cells
- An enzyme-linked immunosorbent assay that detects tumor necrosis factor production by T cells.
+ An enzyme-linked immunosorbent assay that detects tumor necrosis factor alpha production by T cells.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
TNFa release|ELISA
- ELISA measuring epitope specific tumor necrosis factor production by T cells
+ ELISA measuring epitope specific tumor necrosis factor alpha production by T cells
@@ -107204,294 +112590,520 @@ MHB 3-5-13: Need to review axiom on this class in light of clarification that it
-
+
+
+ ELISA measuring epitope specific interleukin-17 production by T cells
+
+ An enzyme-linked immunosorbent assay that detects interleukin-17 production by T cells.
+ PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
+ IEDB
+ IL-17 release|ELISA
+ ELISA measuring epitope specific interleukin-17 production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ ELISA measuring epitope specific interleukin-18 production by T cells
+
+ An enzyme-linked immunosorbent assay that detects interleukin-18 production by T cells.
+ PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
+ IEDB
+ IL-18 release|ELISA
+ ELISA measuring epitope specific interleukin-18 production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ ELISPOT assay measuring epitope specific interleukin-4 production by T cells
+
+ An enzyme-linked immunospot assay that detects interleukin-4 production by T cells.
+ PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
+ IEDB
+ IL-4 release|ELISPOT
+ ELISPOT assay measuring epitope specific interleukin-4 production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ ELISPOT assay measuring epitope specific tumor necrosis factor alpha production by T cells
+
+ An enzyme-linked immunospot assay that detects tumor necrosis factor alpha production by T cells
+ IEDB
+ IEDB
+ TNFa release|ELISPOT
+ ELISPOT assay measuring epitope specific tumor necrosis factor alpha production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ ELISPOT assay measuring epitope specific interleukin-10 production by T cells
+
+ An enzyme-linked immunospot assay that detects interleukin-10 production by T cells.
+ PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
+ IEDB
+ IL-10 release|ELISPOT
+ ELISPOT assay measuring epitope specific interleukin-10 production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ ELISPOT assay measuring epitope specific interleukin-13 production by T cells
+
+ An enzyme-linked immunospot assay that detects interleukin-13 production by T cells.
+ PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
+ IEDB
+ IL-13 release|ELISPOT
+ ELISPOT assay measuring epitope specific interleukin-13 production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ intracellular cytokine staining assay measuring epitope specific interferon-gamma production by T cells
+
+ A flow cytometry assay that detects interferon-gamma production by T cells.
+ PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
+ IEDB
+ IFNg release|ICS
+ intracellular cytokine staining assay measuring epitope specific interferon-gamma production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ intracellular cytokine staining assay measuring epitope specific interleukin-2 production by T cells
+
+ A flow cytometry assay that detects interleukin-2 production by T cells.
+ PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
+ IEDB
+ IL-2 release|ICS
+ intracellular cytokine staining assay measuring epitope specific interleukin-2 production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ intracellular cytokine staining assay measuring epitope specific tumor necrosis factor alpha production by T cells
+
+ A flow cytometry assay that detects tumor necrosis factor alpha production by T cells.
+ PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
+ IEDB
+ TNFa release|ICS
+ intracellular cytokine staining assay measuring epitope specific tumor necrosis factor alpha production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ intracellular cytokine staining assay measuring epitope specific interleukin-4 production by T cells
+
+ A flow cytometry assay that detects interleukin-4 production by T cells.
+ PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
+ IEDB
+ IL-4 release|ICS
+ intracellular cytokine staining assay measuring epitope specific interleukin-4 production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ intracellular cytokine staining assay measuring epitope specific interleukin-10 production by T cells
+
+ A flow cytometry assay that detects interleukin-10 production by T cells.
+ PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
+ IEDB
+ IL-10 release|ICS
+ intracellular cytokine staining assay measuring epitope specific interleukin-10 production by T cells
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
- ELISA measuring epitope specific interleukin-17 production by T cells
-
- An enzyme-linked immunosorbent assay that detects interleukin-17 production by T cells.
- PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
- IEDB
- IL-17 release|ELISA
- ELISA measuring epitope specific interleukin-17 production by T cells
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- ELISA measuring epitope specific interleukin-18 production by T cells
-
- An enzyme-linked immunosorbent assay that detects interleukin-18 production by T cells.
- PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
- IEDB
- IL-18 release|ELISA
- ELISA measuring epitope specific interleukin-18 production by T cells
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- ELISPOT assay measuring epitope specific interleukin-4 production by T cells
+ intracellular cytokine staining assay measuring epitope specific interleukin-17 production by T cells
- An enzyme-linked immunospot assay that detects interleukin-4 production by T cells.
+ A flow cytometry assay that detects interleukin-17 production by T cells.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
- IL-4 release|ELISPOT
- ELISPOT assay measuring epitope specific interleukin-4 production by T cells
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- ELISPOT assay measuring epitope specific tumor necrosis factor production by T cells
-
- An enzyme-linked immunospot assay that detects tumor necrosis factor production by T cells.
- IEDB
- IEDB
- TNFa release|ELISPOT
- ELISPOT assay measuring epitope specific tumor necrosis factor production by T cells
+ IL-17 release|ICS
+ intracellular cytokine staining assay measuring epitope specific interleukin-17 production by T cells
-
+
-
+
-
-
-
-
+
+
+
-
+
-
+
-
-
+
+
-
-
-
-
-
-
-
- ELISPOT assay measuring epitope specific interleukin-10 production by T cells
-
- An enzyme-linked immunospot assay that detects interleukin-10 production by T cells.
- PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
- IEDB
- IL-10 release|ELISPOT
- ELISPOT assay measuring epitope specific interleukin-10 production by T cells
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
-
-
-
-
-
-
-
- ELISPOT assay measuring epitope specific interleukin-13 production by T cells
-
- An enzyme-linked immunospot assay that detects interleukin-13 production by T cells.
- PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
- IEDB
- IL-13 release|ELISPOT
- ELISPOT assay measuring epitope specific interleukin-13 production by T cells
-
-
-
-
-
-
-
-
-
-
-
+
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
-
-
-
-
-
- intracellular cytokine staining assay measuring epitope specific interferon-gamma production by T cells
-
- A flow cytometry assay that detects interferon-gamma production by T cells.
- PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
- IEDB
- IFNg release|ICS
- intracellular cytokine staining assay measuring epitope specific interferon-gamma production by T cells
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
@@ -107499,25 +113111,26 @@ MHB 3-5-13: Need to review axiom on this class in light of clarification that it
-
- intracellular cytokine staining assay measuring epitope specific interleukin-2 production by T cells
+
+
+ MHC tetramer/multimer assay measuring binding of a T cell epitope:MHC:TCR complex
- A flow cytometry assay that detects interleukin-2 production by T cells.
+ A MHC tetramer/multimer assay that measures the binding of an epitope:MHC complex binding with a T cell receptor.
PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
IEDB
- IL-2 release|ICS
- intracellular cytokine staining assay measuring epitope specific interleukin-2 production by T cells
+ qualitative binding|multimer/tetramer
+ MHC tetramer/multimer assay measuring binding of a T cell epitope:MHC:TCR complex
-
+
-
+
-
+
@@ -107526,7 +113139,7 @@ MHB 3-5-13: Need to review axiom on this class in light of clarification that it
-
+
@@ -107537,44 +113150,16 @@ MHB 3-5-13: Need to review axiom on this class in light of clarification that it
-
-
-
-
-
- intracellular cytokine staining assay measuring epitope specific tumor necrosis factor production by T cells
-
- A flow cytometry assay that detects tumor necrosis factor production by T cells.
- PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
- IEDB
- TNFa release|ICS
- intracellular cytokine staining assay measuring epitope specific tumor necrosis factor production by T cells
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
+
+
@@ -107582,26 +113167,26 @@ MHB 3-5-13: Need to review axiom on this class in light of clarification that it
-
-
- intracellular cytokine staining assay measuring epitope specific interleukin-4 production by T cells
+
+
+ 3H-thymidine assay measuring epitope specific proliferation of T cells
- A flow cytometry assay that detects interleukin-4 production by T cells.
- PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
+ A tritiated thymidine incorporation assay that detects T cell epitope specific proliferation in vitro.
+ IEDB
IEDB
- IL-4 release|ICS
- intracellular cytokine staining assay measuring epitope specific interleukin-4 production by T cells
+ proliferation|3H-thymidine
+ 3H-thymidine assay measuring epitope specific proliferation of T cells
-
+
-
+
-
+
@@ -107610,7 +113195,7 @@ MHB 3-5-13: Need to review axiom on this class in light of clarification that it
-
+
@@ -107621,181 +113206,28 @@ MHB 3-5-13: Need to review axiom on this class in light of clarification that it
-
-
-
-
-
- intracellular cytokine staining assay measuring epitope specific interleukin-10 production by T cells
-
- A flow cytometry assay that detects interleukin-10 production by T cells.
- PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
- IEDB
- IL-10 release|ICS
- intracellular cytokine staining assay measuring epitope specific interleukin-10 production by T cells
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- intracellular cytokine staining assay measuring epitope specific interleukin-17 production by T cells
-
- A flow cytometry assay that detects interleukin-17 production by T cells.
- PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
- IEDB
- IL-17 release|ICS
- intracellular cytokine staining assay measuring epitope specific interleukin-17 production by T cells
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
+
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- MHC tetramer/multimer assay measuring binding of a T cell epitope:MHC:TCR complex
-
- A MHC tetramer/multimer assay that measures the binding of an epitope:MHC complex binding with a T cell receptor.
- PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
- IEDB
- qualitative binding|multimer/tetramer
- MHC tetramer/multimer assay measuring binding of a T cell epitope:MHC:TCR complex
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- 3H-thymidine assay measuring epitope specific proliferation of T cells
-
- A T cell epitope specific proliferation assay performed on cells in vitro that uses a tritiated thymidine incorporation assay.
- IEDB
- IEDB
- proliferation|3H-thymidine
- 3H-thymidine assay measuring epitope specific proliferation of T cells
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
BrdU assay measuring epitope specific proliferation of T cells
- A T cell epitope specific proliferation assay performed on cells in vitro that uses a BrdU incorporation assay.
+ A BrdU incorporation assay that detects T cell epitope specific proliferation in vitro.
IEDB
IEDB
proliferation|BrdU
@@ -136939,12 +142371,24 @@ realizes some 'host of immune response role'
+
+
+
+
+ TF_binding_site
+ A DNA site where a transcription factor binds.
+
+ TF_binding_site
+
+
+
+
miRNA
- Small, ~22-nt, RNA molecule that is the endogenous transcript of a miRNA gene (or the product of other non coding RNA genes. Micro RNAs are produced from precursor molecules (SO:0000647) that can form local hairpin structures, which ordinarily are processed (usually via the Dicer pathway) such that a single miRNA molecule accumulates from one arm of a hairpin precursor molecule. Micro RNAs may trigger the cleavage of their target molecules or act as translational repressors.
+ Small, ~22-nt, RNA molecule that is the endogenous transcript of a miRNA gene (or the product of other non coding RNA genes. Micro RNAs are produced from precursor molecules (SO:0001244) that can form local hairpin structures, which ordinarily are processed (usually via the Dicer pathway) such that a single miRNA molecule accumulates from one arm of a hairpin precursor molecule. Micro RNAs may trigger the cleavage of their target molecules or act as translational repressors.
miRNA
@@ -136999,6 +142443,18 @@ realizes some 'host of immune response role'
+
+
+
+
+ regulatory_region
+ A region of sequence that is involved in the control of a biological process.
+
+ regulatory_region
+
+
+
+
@@ -137496,7 +142952,7 @@ realizes some 'host of immune response role'
pancreas
- An endoderm derived structure that produces precursors of digestive enzymes and blood glucose regulating enzymes[GO].
+ An endoderm derived structure that produces precursors of digestive enzymes and blood glucose regulating hormones[GO].
pancreas
@@ -137539,6 +142995,30 @@ realizes some 'host of immune response role'
+
+
+
+
+ arm
+ The part of the forelimb extending from the shoulder to the autopod[cjm].
+
+ arm
+
+
+
+
+
+
+
+
+ digestive tract
+ A tube extending from the mouth to the anus.
+
+ digestive tract
+
+
+
+
@@ -137947,6 +143427,18 @@ realizes some 'host of immune response role'
+
+
+
+
+ lymph
+ Lymph is the fluid that is formed when interstitial fluid enters the conduits of the lymphatic system through lymph capillaries[WP].
+
+ lymph
+
+
+
+
@@ -142733,9 +148225,6 @@ binary, and takes no temporal argument.
-
-
-
diff --git a/views/NIAID-GSC-BRC.owl b/views/NIAID-GSC-BRC.owl
index 44aedb81..c5c583c5 100644
--- a/views/NIAID-GSC-BRC.owl
+++ b/views/NIAID-GSC-BRC.owl
@@ -11,7 +11,7 @@
xmlns:terms="http://purl.org/dc/terms/"
xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#">
-
+
en
Advisors for this project come from the IFOMIS group, Saarbruecken and from the Co-ODE group in Manchester
Alan Ruttenberg
@@ -77,7 +77,7 @@
http://creativecommons.org/licenses/by/4.0/
Ontology for Biomedical Investigations
Please cite the OBI consortium http://purl.obolibrary.org/obo/obi where traditional citation is called for. However it is adequate that individual terms be attributed simply by use of the identifying PURL for the term, in projects that refer to them.
- 2022-07-11
+ 2022-12-14
@@ -1545,6 +1545,7 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
BFO 2 Reference: Material entities (continuants) can preserve their identity even while gaining and losing material parts. Continuants are contrasted with occurrents, which unfold themselves in successive temporal parts or phases [60
BFO 2 Reference: Object, Fiat Object Part and Object Aggregate are not intended to be exhaustive of Material Entity. Users are invited to propose new subcategories of Material Entity.
BFO 2 Reference: ‘Matter’ is intended to encompass both mass and energy (we will address the ontological treatment of portions of energy in a later version of BFO). A portion of matter is anything that includes elementary particles among its proper or improper parts: quarks and leptons, including electrons, as the smallest particles thus far discovered; baryons (including protons and neutrons) at a higher level of granularity; atoms and molecules at still higher levels, forming the cells, organs, organisms and other material entities studied by biologists, the portions of rock studied by geologists, the fossils studied by paleontologists, and so on.Material entities are three-dimensional entities (entities extended in three spatial dimensions), as contrasted with the processes in which they participate, which are four-dimensional entities (entities extended also along the dimension of time).According to the FMA, material entities may have immaterial entities as parts – including the entities identified below as sites; for example the interior (or ‘lumen’) of your small intestine is a part of your body. BFO 2.0 embodies a decision to follow the FMA here.
+
@@ -1634,12 +1635,10 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
cell
- cell
PMID:18089833.Cancer Res. 2007 Dec 15;67(24):12018-25. "...Epithelial cells were harvested from histologically confirmed adenocarcinomas .."
A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.
cell
- cell
@@ -1681,7 +1680,6 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
B cell
A lymphocyte of B lineage that is capable of B cell mediated immunity.
- A lymphocyte of B lineage with the phenotype CD19-positive, CD20-positive, and capable of B cell mediated immunity.
B cell
@@ -2640,10 +2638,23 @@ Request that IAO either clarify these or change definitions not to use them
+
+
+
+ Metazoa
+ metazoans
+ multicellular animals
+
+ Metazoa
+
+
+
+
-
+
Bilateria
Bilateria
@@ -2683,7 +2694,6 @@ Request that IAO either clarify these or change definitions not to use themHomo sapiens
human
human being
- man
Homo sapiens
diff --git a/views/obi-base.owl b/views/obi-base.owl
index a495f0de..3096f367 100644
--- a/views/obi-base.owl
+++ b/views/obi-base.owl
@@ -7,11 +7,13 @@
xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
xmlns:xml="http://www.w3.org/XML/1998/namespace"
xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
+ xmlns:foaf="http://xmlns.com/foaf/0.1/"
xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
xmlns:terms="http://purl.org/dc/terms/"
- xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#">
+ xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#"
+ xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#">
-
+
en
Ontology for Biomedical Investigations
Advisors for this project come from the IFOMIS group, Saarbruecken and from the Co-ODE group in Manchester
@@ -78,7 +80,7 @@
http://creativecommons.org/licenses/by/4.0/
Ontology for Biomedical Investigations
Please cite the OBI consortium http://purl.obolibrary.org/obo/obi where traditional citation is called for. However it is adequate that individual terms be attributed simply by use of the identifying PURL for the term, in projects that refer to them.
- 2022-05-19
+ 2022-12-14
@@ -100,159 +102,536 @@
+
+
+
+ Relates an entity in the ontology to the name of the variable that is used to represent it in the code that generates the BFO OWL file from the lispy specification.
+ Really of interest to developers only
+ BFO OWL specification label
+
+
+
+
+
+
+
+
+ Relates an entity in the ontology to the term that is used to represent it in the the CLIF specification of BFO2
+ Person:Alan Ruttenberg
+ Really of interest to developers only
+ BFO CLIF specification label
+
+
+
+
+
-
+
+ editor preferred label
+ editor preferred label
+ editor preferred term
+ editor preferred term
+ editor preferred term~editor preferred label
+
+ The concise, meaningful, and human-friendly name for a class or property preferred by the ontology developers. (US-English)
+ PERSON:Daniel Schober
+ GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
+
+ editor preferred label
+ editor preferred label
+ editor preferred term
+ editor preferred term
+ editor preferred term~editor preferred label
+
-
+
+ example of usage
+
+ A phrase describing how a term should be used and/or a citation to a work which uses it. May also include other kinds of examples that facilitate immediate understanding, such as widely know prototypes or instances of a class, or cases where a relation is said to hold.
+ PERSON:Daniel Schober
+ GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
+
+ example of usage
+
-
+
+ in branch
+ An annotation property indicating which module the terms belong to. This is currently experimental and not implemented yet.
+ GROUP:OBI
+ OBI_0000277
+ in branch
+
-
+
+ has curation status
+ PERSON:Alan Ruttenberg
+ PERSON:Bill Bug
+ PERSON:Melanie Courtot
+ has curation status
+
-
+
+ definition
+ definition
+ textual definition
+
+ The official OBI definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.
+ The official definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.
+ 2012-04-05:
+Barry Smith
+
+The official OBI definition, explaining the meaning of a class or property: 'Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions' is terrible.
+
+Can you fix to something like:
+
+A statement of necessary and sufficient conditions explaining the meaning of an expression referring to a class or property.
+
+Alan Ruttenberg
+
+Your proposed definition is a reasonable candidate, except that it is very common that necessary and sufficient conditions are not given. Mostly they are necessary, occasionally they are necessary and sufficient or just sufficient. Often they use terms that are not themselves defined and so they effectively can't be evaluated by those criteria.
+
+On the specifics of the proposed definition:
+
+We don't have definitions of 'meaning' or 'expression' or 'property'. For 'reference' in the intended sense I think we use the term 'denotation'. For 'expression', I think we you mean symbol, or identifier. For 'meaning' it differs for class and property. For class we want documentation that let's the intended reader determine whether an entity is instance of the class, or not. For property we want documentation that let's the intended reader determine, given a pair of potential relata, whether the assertion that the relation holds is true. The 'intended reader' part suggests that we also specify who, we expect, would be able to understand the definition, and also generalizes over human and computer reader to include textual and logical definition.
+
+Personally, I am more comfortable weakening definition to documentation, with instructions as to what is desirable.
+
+We also have the outstanding issue of how to aim different definitions to different audiences. A clinical audience reading chebi wants a different sort of definition documentation/definition from a chemistry trained audience, and similarly there is a need for a definition that is adequate for an ontologist to work with.
+ PERSON:Daniel Schober
+ GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
+
+ definition
+ definition
+ textual definition
+
-
+
+ editor note
+
+ An administrative note intended for its editor. It may not be included in the publication version of the ontology, so it should contain nothing necessary for end users to understand the ontology.
+ PERSON:Daniel Schober
+ GROUP:OBI:<http://purl.obofoundry.org/obo/obi>
+
+ editor note
+
-
+
+ term editor
+
+ Name of editor entering the term in the file. The term editor is a point of contact for information regarding the term. The term editor may be, but is not always, the author of the definition, which may have been worked upon by several people
+ 20110707, MC: label update to term editor and definition modified accordingly. See https://github.com/information-artifact-ontology/IAO/issues/115.
+ PERSON:Daniel Schober
+ GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
+
+ term editor
+
-
+
+ alternative term
+
+ An alternative name for a class or property which means the same thing as the preferred name (semantically equivalent)
+ PERSON:Daniel Schober
+ GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
+
+ alternative term
+
-
+
+ definition source
+
+ Formal citation, e.g. identifier in external database to indicate / attribute source(s) for the definition. Free text indicate / attribute source(s) for the definition. EXAMPLE: Author Name, URI, MeSH Term C04, PUBMED ID, Wiki uri on 31.01.2007
+ PERSON:Daniel Schober
+ Discussion on obo-discuss mailing-list, see http://bit.ly/hgm99w
+ GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
+
+ definition source
+
-
+
+ has obsolescence reason
+ Relates an annotation property to an obsolescence reason. The values of obsolescence reasons come from a list of predefined terms, instances of the class obsolescence reason specification.
+ PERSON:Alan Ruttenberg
+ PERSON:Melanie Courtot
+ has obsolescence reason
+
-
+
+ curator note
+
+ An administrative note of use for a curator but of no use for a user
+ PERSON:Alan Ruttenberg
+
+ curator note
+
-
+
+ term tracker item
+ the URI for an OBI Terms ticket at sourceforge, such as https://sourceforge.net/p/obi/obi-terms/772/
+
+ An IRI or similar locator for a request or discussion of an ontology term.
+ Person: Jie Zheng, Chris Stoeckert, Alan Ruttenberg
+ Person: Jie Zheng, Chris Stoeckert, Alan Ruttenberg
+ The 'tracker item' can associate a tracker with a specific ontology term.
+ term tracker item
+
-
+
+ ontology term requester
+
+ The name of the person, project, or organization that motivated inclusion of an ontology term by requesting its addition.
+ Person: Jie Zheng, Chris Stoeckert, Alan Ruttenberg
+ Person: Jie Zheng, Chris Stoeckert, Alan Ruttenberg
+ The 'term requester' can credit the person, organization or project who request the ontology term.
+ ontology term requester
+
-
+
+ is denotator type
+ Relates an class defined in an ontology, to the type of it's denotator
+ In OWL 2 add AnnotationPropertyRange('is denotator type' 'denotator type')
+ Alan Ruttenberg
+ is denotator type
+
-
+
+ imported from
+
+ For external terms/classes, the ontology from which the term was imported
+ PERSON:Alan Ruttenberg
+ PERSON:Melanie Courtot
+ GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
+
+ imported from
+
-
+
+ expand expression to
+ ObjectProperty: RO_0002104
+Label: has plasma membrane part
+Annotations: IAO_0000424 "http://purl.obolibrary.org/obo/BFO_0000051 some (http://purl.org/obo/owl/GO#GO_0005886 and http://purl.obolibrary.org/obo/BFO_0000051 some ?Y)"
+
+ A macro expansion tag applied to an object property (or possibly a data property) which can be used by a macro-expansion engine to generate more complex expressions from simpler ones
+ Chris Mungall
+ expand expression to
+
-
+
+ expand assertion to
+ ObjectProperty: RO???
+Label: spatially disjoint from
+Annotations: expand_assertion_to "DisjointClasses: (http://purl.obolibrary.org/obo/BFO_0000051 some ?X) (http://purl.obolibrary.org/obo/BFO_0000051 some ?Y)"
+
+ A macro expansion tag applied to an annotation property which can be expanded into a more detailed axiom.
+ Chris Mungall
+ expand assertion to
+
-
+
+ first order logic expression
+ PERSON:Alan Ruttenberg
+ first order logic expression
+
-
+
+ antisymmetric property
+ part_of antisymmetric property xsd:true
+ Use boolean value xsd:true to indicate that the property is an antisymmetric property
+ Alan Ruttenberg
+ antisymmetric property
+
-
+
+ OBO foundry unique label
+
+ An alternative name for a class or property which is unique across the OBO Foundry.
+ The intended usage of that property is as follow: OBO foundry unique labels are automatically generated based on regular expressions provided by each ontology, so that SO could specify unique label = 'sequence ' + [label], etc. , MA could specify 'mouse + [label]' etc. Upon importing terms, ontology developers can choose to use the 'OBO foundry unique label' for an imported term or not. The same applies to tools .
+ PERSON:Alan Ruttenberg
+ PERSON:Bjoern Peters
+ PERSON:Chris Mungall
+ PERSON:Melanie Courtot
+ GROUP:OBO Foundry <http://obofoundry.org/>
+ OBO foundry unique label
+
-
+
+ has ID digit count
+ Ontology: <http://purl.obolibrary.org/obo/ro/idrange/>
+ Annotations:
+ 'has ID prefix': "http://purl.obolibrary.org/obo/RO_"
+ 'has ID digit count' : 7,
+ rdfs:label "RO id policy"
+ 'has ID policy for': "RO"
+ Relates an ontology used to record id policy to the number of digits in the URI. The URI is: the 'has ID prefix" annotation property value concatenated with an integer in the id range (left padded with "0"s to make this many digits)
+ Person:Alan Ruttenberg
+ has ID digit count
+
-
+
+ has ID range allocated
+ Datatype: idrange:1
+Annotations: 'has ID range allocated to': "Chris Mungall"
+EquivalentTo: xsd:integer[> 2151 , <= 2300]
+
+ Relates a datatype that encodes a range of integers to the name of the person or organization who can use those ids constructed in that range to define new terms
+ Person:Alan Ruttenberg
+ has ID range allocated to
+
-
+
+ has ID policy for
+ Ontology: <http://purl.obolibrary.org/obo/ro/idrange/>
+ Annotations:
+ 'has ID prefix': "http://purl.obolibrary.org/obo/RO_"
+ 'has ID digit count' : 7,
+ rdfs:label "RO id policy"
+ 'has ID policy for': "RO"
+ Relating an ontology used to record id policy to the ontology namespace whose policy it manages
+ Person:Alan Ruttenberg
+ has ID policy for
+
-
+
+ has ID prefix
+ Ontology: <http://purl.obolibrary.org/obo/ro/idrange/>
+ Annotations:
+ 'has ID prefix': "http://purl.obolibrary.org/obo/RO_"
+ 'has ID digit count' : 7,
+ rdfs:label "RO id policy"
+ 'has ID policy for': "RO"
+ Relates an ontology used to record id policy to a prefix concatenated with an integer in the id range (left padded with "0"s to make this many digits) to construct an ID for a term being created.
+ Person:Alan Ruttenberg
+ has ID prefix
+
+
+
+
+
+
+
+ elucidation
+ person:Alan Ruttenberg
+ Person:Barry Smith
+ Primitive terms in a highest-level ontology such as BFO are terms which are so basic to our understanding of reality that there is no way of defining them in a non-circular fashion. For these, therefore, we can provide only elucidations, supplemented by examples and by axioms
+
+ elucidation
+
+
+
+
+
+
+
+ has associated axiom(nl)
+ Person:Alan Ruttenberg
+ Person:Alan Ruttenberg
+ An axiom associated with a term expressed using natural language
+
+ has associated axiom(nl)
+
+
+
+
+
+
+
+ has associated axiom(fol)
+ Person:Alan Ruttenberg
+ Person:Alan Ruttenberg
+ An axiom expressed in first order logic using CLIF syntax
+
+ has associated axiom(fol)
+
+
+
+
+
+
+
+ is allocated id range
+ Relates an ontology IRI to an (inclusive) range of IRIs in an OBO name space. The range is give as, e.g. "IAO_0020000-IAO_0020999"
+ PERSON:Alan Ruttenberg
+ Add as annotation triples in the granting ontology
+ is allocated id range
+
+
+
+
+
+
+
+ retired from use as of
+ relates a class of CRID to the date after which further instances should not be made, according to the central authority
+ In OWL 2 add AnnotationPropertyRange xsd:dateTimeStamp
+ Alan Ruttenberg
+ retired from use as of
+
+
+
+
+
+
+
+ has ontology root term
+ Ontology annotation property. Relates an ontology to a term that is a designated root term of the ontology. Display tools like OLS can use terms annotated with this property as the starting point for rendering the ontology class hierarchy. There can be more than one root.
+ Nicolas Matentzoglu
+ has ontology root term
+
+
+
+
+
+
+
+ may be identical to
+ A annotation relationship between two terms in an ontology that may refer to the same (natural) type but where more evidence is required before terms are merged.
+ David Osumi-Sutherland
+ #40
+ VFB
+ Edges asserting this should be annotated with to record evidence supporting the assertion and its provenance.
+ may be identical to
+
+
+
+
+
+
+
+ scheduled for obsoletion on or after
+ Used when the class or object is scheduled for obsoletion/deprecation on or after a particular date.
+ Chris Mungall, Jie Zheng
+ https://github.com/geneontology/go-ontology/issues/15532
+ https://github.com/information-artifact-ontology/ontology-metadata/issues/32
+ GO ontology
+ scheduled for obsoletion on or after
+
+
+
+
+
+
+
+
+ has axiom id
+ Person:Alan Ruttenberg
+ Person:Alan Ruttenberg
+ A URI that is intended to be unique label for an axiom used for tracking change to the ontology. For an axiom expressed in different languages, each expression is given the same URI
+
+ has axiom label
+
-
+
+ term replaced by
+
+ Use on obsolete terms, relating the term to another term that can be used as a substitute
+ Person:Alan Ruttenberg
+ Person:Alan Ruttenberg
+ Add as annotation triples in the granting ontology
+ term replaced by
+
+ ISA alternative term
An alternative term used by the ISA tools project (http://isa-tools.org).
Requested by Alejandra Gonzalez-Beltran
@@ -269,6 +648,7 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ NIAID GSCID-BRC alternative term
An alternative term used by the National Institute of Allergy and Infectious Diseases (NIAID) Genomic Sequencing Centers for Infectious Diseases (GSCID) and Bioinformatics Resource Centers (BRC).
PERSON: Chris Stoeckert, Jie Zheng
@@ -282,11 +662,12 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ IEDB alternative term
- An alternative term used by the IEDB.
- PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
- IEDB
- IEDB alternative term
+ An alternative term used by the IEDB.
+ PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters
+ IEDB
+ IEDB alternative term
@@ -295,20 +676,38 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ FGED alternative term
- An alternative term used by the Functional Genomics Data (FGED) Society.
- PERSON: Chris Stoeckert, Jie Zheng
- Penn Group
- FGED alternative term
+ An alternative term used by the Functional Genomics Data (FGED) Society.
+ PERSON: Chris Stoeckert, Jie Zheng
+ Penn Group
+ FGED alternative term
+
+
+
+ An assertion that holds between an OWL Object Property and a temporal interpretation that elucidates how OWL Class Axioms that use this property are to be interpreted in a temporal context.
+ temporal interpretation
+ https://oborel.github.io/obo-relations/temporal-semantics/
+
+
+
+
+ Examples of a Contributor include a person, an
+ organisation, or a service. Typically, the name of a
+ Contributor should be used to indicate the entity.
+ An entity responsible for making contributions to the
+ content of the resource.
+
Contributor
+ Contributor
@@ -316,7 +715,19 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ Coverage will typically include spatial location (a place name
+ or geographic coordinates), temporal period (a period label,
+ date, or date range) or jurisdiction (such as a named
+ administrative entity).
+ Recommended best practice is to select a value from a
+ controlled vocabulary (for example, the Thesaurus of Geographic
+ Names [TGN]) and that, where appropriate, named places or time
+ periods be used in preference to numeric identifiers such as
+ sets of coordinates or date ranges.
+ The extent or scope of the content of the resource.
+
Coverage
+ Coverage
@@ -324,7 +735,14 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ Examples of a Creator include a person, an organisation,
+ or a service. Typically, the name of a Creator should
+ be used to indicate the entity.
+ An entity primarily responsible for making the content
+ of the resource.
+
Creator
+ Creator
@@ -332,7 +750,15 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ Typically, Date will be associated with the creation or
+ availability of the resource. Recommended best practice
+ for encoding the date value is defined in a profile of
+ ISO 8601 [W3CDTF] and follows the YYYY-MM-DD format.
+ A date associated with an event in the life cycle of the
+ resource.
+
Date
+ Date
@@ -340,7 +766,13 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ Description may include but is not limited to: an abstract,
+ table of contents, reference to a graphical representation
+ of content or a free-text account of the content.
+ An account of the content of the resource.
+
Description
+ Description
@@ -348,7 +780,17 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ Typically, Format may include the media-type or dimensions of
+ the resource. Format may be used to determine the software,
+ hardware or other equipment needed to display or operate the
+ resource. Examples of dimensions include size and duration.
+ Recommended best practice is to select a value from a
+ controlled vocabulary (for example, the list of Internet Media
+ Types [MIME] defining computer media formats).
+ The physical or digital manifestation of the resource.
+
Format
+ Format
@@ -356,7 +798,17 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ Recommended best practice is to identify the resource by means
+ of a string or number conforming to a formal identification
+ system.
+ Example formal identification systems include the Uniform
+ Resource Identifier (URI) (including the Uniform Resource
+ Locator (URL)), the Digital Object Identifier (DOI) and the
+ International Standard Book Number (ISBN).
+ An unambiguous reference to the resource within a given context.
+
Resource Identifier
+ Resource Identifier
@@ -364,15 +816,37 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ Recommended best practice is to use RFC 3066 [RFC3066],
+ which, in conjunction with ISO 639 [ISO639], defines two-
+ and three-letter primary language tags with optional
+ subtags. Examples include "en" or "eng" for English,
+ "akk" for Akkadian, and "en-GB" for English used in the
+ United Kingdom.
+ A language of the intellectual content of the resource.
+
Language
+ Language
+
+
+
+
+
+
+ Examples of a Publisher include a person, an organisation,
+ or a service.
+ Typically, the name of a Publisher should be used to
+ indicate the entity.
+ An entity responsible for making the resource available
+
Publisher
+ Publisher
@@ -380,7 +854,15 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+
+ Recommended best practice is to reference the resource by means
+ of a string or number conforming to a formal identification
+ system.
+
+ A reference to a related resource.
+
Relation
+ Relation
@@ -388,7 +870,20 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+
+ Typically, a Rights element will contain a rights
+ management statement for the resource, or reference
+ a service providing such information. Rights information
+ often encompasses Intellectual Property Rights (IPR),
+ Copyright, and various Property Rights.
+ If the Rights element is absent, no assumptions can be made
+ about the status of these and other rights with respect to
+ the resource.
+
+ Information about rights held in and over the resource.
+
Rights Management
+ Rights Management
@@ -396,7 +891,15 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ The present resource may be derived from the Source resource
+ in whole or in part. Recommended best practice is to reference
+ the resource by means of a string or number conforming to a
+ formal identification system.
+ A reference to a resource from which the present resource
+ is derived.
+
Source
+ Source
@@ -404,7 +907,15 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ Typically, a Subject will be expressed as keywords,
+ key phrases or classification codes that describe a topic
+ of the resource. Recommended best practice is to select
+ a value from a controlled vocabulary or formal
+ classification scheme.
+ The topic of the content of the resource.
+
Subject and Keywords
+ Subject and Keywords
@@ -412,7 +923,14 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+
+ Typically, a Title will be a name by which the resource is
+ formally known.
+
+ A name given to the resource.
+
Title
+ Title
@@ -420,7 +938,16 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ Type includes terms describing general categories, functions,
+ genres, or aggregation levels for content. Recommended best
+ practice is to select a value from a controlled vocabulary
+ (for example, the DCMI Type Vocabulary [DCMITYPE]). To
+ describe the physical or digital manifestation of the
+ resource, use the Format element.
+ The nature or genre of the content of the resource.
+
Resource Type
+ Resource Type
@@ -428,7 +955,7 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
- Mark Miller
+ Mark Miller
2018-05-11T13:47:29Z
@@ -440,15 +967,42 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ shorthand
+
+
+
+
+
+
+
+
+
+
+ label
label
@@ -466,6 +1020,24 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
+
+
+ is part of
+ my brain is part of my body (continuant parthood, two material entities)
+ my stomach cavity is part of my stomach (continuant parthood, immaterial entity is part of material entity)
+ this day is part of this year (occurrent parthood)
+ a core relation that holds between a part and its whole
+ Everything is part of itself. Any part of any part of a thing is itself part of that thing. Two distinct things cannot be part of each other.
+ Occurrents are not subject to change and so parthood between occurrents holds for all the times that the part exists. Many continuants are subject to change, so parthood between continuants will only hold at certain times, but this is difficult to specify in OWL. See https://code.google.com/p/obo-relations/wiki/ROAndTime
+ Parthood requires the part and the whole to have compatible classes: only an occurrent can be part of an occurrent; only a process can be part of a process; only a continuant can be part of a continuant; only an independent continuant can be part of an independent continuant; only an immaterial entity can be part of an immaterial entity; only a specifically dependent continuant can be part of a specifically dependent continuant; only a generically dependent continuant can be part of a generically dependent continuant. (This list is not exhaustive.)
+
+A continuant cannot be part of an occurrent: use 'participates in'. An occurrent cannot be part of a continuant: use 'has participant'. A material entity cannot be part of an immaterial entity: use 'has location'. A specifically dependent continuant cannot be part of an independent continuant: use 'inheres in'. An independent continuant cannot be part of a specifically dependent continuant: use 'bearer of'.
+ part_of
+
+ part of
+ http://www.obofoundry.org/ro/#OBO_REL:part_of
+
@@ -534,67 +1123,432 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ has part
+ my body has part my brain (continuant parthood, two material entities)
+ my stomach has part my stomach cavity (continuant parthood, material entity has part immaterial entity)
+ this year has part this day (occurrent parthood)
+ a core relation that holds between a whole and its part
+ Everything has itself as a part. Any part of any part of a thing is itself part of that thing. Two distinct things cannot have each other as a part.
+ Occurrents are not subject to change and so parthood between occurrents holds for all the times that the part exists. Many continuants are subject to change, so parthood between continuants will only hold at certain times, but this is difficult to specify in OWL. See https://code.google.com/p/obo-relations/wiki/ROAndTime
+ Parthood requires the part and the whole to have compatible classes: only an occurrent have an occurrent as part; only a process can have a process as part; only a continuant can have a continuant as part; only an independent continuant can have an independent continuant as part; only a specifically dependent continuant can have a specifically dependent continuant as part; only a generically dependent continuant can have a generically dependent continuant as part. (This list is not exhaustive.)
+
+A continuant cannot have an occurrent as part: use 'participates in'. An occurrent cannot have a continuant as part: use 'has participant'. An immaterial entity cannot have a material entity as part: use 'location of'. An independent continuant cannot have a specifically dependent continuant as part: use 'bearer of'. A specifically dependent continuant cannot have an independent continuant as part: use 'inheres in'.
+ has_part
+
+ has part
-
+
+
+
+
+ realized in
+ this disease is realized in this disease course
+ this fragility is realized in this shattering
+ this investigator role is realized in this investigation
+ is realized by
+ realized_in
+ [copied from inverse property 'realizes'] to say that b realizes c at t is to assert that there is some material entity d & b is a process which has participant d at t & c is a disposition or role of which d is bearer_of at t& the type instantiated by b is correlated with the type instantiated by c. (axiom label in BFO2 Reference: [059-003])
+ Paraphrase of elucidation: a relation between a realizable entity and a process, where there is some material entity that is bearer of the realizable entity and participates in the process, and the realizable entity comes to be realized in the course of the process
+
+ realized in
+
-
+
+
+
+ realizes
+ this disease course realizes this disease
+ this investigation realizes this investigator role
+ this shattering realizes this fragility
+ to say that b realizes c at t is to assert that there is some material entity d & b is a process which has participant d at t & c is a disposition or role of which d is bearer_of at t& the type instantiated by b is correlated with the type instantiated by c. (axiom label in BFO2 Reference: [059-003])
+ Paraphrase of elucidation: a relation between a process and a realizable entity, where there is some material entity that is bearer of the realizable entity and participates in the process, and the realizable entity comes to be realized in the course of the process
+
+ realizes
+
-
+
+
+
+
+
+ preceded by
+ An example is: translation preceded_by transcription; aging preceded_by development (not however death preceded_by aging). Where derives_from links classes of continuants, preceded_by links classes of processes. Clearly, however, these two relations are not independent of each other. Thus if cells of type C1 derive_from cells of type C, then any cell division involving an instance of C1 in a given lineage is preceded_by cellular processes involving an instance of C. The assertion P preceded_by P1 tells us something about Ps in general: that is, it tells us something about what happened earlier, given what we know about what happened later. Thus it does not provide information pointing in the opposite direction, concerning instances of P1 in general; that is, that each is such as to be succeeded by some instance of P. Note that an assertion to the effect that P preceded_by P1 is rather weak; it tells us little about the relations between the underlying instances in virtue of which the preceded_by relation obtains. Typically we will be interested in stronger relations, for example in the relation immediately_preceded_by, or in relations which combine preceded_by with a condition to the effect that the corresponding instances of P and P1 share participants, or that their participants are connected by relations of derivation, or (as a first step along the road to a treatment of causality) that the one process in some way affects (for example, initiates or regulates) the other.
+ is preceded by
+ preceded_by
+ http://www.obofoundry.org/ro/#OBO_REL:preceded_by
+ preceded by
+
+
+
+
+
+
+
+
+
+
+
+ precedes
+ precedes
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+ occurs in
+ b occurs_in c =def b is a process and c is a material entity or immaterial entity& there exists a spatiotemporal region r and b occupies_spatiotemporal_region r.& forall(t) if b exists_at t then c exists_at t & there exist spatial regions s and s’ where & b spatially_projects_onto s at t& c is occupies_spatial_region s’ at t& s is a proper_continuant_part_of s’ at t
+ occurs_in
+ unfolds in
+ unfolds_in
+ Paraphrase of definition: a relation between a process and an independent continuant, in which the process takes place entirely within the independent continuant
+
+ occurs in
+
+
+
+
+
+
+
+ site of
+ [copied from inverse property 'occurs in'] b occurs_in c =def b is a process and c is a material entity or immaterial entity& there exists a spatiotemporal region r and b occupies_spatiotemporal_region r.& forall(t) if b exists_at t then c exists_at t & there exist spatial regions s and s’ where & b spatially_projects_onto s at t& c is occupies_spatial_region s’ at t& s is a proper_continuant_part_of s’ at t
+ Paraphrase of definition: a relation between an independent continuant and a process, in which the process takes place entirely within the independent continuant
+
+ contains process
+
-
+
+
+
+
+ has measurement unit label
+
+
+
+
+
+
+
+
+ The process of creation is, for example, writing down on paper the name of a friend by deliberately creating a certain pattern using ink.
+
+Here the ink + paper is the independent continuant and the carrier is the pattern in the ink.
+
+c = pattern in the ink
+b = paper + ink
+r = friend
+
+ c specifically denotes r =def
+r is a portion of reality
+& c is a particular quality
+& c depends specifically on some independent continuant b
+& b acquired c as the result of the achievement of an objective to enable pointing to r repeatedly.
+
+Marked means there is a changed or additional quality of the bearer - the quality is the information carrier.
+
+Case 1
+Memory trace as mark created when reading some description of some friend. The trace can denote.
+
+Case 2
+Pattern of ink arrayed on paper as mark when writing down a friend's name
+
+Case 3
+Pattern of magnetic domains on scattered pieces of a hard disk platter as mark when saving a file.
+ 8/6/2009 Alan Ruttenberg: The suggestions is to deprecate specific and generically denotes in favor of a single denote relationship that corresponds to the generic sense
+ see https://github.com/information-artifact-ontology/IAO/issues/25&q=denote
+ Alan Ruttenberg
+ Smith, Ceusters, Ruttenberg, 2000 years of philosophy
+
+ obsolete_specifically denotes
+ true
+
-
+
+
+ This document is about information artifacts and their representations
+
+ A (currently) primitive relation that relates an information artifact to an entity.
+ 7/6/2009 Alan Ruttenberg. Following discussion with Jonathan Rees, and introduction of "mentions" relation. Weaken the is_about relationship to be primitive.
+
+We will try to build it back up by elaborating the various subproperties that are more precisely defined.
+
+Some currently missing phenomena that should be considered "about" are predications - "The only person who knows the answer is sitting beside me" , Allegory, Satire, and other literary forms that can be topical without explicitly mentioning the topic.
+ person:Alan Ruttenberg
+ Smith, Ceusters, Ruttenberg, 2000 years of philosophy
+ is about
+
+
+
+
+
+
+
+
+
+ An information artifact IA mentions an entity E exactly when it has a component/part that denotes E
+ 7/6/2009 Alan Ruttenberg. P4 RC1 munges our GCI so remove it for now: mentions some entity equivalentTo has_part some ('generically denotes' some entity)
+ 7/6/2009 Alan Ruttenberg: Add this relation following conversation with Jonathan Rees that N&S GCI for is_about was too strong. Really it was simply sufficient. To effect this change we introduce this relation, which is subproperty of is_about, and have previous GCI use this relation "mentions" in it's (logical) definition
+ PERSON: Jonathan Rees
+ Person: Alan Ruttenberg
+ mentions
+
-
+
+
+
+
+
+ A person's name denotes the person. A variable name in a computer program denotes some piece of memory. Lexically equivalent strings can denote different things, for instance "Alan" can denote different people. In each case of use, there is a case of the denotation relation obtaining, between "Alan" and the person that is being named.
+ A primitive, instance-level, relation obtaining between an information content entity and some portion of reality. Denotation is what happens when someone creates an information content entity E in order to specifically refer to something. The only relation between E and the thing is that E can be used to 'pick out' the thing. This relation connects those two together. Freedictionary.com sense 3: To signify directly; refer to specifically
+ 2009-11-10 Alan Ruttenberg. Old definition said the following to emphasize the generic nature of this relation. We no longer have 'specifically denotes', which would have been primitive, so make this relation primitive.
+g denotes r =def
+r is a portion of reality
+there is some c that is a concretization of g
+every c that is a concretization of g specifically denotes r
+ person:Alan Ruttenberg
+ Conversations with Barry Smith, Werner Ceusters, Bjoern Peters, Michel Dumontier, Melanie Courtot, James Malone, Bill Hogan
+
+ denotes
+
+
+
+
+
+
+
+
+ see https://github.com/information-artifact-ontology/IAO/issues/25&q=denote
+
+ obsolete_materially denotes
+ true
+
-
+
+
+
+
+
+ m is a quality measurement of q at t. When q is a quality, there is a measurement process p that has specified output m, a measurement datum, that is about q
+ 8/6/2009 Alan Ruttenberg: The strategy is to be rather specific with this relationship. There are other kinds of measurements that are not of qualities, such as those that measure time. We will add these as separate properties for the moment and see about generalizing later
+ From the second IAO workshop [Alan Ruttenberg 8/6/2009: not completely current, though bringing in comparison is probably important]
+
+This one is the one we are struggling with at the moment. The issue is what a measurement measures. On the one hand saying that it measures the quality would include it "measuring" the bearer = referring to the bearer in the measurement. However this makes comparisons of two different things not possible. On the other hand not having it inhere in the bearer, on the face of it, breaks the audit trail.
+
+Werner suggests a solution based on "Magnitudes" a proposal for which we are awaiting details.
+--
+From the second IAO workshop, various comments, [commented on by Alan Ruttenberg 8/6/2009]
+
+unit of measure is a quality, e.g. the length of a ruler.
+
+[We decided to hedge on what units of measure are, instead talking about measurement unit labels, which are the information content entities that are about whatever measurement units are. For IAO we need that information entity in any case. See the term measurement unit label]
+
+[Some struggling with the various subflavors of is_about. We subsequently removed the relation represents, and describes until and only when we have a better theory]
+
+a represents b means either a denotes b or a describes
+
+describe:
+a describes b means a is about b and a allows an inference of at least one quality of b
+
+We have had a long discussion about denotes versus describes.
+ From the second IAO workshop: An attempt at tieing the quality to the measurement datum more carefully.
+
+a is a magnitude means a is a determinate quality particular inhering in some bearer b existing at a time t that can be represented/denoted by an information content entity e that has parts denoting a unit of measure, a number, and b. The unit of measure is an instance of the determinable quality.
+ From the second meeting on IAO:
+
+An attempt at defining assay using Barry's "reliability" wording
+
+assay:
+process and has_input some material entity
+and has_output some information content entity
+and which is such that instances of this process type reliably generate
+outputs that describes the input.
+ This one is the one we are struggling with at the moment. The issue is what a measurement measures. On the one hand saying that it measures the quality would include it "measuring" the bearer = referring to the bearer in the measurement. However this makes comparisons of two different things not possible. On the other hand not having it inhere in the bearer, on the face of it, breaks the audit trail.
+
+Werner suggests a solution based on "Magnitudes" a proposal for which we are awaiting details.
+ Alan Ruttenberg
+ is quality measurement of
+
+
+
+
+
+
+
+
+
+ obsolete_describes
+ true
+
+
+
+
+
+
+
+
+
+ obsolete_represents
+ true
+
+
+
+
+
+
+
+
+
+ inverse of the relation 'denotes'
+ Person: Jie Zheng, Chris Stoeckert, Mike Conlon
+
+ denoted by
+
-
+
+
+
+
+
+ relating a cartesian spatial coordinate datum to a unit label that together with the values represent a point
+ has coordinate unit label
+
-
+
+
+
+
+
+ relates a process to a time-measurement-datum that represents the duration of the process
+ Person:Alan Ruttenberg
+ is duration of
+
+
+
+
+
+
+
+
+ inverse of the relation of is quality measurement of
+ 2009/10/19 Alan Ruttenberg. Named 'junk' relation useful in restrictions, but not a real instance relationship
+ Person:Alan Ruttenberg
+ is quality measured as
+
+
+
+
+
+
+
+
+
+
+ A relation between a data item and a quality of a material entity where the material entity is the specified output of a material transformation which achieves an objective specification that indicates the intended value of the specified quality.
+ Person:Alan Ruttenberg
+ Person:Bjoern Peters
+ is quality specification of
+
+
+
+
+
+
+
+
+ inverse of the relation of is quality specification of
+ 2009/10/19 Alan Ruttenberg. Named 'junk' relation useful in restrictions, but not a real instance relationship
+ Person:Alan Ruttenberg
+ Person:Bjoern Peters
+ quality is specified as
+
+
+
+
+
+
+
+
+
+
+
+
+ relates a time stamped measurement datum to the time measurement datum that denotes the time when the measurement was taken
+ Alan Ruttenberg
+ has time stamp
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ relates a time stamped measurement datum to the measurement datum that was measured
+ Alan Ruttenberg
+ has measurement datum
+
@@ -603,9 +1557,11 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+ provides_service_consumer_with
The provides_service_consumer_with relation links the service to its primary process it provides for the consumer (as opposed to secondary processual parts of a service process such as payment or documentation). For example, a 'DNA sequencing service' provides_service_consumer_with 'DNA sequencing' as the essential process performed by the provider for the client.
+
A relation between a service and the primary processual part of the service that is performed by the provider for the consumer.
- provides_service_consumer_with
+ provides_service_consumer_with
@@ -615,13 +1571,14 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
- The relation between the conclusion "Gene tpbA is involved in EPS production" and the data items produced using two sets of organisms, one being a tpbA knockout, the other being tpbA wildtype tested in polysacharide production assays and analyzed using an ANOVA.
+ is_supported_by_data
+ The relation between the conclusion "Gene tpbA is involved in EPS production" and the data items produced using two sets of organisms, one being a tpbA knockout, the other being tpbA wildtype tested in polysacharide production assays and analyzed using an ANOVA.
- The relation between a data item and a conclusion where the conclusion is the output of a data interpreting process and the data item is used as an input to that process
+ The relation between a data item and a conclusion where the conclusion is the output of a data interpreting process and the data item is used as an input to that process
OBI
OBI
- Philly 2011 workshop
- is_supported_by_data
+ Philly 2011 workshop
+ is_supported_by_data
@@ -629,18 +1586,25 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
+
+
+
+
+
- has_specified_input
+ has_specified_input
+ has_specified_input
see is_input_of example_of_usage
The inverse property of is_specified_input_of
- 8/17/09: specified inputs of one process are not necessarily specified inputs of a larger process that it is part of. This is in contrast to how 'has participant' works.
+ 8/17/09: specified inputs of one process are not necessarily specified inputs of a larger process that it is part of. This is in contrast to how 'has participant' works.
PERSON: Alan Ruttenberg
- PERSON: Bjoern Peters
- PERSON: Larry Hunter
- PERSON: Melanie Coutot
+ PERSON: Bjoern Peters
+ PERSON: Larry Hunter
+ PERSON: Melanie Coutot
+
has_specified_input
@@ -650,11 +1614,12 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
- is_concretization_of
- Is a relationship between a generically dependent continuant and a specifically dependent continuant. A generically dependent continuant may inhere in more than one entity. It does so by virtue of the fact that there is, for each entity that it inheres, a specifically dependent *concretization* of the generically dependent continuant that is specifically dependent. For instance, consider a story, which is an information artifact that inheres in some number of books. Each book bears some quality that carries the story. The relation between this quality and the generically dependent continuant is that the former is the concretization of the latter.
- replaced by: http://purl.obolibrary.org/obo/BFO_0000058
- PERSON: Alan Ruttenburg
- PERSON: Barry Smith
+ is_concretization_of
+
+ Is a relationship between a generically dependent continuant and a specifically dependent continuant. A generically dependent continuant may inhere in more than one entity. It does so by virtue of the fact that there is, for each entity that it inheres, a specifically dependent *concretization* of the generically dependent continuant that is specifically dependent. For instance, consider a story, which is an information artifact that inheres in some number of books. Each book bears some quality that carries the story. The relation between this quality and the generically dependent continuant is that the former is the concretization of the latter.
+ replaced by: http://purl.obolibrary.org/obo/BFO_0000058
+ PERSON: Alan Ruttenburg
+ PERSON: Barry Smith
obsolete_is_concretization_of
true
@@ -667,12 +1632,12 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
- is_specified_input_of
+ is_specified_input_of
some Autologous EBV(Epstein-Barr virus)-transformed B-LCL (B lymphocyte cell line) is_input_for instance of Chromum Release Assay described at https://wiki.cbil.upenn.edu/obiwiki/index.php/Chromium_Release_assay
A relation between a planned process and a continuant participating in that process that is not created during the process. The presence of the continuant during the process is explicitly specified in the plan specification which the process realizes the concretization of.
Alan Ruttenberg
- PERSON:Bjoern Peters
+ PERSON:Bjoern Peters
is_specified_input_of
@@ -682,11 +1647,12 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
- is_concretized_as
- Is a relationship between a specifically dependent continuant and a generically dependent continuant. A generically dependent continuant may inhere in more than one entity. It does so by virtue of the fact that there is, for each entity that it inheres, a specifically dependent *concretization* of the generically dependent continuant that is specifically dependent. For instance, consider a story, which is an information artifact that inheres in some number of books. Each book bears some quality that carries the story. The relation between this quality and the generically dependent continuant is that the former is the concretization of the latter.
- replaced by: http://purl.obolibrary.org/obo/BFO_0000059
- PERSON: Alan Ruttenberg
- PERSON: Barry Smith
+ is_concretized_as
+
+ Is a relationship between a specifically dependent continuant and a generically dependent continuant. A generically dependent continuant may inhere in more than one entity. It does so by virtue of the fact that there is, for each entity that it inheres, a specifically dependent *concretization* of the generically dependent continuant that is specifically dependent. For instance, consider a story, which is an information artifact that inheres in some number of books. Each book bears some quality that carries the story. The relation between this quality and the generically dependent continuant is that the former is the concretization of the latter.
+ replaced by: http://purl.obolibrary.org/obo/BFO_0000059
+ PERSON: Alan Ruttenberg
+ PERSON: Barry Smith
obsolete_is_concretized_as
true
@@ -698,14 +1664,14 @@ https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891
- has_quality
+ has_quality
- A relation between an entity and a quality. For types: E has_quality Q iff:
+ A relation between an entity and a quality. For types: E has_quality Q iff:
for any eEt, exists qQt such that q inheres_in e at t.
For instances: e has_quality q at t iff q inheres_in e at t and q instance-of Quality [GOC:cjm]
- replaced by: http://purl.obolibrary.org/obo/BFO_0000086
- GROUP:OBI:<http://obi.sourceforge.net>
- PERSON: Chris Mungall
+ replaced by: http://purl.obolibrary.org/obo/BFO_0000086
+ GROUP:OBI:<http://obi.sourceforge.net>
+ PERSON: Chris Mungall
obsolete_has_quality
true
@@ -716,16 +1682,23 @@ For instances: e has_quality q at t iff q inheres_in e at t and q instance-of Qu
+
+
+
+
+
- has_specified_output
+ has_specified_output
+ has_specified_output
The inverse property of is_specified_output_of
PERSON: Alan Ruttenberg
- PERSON: Bjoern Peters
- PERSON: Larry Hunter
- PERSON: Melanie Courtot
+ PERSON: Bjoern Peters
+ PERSON: Larry Hunter
+ PERSON: Melanie Courtot
+
has_specified_output
@@ -735,15 +1708,15 @@ For instances: e has_quality q at t iff q inheres_in e at t and q instance-of Qu
- is_realized_by
-
- Relation between a realizable and a process. Reciprocal relation of realizes [GOC:cjm]
- replaced by http://purl.obolibrary.org/obo/BFO_0000054: 'is realized by'
- GROUP:OBI:<http://obi.sourceforge.net>
- PERSON: Chris Mungall
- executed_during
- has_realization
- is_realized_as
+ is_realized_by
+
+ Relation between a realizable and a process. Reciprocal relation of realizes [GOC:cjm]
+ replaced by http://purl.obolibrary.org/obo/BFO_0000054: 'is realized by'
+ GROUP:OBI:<http://obi.sourceforge.net>
+ PERSON: Chris Mungall
+ executed_during
+ has_realization
+ is_realized_as
obsolete_is_realized_by
true
@@ -755,10 +1728,11 @@ For instances: e has_quality q at t iff q inheres_in e at t and q instance-of Qu
- obsoleted_has_specified_output_information
+ obsoleted_has_specified_output_information
+
A relation between a participant in a process, that produces a data set . The process is the realization of a concretization of a realizable information entity (objective specification or plan specification). In general, not all data present at the end of the process are specified_data.
PERSON: Alan Ruttenberg
- PERSON: Frank Gibson
+ PERSON: Frank Gibson
obsoleted_has_specified_output_information
true
@@ -780,6 +1754,7 @@ For instances: e has_quality q at t iff q inheres_in e at t and q instance-of Qu
is_manufactured_by
http://www.affymetrix.com/products/arrays/specific/hgu133.affx is_manufactered_by http://www.affymetrix.com/ (if we decide to use these URIs for the actual entities)
+
c is_manufactured_by o means that there was a process p in which c was built in which a person, or set of people or machines did the work(bore the "Manufacturer Role", and those people/and or machines were members or of directed by the organization to do this.
Alan Ruttenberg
Liju Fan
@@ -794,13 +1769,13 @@ For instances: e has_quality q at t iff q inheres_in e at t and q instance-of Qu
- has_function
- heart has_function to-pump-blood
+ has_function
+ heart has_function to-pump-blood
- Relation between an independent continuant and a function.
- replaced by: http://purl.obolibrary.org/obo/BFO_0000085
- GROUP:OBI:<http://obi.sourceforge.net>
- PERSON: Chris Mungall
+ Relation between an independent continuant and a function.
+ replaced by: http://purl.obolibrary.org/obo/BFO_0000085
+ GROUP:OBI:<http://obi.sourceforge.net>
+ PERSON: Chris Mungall
obsolete_has_function
true
@@ -812,8 +1787,9 @@ For instances: e has_quality q at t iff q inheres_in e at t and q instance-of Qu
- obsoleted_is_reagent_in
+ obsoleted_is_reagent_in
some Triton X-100 (Sigma-Aldrich) is_reagent_in instance of Chromium Release Assay described at https://wiki.cbil.upenn.edu/obiwiki/index.php/Chromium_Release_assay
+
Relationship between a substance and a protocol application in which it participates, where the substance has a ReagentRole
Alan Ruttenberg
@@ -827,25 +1803,25 @@ For instances: e has_quality q at t iff q inheres_in e at t and q instance-of Qu
- realizes
- example of usage: The process of 'histidine catabolism' (GO:0006548) realizes the
+ realizes
+ example of usage: The process of 'histidine catabolism' (GO:0006548) realizes the
function 'histidine ammonia lyase activity' (GO:0004397) (note: here 'activity'
denotes a function and not a process). We leave open the possibility of defining
in future the sub-relations directly_realizes (as bewteen a function and it's
functioning) and indirectly_realizes.
- Relation between a process and a function, where the unfolding of the
+ Relation between a process and a function, where the unfolding of the
process requires the execution of the function. Class level: P realizes F iff:
given any p that instantiates P, there exists some f, t such that f instantiates
F at t and p *realizes* f. Here, *realizes* is the primitive
instance level relation [GOC:cjm]
- replaced by http://purl.obolibrary.org/obo/BFO_0000055: 'realizes'
- GROUP:OBI:<http://obi.sourceforge.net>
- PERSON: Chris Mungal
- executes
- has_function_part
- involves_execution_of
- is_realization_of
+ replaced by http://purl.obolibrary.org/obo/BFO_0000055: 'realizes'
+ GROUP:OBI:<http://obi.sourceforge.net>
+ PERSON: Chris Mungal
+ executes
+ has_function_part
+ involves_execution_of
+ is_realization_of
obsolete_realizes
true
@@ -857,8 +1833,9 @@ instance level relation [GOC:cjm]
- obsoleted_utilizes_reagent
+ obsoleted_utilizes_reagent
see example_of_usage for is_reagent_in
+
Relationship between a protocol application and a substance that has role reagent that participates in the protocol application
Alan Ruttenberg
@@ -872,8 +1849,9 @@ instance level relation [GOC:cjm]
- obsoleted_is_device_for
+ obsoleted_is_device_for
some LKB 1272 Clinigamma counter is_device_for instance of Chromium Release Assay described at https://wiki.cbil.upenn.edu/obiwiki/index.php/Chromium_Release_assay
+
Relationship between a device and a protocol application in which it participates
Alan Ruttenberg
@@ -886,13 +1864,20 @@ instance level relation [GOC:cjm]
+
+
+
+
+
- is_specified_output_of
+ is_specified_output_of
+ is_specified_output_of
A relation between a planned process and a continuant participating in that process. The presence of the continuant at the end of the process is explicitly specified in the objective specification which the process realizes the concretization of.
Alan Ruttenberg
- PERSON:Bjoern Peters
+ PERSON:Bjoern Peters
+
is_specified_output_of
@@ -902,8 +1887,9 @@ instance level relation [GOC:cjm]
- obsoleted_utilizes_device
+ obsoleted_utilizes_device
see example_of_usage for is_device_for
+
Relationship between protocol application and an intrument in which it participates
Alan Ruttenberg
@@ -918,12 +1904,13 @@ instance level relation [GOC:cjm]
- is_proxy_for
+ is_proxy_for
position on a gel is_proxy_for mass and charge of molecule in an western blot. Florescent intensity is_proxy_for amount of protein labeled with GFP. Examples:
A260/A280 (of a DNA sample) is_proxy_for DNA-purity. NMR Sample scan is a proxy for sample quality.
Within the assay mentioned here: https://wiki.cbil.upenn.edu/obiwiki/index.php/Chromium_Release_assay
level of radioactivity is_proxy_for level of toxicity
+
A relation between continuant instances c1 and c2 where within an experiment/ protocol application, measurement of c1 is used to determine what a measurement of c2 would be.
A relation between continuant instances c1 and c2 where within a protocol
application, measurement of c1 is related to a what would be the
@@ -939,11 +1926,12 @@ level of radioactivity is_proxy_for level of toxicity
- has specified input information
+ has specified input information
+
A relation between a process and a participant in that process, that consumes a data set . The process is the realization of a concretization of a directive information entity (objective specification or plan specification). In general, not all data present at the beginning of the process are specified_data.
- PERSON: Frank Gibson
+ PERSON: Frank Gibson
PERSON:Alan Ruttenberg
- consumes data
+ consumes data
obsoleted_has_specified_input_information
true
@@ -955,12 +1943,12 @@ level of radioactivity is_proxy_for level of toxicity
- has_role
+ has_role
- A relation between a continuant C and a role R. The reciprocal relation of role_of.
- replaced by: http://purl.obolibrary.org/obo/BFO_0000087
- GROUP:OBI:<http://obi.sourceforge.net>
- PERSON:Chris Mungal
+ A relation between a continuant C and a role R. The reciprocal relation of role_of.
+ replaced by: http://purl.obolibrary.org/obo/BFO_0000087
+ GROUP:OBI:<http://obi.sourceforge.net>
+ PERSON:Chris Mungal
obsolete_has_role
true
@@ -972,11 +1960,12 @@ level of radioactivity is_proxy_for level of toxicity
- obsolete_results_from
- 2009/11/23: BP, dev call:o bsoleted as discussed in tracker https://sourceforge.net/tracker/?func=detail&aid=2899860&group_id=177891&atid=886178
+ obsolete_results_from
+
+ 2009/11/23: BP, dev call:o bsoleted as discussed in tracker https://sourceforge.net/tracker/?func=detail&aid=2899860&group_id=177891&atid=886178
. Should be replaced by instead creating defined classes for materials, which are specified output of the process that conveys the
- obsolete_results_from
+ obsolete_results_from
true
@@ -988,13 +1977,14 @@ level of radioactivity is_proxy_for level of toxicity
- achieves_planned_objective
- A cell sorting process achieves the objective specification 'material separation objective'
- This relation obtains between a planned process and a objective specification when the criteria specified in the objective specification are met at the end of the planned process.
- BP, AR, PPPB branch
- PPPB branch derived
- modified according to email thread from 1/23/09 in accordince with DT and PPPB branch
- achieves_planned_objective
+ achieves_planned_objective
+ A cell sorting process achieves the objective specification 'material separation objective'
+
+ This relation obtains between a planned process and a objective specification when the criteria specified in the objective specification are met at the end of the planned process.
+ BP, AR, PPPB branch
+ PPPB branch derived
+ modified according to email thread from 1/23/09 in accordince with DT and PPPB branch
+ achieves_planned_objective
@@ -1003,13 +1993,14 @@ level of radioactivity is_proxy_for level of toxicity
- is_specified_information_output_of
- A relation between a data set and the process in which it participates and was produced. Inverse of outputs_specified_data relation.
- is replaced by has_specified_output_of
- PERSON: James Malone
- Editor
+ is_specified_information_output_of
+
+ A relation between a data set and the process in which it participates and was produced. Inverse of outputs_specified_data relation.
+ is replaced by has_specified_output_of
+ PERSON: James Malone
+ Editor
- obsoleted_is_specified_information_output_of
+ obsoleted_is_specified_information_output_of
true
@@ -1019,12 +2010,13 @@ level of radioactivity is_proxy_for level of toxicity
- has grain
- the relation of the cells in the finger of the skin to the finger, in which an indeterminate number of grains are parts of the whole by virtue of being grains in a collective that is part of the whole, and in which removing one granular part does not nec- essarily damage or diminish the whole. Ontological Whether there is a fixed, or nearly fixed number of parts - e.g. fingers of the hand, chambers of the heart, or wheels of a car - such that there can be a notion of a single one being missing, or whether, by contrast, the number of parts is indeterminate - e.g., cells in the skin of the hand, red cells in blood, or rubber molecules in the tread of the tire of the wheel of the car.
+ has grain
+
+ the relation of the cells in the finger of the skin to the finger, in which an indeterminate number of grains are parts of the whole by virtue of being grains in a collective that is part of the whole, and in which removing one granular part does not nec- essarily damage or diminish the whole. Ontological Whether there is a fixed, or nearly fixed number of parts - e.g. fingers of the hand, chambers of the heart, or wheels of a car - such that there can be a notion of a single one being missing, or whether, by contrast, the number of parts is indeterminate - e.g., cells in the skin of the hand, red cells in blood, or rubber molecules in the tread of the tire of the wheel of the car.
Discussion in Karslruhe with, among others, Alan Rector, Stefan Schulz, Marijke Keet, Melanie Courtot, and Alan Ruttenberg. Definition take from the definition of granular parthood in the cited paper. Needs work to put into standard form
PERSON: Alan Ruttenberg
- PAPER: Granularity, scale and collectivity: When size does and does not matter, Alan Rector, Jeremy Rogers, Thomas Bittner, Journal of Biomedical Informatics 39 (2006) 333-349
- has grain
+ PAPER: Granularity, scale and collectivity: When size does and does not matter, Alan Rector, Jeremy Rogers, Thomas Bittner, Journal of Biomedical Informatics 39 (2006) 333-349
+ has grain
@@ -1033,11 +2025,12 @@ level of radioactivity is_proxy_for level of toxicity
- obsoleted_is_specified_information_intput_of
- Is the inverse relation of has_specfied_input_information
- is replaced by is_specified_intput_of
+ obsoleted_is_specified_information_intput_of
+
+ Is the inverse relation of has_specfied_input_information
+ is replaced by is_specified_intput_of
- obsoleted_is_specified_information_intput_of
+ obsoleted_is_specified_information_intput_of
true
@@ -1047,7 +2040,8 @@ level of radioactivity is_proxy_for level of toxicity
- is grain of
+ is grain of
+
A relation between granular parts and the whole of which they are a part. Granular parts have indeterminate number such that removing one granular part does not necessarily damage or diminish the whole.
JAO: Added definition 2013-10-25 based on 'has grain', but both these terms seem problematic.
PERSON: Alan Ruttenberg
@@ -1061,12 +2055,13 @@ level of radioactivity is_proxy_for level of toxicity
- provisions
- A relation between an organisation or person and a material entity, where the organization or person provides or supplies the material entity for others to use
+ provisions
+
+ A relation between an organisation or person and a material entity, where the organization or person provides or supplies the material entity for others to use
5/11/2020: A prior definition contained reference to transfer of ownership. ("A relation between an organisation or person and a material entity who owned or has license to the material entity and there was a legal transfer of ownership or licensing of the material entity to the current owner"). This was left out as it was hard to read and it was unclear if/how that transfer restricts the relationship.
- GROUP: Relations branch
+ GROUP: Relations branch
supplies
- provisions
+ provisions
@@ -1083,14 +2078,14 @@ level of radioactivity is_proxy_for level of toxicity
- has_supplier
-
- A relation between a material entity and an organisation or person who owned or has license to the material entity and there was a legal transfer of ownership or licensing of the material entity to the current owner.
- PERSON: Alan Rutternberg
- PERSON: Cristian Cocos
- PERSON: Frank Gibson
- PERSON: Melanie Courtot
- has_supplier
+ has_supplier
+
+ A relation between a material entity and an organisation or person who owned or has license to the material entity and there was a legal transfer of ownership or licensing of the material entity to the current owner.
+ PERSON: Alan Rutternberg
+ PERSON: Cristian Cocos
+ PERSON: Frank Gibson
+ PERSON: Melanie Courtot
+ has_supplier
@@ -1100,12 +2095,12 @@ level of radioactivity is_proxy_for level of toxicity
- objective_achieved_by
+ objective_achieved_by
- This relation obtains between an objective specification and a planned process when the criteria specified in the objective specification are met at the end of the planned process.
+ This relation obtains between an objective specification and a planned process when the criteria specified in the objective specification are met at the end of the planned process.
OBI
OBI
- objective_achieved_by
+ objective_achieved_by
@@ -1123,16 +2118,17 @@ level of radioactivity is_proxy_for level of toxicity
- is member of organization
- Relating a legal person or organization to an organization in the case where the legal person or organization has a role as member of the organization.
- 2009/10/01 Alan Ruttenberg. Barry prefers generic is-member-of. Question of what the range should be. For now organization. Is organization a population? Would the same relation be used to record members of a population
- JZ: Discussed on May 7, 2012 OBI dev call. Bjoern points out that we need to allow for organizations to be members of organizations. And agreed by the other OBI developers. So, human and organization were specified in 'Domains'. The textual definition was updated based on it.
- Person:Alan Ruttenberg
- Person:Helen Parkinson
- Person:Alan Ruttenberg
- Person:Helen Parkinson
- 2009/09/28 Alan Ruttenberg. Fucoidan-use-case
- is member of organization
+ is member of organization
+
+ Relating a legal person or organization to an organization in the case where the legal person or organization has a role as member of the organization.
+ 2009/10/01 Alan Ruttenberg. Barry prefers generic is-member-of. Question of what the range should be. For now organization. Is organization a population? Would the same relation be used to record members of a population
+ JZ: Discussed on May 7, 2012 OBI dev call. Bjoern points out that we need to allow for organizations to be members of organizations. And agreed by the other OBI developers. So, human and organization were specified in 'Domains'. The textual definition was updated based on it.
+ Person:Alan Ruttenberg
+ Person:Helen Parkinson
+ Person:Alan Ruttenberg
+ Person:Helen Parkinson
+ 2009/09/28 Alan Ruttenberg. Fucoidan-use-case
+ is member of organization
@@ -1143,9 +2139,10 @@ level of radioactivity is_proxy_for level of toxicity
- has category label
+ has category label
+
A relation between a categorical measurement data item and the categorical label that indicates the value of that data item on the categorical scale.
- has category label
+ has category label
@@ -1156,11 +2153,12 @@ level of radioactivity is_proxy_for level of toxicity
- has disposition to bind
- A relationship between two material entitites that each have disposition to form a complex with the other.
- This is a shortcut relation, and should expand to say that the two material entities have dispositions, point to the process in which they from a complex that realizes those dispositions, and points to the complex in which the two entities are 'bound to' each other
- IEDB
- has disposition to bind
+ has disposition to bind
+
+ A relationship between two material entitites that each have disposition to form a complex with the other.
+ This is a shortcut relation, and should expand to say that the two material entities have dispositions, point to the process in which they from a complex that realizes those dispositions, and points to the complex in which the two entities are 'bound to' each other
+ IEDB
+ has disposition to bind
@@ -1177,10 +2175,12 @@ level of radioactivity is_proxy_for level of toxicity
- Relating an organization to a legal person or organization.
- See tracker:
+ has organization member
+
+ Relating an organization to a legal person or organization.
+ See tracker:
https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_id=177891&atid=886178
- Person: Jie Zheng
+ Person: Jie Zheng
has organization member
@@ -1191,6 +2191,8 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ specifies value of
+
A relation between a value specification and an entity which the specification is about.
specifies value of
@@ -1203,6 +2205,7 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ has value specification
A relation between an information content entity and a value specification that specifies its value.
PERSON: James A. Overton
@@ -1234,25 +2237,45 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ has performer
- performer relation covers the need to report on who performed a planned processed. it has to cover processes done by People or Devices (such as a robot controlled by software WF management system)
+ A relation between a planned process and a continuant where the continuant can be a person, organization or device (such as a robot controlled by software workflow management system) that performs the planned process.
+ OBI
+ OBI
+ The 'has performer' relation covers the need to report on who performed a planned processed. It has to cover processes done by People or Devices (such as a robot controlled by software WF management system).
has performer
+
+
+
+
+ has assay target context
+
+ A relation between the target entity of an assay and a material entity, where the material entity is the environment in which the target entity of an assay is measured, such as a live mouse, cell culture, test tube, etc.
+ Hector Guzman-Orozco
+ OBI
+ https://github.com/obi-ontology/obi/issues/1516
+ has assay target context
+
+
+
+
- process is result of
- The production of IFN-gamma by effector T cells is a process result of T cell stimulation through the TCR
- is a relationship between a process and a preceding occurrent that directly caused the later one to occur
- IEDB
- PERSON:Bjoern Peters
- process is result of
+ process is result of
+ The production of IFN-gamma by effector T cells is a process result of T cell stimulation through the TCR
+
+ is a relationship between a process and a preceding occurrent that directly caused the later one to occur
+ IEDB
+ PERSON:Bjoern Peters
+ process is result of
@@ -1261,9 +2284,10 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
- is_described_by
+ is_described_by
+
- obsolete_is_described_by
+ obsolete_is_described_by
true
@@ -1274,110 +2298,422 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
- bound_to
+ bound_to
+
A relationship between two material entities that form a complex based on a selective, non-covalent interaction.
The definition of this term is modeled after the Chebi:50967 and GO:0005488 terms. Further alignment of the logical definitions with those ontologies will require agreement on the placement of GO:molecular function in BFO among other things. OBI will retire this term once such an alignment is achieved as 'bound to' is not in the primary OBI scope.
- bound_to
+ bound_to
-
+
+
+ inheres in
+ this fragility inheres in this vase
+ this red color inheres in this apple
+ a relation between a specifically dependent continuant (the dependent) and an independent continuant (the bearer), in which the dependent specifically depends on the bearer for its existence
+ A dependent inheres in its bearer at all times for which the dependent exists.
+ inheres_in
+
+ inheres in
+
-
+
+
+ bearer of
+ this apple is bearer of this red color
+ this vase is bearer of this fragility
+ a relation between an independent continuant (the bearer) and a specifically dependent continuant (the dependent), in which the dependent specifically depends on the bearer for its existence
+ A bearer can have many dependents, and its dependents can exist for different periods of time, but none of its dependents can exist when the bearer does not exist.
+ bearer_of
+ is bearer of
+
+ bearer of
+
-
+
+
+
+
+ participates in
+ this blood clot participates in this blood coagulation
+ this input material (or this output material) participates in this process
+ this investigator participates in this investigation
+ a relation between a continuant and a process, in which the continuant is somehow involved in the process
+ participates_in
+ participates in
+
-
+
+
+
+ has participant
+ this blood coagulation has participant this blood clot
+ this investigation has participant this investigator
+ this process has participant this input material (or this output material)
+ a relation between a process and a continuant, in which the continuant is somehow involved in the process
+ Has_participant is a primitive instance-level relation between a process, a continuant, and a time at which the continuant participates in some way in the process. The relation obtains, for example, when this particular process of oxygen exchange across this particular alveolar membrane has_participant this particular sample of hemoglobin at this particular time.
+ has_participant
+ http://www.obofoundry.org/ro/#OBO_REL:has_participant
+ has participant
+
-
+
+
+
+
+ A journal article is an information artifact that inheres in some number of printed journals. For each copy of the printed journal there is some quality that carries the journal article, such as a pattern of ink. The journal article (a generically dependent continuant) is concretized as the quality (a specifically dependent continuant), and both depend on that copy of the printed journal (an independent continuant).
+ An investigator reads a protocol and forms a plan to carry out an assay. The plan is a realizable entity (a specifically dependent continuant) that concretizes the protocol (a generically dependent continuant), and both depend on the investigator (an independent continuant). The plan is then realized by the assay (a process).
+ A relationship between a generically dependent continuant and a specifically dependent continuant, in which the generically dependent continuant depends on some independent continuant in virtue of the fact that the specifically dependent continuant also depends on that same independent continuant. A generically dependent continuant may be concretized as multiple specifically dependent continuants.
+ is concretized as
+
-
+
+
+
+ A journal article is an information artifact that inheres in some number of printed journals. For each copy of the printed journal there is some quality that carries the journal article, such as a pattern of ink. The quality (a specifically dependent continuant) concretizes the journal article (a generically dependent continuant), and both depend on that copy of the printed journal (an independent continuant).
+ An investigator reads a protocol and forms a plan to carry out an assay. The plan is a realizable entity (a specifically dependent continuant) that concretizes the protocol (a generically dependent continuant), and both depend on the investigator (an independent continuant). The plan is then realized by the assay (a process).
+ A relationship between a specifically dependent continuant and a generically dependent continuant, in which the generically dependent continuant depends on some independent continuant in virtue of the fact that the specifically dependent continuant also depends on that same independent continuant. Multiple specifically dependent continuants can concretize the same generically dependent continuant.
+ concretizes
+
-
+
+
+
+
+ this catalysis function is a function of this enzyme
+ a relation between a function and an independent continuant (the bearer), in which the function specifically depends on the bearer for its existence
+ A function inheres in its bearer at all times for which the function exists, however the function need not be realized at all the times that the function exists.
+ function_of
+ is function of
+ function of
+
+
+
+
+
+
+
+
+
+ this red color is a quality of this apple
+ a relation between a quality and an independent continuant (the bearer), in which the quality specifically depends on the bearer for its existence
+ A quality inheres in its bearer at all times for which the quality exists.
+ is quality of
+ quality_of
+ quality of
+
-
+
+
+
+ this investigator role is a role of this person
+ a relation between a role and an independent continuant (the bearer), in which the role specifically depends on the bearer for its existence
+ A role inheres in its bearer at all times for which the role exists, however the role need not be realized at all the times that the role exists.
+ is role of
+ role_of
+ role of
+
-
+
+
+
+
+ this enzyme has function this catalysis function (more colloquially: this enzyme has this catalysis function)
+ a relation between an independent continuant (the bearer) and a function, in which the function specifically depends on the bearer for its existence
+ A bearer can have many functions, and its functions can exist for different periods of time, but none of its functions can exist when the bearer does not exist. A function need not be realized at all the times that the function exists.
+ has_function
+ has function
+
-
+
+
+
+ this apple has quality this red color
+ a relation between an independent continuant (the bearer) and a quality, in which the quality specifically depends on the bearer for its existence
+ A bearer can have many qualities, and its qualities can exist for different periods of time, but none of its qualities can exist when the bearer does not exist.
+ has_quality
+ has quality
+
-
+
+
+
+
+ this person has role this investigator role (more colloquially: this person has this role of investigator)
+ a relation between an independent continuant (the bearer) and a role, in which the role specifically depends on the bearer for its existence
+ A bearer can have many roles, and its roles can exist for different periods of time, but none of its roles can exist when the bearer does not exist. A role need not be realized at all the times that the role exists.
+ has_role
+ has role
+
+
+
+
+
+
+
+
+
+
+
+ a relation between an independent continuant (the bearer) and a disposition, in which the disposition specifically depends on the bearer for its existence
+ has disposition
+
+
+
+
+
+
+
+
+ disposition of
+
+
+
+ derives from
+ this cell derives from this parent cell (cell division)
+ this nucleus derives from this parent nucleus (nuclear division)
+
+ a relation between two distinct material entities, the new entity and the old entity, in which the new entity begins to exist when the old entity ceases to exist, and the new entity inherits the significant portion of the matter of the old entity
+ This is a very general relation. More specific relations are preferred when applicable, such as 'directly develops from'.
+ derives_from
+
+ derives from
+
+
+
+
+
+
+
+ this parent cell derives into this cell (cell division)
+ this parent nucleus derives into this nucleus (nuclear division)
+
+ a relation between two distinct material entities, the old entity and the new entity, in which the new entity begins to exist when the old entity ceases to exist, and the new entity inherits the significant portion of the matter of the old entity
+ This is a very general relation. More specific relations are preferred when applicable, such as 'directly develops into'. To avoid making statements about a future that may not come to pass, it is often better to use the backward-looking 'derives from' rather than the forward-looking 'derives into'.
+ derives_into
+ derives into
+
+
+
+
+
+
+
+
+
+ is location of
+ my head is the location of my brain
+ this cage is the location of this rat
+ a relation between two independent continuants, the location and the target, in which the target is entirely within the location
+ Most location relations will only hold at certain times, but this is difficult to specify in OWL. See https://code.google.com/p/obo-relations/wiki/ROAndTime
+ location_of
+
+ location of
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ located in
+ my brain is located in my head
+ this rat is located in this cage
+ a relation between two independent continuants, the target and the location, in which the target is entirely within the location
+ Location as a relation between instances: The primitive instance-level relation c located_in r at t reflects the fact that each continuant is at any given time associated with exactly one spatial region, namely its exact location. Following we can use this relation to define a further instance-level location relation - not between a continuant and the region which it exactly occupies, but rather between one continuant and another. c is located in c1, in this sense, whenever the spatial region occupied by c is part_of the spatial region occupied by c1. Note that this relation comprehends both the relation of exact location between one continuant and another which obtains when r and r1 are identical (for example, when a portion of fluid exactly fills a cavity), as well as those sorts of inexact location relations which obtain, for example, between brain and head or between ovum and uterus
+ Most location relations will only hold at certain times, but this is difficult to specify in OWL. See https://code.google.com/p/obo-relations/wiki/ROAndTime
+ located_in
+
+ http://www.obofoundry.org/ro/#OBO_REL:located_in
+ located in
+
+
+
+
+
+ This is redundant with the more specific 'independent and not spatial region' constraint. We leave in the redundant axiom for use with reasoners that do not use negation.
+
+
+
+
+
+ This is redundant with the more specific 'independent and not spatial region' constraint. We leave in the redundant axiom for use with reasoners that do not use negation.
+
+
+
+
+
+
+
+
+ the surface of my skin is a 2D boundary of my body
+ a relation between a 2D immaterial entity (the boundary) and a material entity, in which the boundary delimits the material entity
+ A 2D boundary may have holes and gaps, but it must be a single connected entity, not an aggregate of several disconnected parts.
+ Although the boundary is two-dimensional, it exists in three-dimensional space and thus has a 3D shape.
+ 2D_boundary_of
+ boundary of
+ is 2D boundary of
+ is boundary of
+
+ 2D boundary of
+
+
+
+
+
+
+
+
+
+ my body has 2D boundary the surface of my skin
+ a relation between a material entity and a 2D immaterial entity (the boundary), in which the boundary delimits the material entity
+ A 2D boundary may have holes and gaps, but it must be a single connected entity, not an aggregate of several disconnected parts.
+ Although the boundary is two-dimensional, it exists in three-dimensional space and thus has a 3D shape.
+ has boundary
+ has_2D_boundary
+
+ has 2D boundary
+
-
+
+
+
+ David Osumi-Sutherland
+ starts_at_end_of
+ X immediately_preceded_by Y iff: end(X) simultaneous_with start(Y)
+ immediately preceded by
+
+
+
+
+
+
+
+
+ David Osumi-Sutherland
+ ends_at_start_of
+ meets
+ X immediately_precedes_Y iff: end(X) simultaneous_with start(Y)
+ immediately precedes
+
-
+
+
+
+ w 'has component' p if w 'has part' p and w is such that it can be directly disassembled into into n parts p, p2, p3, ..., pn, where these parts are of similar type.
+ The definition of 'has component' is still under discussion. The challenge is in providing a definition that does not imply transitivity.
+ For use in recording has_part with a cardinality constraint, because OWL does not permit cardinality constraints to be used in combination with transitive object properties. In situations where you would want to say something like 'has part exactly 5 digit, you would instead use has_component exactly 5 digit.
+
+ has component
+
+
+
+
+
+
+
+
+
+
+ A relation between a material entity (such as a cell) and a process, in which the material entity has the ability to carry out the process.
+ has function realized in
+ capable of
+
-
+
+
+ surrounded by
+ x surrounded_by y if and only if x is adjacent to y and for every region r that is adjacent to x, r overlaps y
+
+ surrounded by
+
@@ -1389,15 +2725,59 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+
+
+
+
+ move to BFO?
+ Allen
+ A relation that holds between two occurrents. This is a grouping relation that collects together all the Allen relations.
+ temporal relation
+
+
+
+
-
+
+
+
+
+ inverse of starts with
+ Chris Mungall
+ Allen
+ starts
+
+
+
+
+
+
+
+
+
+ An organism that is a member of a population of organisms
+ is member of is a mereological relation between a item and a collection.
+ is member of
+ member part of
+ SIO
+
+ member of
+
-
+
+
+
+ has member is a mereological relation between a collection and an item.
+ SIO
+
+ has member
+
@@ -1420,7 +2800,45 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
-
+
+
+
+
+ has measurement value
+
+
+
+
+
+
+
+
+
+
+ has x coordinate value
+
+
+
+
+
+
+
+
+
+
+ has z coordinate value
+
+
+
+
+
+
+
+
+
+
+ has y coordinate value
+
@@ -1428,7 +2846,8 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
- has_feature_value
+ has_feature_value
+
has_feature_value datatype property is used to describe the feature values which the feature class can contain, for example has_base can have feature values of nonNegativeInteger values.
James Malone
has_feature_value
@@ -1442,6 +2861,7 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ has specified numeric value
A relation between a value specification and a number that quantifies it.
A range of 'real' might be better than 'float'. For now we follow 'has measurement value' until we can consider technical issues with SPARQL queries and reasoning.
@@ -1456,6 +2876,8 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ has specified value
+
A relation between a value specification and a literal.
This is not an RDF/OWL object property. It is intended to link a value found in e.g. a database column of 'M' (the literal) to an instance of a value specification class, which can then be linked to indicate that this is about the biological gender of a human subject.
OBI
@@ -1467,14 +2889,15 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ has representation
12th arrondissement of Paris
- 20g
+ 20g
I feel sick to my stomach every Tuesday
'has representation' is a data property that attaches between an information content entity and a value that contains linguistically or computationally coded text.
Further processing may enable the value to be represented in a component data structure such as an OBI value specification.
- Damion Dooley
- Mark Miller
+ Damion Dooley
+ Mark Miller
2019-07-14T07:05:50Z
has representation
@@ -1492,509 +2915,2598 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
-
+
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ A planned process that has specified output a software product and that involves the creation of source code.
+ Mathias Brochhausen
+ William R. Hogan
+ http://en.wikipedia.org/wiki/Software_development
+ A planned process resulting in a software product involving the creation of source code.
+ software development
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+ A measurement datum that is the output of counting.
+ Mathias Brochhausen
+ A measurement datum that is the output of counting.
+ count
+
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+ The planned process of finding the number of elements in a finite set of objects.
+ Mathias Brochhausen
+ http://en.wikipedia.org/wiki/Counting
+ The planned process of finding the number of elements in a finite set of objects.
+ counting
+
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ software source code version control repository
+ A document that comprises at least one source code module and provenance data about who contributed the set of files making up the module(s), and optionally comprises also multiple versions of files with detailed change history about who committed files and when, a license for the software, readme files, documentation, executables, etc.
+ William R. Hogan
+ Refers to the stuff that lives on GitHub, not to GitHub or the git software on which it is based
+ source code repository
+
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ process of compiling software
+ A planned process that converts human-written or curated software into a machine-executable or interpretable set of instructions.
+ William R. Hogan
+ It's compiling "software" (scare quotes) and not "source code" because you can compile Java bytecode to machine code, and Java bytecode is not technically "source code". Compiling source code would be a subclass of this class (as would compiling Java bytecode, etc.).
+ Source code can be automatically generated to some extent, but we're assuming humans still curate it minimally. Also, in the case of Java and its JVM, it's machine interpretable instructions, not directly executable. Ditto for other languages with intermediate form like Java byte code.
+ compiling software
+
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+ creating a data set
+ A planned process that has a data set as its specified output.
+ William R. Hogan
+ data set creation
+ dataset creation
+ dataset creating
+
-
+
-
+
+
+
+ entity
+ Entity
+ Julius Caesar
+ Verdi’s Requiem
+ the Second World War
+ your body mass index
+ BFO 2 Reference: In all areas of empirical inquiry we encounter general terms of two sorts. First are general terms which refer to universals or types:animaltuberculosissurgical procedurediseaseSecond, are general terms used to refer to groups of entities which instantiate a given universal but do not correspond to the extension of any subuniversal of that universal because there is nothing intrinsic to the entities in question by virtue of which they – and only they – are counted as belonging to the given group. Examples are: animal purchased by the Emperortuberculosis diagnosed on a Wednesdaysurgical procedure performed on a patient from Stockholmperson identified as candidate for clinical trial #2056-555person who is signatory of Form 656-PPVpainting by Leonardo da VinciSuch terms, which represent what are called ‘specializations’ in [81
+ Entity doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example Werner Ceusters 'portions of reality' include 4 sorts, entities (as BFO construes them), universals, configurations, and relations. It is an open question as to whether entities as construed in BFO will at some point also include these other portions of reality. See, for example, 'How to track absolutely everything' at http://www.referent-tracking.com/_RTU/papers/CeustersICbookRevised.pdf
+ An entity is anything that exists or has existed or will exist. (axiom label in BFO2 Reference: [001-001])
+
+ entity
+
+
+
+
+ Entity doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example Werner Ceusters 'portions of reality' include 4 sorts, entities (as BFO construes them), universals, configurations, and relations. It is an open question as to whether entities as construed in BFO will at some point also include these other portions of reality. See, for example, 'How to track absolutely everything' at http://www.referent-tracking.com/_RTU/papers/CeustersICbookRevised.pdf
+
+ per discussion with Barry Smith
+
+
+
+
+
+ An entity is anything that exists or has existed or will exist. (axiom label in BFO2 Reference: [001-001])
+
+
-
+
-
+
+
+
+
+
+
+
+
+
+ continuant
+ Continuant
+ continuant
+ An entity that exists in full at any time in which it exists at all, persists through time while maintaining its identity and has no temporal parts.
+ BFO 2 Reference: Continuant entities are entities which can be sliced to yield parts only along the spatial dimension, yielding for example the parts of your table which we call its legs, its top, its nails. ‘My desk stretches from the window to the door. It has spatial parts, and can be sliced (in space) in two. With respect to time, however, a thing is a continuant.’ [60, p. 240
+ Continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example, in an expansion involving bringing in some of Ceuster's other portions of reality, questions are raised as to whether universals are continuants
+
+ A continuant is an entity that persists, endures, or continues to exist through time while maintaining its identity. (axiom label in BFO2 Reference: [008-002])
+ if b is a continuant and if, for some t, c has_continuant_part b at t, then c is a continuant. (axiom label in BFO2 Reference: [126-001])
+ if b is a continuant and if, for some t, cis continuant_part of b at t, then c is a continuant. (axiom label in BFO2 Reference: [009-002])
+ if b is a material entity, then there is some temporal interval (referred to below as a one-dimensional temporal region) during which b exists. (axiom label in BFO2 Reference: [011-002])
+ (forall (x y) (if (and (Continuant x) (exists (t) (continuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [009-002]
+ (forall (x y) (if (and (Continuant x) (exists (t) (hasContinuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [126-001]
+ (forall (x) (if (Continuant x) (Entity x))) // axiom label in BFO2 CLIF: [008-002]
+ (forall (x) (if (Material Entity x) (exists (t) (and (TemporalRegion t) (existsAt x t))))) // axiom label in BFO2 CLIF: [011-002]
+
+ continuant
+
+
+
+
+ Continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example, in an expansion involving bringing in some of Ceuster's other portions of reality, questions are raised as to whether universals are continuants
+
+
+
+
+
+ A continuant is an entity that persists, endures, or continues to exist through time while maintaining its identity. (axiom label in BFO2 Reference: [008-002])
+
+
+
+
+
+ if b is a continuant and if, for some t, c has_continuant_part b at t, then c is a continuant. (axiom label in BFO2 Reference: [126-001])
+
+
+
+
+
+ if b is a continuant and if, for some t, cis continuant_part of b at t, then c is a continuant. (axiom label in BFO2 Reference: [009-002])
+
+
+
+
+
+ if b is a material entity, then there is some temporal interval (referred to below as a one-dimensional temporal region) during which b exists. (axiom label in BFO2 Reference: [011-002])
+
+
+
+
+
+ (forall (x y) (if (and (Continuant x) (exists (t) (continuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [009-002]
+
+
+
+
+
+ (forall (x y) (if (and (Continuant x) (exists (t) (hasContinuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [126-001]
+
+
+
+
+
+ (forall (x) (if (Continuant x) (Entity x))) // axiom label in BFO2 CLIF: [008-002]
+
+
+
+
+
+ (forall (x) (if (Material Entity x) (exists (t) (and (TemporalRegion t) (existsAt x t))))) // axiom label in BFO2 CLIF: [011-002]
+
+
-
+
-
+
+
+
+
+
+
+
+
+ occurrent
+ Occurrent
+ An entity that has temporal parts and that happens, unfolds or develops through time.
+ BFO 2 Reference: every occurrent that is not a temporal or spatiotemporal region is s-dependent on some independent continuant that is not a spatial region
+ BFO 2 Reference: s-dependence obtains between every process and its participants in the sense that, as a matter of necessity, this process could not have existed unless these or those participants existed also. A process may have a succession of participants at different phases of its unfolding. Thus there may be different players on the field at different times during the course of a football game; but the process which is the entire game s-depends_on all of these players nonetheless. Some temporal parts of this process will s-depend_on on only some of the players.
+ Occurrent doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the sum of a process and the process boundary of another process.
+ Simons uses different terminology for relations of occurrents to regions: Denote the spatio-temporal location of a given occurrent e by 'spn[e]' and call this region its span. We may say an occurrent is at its span, in any larger region, and covers any smaller region. Now suppose we have fixed a frame of reference so that we can speak not merely of spatio-temporal but also of spatial regions (places) and temporal regions (times). The spread of an occurrent, (relative to a frame of reference) is the space it exactly occupies, and its spell is likewise the time it exactly occupies. We write 'spr[e]' and `spl[e]' respectively for the spread and spell of e, omitting mention of the frame.
+ An occurrent is an entity that unfolds itself in time or it is the instantaneous boundary of such an entity (for example a beginning or an ending) or it is a temporal or spatiotemporal region which such an entity occupies_temporal_region or occupies_spatiotemporal_region. (axiom label in BFO2 Reference: [077-002])
+ Every occurrent occupies_spatiotemporal_region some spatiotemporal region. (axiom label in BFO2 Reference: [108-001])
+ b is an occurrent entity iff b is an entity that has temporal parts. (axiom label in BFO2 Reference: [079-001])
+ (forall (x) (if (Occurrent x) (exists (r) (and (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion x r))))) // axiom label in BFO2 CLIF: [108-001]
+ (forall (x) (iff (Occurrent x) (and (Entity x) (exists (y) (temporalPartOf y x))))) // axiom label in BFO2 CLIF: [079-001]
+
+ occurrent
+
+
+
+
+ Occurrent doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the sum of a process and the process boundary of another process.
+
+ per discussion with Barry Smith
+
+
+
+
+ Simons uses different terminology for relations of occurrents to regions: Denote the spatio-temporal location of a given occurrent e by 'spn[e]' and call this region its span. We may say an occurrent is at its span, in any larger region, and covers any smaller region. Now suppose we have fixed a frame of reference so that we can speak not merely of spatio-temporal but also of spatial regions (places) and temporal regions (times). The spread of an occurrent, (relative to a frame of reference) is the space it exactly occupies, and its spell is likewise the time it exactly occupies. We write 'spr[e]' and `spl[e]' respectively for the spread and spell of e, omitting mention of the frame.
+
+
+
+
+
+ An occurrent is an entity that unfolds itself in time or it is the instantaneous boundary of such an entity (for example a beginning or an ending) or it is a temporal or spatiotemporal region which such an entity occupies_temporal_region or occupies_spatiotemporal_region. (axiom label in BFO2 Reference: [077-002])
+
+
+
+
+
+ Every occurrent occupies_spatiotemporal_region some spatiotemporal region. (axiom label in BFO2 Reference: [108-001])
+
+
+
+
+
+ b is an occurrent entity iff b is an entity that has temporal parts. (axiom label in BFO2 Reference: [079-001])
+
+
+
+
+
+ (forall (x) (if (Occurrent x) (exists (r) (and (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion x r))))) // axiom label in BFO2 CLIF: [108-001]
+
+
+
+
+
+ (forall (x) (iff (Occurrent x) (and (Entity x) (exists (y) (temporalPartOf y x))))) // axiom label in BFO2 CLIF: [079-001]
+
+
-
+
-
+
+
+
+
+ ic
+ IndependentContinuant
+ a chair
+ a heart
+ a leg
+ a molecule
+ a spatial region
+ an atom
+ an orchestra.
+ an organism
+ the bottom right portion of a human torso
+ the interior of your mouth
+ A continuant that is a bearer of quality and realizable entity entities, in which other entities inhere and which itself cannot inhere in anything.
+ b is an independent continuant = Def. b is a continuant which is such that there is no c and no t such that b s-depends_on c at t. (axiom label in BFO2 Reference: [017-002])
+ For any independent continuant b and any time t there is some spatial region r such that b is located_in r at t. (axiom label in BFO2 Reference: [134-001])
+ For every independent continuant b and time t during the region of time spanned by its life, there are entities which s-depends_on b during t. (axiom label in BFO2 Reference: [018-002])
+ (forall (x t) (if (IndependentContinuant x) (exists (r) (and (SpatialRegion r) (locatedInAt x r t))))) // axiom label in BFO2 CLIF: [134-001]
+ (forall (x t) (if (and (IndependentContinuant x) (existsAt x t)) (exists (y) (and (Entity y) (specificallyDependsOnAt y x t))))) // axiom label in BFO2 CLIF: [018-002]
+ (iff (IndependentContinuant a) (and (Continuant a) (not (exists (b t) (specificallyDependsOnAt a b t))))) // axiom label in BFO2 CLIF: [017-002]
+
+ independent continuant
+
+
+
+
+ For every independent continuant b and time t during the region of time spanned by its life, there are entities which s-depends_on b during t. (axiom label in BFO2 Reference: [018-002])
+
+
+
+
+
+ (forall (x t) (if (IndependentContinuant x) (exists (r) (and (SpatialRegion r) (locatedInAt x r t))))) // axiom label in BFO2 CLIF: [134-001]
+
+
+
+
+
+ (forall (x t) (if (and (IndependentContinuant x) (existsAt x t)) (exists (y) (and (Entity y) (specificallyDependsOnAt y x t))))) // axiom label in BFO2 CLIF: [018-002]
+
+
+
+
+
+ (iff (IndependentContinuant a) (and (Continuant a) (not (exists (b t) (specificallyDependsOnAt a b t))))) // axiom label in BFO2 CLIF: [017-002]
+
+
+
+
+
+ b is an independent continuant = Def. b is a continuant which is such that there is no c and no t such that b s-depends_on c at t. (axiom label in BFO2 Reference: [017-002])
+
+
+
+
+
+ For any independent continuant b and any time t there is some spatial region r such that b is located_in r at t. (axiom label in BFO2 Reference: [134-001])
+
+
-
+
-
+
+
+ A continuant that is either dependent on one or other independent continuant bearers or inheres in or is borne by other entities.
+ obsolete dependent continuant
+ true
+
-
+
-
+
+
+
+
+ s-region
+ SpatialRegion
+ BFO 2 Reference: Spatial regions do not participate in processes.
+ Spatial region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the union of a spatial point and a spatial line that doesn't overlap the point, or two spatial lines that intersect at a single point. In both cases the resultant spatial region is neither 0-dimensional, 1-dimensional, 2-dimensional, or 3-dimensional.
+ A spatial region is a continuant entity that is a continuant_part_of spaceR as defined relative to some frame R. (axiom label in BFO2 Reference: [035-001])
+ All continuant parts of spatial regions are spatial regions. (axiom label in BFO2 Reference: [036-001])
+ (forall (x y t) (if (and (SpatialRegion x) (continuantPartOfAt y x t)) (SpatialRegion y))) // axiom label in BFO2 CLIF: [036-001]
+ (forall (x) (if (SpatialRegion x) (Continuant x))) // axiom label in BFO2 CLIF: [035-001]
+
+ spatial region
+
+
+
+
+ Spatial region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the union of a spatial point and a spatial line that doesn't overlap the point, or two spatial lines that intersect at a single point. In both cases the resultant spatial region is neither 0-dimensional, 1-dimensional, 2-dimensional, or 3-dimensional.
+
+ per discussion with Barry Smith
+
+
+
+
+ A spatial region is a continuant entity that is a continuant_part_of spaceR as defined relative to some frame R. (axiom label in BFO2 Reference: [035-001])
+
+
+
+
+
+ All continuant parts of spatial regions are spatial regions. (axiom label in BFO2 Reference: [036-001])
+
+
+
+
+
+ (forall (x y t) (if (and (SpatialRegion x) (continuantPartOfAt y x t)) (SpatialRegion y))) // axiom label in BFO2 CLIF: [036-001]
+
+
+
+
+
+ (forall (x) (if (SpatialRegion x) (Continuant x))) // axiom label in BFO2 CLIF: [035-001]
+
+
-
+
-
+
+
+
+
+
+ t-region
+ TemporalRegion
+ Temporal region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the mereological sum of a temporal instant and a temporal interval that doesn't overlap the instant. In this case the resultant temporal region is neither 0-dimensional nor 1-dimensional
+ A temporal region is an occurrent entity that is part of time as defined relative to some reference frame. (axiom label in BFO2 Reference: [100-001])
+ All parts of temporal regions are temporal regions. (axiom label in BFO2 Reference: [101-001])
+ Every temporal region t is such that t occupies_temporal_region t. (axiom label in BFO2 Reference: [119-002])
+ (forall (r) (if (TemporalRegion r) (occupiesTemporalRegion r r))) // axiom label in BFO2 CLIF: [119-002]
+ (forall (x y) (if (and (TemporalRegion x) (occurrentPartOf y x)) (TemporalRegion y))) // axiom label in BFO2 CLIF: [101-001]
+ (forall (x) (if (TemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [100-001]
+
+ temporal region
+
+
+
+
+ Temporal region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the mereological sum of a temporal instant and a temporal interval that doesn't overlap the instant. In this case the resultant temporal region is neither 0-dimensional nor 1-dimensional
+
+ per discussion with Barry Smith
+
+
+
+
+ A temporal region is an occurrent entity that is part of time as defined relative to some reference frame. (axiom label in BFO2 Reference: [100-001])
+
+
+
+
+
+ All parts of temporal regions are temporal regions. (axiom label in BFO2 Reference: [101-001])
+
+
+
+
+
+ Every temporal region t is such that t occupies_temporal_region t. (axiom label in BFO2 Reference: [119-002])
+
+
+
+
+
+ (forall (r) (if (TemporalRegion r) (occupiesTemporalRegion r r))) // axiom label in BFO2 CLIF: [119-002]
+
+
+
+
+
+ (forall (x y) (if (and (TemporalRegion x) (occurrentPartOf y x)) (TemporalRegion y))) // axiom label in BFO2 CLIF: [101-001]
+
+
+
+
+
+ (forall (x) (if (TemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [100-001]
+
+
-
+
-
+
+
+
+ 2d-s-region
+ TwoDimensionalSpatialRegion
+ an infinitely thin plane in space.
+ the surface of a sphere-shaped part of space
+ A two-dimensional spatial region is a spatial region that is of two dimensions. (axiom label in BFO2 Reference: [039-001])
+ (forall (x) (if (TwoDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [039-001]
+
+ two-dimensional spatial region
+
+
+
+
+ A two-dimensional spatial region is a spatial region that is of two dimensions. (axiom label in BFO2 Reference: [039-001])
+
+
+
+
+
+ (forall (x) (if (TwoDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [039-001]
+
+
-
-
-
+
+
+
+
+ st-region
+ SpatiotemporalRegion
+ the spatiotemporal region occupied by a human life
+ the spatiotemporal region occupied by a process of cellular meiosis.
+ the spatiotemporal region occupied by the development of a cancer tumor
+ A spatiotemporal region is an occurrent entity that is part of spacetime. (axiom label in BFO2 Reference: [095-001])
+ All parts of spatiotemporal regions are spatiotemporal regions. (axiom label in BFO2 Reference: [096-001])
+ Each spatiotemporal region at any time t projects_onto some spatial region at t. (axiom label in BFO2 Reference: [099-001])
+ Each spatiotemporal region projects_onto some temporal region. (axiom label in BFO2 Reference: [098-001])
+ Every spatiotemporal region occupies_spatiotemporal_region itself.
+ Every spatiotemporal region s is such that s occupies_spatiotemporal_region s. (axiom label in BFO2 Reference: [107-002])
+ (forall (r) (if (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion r r))) // axiom label in BFO2 CLIF: [107-002]
+ (forall (x t) (if (SpatioTemporalRegion x) (exists (y) (and (SpatialRegion y) (spatiallyProjectsOntoAt x y t))))) // axiom label in BFO2 CLIF: [099-001]
+ (forall (x y) (if (and (SpatioTemporalRegion x) (occurrentPartOf y x)) (SpatioTemporalRegion y))) // axiom label in BFO2 CLIF: [096-001]
+ (forall (x) (if (SpatioTemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [095-001]
+ (forall (x) (if (SpatioTemporalRegion x) (exists (y) (and (TemporalRegion y) (temporallyProjectsOnto x y))))) // axiom label in BFO2 CLIF: [098-001]
+
+ spatiotemporal region
+
+
+
+
+ A spatiotemporal region is an occurrent entity that is part of spacetime. (axiom label in BFO2 Reference: [095-001])
+
+
+
+
+
+ All parts of spatiotemporal regions are spatiotemporal regions. (axiom label in BFO2 Reference: [096-001])
+
+
+
+
+
+ Each spatiotemporal region at any time t projects_onto some spatial region at t. (axiom label in BFO2 Reference: [099-001])
+
+
+
+
+
+ Each spatiotemporal region projects_onto some temporal region. (axiom label in BFO2 Reference: [098-001])
+
+
+
+
+
+ Every spatiotemporal region s is such that s occupies_spatiotemporal_region s. (axiom label in BFO2 Reference: [107-002])
+
+
+
+
+
+ (forall (r) (if (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion r r))) // axiom label in BFO2 CLIF: [107-002]
+
+
+
+
+
+ (forall (x t) (if (SpatioTemporalRegion x) (exists (y) (and (SpatialRegion y) (spatiallyProjectsOntoAt x y t))))) // axiom label in BFO2 CLIF: [099-001]
+
+
+
+
+
+ (forall (x y) (if (and (SpatioTemporalRegion x) (occurrentPartOf y x)) (SpatioTemporalRegion y))) // axiom label in BFO2 CLIF: [096-001]
+
+
+
+
+
+ (forall (x) (if (SpatioTemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [095-001]
+
+
+
+
+
+ (forall (x) (if (SpatioTemporalRegion x) (exists (y) (and (TemporalRegion y) (temporallyProjectsOnto x y))))) // axiom label in BFO2 CLIF: [098-001]
+
+
-
+
-
+
+
+ process
+ Process
+ a process of cell-division, \ a beating of the heart
+ a process of meiosis
+ a process of sleeping
+ the course of a disease
+ the flight of a bird
+ the life of an organism
+ your process of aging.
+ An occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t.
+ p is a process = Def. p is an occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. (axiom label in BFO2 Reference: [083-003])
+ BFO 2 Reference: The realm of occurrents is less pervasively marked by the presence of natural units than is the case in the realm of independent continuants. Thus there is here no counterpart of ‘object’. In BFO 1.0 ‘process’ served as such a counterpart. In BFO 2.0 ‘process’ is, rather, the occurrent counterpart of ‘material entity’. Those natural – as contrasted with engineered, which here means: deliberately executed – units which do exist in the realm of occurrents are typically either parasitic on the existence of natural units on the continuant side, or they are fiat in nature. Thus we can count lives; we can count football games; we can count chemical reactions performed in experiments or in chemical manufacturing. We cannot count the processes taking place, for instance, in an episode of insect mating behavior.Even where natural units are identifiable, for example cycles in a cyclical process such as the beating of a heart or an organism’s sleep/wake cycle, the processes in question form a sequence with no discontinuities (temporal gaps) of the sort that we find for instance where billiard balls or zebrafish or planets are separated by clear spatial gaps. Lives of organisms are process units, but they too unfold in a continuous series from other, prior processes such as fertilization, and they unfold in turn in continuous series of post-life processes such as post-mortem decay. Clear examples of boundaries of processes are almost always of the fiat sort (midnight, a time of death as declared in an operating theater or on a death certificate, the initiation of a state of war)
+ (iff (Process a) (and (Occurrent a) (exists (b) (properTemporalPartOf b a)) (exists (c t) (and (MaterialEntity c) (specificallyDependsOnAt a c t))))) // axiom label in BFO2 CLIF: [083-003]
+
+ process
+
+
+
+
+ p is a process = Def. p is an occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. (axiom label in BFO2 Reference: [083-003])
+
+
+
+
+
+ (iff (Process a) (and (Occurrent a) (exists (b) (properTemporalPartOf b a)) (exists (c t) (and (MaterialEntity c) (specificallyDependsOnAt a c t))))) // axiom label in BFO2 CLIF: [083-003]
+
+
-
+
-
+
+
+
+ disposition
+ Disposition
+ an atom of element X has the disposition to decay to an atom of element Y
+ certain people have a predisposition to colon cancer
+ children are innately disposed to categorize objects in certain ways.
+ the cell wall is disposed to filter chemicals in endocytosis and exocytosis
+ BFO 2 Reference: Dispositions exist along a strength continuum. Weaker forms of disposition are realized in only a fraction of triggering cases. These forms occur in a significant number of cases of a similar type.
+ b is a disposition means: b is a realizable entity & b’s bearer is some material entity & b is such that if it ceases to exist, then its bearer is physically changed, & b’s realization occurs when and because this bearer is in some special physical circumstances, & this realization occurs in virtue of the bearer’s physical make-up. (axiom label in BFO2 Reference: [062-002])
+ If b is a realizable entity then for all t at which b exists, b s-depends_on some material entity at t. (axiom label in BFO2 Reference: [063-002])
+ (forall (x t) (if (and (RealizableEntity x) (existsAt x t)) (exists (y) (and (MaterialEntity y) (specificallyDepends x y t))))) // axiom label in BFO2 CLIF: [063-002]
+ (forall (x) (if (Disposition x) (and (RealizableEntity x) (exists (y) (and (MaterialEntity y) (bearerOfAt x y t)))))) // axiom label in BFO2 CLIF: [062-002]
+
+ disposition
+
+
+
+
+ b is a disposition means: b is a realizable entity & b’s bearer is some material entity & b is such that if it ceases to exist, then its bearer is physically changed, & b’s realization occurs when and because this bearer is in some special physical circumstances, & this realization occurs in virtue of the bearer’s physical make-up. (axiom label in BFO2 Reference: [062-002])
+
+
+
+
+
+ If b is a realizable entity then for all t at which b exists, b s-depends_on some material entity at t. (axiom label in BFO2 Reference: [063-002])
+
+
+
+
+
+ (forall (x t) (if (and (RealizableEntity x) (existsAt x t)) (exists (y) (and (MaterialEntity y) (specificallyDepends x y t))))) // axiom label in BFO2 CLIF: [063-002]
+
+
+
+
+
+ (forall (x) (if (Disposition x) (and (RealizableEntity x) (exists (y) (and (MaterialEntity y) (bearerOfAt x y t)))))) // axiom label in BFO2 CLIF: [062-002]
+
+
-
+
-
-
-
-
-
-
-
+
+
+
+ realizable
+ RealizableEntity
+ the disposition of this piece of metal to conduct electricity.
+ the disposition of your blood to coagulate
+ the function of your reproductive organs
+ the role of being a doctor
+ the role of this boundary to delineate where Utah and Colorado meet
+ A specifically dependent continuant that inheres in continuant entities and are not exhibited in full at every time in which it inheres in an entity or group of entities. The exhibition or actualization of a realizable entity is a particular manifestation, functioning or process that occurs under certain circumstances.
+ To say that b is a realizable entity is to say that b is a specifically dependent continuant that inheres in some independent continuant which is not a spatial region and is of a type instances of which are realized in processes of a correlated type. (axiom label in BFO2 Reference: [058-002])
+ All realizable dependent continuants have independent continuants that are not spatial regions as their bearers. (axiom label in BFO2 Reference: [060-002])
+ (forall (x t) (if (RealizableEntity x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (bearerOfAt y x t))))) // axiom label in BFO2 CLIF: [060-002]
+ (forall (x) (if (RealizableEntity x) (and (SpecificallyDependentContinuant x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (inheresIn x y)))))) // axiom label in BFO2 CLIF: [058-002]
+
+ realizable entity
+
+
+
+ To say that b is a realizable entity is to say that b is a specifically dependent continuant that inheres in some independent continuant which is not a spatial region and is of a type instances of which are realized in processes of a correlated type. (axiom label in BFO2 Reference: [058-002])
+
+
+
+
+
+ All realizable dependent continuants have independent continuants that are not spatial regions as their bearers. (axiom label in BFO2 Reference: [060-002])
+
+
+
+
+
+ (forall (x t) (if (RealizableEntity x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (bearerOfAt y x t))))) // axiom label in BFO2 CLIF: [060-002]
+
+
+
+
+
+ (forall (x) (if (RealizableEntity x) (and (SpecificallyDependentContinuant x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (inheresIn x y)))))) // axiom label in BFO2 CLIF: [058-002]
+
+
-
+
-
+
+
+
+ 0d-s-region
+ ZeroDimensionalSpatialRegion
+ A zero-dimensional spatial region is a point in space. (axiom label in BFO2 Reference: [037-001])
+ (forall (x) (if (ZeroDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [037-001]
+
+ zero-dimensional spatial region
+
+
+
+
+ A zero-dimensional spatial region is a point in space. (axiom label in BFO2 Reference: [037-001])
+
+
+
+
+
+ (forall (x) (if (ZeroDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [037-001]
+
+
-
+
-
+
+
+ quality
+ Quality
+ quality
+ the ambient temperature of this portion of air
+ the color of a tomato
+ the length of the circumference of your waist
+ the mass of this piece of gold.
+ the shape of your nose
+ the shape of your nostril
+
+ a quality is a specifically dependent continuant that, in contrast to roles and dispositions, does not require any further process in order to be realized. (axiom label in BFO2 Reference: [055-001])
+ If an entity is a quality at any time that it exists, then it is a quality at every time that it exists. (axiom label in BFO2 Reference: [105-001])
+ (forall (x) (if (Quality x) (SpecificallyDependentContinuant x))) // axiom label in BFO2 CLIF: [055-001]
+ (forall (x) (if (exists (t) (and (existsAt x t) (Quality x))) (forall (t_1) (if (existsAt x t_1) (Quality x))))) // axiom label in BFO2 CLIF: [105-001]
+
+ quality
+
+
+
+
+ a quality is a specifically dependent continuant that, in contrast to roles and dispositions, does not require any further process in order to be realized. (axiom label in BFO2 Reference: [055-001])
+
+
+
+
+
+ If an entity is a quality at any time that it exists, then it is a quality at every time that it exists. (axiom label in BFO2 Reference: [105-001])
+
+
+
+
+
+ (forall (x) (if (Quality x) (SpecificallyDependentContinuant x))) // axiom label in BFO2 CLIF: [055-001]
+
+
+
+
+
+ (forall (x) (if (exists (t) (and (existsAt x t) (Quality x))) (forall (t_1) (if (existsAt x t_1) (Quality x))))) // axiom label in BFO2 CLIF: [105-001]
+
+
-
+
-
+
+
+
+ sdc
+ SpecificallyDependentContinuant
+ specifically dependent continuant
+ Reciprocal specifically dependent continuants: the function of this key to open this lock and the mutually dependent disposition of this lock: to be opened by this key
+ of one-sided specifically dependent continuants: the mass of this tomato
+ of relational dependent continuants (multiple bearers): John’s love for Mary, the ownership relation between John and this statue, the relation of authority between John and his subordinates.
+ the disposition of this fish to decay
+ the function of this heart: to pump blood
+ the mutual dependence of proton donors and acceptors in chemical reactions [79
+ the mutual dependence of the role predator and the role prey as played by two organisms in a given interaction
+ the pink color of a medium rare piece of grilled filet mignon at its center
+ the role of being a doctor
+ the shape of this hole.
+ the smell of this portion of mozzarella
+ A continuant that inheres in or is borne by other entities. Every instance of A requires some specific instance of B which must always be the same.
+ b is a relational specifically dependent continuant = Def. b is a specifically dependent continuant and there are n > 1 independent continuants c1, … cn which are not spatial regions are such that for all 1 i < j n, ci and cj share no common parts, are such that for each 1 i n, b s-depends_on ci at every time t during the course of b’s existence (axiom label in BFO2 Reference: [131-004])
+ b is a specifically dependent continuant = Def. b is a continuant & there is some independent continuant c which is not a spatial region and which is such that b s-depends_on c at every time t during the course of b’s existence. (axiom label in BFO2 Reference: [050-003])
+ Specifically dependent continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. We're not sure what else will develop here, but for example there are questions such as what are promises, obligation, etc.
+
+ (iff (RelationalSpecificallyDependentContinuant a) (and (SpecificallyDependentContinuant a) (forall (t) (exists (b c) (and (not (SpatialRegion b)) (not (SpatialRegion c)) (not (= b c)) (not (exists (d) (and (continuantPartOfAt d b t) (continuantPartOfAt d c t)))) (specificallyDependsOnAt a b t) (specificallyDependsOnAt a c t)))))) // axiom label in BFO2 CLIF: [131-004]
+ (iff (SpecificallyDependentContinuant a) (and (Continuant a) (forall (t) (if (existsAt a t) (exists (b) (and (IndependentContinuant b) (not (SpatialRegion b)) (specificallyDependsOnAt a b t))))))) // axiom label in BFO2 CLIF: [050-003]
+
+ specifically dependent continuant
+
+
+
+
+ b is a relational specifically dependent continuant = Def. b is a specifically dependent continuant and there are n > 1 independent continuants c1, … cn which are not spatial regions are such that for all 1 i < j n, ci and cj share no common parts, are such that for each 1 i n, b s-depends_on ci at every time t during the course of b’s existence (axiom label in BFO2 Reference: [131-004])
+
+
+
+
+
+ b is a specifically dependent continuant = Def. b is a continuant & there is some independent continuant c which is not a spatial region and which is such that b s-depends_on c at every time t during the course of b’s existence. (axiom label in BFO2 Reference: [050-003])
+
+
+
+
+
+ Specifically dependent continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. We're not sure what else will develop here, but for example there are questions such as what are promises, obligation, etc.
+
+ per discussion with Barry Smith
+
+
+
+
+ (iff (RelationalSpecificallyDependentContinuant a) (and (SpecificallyDependentContinuant a) (forall (t) (exists (b c) (and (not (SpatialRegion b)) (not (SpatialRegion c)) (not (= b c)) (not (exists (d) (and (continuantPartOfAt d b t) (continuantPartOfAt d c t)))) (specificallyDependsOnAt a b t) (specificallyDependsOnAt a c t)))))) // axiom label in BFO2 CLIF: [131-004]
+
+
+
+
+
+ (iff (SpecificallyDependentContinuant a) (and (Continuant a) (forall (t) (if (existsAt a t) (exists (b) (and (IndependentContinuant b) (not (SpatialRegion b)) (specificallyDependsOnAt a b t))))))) // axiom label in BFO2 CLIF: [050-003]
+
+
-
+
-
+
+
+ role
+ Role
+ John’s role of husband to Mary is dependent on Mary’s role of wife to John, and both are dependent on the object aggregate comprising John and Mary as member parts joined together through the relational quality of being married.
+ the priest role
+ the role of a boundary to demarcate two neighboring administrative territories
+ the role of a building in serving as a military target
+ the role of a stone in marking a property boundary
+ the role of subject in a clinical trial
+ the student role
+ A realizable entity the manifestation of which brings about some result or end that is not essential to a continuant in virtue of the kind of thing that it is but that can be served or participated in by that kind of continuant in some kinds of natural, social or institutional contexts.
+ BFO 2 Reference: One major family of examples of non-rigid universals involves roles, and ontologies developed for corresponding administrative purposes may consist entirely of representatives of entities of this sort. Thus ‘professor’, defined as follows,b instance_of professor at t =Def. there is some c, c instance_of professor role & c inheres_in b at t.denotes a non-rigid universal and so also do ‘nurse’, ‘student’, ‘colonel’, ‘taxpayer’, and so forth. (These terms are all, in the jargon of philosophy, phase sortals.) By using role terms in definitions, we can create a BFO conformant treatment of such entities drawing on the fact that, while an instance of professor may be simultaneously an instance of trade union member, no instance of the type professor role is also (at any time) an instance of the type trade union member role (any more than any instance of the type color is at any time an instance of the type length).If an ontology of employment positions should be defined in terms of roles following the above pattern, this enables the ontology to do justice to the fact that individuals instantiate the corresponding universals – professor, sergeant, nurse – only during certain phases in their lives.
+ b is a role means: b is a realizable entity & b exists because there is some single bearer that is in some special physical, social, or institutional set of circumstances in which this bearer does not have to be& b is not such that, if it ceases to exist, then the physical make-up of the bearer is thereby changed. (axiom label in BFO2 Reference: [061-001])
+ (forall (x) (if (Role x) (RealizableEntity x))) // axiom label in BFO2 CLIF: [061-001]
+
+ role
+
+
+
+
+ b is a role means: b is a realizable entity & b exists because there is some single bearer that is in some special physical, social, or institutional set of circumstances in which this bearer does not have to be& b is not such that, if it ceases to exist, then the physical make-up of the bearer is thereby changed. (axiom label in BFO2 Reference: [061-001])
+
+
+
+
+
+ (forall (x) (if (Role x) (RealizableEntity x))) // axiom label in BFO2 CLIF: [061-001]
+
+
-
+
-
+
+
+ fiat-object
+ fiat-object-part
+ FiatObjectPart
+ or with divisions drawn by cognitive subjects for practical reasons, such as the division of a cake (before slicing) into (what will become) slices (and thus member parts of an object aggregate). However, this does not mean that fiat object parts are dependent for their existence on divisions or delineations effected by cognitive subjects. If, for example, it is correct to conceive geological layers of the Earth as fiat object parts of the Earth, then even though these layers were first delineated in recent times, still existed long before such delineation and what holds of these layers (for example that the oldest layers are also the lowest layers) did not begin to hold because of our acts of delineation.Treatment of material entity in BFOExamples viewed by some as problematic cases for the trichotomy of fiat object part, object, and object aggregate include: a mussel on (and attached to) a rock, a slime mold, a pizza, a cloud, a galaxy, a railway train with engine and multiple carriages, a clonal stand of quaking aspen, a bacterial community (biofilm), a broken femur. Note that, as Aristotle already clearly recognized, such problematic cases – which lie at or near the penumbra of instances defined by the categories in question – need not invalidate these categories. The existence of grey objects does not prove that there are not objects which are black and objects which are white; the existence of mules does not prove that there are not objects which are donkeys and objects which are horses. It does, however, show that the examples in question need to be addressed carefully in order to show how they can be fitted into the proposed scheme, for example by recognizing additional subdivisions [29
+ the FMA:regional parts of an intact human body.
+ the Western hemisphere of the Earth
+ the division of the brain into regions
+ the division of the planet into hemispheres
+ the dorsal and ventral surfaces of the body
+ the upper and lower lobes of the left lung
+ BFO 2 Reference: Most examples of fiat object parts are associated with theoretically drawn divisions
+ b is a fiat object part = Def. b is a material entity which is such that for all times t, if b exists at t then there is some object c such that b proper continuant_part of c at t and c is demarcated from the remainder of c by a two-dimensional continuant fiat boundary. (axiom label in BFO2 Reference: [027-004])
+ (forall (x) (if (FiatObjectPart x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y) (and (Object y) (properContinuantPartOfAt x y t)))))))) // axiom label in BFO2 CLIF: [027-004]
+
+ fiat object
+ fiat object part
+
+
+
+
+ b is a fiat object part = Def. b is a material entity which is such that for all times t, if b exists at t then there is some object c such that b proper continuant_part of c at t and c is demarcated from the remainder of c by a two-dimensional continuant fiat boundary. (axiom label in BFO2 Reference: [027-004])
+
+
+
+
+
+ (forall (x) (if (FiatObjectPart x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y) (and (Object y) (properContinuantPartOfAt x y t)))))))) // axiom label in BFO2 CLIF: [027-004]
+
+
-
+
-
+
+
+
+ 1d-s-region
+ OneDimensionalSpatialRegion
+ an edge of a cube-shaped portion of space.
+ A one-dimensional spatial region is a line or aggregate of lines stretching from one point in space to another. (axiom label in BFO2 Reference: [038-001])
+ (forall (x) (if (OneDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [038-001]
+
+ one-dimensional spatial region
+
+
+
+
+ A one-dimensional spatial region is a line or aggregate of lines stretching from one point in space to another. (axiom label in BFO2 Reference: [038-001])
+
+
+
+
+
+ (forall (x) (if (OneDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [038-001]
+
+
-
+
-
+
+
+ object-aggregate
+ ObjectAggregate
+ a collection of cells in a blood biobank.
+ a swarm of bees is an aggregate of members who are linked together through natural bonds
+ a symphony orchestra
+ an organization is an aggregate whose member parts have roles of specific types (for example in a jazz band, a chess club, a football team)
+ defined by fiat: the aggregate of members of an organization
+ defined through physical attachment: the aggregate of atoms in a lump of granite
+ defined through physical containment: the aggregate of molecules of carbon dioxide in a sealed container
+ defined via attributive delimitations such as: the patients in this hospital
+ the aggregate of bearings in a constant velocity axle joint
+ the aggregate of blood cells in your body
+ the nitrogen atoms in the atmosphere
+ the restaurants in Palo Alto
+ your collection of Meissen ceramic plates.
+ An entity a is an object aggregate if and only if there is a mutually exhaustive and pairwise disjoint partition of a into objects
+ BFO 2 Reference: object aggregates may gain and lose parts while remaining numerically identical (one and the same individual) over time. This holds both for aggregates whose membership is determined naturally (the aggregate of cells in your body) and aggregates determined by fiat (a baseball team, a congressional committee).
+ ISBN:978-3-938793-98-5pp124-158#Thomas Bittner and Barry Smith, 'A Theory of Granular Partitions', in K. Munn and B. Smith (eds.), Applied Ontology: An Introduction, Frankfurt/Lancaster: ontos, 2008, 125-158.
+ b is an object aggregate means: b is a material entity consisting exactly of a plurality of objects as member_parts at all times at which b exists. (axiom label in BFO2 Reference: [025-004])
+ (forall (x) (if (ObjectAggregate x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y z) (and (Object y) (Object z) (memberPartOfAt y x t) (memberPartOfAt z x t) (not (= y z)))))) (not (exists (w t_1) (and (memberPartOfAt w x t_1) (not (Object w)))))))) // axiom label in BFO2 CLIF: [025-004]
+
+ object aggregate
+
+
+
+
+ An entity a is an object aggregate if and only if there is a mutually exhaustive and pairwise disjoint partition of a into objects
+
+
+
+
+
+ An entity a is an object aggregate if and only if there is a mutually exhaustive and pairwise disjoint partition of a into objects
+
+
+
+
+
+ ISBN:978-3-938793-98-5pp124-158#Thomas Bittner and Barry Smith, 'A Theory of Granular Partitions', in K. Munn and B. Smith (eds.), Applied Ontology: An Introduction, Frankfurt/Lancaster: ontos, 2008, 125-158.
+
+
+
+
+
+ b is an object aggregate means: b is a material entity consisting exactly of a plurality of objects as member_parts at all times at which b exists. (axiom label in BFO2 Reference: [025-004])
+
+
+
+
+
+ (forall (x) (if (ObjectAggregate x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y z) (and (Object y) (Object z) (memberPartOfAt y x t) (memberPartOfAt z x t) (not (= y z)))))) (not (exists (w t_1) (and (memberPartOfAt w x t_1) (not (Object w)))))))) // axiom label in BFO2 CLIF: [025-004]
+
+
-
-
-
-
-
+
+
+
+
+ 3d-s-region
+ ThreeDimensionalSpatialRegion
+ a cube-shaped region of space
+ a sphere-shaped region of space,
+ A three-dimensional spatial region is a spatial region that is of three dimensions. (axiom label in BFO2 Reference: [040-001])
+ (forall (x) (if (ThreeDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [040-001]
+
+ three-dimensional spatial region
+
+
+
+
+ A three-dimensional spatial region is a spatial region that is of three dimensions. (axiom label in BFO2 Reference: [040-001])
+
+
+
+
+
+ (forall (x) (if (ThreeDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [040-001]
+
+
+
+
+
+
+
+
+
+ site
+ Site
+ Manhattan Canyon)
+ a hole in the interior of a portion of cheese
+ a rabbit hole
+ an air traffic control region defined in the airspace above an airport
+ the Grand Canyon
+ the Piazza San Marco
+ the cockpit of an aircraft
+ the hold of a ship
+ the interior of a kangaroo pouch
+ the interior of the trunk of your car
+ the interior of your bedroom
+ the interior of your office
+ the interior of your refrigerator
+ the lumen of your gut
+ your left nostril (a fiat part – the opening – of your left nasal cavity)
+ b is a site means: b is a three-dimensional immaterial entity that is (partially or wholly) bounded by a material entity or it is a three-dimensional immaterial part thereof. (axiom label in BFO2 Reference: [034-002])
+ (forall (x) (if (Site x) (ImmaterialEntity x))) // axiom label in BFO2 CLIF: [034-002]
+
+ site
+
+
+
+
+ b is a site means: b is a three-dimensional immaterial entity that is (partially or wholly) bounded by a material entity or it is a three-dimensional immaterial part thereof. (axiom label in BFO2 Reference: [034-002])
+
+
+
+
+
+ (forall (x) (if (Site x) (ImmaterialEntity x))) // axiom label in BFO2 CLIF: [034-002]
+
+
+
+
+
+
+
+
+
+ object
+ Object
+ atom
+ cell
+ cells and organisms
+ engineered artifacts
+ grain of sand
+ molecule
+ organelle
+ organism
+ planet
+ solid portions of matter
+ star
+ BFO 2 Reference: BFO rests on the presupposition that at multiple micro-, meso- and macroscopic scales reality exhibits certain stable, spatially separated or separable material units, combined or combinable into aggregates of various sorts (for example organisms into what are called ‘populations’). Such units play a central role in almost all domains of natural science from particle physics to cosmology. Many scientific laws govern the units in question, employing general terms (such as ‘molecule’ or ‘planet’) referring to the types and subtypes of units, and also to the types and subtypes of the processes through which such units develop and interact. The division of reality into such natural units is at the heart of biological science, as also is the fact that these units may form higher-level units (as cells form multicellular organisms) and that they may also form aggregates of units, for example as cells form portions of tissue and organs form families, herds, breeds, species, and so on. At the same time, the division of certain portions of reality into engineered units (manufactured artifacts) is the basis of modern industrial technology, which rests on the distributed mass production of engineered parts through division of labor and on their assembly into larger, compound units such as cars and laptops. The division of portions of reality into units is one starting point for the phenomenon of counting.
+ BFO 2 Reference: Each object is such that there are entities of which we can assert unproblematically that they lie in its interior, and other entities of which we can assert unproblematically that they lie in its exterior. This may not be so for entities lying at or near the boundary between the interior and exterior. This means that two objects – for example the two cells depicted in Figure 3 – may be such that there are material entities crossing their boundaries which belong determinately to neither cell. Something similar obtains in certain cases of conjoined twins (see below).
+ BFO 2 Reference: To say that b is causally unified means: b is a material entity which is such that its material parts are tied together in such a way that, in environments typical for entities of the type in question,if c, a continuant part of b that is in the interior of b at t, is larger than a certain threshold size (which will be determined differently from case to case, depending on factors such as porosity of external cover) and is moved in space to be at t at a location on the exterior of the spatial region that had been occupied by b at t, then either b’s other parts will be moved in coordinated fashion or b will be damaged (be affected, for example, by breakage or tearing) in the interval between t and t.causal changes in one part of b can have consequences for other parts of b without the mediation of any entity that lies on the exterior of b. Material entities with no proper material parts would satisfy these conditions trivially. Candidate examples of types of causal unity for material entities of more complex sorts are as follows (this is not intended to be an exhaustive list):CU1: Causal unity via physical coveringHere the parts in the interior of the unified entity are combined together causally through a common membrane or other physical covering\. The latter points outwards toward and may serve a protective function in relation to what lies on the exterior of the entity [13, 47
+ BFO 2 Reference: an object is a maximal causally unified material entity
+ BFO 2 Reference: ‘objects’ are sometimes referred to as ‘grains’ [74
+ b is an object means: b is a material entity which manifests causal unity of one or other of the types CUn listed above & is of a type (a material universal) instances of which are maximal relative to this criterion of causal unity. (axiom label in BFO2 Reference: [024-001])
+
+ object
+
+
+
+
+ b is an object means: b is a material entity which manifests causal unity of one or other of the types CUn listed above & is of a type (a material universal) instances of which are maximal relative to this criterion of causal unity. (axiom label in BFO2 Reference: [024-001])
+
+
+
+
+
+
+
+
+
+ gdc
+ GenericallyDependentContinuant
+ The entries in your database are patterns instantiated as quality instances in your hard drive. The database itself is an aggregate of such patterns. When you create the database you create a particular instance of the generically dependent continuant type database. Each entry in the database is an instance of the generically dependent continuant type IAO: information content entity.
+ the pdf file on your laptop, the pdf file that is a copy thereof on my laptop
+ the sequence of this protein molecule; the sequence that is a copy thereof in that protein molecule.
+ A continuant that is dependent on one or other independent continuant bearers. For every instance of A requires some instance of (an independent continuant type) B but which instance of B serves can change from time to time.
+ b is a generically dependent continuant = Def. b is a continuant that g-depends_on one or more other entities. (axiom label in BFO2 Reference: [074-001])
+ (iff (GenericallyDependentContinuant a) (and (Continuant a) (exists (b t) (genericallyDependsOnAt a b t)))) // axiom label in BFO2 CLIF: [074-001]
+
+ generically dependent continuant
+
+
+
+
+ b is a generically dependent continuant = Def. b is a continuant that g-depends_on one or more other entities. (axiom label in BFO2 Reference: [074-001])
+
+
+
+
+
+ (iff (GenericallyDependentContinuant a) (and (Continuant a) (exists (b t) (genericallyDependsOnAt a b t)))) // axiom label in BFO2 CLIF: [074-001]
+
+
+
+
+
+
+
+
+
+ function
+ Function
+ the function of a hammer to drive in nails
+ the function of a heart pacemaker to regulate the beating of a heart through electricity
+ the function of amylase in saliva to break down starch into sugar
+ BFO 2 Reference: In the past, we have distinguished two varieties of function, artifactual function and biological function. These are not asserted subtypes of BFO:function however, since the same function – for example: to pump, to transport – can exist both in artifacts and in biological entities. The asserted subtypes of function that would be needed in order to yield a separate monoheirarchy are not artifactual function, biological function, etc., but rather transporting function, pumping function, etc.
+ A function is a disposition that exists in virtue of the bearer’s physical make-up and this physical make-up is something the bearer possesses because it came into being, either through evolution (in the case of natural biological entities) or through intentional design (in the case of artifacts), in order to realize processes of a certain sort. (axiom label in BFO2 Reference: [064-001])
+ (forall (x) (if (Function x) (Disposition x))) // axiom label in BFO2 CLIF: [064-001]
+
+ function
+
+
+
+
+ A function is a disposition that exists in virtue of the bearer’s physical make-up and this physical make-up is something the bearer possesses because it came into being, either through evolution (in the case of natural biological entities) or through intentional design (in the case of artifacts), in order to realize processes of a certain sort. (axiom label in BFO2 Reference: [064-001])
+
+
+
+
+
+ (forall (x) (if (Function x) (Disposition x))) // axiom label in BFO2 CLIF: [064-001]
+
+
+
+
+
+
+
+
+
+ p-boundary
+ ProcessBoundary
+ the boundary between the 2nd and 3rd year of your life.
+ p is a process boundary =Def. p is a temporal part of a process & p has no proper temporal parts. (axiom label in BFO2 Reference: [084-001])
+ Every process boundary occupies_temporal_region a zero-dimensional temporal region. (axiom label in BFO2 Reference: [085-002])
+ (forall (x) (if (ProcessBoundary x) (exists (y) (and (ZeroDimensionalTemporalRegion y) (occupiesTemporalRegion x y))))) // axiom label in BFO2 CLIF: [085-002]
+ (iff (ProcessBoundary a) (exists (p) (and (Process p) (temporalPartOf a p) (not (exists (b) (properTemporalPartOf b a)))))) // axiom label in BFO2 CLIF: [084-001]
+
+ process boundary
+
+
+
+
+ p is a process boundary =Def. p is a temporal part of a process & p has no proper temporal parts. (axiom label in BFO2 Reference: [084-001])
+
+
+
+
+
+ Every process boundary occupies_temporal_region a zero-dimensional temporal region. (axiom label in BFO2 Reference: [085-002])
+
+
+
+
+
+ (forall (x) (if (ProcessBoundary x) (exists (y) (and (ZeroDimensionalTemporalRegion y) (occupiesTemporalRegion x y))))) // axiom label in BFO2 CLIF: [085-002]
+
+
+
+
+
+ (iff (ProcessBoundary a) (exists (p) (and (Process p) (temporalPartOf a p) (not (exists (b) (properTemporalPartOf b a)))))) // axiom label in BFO2 CLIF: [084-001]
+
+
+
+
+
+
+
+
+
+
+ 1d-t-region
+ OneDimensionalTemporalRegion
+ the temporal region during which a process occurs.
+ BFO 2 Reference: A temporal interval is a special kind of one-dimensional temporal region, namely one that is self-connected (is without gaps or breaks).
+ A one-dimensional temporal region is a temporal region that is extended. (axiom label in BFO2 Reference: [103-001])
+ (forall (x) (if (OneDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [103-001]
+
+ one-dimensional temporal region
+
+
+
+
+ A one-dimensional temporal region is a temporal region that is extended. (axiom label in BFO2 Reference: [103-001])
+
+
+
+
+
+ (forall (x) (if (OneDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [103-001]
+
+
+
+
+
+
+
+
+
+
+ material
+ MaterialEntity
+ material entity
+ material entity
+ a flame
+ a forest fire
+ a human being
+ a hurricane
+ a photon
+ a puff of smoke
+ a sea wave
+ a tornado
+ an aggregate of human beings.
+ an energy wave
+ an epidemic
+ the undetached arm of a human being
+ An independent continuant that is spatially extended whose identity is independent of that of other entities and can be maintained through time.
+ BFO 2 Reference: Material entities (continuants) can preserve their identity even while gaining and losing material parts. Continuants are contrasted with occurrents, which unfold themselves in successive temporal parts or phases [60
+ BFO 2 Reference: Object, Fiat Object Part and Object Aggregate are not intended to be exhaustive of Material Entity. Users are invited to propose new subcategories of Material Entity.
+ BFO 2 Reference: ‘Matter’ is intended to encompass both mass and energy (we will address the ontological treatment of portions of energy in a later version of BFO). A portion of matter is anything that includes elementary particles among its proper or improper parts: quarks and leptons, including electrons, as the smallest particles thus far discovered; baryons (including protons and neutrons) at a higher level of granularity; atoms and molecules at still higher levels, forming the cells, organs, organisms and other material entities studied by biologists, the portions of rock studied by geologists, the fossils studied by paleontologists, and so on.Material entities are three-dimensional entities (entities extended in three spatial dimensions), as contrasted with the processes in which they participate, which are four-dimensional entities (entities extended also along the dimension of time).According to the FMA, material entities may have immaterial entities as parts – including the entities identified below as sites; for example the interior (or ‘lumen’) of your small intestine is a part of your body. BFO 2.0 embodies a decision to follow the FMA here.
+
+
+
+ A material entity is an independent continuant that has some portion of matter as proper or improper continuant part. (axiom label in BFO2 Reference: [019-002])
+ Every entity which has a material entity as continuant part is a material entity. (axiom label in BFO2 Reference: [020-002])
+ every entity of which a material entity is continuant part is also a material entity. (axiom label in BFO2 Reference: [021-002])
+ (forall (x) (if (MaterialEntity x) (IndependentContinuant x))) // axiom label in BFO2 CLIF: [019-002]
+ (forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt x y t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [021-002]
+ (forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt y x t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [020-002]
+
+ material entity
+ material entity
+
+
+
+
+ A material entity is an independent continuant that has some portion of matter as proper or improper continuant part. (axiom label in BFO2 Reference: [019-002])
+
+
+
+
+
+ Every entity which has a material entity as continuant part is a material entity. (axiom label in BFO2 Reference: [020-002])
+
+
+
+
+
+ every entity of which a material entity is continuant part is also a material entity. (axiom label in BFO2 Reference: [021-002])
+
+
+
+
+
+ (forall (x) (if (MaterialEntity x) (IndependentContinuant x))) // axiom label in BFO2 CLIF: [019-002]
+
+
+
+
+
+ (forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt x y t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [021-002]
+
+
+
+
+
+ (forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt y x t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [020-002]
+
+
+
+
+
+
+
+
+
+ cf-boundary
+ ContinuantFiatBoundary
+ b is a continuant fiat boundary = Def. b is an immaterial entity that is of zero, one or two dimensions and does not include a spatial region as part. (axiom label in BFO2 Reference: [029-001])
+ BFO 2 Reference: In BFO 1.1 the assumption was made that the external surface of a material entity such as a cell could be treated as if it were a boundary in the mathematical sense. The new document propounds the view that when we talk about external surfaces of material objects in this way then we are talking about something fiat. To be dealt with in a future version: fiat boundaries at different levels of granularity.More generally, the focus in discussion of boundaries in BFO 2.0 is now on fiat boundaries, which means: boundaries for which there is no assumption that they coincide with physical discontinuities. The ontology of boundaries becomes more closely allied with the ontology of regions.
+ BFO 2 Reference: a continuant fiat boundary is a boundary of some material entity (for example: the plane separating the Northern and Southern hemispheres; the North Pole), or it is a boundary of some immaterial entity (for example of some portion of airspace). Three basic kinds of continuant fiat boundary can be distinguished (together with various combination kinds [29
+ Continuant fiat boundary doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the mereological sum of two-dimensional continuant fiat boundary and a one dimensional continuant fiat boundary that doesn't overlap it. The situation is analogous to temporal and spatial regions.
+ Every continuant fiat boundary is located at some spatial region at every time at which it exists
+ (iff (ContinuantFiatBoundary a) (and (ImmaterialEntity a) (exists (b) (and (or (ZeroDimensionalSpatialRegion b) (OneDimensionalSpatialRegion b) (TwoDimensionalSpatialRegion b)) (forall (t) (locatedInAt a b t)))) (not (exists (c t) (and (SpatialRegion c) (continuantPartOfAt c a t)))))) // axiom label in BFO2 CLIF: [029-001]
+
+ continuant fiat boundary
+
+
+
+
+ b is a continuant fiat boundary = Def. b is an immaterial entity that is of zero, one or two dimensions and does not include a spatial region as part. (axiom label in BFO2 Reference: [029-001])
+
+
+
+
+
+ Continuant fiat boundary doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the mereological sum of two-dimensional continuant fiat boundary and a one dimensional continuant fiat boundary that doesn't overlap it. The situation is analogous to temporal and spatial regions.
+
+
+
+
+
+ (iff (ContinuantFiatBoundary a) (and (ImmaterialEntity a) (exists (b) (and (or (ZeroDimensionalSpatialRegion b) (OneDimensionalSpatialRegion b) (TwoDimensionalSpatialRegion b)) (forall (t) (locatedInAt a b t)))) (not (exists (c t) (and (SpatialRegion c) (continuantPartOfAt c a t)))))) // axiom label in BFO2 CLIF: [029-001]
+
+
+
+
+
+
+
+
+
+ immaterial
+ ImmaterialEntity
+ BFO 2 Reference: Immaterial entities are divided into two subgroups:boundaries and sites, which bound, or are demarcated in relation, to material entities, and which can thus change location, shape and size and as their material hosts move or change shape or size (for example: your nasal passage; the hold of a ship; the boundary of Wales (which moves with the rotation of the Earth) [38, 7, 10
+
+ immaterial entity
+
+
+
+
+
+
+
+
+
+
+ 1d-cf-boundary
+ OneDimensionalContinuantFiatBoundary
+ The Equator
+ all geopolitical boundaries
+ all lines of latitude and longitude
+ the line separating the outer surface of the mucosa of the lower lip from the outer surface of the skin of the chin.
+ the median sulcus of your tongue
+ a one-dimensional continuant fiat boundary is a continuous fiat line whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [032-001])
+ (iff (OneDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (OneDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [032-001]
+
+ one-dimensional continuant fiat boundary
+
+
+
+
+ a one-dimensional continuant fiat boundary is a continuous fiat line whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [032-001])
+
+
+
+
+
+ (iff (OneDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (OneDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [032-001]
+
+
+
+
+
+
+
+
+
+
+ process-profile
+ ProcessProfile
+ On a somewhat higher level of complexity are what we shall call rate process profiles, which are the targets of selective abstraction focused not on determinate quality magnitudes plotted over time, but rather on certain ratios between these magnitudes and elapsed times. A speed process profile, for example, is represented by a graph plotting against time the ratio of distance covered per unit of time. Since rates may change, and since such changes, too, may have rates of change, we have to deal here with a hierarchy of process profile universals at successive levels
+ One important sub-family of rate process profiles is illustrated by the beat or frequency profiles of cyclical processes, illustrated by the 60 beats per minute beating process of John’s heart, or the 120 beats per minute drumming process involved in one of John’s performances in a rock band, and so on. Each such process includes what we shall call a beat process profile instance as part, a subtype of rate process profile in which the salient ratio is not distance covered but rather number of beat cycles per unit of time. Each beat process profile instance instantiates the determinable universal beat process profile. But it also instantiates multiple more specialized universals at lower levels of generality, selected from rate process profilebeat process profileregular beat process profile3 bpm beat process profile4 bpm beat process profileirregular beat process profileincreasing beat process profileand so on.In the case of a regular beat process profile, a rate can be assigned in the simplest possible fashion by dividing the number of cycles by the length of the temporal region occupied by the beating process profile as a whole. Irregular process profiles of this sort, for example as identified in the clinic, or in the readings on an aircraft instrument panel, are often of diagnostic significance.
+ The simplest type of process profiles are what we shall call ‘quality process profiles’, which are the process profiles which serve as the foci of the sort of selective abstraction that is involved when measurements are made of changes in single qualities, as illustrated, for example, by process profiles of mass, temperature, aortic pressure, and so on.
+ b is a process_profile =Def. there is some process c such that b process_profile_of c (axiom label in BFO2 Reference: [093-002])
+ b process_profile_of c holds when b proper_occurrent_part_of c& there is some proper_occurrent_part d of c which has no parts in common with b & is mutually dependent on b& is such that b, c and d occupy the same temporal region (axiom label in BFO2 Reference: [094-005])
+ (forall (x y) (if (processProfileOf x y) (and (properContinuantPartOf x y) (exists (z t) (and (properOccurrentPartOf z y) (TemporalRegion t) (occupiesSpatioTemporalRegion x t) (occupiesSpatioTemporalRegion y t) (occupiesSpatioTemporalRegion z t) (not (exists (w) (and (occurrentPartOf w x) (occurrentPartOf w z))))))))) // axiom label in BFO2 CLIF: [094-005]
+ (iff (ProcessProfile a) (exists (b) (and (Process b) (processProfileOf a b)))) // axiom label in BFO2 CLIF: [093-002]
+
+ process profile
+
+
+
+
+ b is a process_profile =Def. there is some process c such that b process_profile_of c (axiom label in BFO2 Reference: [093-002])
+
+
+
+
+
+ b process_profile_of c holds when b proper_occurrent_part_of c& there is some proper_occurrent_part d of c which has no parts in common with b & is mutually dependent on b& is such that b, c and d occupy the same temporal region (axiom label in BFO2 Reference: [094-005])
+
+
+
+
+
+ (forall (x y) (if (processProfileOf x y) (and (properContinuantPartOf x y) (exists (z t) (and (properOccurrentPartOf z y) (TemporalRegion t) (occupiesSpatioTemporalRegion x t) (occupiesSpatioTemporalRegion y t) (occupiesSpatioTemporalRegion z t) (not (exists (w) (and (occurrentPartOf w x) (occurrentPartOf w z))))))))) // axiom label in BFO2 CLIF: [094-005]
+
+
+
+
+
+ (iff (ProcessProfile a) (exists (b) (and (Process b) (processProfileOf a b)))) // axiom label in BFO2 CLIF: [093-002]
+
+
+
+
+
+
+
+
+
+ r-quality
+ RelationalQuality
+ John’s role of husband to Mary is dependent on Mary’s role of wife to John, and both are dependent on the object aggregate comprising John and Mary as member parts joined together through the relational quality of being married.
+ a marriage bond, an instance of love, an obligation between one person and another.
+ a marriage bond, an instance of requited love, an obligation between one person and another.
+ b is a relational quality = Def. for some independent continuants c, d and for some time t: b quality_of c at t & b quality_of d at t. (axiom label in BFO2 Reference: [057-001])
+ (iff (RelationalQuality a) (exists (b c t) (and (IndependentContinuant b) (IndependentContinuant c) (qualityOfAt a b t) (qualityOfAt a c t)))) // axiom label in BFO2 CLIF: [057-001]
+
+ relational quality
+
+
+
+
+ b is a relational quality = Def. for some independent continuants c, d and for some time t: b quality_of c at t & b quality_of d at t. (axiom label in BFO2 Reference: [057-001])
+
+
+
+
+
+ (iff (RelationalQuality a) (exists (b c t) (and (IndependentContinuant b) (IndependentContinuant c) (qualityOfAt a b t) (qualityOfAt a c t)))) // axiom label in BFO2 CLIF: [057-001]
+
+
+
+
+
+
+
+
+
+ 2d-cf-boundary
+ TwoDimensionalContinuantFiatBoundary
+ a two-dimensional continuant fiat boundary (surface) is a self-connected fiat surface whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [033-001])
+ (iff (TwoDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (TwoDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [033-001]
+
+ two-dimensional continuant fiat boundary
+
+
+
+
+ a two-dimensional continuant fiat boundary (surface) is a self-connected fiat surface whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [033-001])
+
+
+
+
+
+ (iff (TwoDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (TwoDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [033-001]
+
+
+
+
+
+
+
+
+
+ 0d-cf-boundary
+ ZeroDimensionalContinuantFiatBoundary
+ the geographic North Pole
+ the point of origin of some spatial coordinate system.
+ the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet
+ zero dimension continuant fiat boundaries are not spatial points. Considering the example 'the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet' : There are many frames in which that point is zooming through many points in space. Whereas, no matter what the frame, the quadripoint is always in the same relation to the boundaries of Colorado, Utah, New Mexico, and Arizona.
+ a zero-dimensional continuant fiat boundary is a fiat point whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [031-001])
+ (iff (ZeroDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (ZeroDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [031-001]
+
+ zero-dimensional continuant fiat boundary
+
+
+
+
+ zero dimension continuant fiat boundaries are not spatial points. Considering the example 'the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet' : There are many frames in which that point is zooming through many points in space. Whereas, no matter what the frame, the quadripoint is always in the same relation to the boundaries of Colorado, Utah, New Mexico, and Arizona.
+
+ requested by Melanie Courtot
+
+
+
+
+
+ a zero-dimensional continuant fiat boundary is a fiat point whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [031-001])
+
+
+
+
+
+ (iff (ZeroDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (ZeroDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [031-001]
+
+
+
+
+
+
+
+
+
+ 0d-t-region
+ ZeroDimensionalTemporalRegion
+ a temporal region that is occupied by a process boundary
+ right now
+ the moment at which a child is born
+ the moment at which a finger is detached in an industrial accident
+ the moment of death.
+ temporal instant.
+ A zero-dimensional temporal region is a temporal region that is without extent. (axiom label in BFO2 Reference: [102-001])
+ (forall (x) (if (ZeroDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [102-001]
+
+ zero-dimensional temporal region
+
+
+
+
+ A zero-dimensional temporal region is a temporal region that is without extent. (axiom label in BFO2 Reference: [102-001])
+
+
+
+
+
+ (forall (x) (if (ZeroDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [102-001]
+
+
+
+
+
+
+
+
+
+ history
+ History
+ A history is a process that is the sum of the totality of processes taking place in the spatiotemporal region occupied by a material entity or site, including processes on the surface of the entity or within the cavities to which it serves as host. (axiom label in BFO2 Reference: [138-001])
+
+ history
+
+
+
+
+ A history is a process that is the sum of the totality of processes taking place in the spatiotemporal region occupied by a material entity or site, including processes on the surface of the entity or within the cavities to which it serves as host. (axiom label in BFO2 Reference: [138-001])
+
+
+
+
+
+
+
+
+
+
+ insulin
+ A peptide hormone which consists of two polypeptide chains, A- and B- chains which are linked together by disulfide bonds. The amino acid sequence of insulin varies across species and certain segments of the molecule are highly conserved. In most species, the A chain consists of 21 amino acids and the B chain consists of 30 amino acids. In mammals, insulin is synthesised in the pancreas within the beta cells whereas in certain species of fish, the insulin-producing tissue is uniquely located in separate structures called Brockmann bodies.
+
+ insulin
+
+
+
+
+
+
+
+
+ water
+ An oxygen hydride consisting of an oxygen atom that is covalently bonded to two hydrogen atoms.
+
+ water
+
+
+
+
+
+
+
+
+ ATP
+ An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways.
+
+ ATP
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ biotin
+ An organic heterobicyclic compound that consists of 2-oxohexahydro-1H-thieno[3,4-d]imidazole having a valeric acid substituent attached to the tetrahydrothiophene ring. The parent of the class of biotins.
+
+ biotin
+
+
+
+
+
+
+
+
+ cholesterol
+ A cholestanoid consisting of cholestane having a double bond at the 5,6-position as well as a 3beta-hydroxy group.
+
+ cholesterol
+
+
+
+
+
+
+
+
+ ammonia
+ An azane that consists of a single nitrogen atom covelently bonded to three hydrogen atoms.
+
+ ammonia
+
+
+
+
+
+
+
+
+ phospholipid
+ A lipid containing phosphoric acid as a mono- or di-ester. The term encompasses phosphatidic acids and phosphoglycerides.
+
+ phospholipid
+
+
+
+
+
+
+
+
+ nitrite
+ The nitrogen oxoanion formed by loss of a proton from nitrous acid.
+
+ nitrite
+
+
+
+
+
+
+
+
+ carbon dioxide
+ A one-carbon compound with formula CO2 in which the carbon is attached to each oxygen atom by a double bond. A colourless, odourless gas under normal conditions, it is produced during respiration by all animals, fungi and microorganisms that depend directly or indirectly on living or decaying plants for food.
+
+ carbon dioxide
+
+
+
+
+
+
+
+
+ peptide
+ Amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another with formal loss of water. The term is usually applied to structures formed from alpha-amino acids, but it includes those derived from any amino carboxylic acid. X = OH, OR, NH2, NHR, etc.
+
+ peptide
+
+
+
+
+
+
+
+
+
+ globulin type
+ One of the major classifications of proteins, which may be further divided into the euglobulins and the pseudoglobulins. The former group is insoluble in water but soluble in saline solutions and may be precipitated in water that has been half-saturated with a salt such as ammonium sulfate. The latter group is soluble in water and has properties that resemble those of the true globulins. Globulins are an important source of protein in seed plants and are found in minute amounts in cereals. Globulins found in animal fluids are enzymes, antibodies, and fibrous and contractile proteins usually contained in the blood plasma.
+
+ globulin type
+
+
+
+
+
+
+
+
+ creatinine
+ A lactam obtained by formal cyclocondensation of creatine. It is a metabolite of creatine.
+
+ creatinine
+
+
-
-
+
+
+
+
+ mycophenolic acid
+ A member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one which is substituted at positions 4, 5, 6, and 7 by methyl, methoxy, (2E)-5-carboxy-3-methylpent-2-en-1-yl, and hydroxy groups, respectively. It is an antibiotic produced by Penicillium brevi-compactum, P. stoloniferum, P. echinulatum and related species. An immunosuppressant, it is widely used (partiularly as its sodium salt and as the 2-(morpholin-4-yl)ethyl ester prodrug, mycophenolate mofetil) to prevent tissue rejection following organ transplants and for the treatment of certain autoimmune diseases.
+
+ mycophenolic acid
+
-
+
+
+ creatine
+ A glycine derivative having methyl and amidino groups attached to the nitrogen.
+
+ creatine
+
-
+
+
+ bilirubin IXalpha
+ A member of the class of biladienes that is a linear tetrapyrrole with the dipyrrole units being of both exovinyl and endovinyl type. A product of heme degradation, it is produced in the reticuloendothelial system by the reduction of biliverdin and transported to the liver as a complex with serum albumin.
+
+ bilirubin IXalpha
+
-
+
+
+ deoxyribonucleic acid
+ High molecular weight, linear polymers, composed of nucleotides containing deoxyribose and linked by phosphodiester bonds; DNA contain the genetic information of organisms.
+
+ deoxyribonucleic acid
+
-
+
+
+ progesterone
+ A C21-steroid hormone in which a pregnane skeleton carries oxo substituents at positions 3 and 20 and is unsaturated at C(4)-C(5). As a hormone, it is involved in the female menstrual cycle, pregnancy and embryogenesis of humans and other species.
+
+ progesterone
+
-
+
+
+ hydrogensulfite
+
+ hydrogensulfite
+
-
+
+
+
+ homocysteine
+ A sulfur-containing amino acid consisting of a glycine core with a 2-mercaptoethyl side-chain.
+
+ homocysteine
+
-
+
+
+ glucose
+ An aldohexose used as a source of energy and metabolic intermediate.
+
+ glucose
+
-
+
+
+ testosterone
+ An androstanoid having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5..
+
+ testosterone
+
-
+
+
+
+ methemoglobin
+ A hemoprotein that is the ferric (Fe(3+)) form of hemoglobin.
+
+ methemoglobin
+
-
+
+
+ hydrogencarbonate
+ The carbon oxoanion resulting from the removal of a proton from carbonic acid.
+
+ hydrogencarbonate
+
-
+
+
+ cortisol
+ A 17alpha-hydroxy-C21-steroid that is pregn-4-ene substituted by oxo groups at positions 3 and 20 and hydroxy groups at positions 11, 17 and 21. Cortisol is a corticosteroid hormone or glucocorticoid produced by zona fasciculata of the adrenal cortex, which is a part of the adrenal gland. It is usually referred to as the "stress hormone" as it is involved in response to stress and anxiety, controlled by corticotropin-releasing hormone (CRH). It increases blood pressure and blood sugar, and reduces immune responses
+
+ cortisol
+
+
+
+
+
+
+
+
+ 5'-adenylyl sulfate
+ An adenosine 5'-phosphate having a sulfo group attached to one the phosphate OH groups.
+
+ 5'-adenylyl sulfate
+
-
+
+
+ triglyceride
+ Any glyceride resulting from the condensation of all three hydroxy groups of glycerol (propane-1,2,3-triol) with fatty acids.
+
+ triglyceride
+
-
+
+
+ chloride
+ A halide anion formed when chlorine picks up an electron to form an an anion.
+
+ chloride
+
-
+
+
+
+ 3-hydroxybutyric acid
+ A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
+
+ 3-hydroxybutyric acid
+
-
+
+
+ bile salt
+ A sodium salt of the conjugate of any bile acid with either glycine or taurine.
+
+ bile salt
+
+
+ molecular entity
+ Any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer etc., identifiable as a separately distinguishable entity.
We are assuming that every molecular entity has to be completely connected by chemical bonds. This excludes protein complexes, which are comprised of minimally two separate molecular entities. We will follow up with Chebi to ensure this is their understanding as well
+
+ molecular entity
-
+
+
+ cytochalasin
+
+ cytochalasin
+
-
+
+
+ estradiol
+ A 3-hydroxy steroid that is estra-1,3,5(10)-triene substituted by hydroxy groups at positions 3 and 17.
+
+ estradiol
+
-
+
+
+ N-ethyl-N-nitrosourea
+ A member of the class of N-nitrosoureas that is urea in which one of the nitrogens is substituted by ethyl and nitroso groups.
+
+ N-ethyl-N-nitrosourea
+
+
+
+
+
+
+
+
+ proton
+ Nuclear particle of charge number +1, spin 1/2 and rest mass of 1.007276470(12) u.
+
+ proton
+
-
+
+
+ iron cation
+
+ iron cation
+
+
+
+
+
+
+
+
+ luciferin
+ A low-molecular-mass compound present in bioluminescent organisms that emits light when oxidized in presence of enzyme luciferase.
+
+ luciferin
+
-
+
+
+ amikacin
+ An amino cyclitol glycoside that is kanamycin A acylated at the N-1 position by a 4-amino-2-hydroxybutyryl group.
+
+ amikacin
+
-
+
+
+ sodium chloride
+ An inorganic chloride salt having sodium(1+) as the counterion.
+
+ sodium chloride
+
-
+
+
+ uric acid
+ An oxopurine that is the final oxidation product of purine metabolism.
+
+ uric acid
+
-
+
+
+ lead(0)
+
+ lead(0)
+
-
+
+
+
+ vancomycin
+ A complex glycopeptide from Streptomyces orientalis. It inhibits a specific step in the synthesis of the peptidoglycan layer in the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile.
+
+ vancomycin
+
-
+
+
+ rac-lactic acid
+ A racemate comprising equimolar amounts of (R)- and (S)-lactic acid.
+
+ rac-lactic acid
+
-
+
+
+ acrylamide
+ A member of the class of acrylamides that results from the formal condensation of acrylic acid with ammonia.
+
+ acrylamide
+
-
+
+
+ dehydroepiandrosterone
+ An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
+
+ dehydroepiandrosterone
+
-
+
+
+
+ 3,3',5'-triiodothyronine
+
+ 3,3',5'-triiodothyronine
+
-
+
+
+ tobramycin
+ A amino cyclitol glycoside that is kanamycin B lacking the 3-hydroxy substituent from the 2,6-diaminoglucose ring.
+
+ tobramycin
+
-
+
+
+ sodium(1+)
+ A monoatomic monocation obtained from sodium.
+
+ sodium(1+)
+
-
+
+
+ potassium(1+)
+ A monoatomic monocation obtained from potassium.
+
+ potassium(1+)
+
-
+
+
+ hydroxyl
+
+ hydroxyl
+
-
+
+
+
+ deuterium atom
+ The stable isotope of hydrogen with relative atomic mass 2.014102 and a natural abundance of 0.0115 atom percent (from Greek deltaepsilonupsilontauepsilonrhoomicronnu, second).
+
+ deuterium atom
+
-
+
+
+
+ thyroxine
+ An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
+
+ thyroxine
+
-
+
+
+ ruthenium atom
+
+ ruthenium atom
+
+
+ fluorescein (lactone form)
+ A xanthene dye that is highly fluorescent, detectable even when present in minute quantities. Used forensically to detect traces of blood, in analytical chemistry as an indicator in silver nitrate titrations and in microscopy.
+
+ fluorescein (lactone form)
+
+
+
+
+
+
+
+
+ gadodiamide hydrate
+ The hydrate of gadodiamide.
+
+ gadodiamide hydrate
+
+
+
+
+
+
+
+
+ gadoteridol
+ A non-ionic gadolinium chelate having a macrocyclic tetraamine framework. It is used as a paramagnetic contrast agent in magnetic resonance imaging (MRI).
+
+ gadoteridol
+
+
+
+
+
+
+
+
+ phenol red
+ 3H-2,1-Benzoxathiole 1,1-dioxide in which both of the hydrogens at position 3 have been substituted by 4-hydroxyphenyl groups. A pH indicator changing colour from yellow below pH 6.8 to bright pink above pH 8.2, it is commonly used as an indicator in cell cultures and in home swimming pool test kits. It is also used in the (now infrequently performed) phenolsulfonphthalein (PSP) test for estimation of overall blood flow through the kidney.
+
+ phenol red
-
+
+
+ sodium citrate dihydrate
+ The dihydrate of trisodium citrate.
+
+ sodium citrate dihydrate
+
-
+
+
+ atom
+ A chemical entity constituting the smallest component of an element having the chemical properties of the element.
+
+ atom
+
-
+
+
+ elemental oxygen
+
+ elemental oxygen
+
-
+
+
+ rare earth metal atom
+
+ rare earth metal atom
+
-
+
+
+ rhodium atom
+ A cobalt group element atom of atomic number 45.
+
+ rhodium atom
+
+
+
+
+
+
+
+
+ gadolinium atom
+
+ gadolinium atom
+
-
+
+
+ terbium atom
+
+ terbium atom
+
-
+
+
+ nucleic acid
+ A macromolecule made up of nucleotide units and hydrolysable into certain pyrimidine or purine bases (usually adenine, cytosine, guanine, thymine, uracil), D-ribose or 2-deoxy-D-ribose and phosphoric acid.
+
+ nucleic acid
+
-
+
+
+ ribonucleic acid
+ High molecular weight, linear polymers, composed of nucleotides containing ribose and linked by phosphodiester bonds; RNA is central to the synthesis of proteins.
+
+ ribonucleic acid
+
-
+
+
+ amino acid
+ A carboxylic acid containing one or more amino groups.
+
+ amino acid
+
+
+ macromolecule
+ A macromolecule is a molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.
polymer
+
+ macromolecule
-
+
+
+
+ hemoglobin
+
+ hemoglobin
+
-
+
+
+ fatty acid
+ Any aliphatic monocarboxylic acid derived from or contained in esterified form in an animal or vegetable fat, oil or wax. Natural fatty acids commonly have a chain of 4 to 28 carbons (usually unbranched and even-numbered), which may be saturated or unsaturated. By extension, the term is sometimes used to embrace all acyclic aliphatic carboxylic acids.
+
+ fatty acid
+
+
+
+
+
+
+
+
+ gadolinium molecular entity
+
+ gadolinium molecular entity
+
-
+
+
+ phosphate ion
+ A phosphorus oxoanion that is the conjugate base of phosphoric acid.
+
+ phosphate ion
+
+
+
+
+
+
+
+
+ gadodiamide
+ A non-ionic gadolinium chelate having a macrocyclic triamine framework. It is used as a paramagnetic contrast agent in magnetic resonance imaging (MRI).
+
+ gadodiamide
+
-
+
+
+ folic acids
+ A group of heterocyclic compounds based on the pteroic acid skeleton conjugated with one or more L-glutamic acid units.
+
+ folic acids
+
-
+
+
+ sodium phosphate
+
+ sodium phosphate
+
+
+ phosphorus-32 atom
+ The radioactive isotope of phosphorus with relative atomic mass 31.973907 and half-life of 14.26 days.
+
+ phosphorus-32 atom
@@ -2002,12 +5514,17 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+ phosphorus-33 atom
+ The radioactive isotope of phosphorus with relative atomic mass 32.971725, half-life of 25.34 days and nuclear spin (1)/2.
+
+ phosphorus-33 atom
@@ -2015,12 +5532,16 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+ Cy3 dye
+
+ Cy3 dye
@@ -2028,116 +5549,216 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+ Cy5 dye
+
+ Cy5 dye
-
+
+
+ high-density lipoprotein
+ A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. They are synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport).
+
+ high-density lipoprotein
+
-
+
+
+ low-density lipoprotein
+ A class of lipoproteins of small size (18-25 nm) and low density (1.019-1.063 g/ml) particles with a core composed mainly of cholesterol esters and smaller amounts of triglycerides. The surface monolayer consists mostly of phospholipids, a single copy of apolipoprotein B-100, and free cholesterol molecules. The main function of LDL is to transport cholesterol and cholesterol esters from the liver. Excessive levels are associated with cardiovascular disease.
+
+ low-density lipoprotein
+
-
+
+
+ very-low-density lipoprotein
+ A class of lipoproteins of large size (30-80 nm), very low density (0.93-1.006 g/ml) particles with a core composed mainly of triglycerides and a surface monolayer of phospholipids and cholesterol into which are imbedded the apolipoproteins B, E, and C. VLDL facilitate the transport of endogenously made triglycerides to extrahepatic tissues.
+
+ very-low-density lipoprotein
+
-
+
+
+
+ calcium cation
+
+ calcium cation
+
-
+
+
+ calcium ion
+
+ calcium ion
+
-
+
+
+ magnesium cation
+ Any magnesium ion that is positively charged.
+
+ magnesium cation
+
-
+
+
+ valproic acid
+ A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
+
+ valproic acid
+
+
+ digoxigenin
+ A hydroxy steroid that consists of 5beta-cardanolide having a double bond at the 20(22)-position as well as hydroxy groups at the 3beta-, 12beta- and 14beta-positions. It has been isolated from the plant species of the genus Digitalis.
+
+ digoxigenin
+
+
+
+
+
+
+
+
+ ethylenediaminetetraacetic acid
+
+ ethylenediaminetetraacetic acid
-
+
+
+ digoxin
+ A cardenolide glycoside that is digitoxin beta-hydroxylated at C-12. A cardiac glycoside extracted from the foxglove plant, Digitalis lanata, it is used to control ventricular rate in atrial fibrillation and in the management of congestive heart failure with atrial fibrillation, but the margin between toxic and therapeutic doses is small.
+
+ digoxin
+
-
+
+
+ double-stranded DNA
+
+ double-stranded DNA
+
-
+
+
+ 5-bromo-2'-deoxyuridine
+ A pyrimidine 2'-deoxyribonucleoside compound having 5-bromouracil as the nucleobase.
+
+ 5-bromo-2'-deoxyuridine
+
-
+
+
+ low-density lipoprotein cholesterol
+ Cholesterol esters and free cholesterol which are contained in or bound to low-density lipoproteins (LDL).
+
+ low-density lipoprotein cholesterol
+
-
+
+
+ high-density lipoprotein cholesterol
+ Cholesterol esters and free cholesterol which are contained in or bound to high-density lipoproteins (HDL).
+
+ high-density lipoprotein cholesterol
+
-
+
+
+ chromium-51
+ A synthetic radioactive isotope of chromium having a half-life of 27.7 days and decaying by electron capture with emission of gamma rays (0.32 MeV); it is used to label red blood cells for measurement of mass or volume, survival time, and sequestration studies, for the diagnosis of gastrointestinal bleeding, and to label platelets to study their survival.
+
+ chromium-51
+
+
+ Alexa Fluor 532
+
+ Alexa Fluor 532
@@ -2145,12 +5766,16 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+ Alexa Fluor 546
+
+ Alexa Fluor 546
@@ -2158,97 +5783,221 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+ Alexa Fluor 555
+ A fluorescent dye of absorption wavelength 555 nm and emission wavelength 565 nm, derived from a 3,6-diaminoxanthene-4,5-disulfate.
+
+ Alexa Fluor 555
-
+
+
+ tritiated thymidine
+ Thymidine linked to the radioisotope tritium. Used to label DNA in the study of cellular and viral DNA synthesis.
+
+ tritiated thymidine
+
-
+
+
+ dimethyl sulfate
+ The dimethyl ester of sulfuric acid.
+
+ dimethyl sulfate
+
-
+
+
+ diethyl pyrocarbonate
+ The diethyl ester of dicarbonic acid.
+
+ diethyl pyrocarbonate
+
-
+
+
+ 1,1-dihydroxy-3-ethoxy-2-butanone
+ A butanone derivative having two hydroxy substituents at the 1-position and an ethoxy substituent at the 3-position.
+
+ 1,1-dihydroxy-3-ethoxy-2-butanone
+
+
+
+
+
+
+
+
+ N-cyclohexyl-N'-(2-(4-morpholinyl)ethyl)carbodiimide
+ A carbodiimide having cyclcohexyl and 2-(4-morpholinyl)ethyl as the two N-substituents.
+
+ N-cyclohexyl-N'-(2-(4-morpholinyl)ethyl)carbodiimide
+
-
+
+
+ N-methylisatoic anhydride
+ A 3,1-benzoxazin-1,4-dione having an N-methyl substituent.
+
+ N-methylisatoic anhydride
+
-
+
+
+ (S)-1-(4-bromoacetamidobenzyl)EDTA
+ A tetracarboxylic acid consisting of ethylenediaminetetraacetic acid having a 4-bromoacetamidobenzyl group at the C1-position and (S)-configuration.
+
+ (S)-1-(4-bromoacetamidobenzyl)EDTA
+
-
+
+
+ EDTA methidiumpropylamide
+ A combined intercalating and chelating reagent. The iron chelate, prepared by adding Fe(NH4)2(SO4)2, effects random oxidative cleavage of DNA in the presence of O2 and a reducing agent. This activity is useful as a footprinting probe.
+
+ EDTA methidiumpropylamide
+
+
+
+
+
+
+
+
+ bromophenol blue
+ 3H-2,1-Benzoxathiole 1,1-dioxide in which both of the hydrogens at position 3 have been substituted by 3,5-dibromo-4-hydroxyphenyl groups. It is used as a laboratory indicator, changing from yellow below pH 3 to purple at pH 4.6, and as a size marker for monitoring the progress of agarose gel and polyacrylamide gel electrophoresis. It has also been used as an industrial dye.
+
+ bromophenol blue
+
-
+
+
+ tacrolimus hydrate
+ A hydrate that is the monohydrate form of tacrolimus.
+
+ tacrolimus hydrate
+
-
+
+
+ oxygen radical
+ An inorganic radical in which a free electron resides on one or more oxygen atoms of an oxygen species.
+
+ oxygen radical
+
-
+
+
+
+ lipoprotein
+ A clathrate complex consisting of a lipid enwrapped in a protein host without covalent binding in such a way that the complex has a hydrophilic outer surface consisting of all the protein and the polar ends of any phospholipids.
+
+ lipoprotein
+
-
+
+
+
+ thyroid stimulating hormone
+
+ thyroid stimulating hormone
+
-
+
+
+ Luteinizing hormone
+
+ Luteinizing hormone
+
-
+
+
+ Follicle stimulating hormone
+
+ Follicle stimulating hormone
+
-
+
+
+ 25-hydroxyvitamin D2
+ A hydroxycalciol that is vitamin D2 in which the hydrogen at position 25 has been replaced by a hydroxy group.
+
+ 25-hydroxyvitamin D2
+
+
+
+
+
+
+
+
+ tris
+ A primary amino compound that is tert-butylamine in which one hydrogen attached to each methyl group is replaced by a hydroxy group. A compound widely used as a biological buffer substance in the pH range 7--9; pKa = 8.3 at 20 degreeC; pKa = 7.82 at 37 degreeC.
+
+ tris
+
@@ -2272,12 +6021,12 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
- Any type of light microscopy assay where the specimen can be made to fluoresce (emit energy as visible light) by illuminating it with light of specific wavelengths. These specimens are called fluorophores.
- FM
- fluorescence imaging
- fluorescence microscopic imaging
- CHMO
- fluorescence microscopy assay
+ Any type of light microscopy assay where the specimen can be made to fluoresce (emit energy as visible light) by illuminating it with light of specific wavelengths. These specimens are called fluorophores.
+ FM
+ fluorescence imaging
+ fluorescence microscopic imaging
+ CHMO
+ fluorescence microscopy assay
@@ -2286,18 +6035,18 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
- Microscopy where the specimen can be made to fluoresce (emit energy as visible light) by scanning a gas (Ar or Kr) laser spot of specific wavelength over its surface and using a spatial pinhole to eliminate out-of-focus fluorescence.
- CLSM
- LSCM
- confocal fluorescence imaging
- confocal laser scanning fluorescence microscopy
- confocal laser scanning microscopy
- confocal-laser scanning microscopy
- fluorescence confocal microscopy
- fluorescence confocal scanning laser microscopy
- scanning confocal fluorescence microscopy
- CHMO
- confocal fluorescence microscopy assay
+ Microscopy where the specimen can be made to fluoresce (emit energy as visible light) by scanning a gas (Ar or Kr) laser spot of specific wavelength over its surface and using a spatial pinhole to eliminate out-of-focus fluorescence.
+ CLSM
+ LSCM
+ confocal fluorescence imaging
+ confocal laser scanning fluorescence microscopy
+ confocal laser scanning microscopy
+ confocal-laser scanning microscopy
+ fluorescence confocal microscopy
+ fluorescence confocal scanning laser microscopy
+ scanning confocal fluorescence microscopy
+ CHMO
+ confocal fluorescence microscopy assay
@@ -2306,12 +6055,12 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
- Microscopy where the specimen is illuminated with visible light and a system of lenses is used to produce an image.
- OM
- light microscopy
- optical microscopy
- CHMO
- light microscopy assay
+ Microscopy where the specimen is illuminated with visible light and a system of lenses is used to produce an image.
+ OM
+ light microscopy
+ optical microscopy
+ CHMO
+ light microscopy assay
@@ -2320,18 +6069,18 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
- A method where a sample mixture is first separated by liquid chromatography before being ionised and characterised by mass-to-charge ratio and relative abundance using two mass spectrometers in series.
- LC-MS-MS
- LC-MS/MS
- LC-MS2
- LC-MSMS
- LC/MS/MS
- LCMSMS
- liquid chromatography tandem mass spectrometry
- liquid chromatography tandem mass spectroscopy
- liquid chromatography-tandem mass spectroscopy
+ A method where a sample mixture is first separated by liquid chromatography before being ionised and characterised by mass-to-charge ratio and relative abundance using two mass spectrometers in series.
+ LC-MS-MS
+ LC-MS/MS
+ LC-MS2
+ LC-MSMS
+ LC/MS/MS
+ LCMSMS
+ liquid chromatography tandem mass spectrometry
+ liquid chromatography tandem mass spectroscopy
+ liquid chromatography-tandem mass spectroscopy
CHMO
- liquid chromatography-tandem mass spectrometry
+ liquid chromatography-tandem mass spectrometry
@@ -2339,6 +6088,7 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
@@ -2364,6 +6114,19 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ cell line cell
+ cell line cell
+ 细胞系细胞
+ A cultured cell that is part of a cell line - a stable and homogeneous population of cells with a common biological origin and propagation history in culture
+ A cultured cell that is part of a cell line - a stable and homogeneous population of cells with a common biological origin and propagation history in culture
+
+ 一个培养细胞,它是一个细胞株(一个稳定的,同质的细胞群,具有共同的生物学起源和增殖史)的一部分
+ 一个培养细胞,它是一个细胞株(一个稳定的,同质的细胞群,具有共同的生物学起源和增殖史)的一部分
+
+
+ cell line cell
+ cell line cell
+ 细胞系细胞
@@ -2381,19 +6144,43 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
-
+
+
+ mortal cell line cell
+ mortal cell line cell
+ 非永生细胞系细胞
+ A cell line cell that is capable of replicating a limited number of times in culture before undergoing senescence.
+ A cell line cell that is capable of replicating a limited number of times in culture before undergoing senescence.
+
+ mortal cell line cell
+ mortal cell line cell
+ 非永生细胞系细胞
+
-
+
+
+ immortal cell line cell
+ immortal cell line cell
+ 永生细胞系细胞
+ A cell line cell that is expected to be capable of an unlimited number of divisions, and is thus able to support indefinite propagation in vitro as part of an immortal cell line.
+ A cell line cell that is expected to be capable of an unlimited number of divisions, and is thus able to support indefinite propagation in vitro as part of an immortal cell line.
+ 预期能够进行无限次分裂的细胞系细胞,作为永生细胞系一部分,能够支持体外无限增殖。
+
+ immortal cell line cell
+ immortal cell line cell
+ 永生细胞系细胞
+
+
@@ -2406,6 +6193,17 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ cell line
+ 细胞系
+ A cultured cell population that represents a genetically stable and homogenous population of cultured cells that shares a common propagation history (i.e. has been successively passaged together in culture).
+ A cultured cell population that represents a genetically stable and homogenous population of cultured cells that shares a common propagation history (i.e. has been successively passaged together in culture).
+
+ 一个培养细胞群体,其代表具有共同增殖历史(即已经在培养中一起连续传代)的遗传稳定且同质的培养细胞群体。
+ 培养的细胞群体代表具有共同繁殖历史(即已经在培养中一起连续传代)的遗传稳定且同质的培养细胞群体。
+
+
+ cell line
+ 细胞系
@@ -2413,6 +6211,7 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
@@ -2425,6 +6224,10 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ immortal cell line
+ A cell line that is expected to be capable of indefinite propagation in an vitro culture.
+
+ immortal cell line
@@ -2432,6 +6235,7 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
@@ -2451,6 +6255,10 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ mortal cell line
+ A cell line is able to support only a limited number of passages in vitro.
+
+ mortal cell line
@@ -2458,7 +6266,12 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+ cell
PMID:18089833.Cancer Res. 2007 Dec 15;67(24):12018-25. "...Epithelial cells were harvested from histologically confirmed adenocarcinomas .."
+ A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.
+
+ cell
@@ -2466,6 +6279,7 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
@@ -2496,15 +6310,32 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ primary cultured cell
+ A cultured cell that is freshly isolated from a organismal source, or derives in culture from such a cell prior to the culture being passaged.
+
+ primary cultured cell
-
+
-
-
-
+
+
+ native cell
+ A cell that is found in a natural setting, which includes multicellular organism cells 'in vivo' (i.e. part of an organism), and unicellular organisms 'in environment' (i.e. part of a natural environment).
+
+ native cell
+
+
+
+
+
+
+
+
+
+
@@ -2522,623 +6353,1852 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ cultured cell
+ A cell in vitro that is or has been maintained or propagated as part of a cell culture.
+
+ cultured cell
+
+
+
+
+
+
+
+
+ fibroblast
+ A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.
+
+ fibroblast
+
+
+
+
+
+
+
+
+ epithelial cell
+ A cell that is usually found in a two-dimensional sheet with a free surface. The cell has a cytoskeleton that allows for tight cell to cell contact and for cell polarity where apical part is directed towards the lumen and the basal part to the basal lamina.
+
+ epithelial cell
-
+
+
+
+ mesothelial cell
+ A flattened epithelial cell of mesenchymal origin that lines the serous cavity.
+
+ mesothelial cell
+
-
+
+
+ T cell
+ A type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex.
+
+ T cell
+
+
+
+
+
+
+
+
+ mast cell
+ A cell that is found in almost all tissues containing numerous basophilic granules and capable of releasing large amounts of histamine and heparin upon activation. Progenitors leave bone marrow and mature in connective and mucosal tissue. Mature mast cells are found in all tissues, except the bloodstream. Their phenotype is CD117-high, CD123-negative, CD193-positive, CD200R3-positive, and FceRI-high. Stem-cell factor (KIT-ligand; SCF) is the main controlling signal of their survival and development.
+
+ mast cell
+
+
+
+
+
+
+
+
+ hepatocyte
+ The main structural component of the liver. They are specialized epithelial cells that are organized into interconnected plates called lobules. Majority of cell population of liver, polygonal in shape, arranged in plates or trabeculae between sinusoids; may have single nucleus or binucleated.
+
+ hepatocyte
+
-
+
+
+ erythrocyte
+ A red blood cell. In mammals, mature erythrocytes are biconcave disks containing hemoglobin whose function is to transport oxygen.
+
+ erythrocyte
+
-
+
+
+
+ platelet
+ A non-nucleated disk-shaped cell formed by extrusion from megakaryocytes, found in the blood of all mammals, and mainly involved in blood coagulation.
+
+ platelet
+
-
+
+
+ macrophage
+ A mononuclear phagocyte present in variety of tissues, typically differentiated from monocytes, capable of phagocytosing a variety of extracellular particulate material, including immune complexes, microorganisms, and dead cells.
+
+ macrophage
+
-
+
+
+ B cell
+ A lymphocyte of B lineage that is capable of B cell mediated immunity.
+
+ B cell
+
+
+
+
+
+
+
+
+ dendritic cell
+ A cell of hematopoietic origin, typically resident in particular tissues, specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation. These cells are lineage negative (CD3-negative, CD19-negative, CD34-negative, and CD56-negative).
+
+ dendritic cell
+
-
+
+
+ neuron
+ The basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.
+
+ neuron
+
-
+
+
+ lymphocyte
+ A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.
+
+ lymphocyte
+
-
+
+
+ megakaryocyte
+ A giant cell 50 to 100 micron in diameter, with a greatly lobulated nucleus, found in the bone marrow; mature blood platelets are released from its cytoplasm.
+
+ megakaryocyte
+
-
+
+
+ reticulocyte
+ An immature erythrocyte that changes the protein composition of its plasma membrane by exosome formation and extrusion. The types of protein removed differ between species though removal of the transferrin receptor is apparent in mammals and birds.
+
+ reticulocyte
+
-
+
+
+
+
+ band form neutrophil
+ A late neutrophilic metamyelocyte in which the nucleus is indented to more than half the distance to the farthest nuclear margin but in no area being condensed to a single filament. The nucleus is in the form of a curved or coiled band, not having acquired the typical multilobar shape of the mature neutrophil. These cells are fMLP receptor-positive, CD11b-positive, CD35-negative, and CD49d-negative.
+
+ band form neutrophil
+
-
+
+
+
+ nucleate erythrocyte
+ An erythrocyte having a nucleus.
+
+ nucleate erythrocyte
+
-
+
+
+
+
+
+ monocyte
+ Myeloid mononuclear recirculating leukocyte that can act as a precursor of tissue macrophages, osteoclasts and some populations of tissue dendritic cells.
+
+ monocyte
+
+
+ experimentally modified cell in vitro
+ A cell in vitro that has undergone physical changes as a consequence of a deliberate and specific experimental procedure.
+
+ experimentally modified cell in vitro
+
+
+
+
+
+
+
+
+ CD4-positive, alpha-beta T cell
+ A mature alpha-beta T cell that expresses an alpha-beta T cell receptor and the CD4 coreceptor.
+
+ CD4-positive, alpha-beta T cell
+
+
+
+
+
+
+
+
+ CD8-positive, alpha-beta T cell
+ A T cell expressing an alpha-beta T cell receptor and the CD8 coreceptor.
+
+ CD8-positive, alpha-beta T cell
-
+
+
+ leukocyte
+ An achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue.
+
+ leukocyte
+
-
+
+
+ basophil
+ Any of the immature or mature forms of a granular leukocyte that in its mature form has an irregularly shaped, pale-staining nucleus that is partially constricted into two lobes, and with cytoplasm that contains coarse, bluish-black granules of variable size. Basophils contain vasoactive amines such as histamine and serotonin, which are released on appropriate stimulation. A basophil is CD123-positive, CD193-positive, CD203c-positive, and FceRIa-positive.
+
+ basophil
+
-
+
+
+
+
+ eosinophil
+ Any of the immature or mature forms of a granular leukocyte with a nucleus that usually has two lobes connected by one or more slender threads of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and which can be stained by the dye eosin. Eosinophils are CD9-positive, CD191-positive, and CD193-positive.
+
+ eosinophil
+
-
+
+
+
+
+ neutrophil
+ Any of the immature or mature forms of a granular leukocyte that in its mature form has a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.
+
+ neutrophil
+
-
+
+
+ immature neutrophil
+ Any of the immature forms of a neutrophil in which neutrophilic specific granules are present but other phenotypic features of the mature form may be lacking.
+
+ immature neutrophil
+
-
+
+
+ plasma cell
+ A terminally differentiated, post-mitotic, antibody secreting cell of the B cell lineage with the phenotype CD138-positive, surface immunonoglobulin-negative, and MHC Class II-negative. Plasma cells are oval or round with extensive rough endoplasmic reticulum, a well-developed Golgi apparatus, and a round nucleus having a characteristic cartwheel heterochromatin pattern and are devoted to producing large amounts of immunoglobulin.
+
+ plasma cell
+
+
+
+
+
+
+
+
+ alpha-beta T cell
+ A T cell that expresses an alpha-beta T cell receptor complex.
+
+ alpha-beta T cell
+
+
+
+
+
+
+
+
+ CD8-positive, alpha-beta cytotoxic T cell
+ A CD8-positive, alpha-beta T cell that is capable of killing target cells in an antigen specific manner with the phenotype perforin-positive and granzyme B-positive.
+
+ CD8-positive, alpha-beta cytotoxic T cell
+
+
+
+
+
+
+
+
+ mature NK T cell
+ A mature alpha-beta T cell of a distinct lineage that bears natural killer markers and a T cell receptor specific for a limited set of ligands. NK T cells have activation and regulatory roles particularly early in an immune response.
+
+ mature NK T cell
+
-
+
+
+
+ promyelocyte
+ A precursor in the granulocytic series, being a cell intermediate in development between a myeloblast and myelocyte, that has distinct nucleoli, a nuclear-to-cytoplasmic ratio of 5:1 to 3:1, and containing a few primary cytoplasmic granules. Markers for this cell are fucosyltransferase FUT4-positive, CD33-positive, integrin alpha-M-negative, low affinity immunoglobulin gamma Fc region receptor III-negative, and CD24-negative.
+
+ promyelocyte
+
+
+
+
+
+
+
+
+ mononuclear cell
+ A leukocyte with a single non-segmented nucleus in the mature form.
+
+ mononuclear cell
+
+
+
+
+
+
+
+
+ malignant cell
+ A neoplastic cell that is capable of entering a surrounding tissue
+
+ malignant cell
+
-
+
+
+
+ metamyelocyte
+ A eosinophil precursor in the granulocytic series, being a cell intermediate in development between a myelocyte and a band form cell. The nucleus becomes indented where the indentation is smaller than half the distance to the farthest nuclear margin; chromatin becomes coarse and clumped; specific granules predominate while primary granules are rare.
+
+ metamyelocyte
+
-
+
+
+
+ myelocyte
+ A cell type that is the first of the maturation stages of the granulocytic leukocytes normally found in the bone marrow. Granules are seen in the cytoplasm. The nuclear material of the myelocyte is denser than that of the myeloblast but lacks a definable membrane. The cell is flat and contains increasing numbers of granules as maturation progresses.
+
+ myelocyte
+
-
+
+
+ neural cell
+ A cell that is part of the nervous system.
+
+ neural cell
+
-
+
+
+
+
+ segmented neutrophil of bone marrow
+ A segmented neutrophilic cell of the bone marrow reserve pool that expresses CD11b (integrin alpha-M) and high levels of CD16 (low affinity immunoglobulin gamma Fc region receptor III) on its cell surface.
+
+ segmented neutrophil of bone marrow
+
+
+
+
+
+
+
+
+
+ peripheral blood mononuclear cell
+ A leukocyte with a single non-segmented nucleus in the mature form found in the circulatory pool of blood.
+
+ peripheral blood mononuclear cell
+
-
+
+
+ complex of molecular entities
+ A complex of two or more molecular entities that are not covalently bound.
+
+ complex of molecular entities
+
+
+
+
+
+
+
+
+ soil
+ Soil is an environmental material which is primarily composed of minerals, varying proportions of sand, silt, and clay, organic material such as humus, gases, liquids, and a broad range of resident micro- and macroorganisms.
+
+ soil
+
+
+
+
+
+
+
+
+ podzol
+ Podzols are soils with a typically ash-grey upper subsurface horizon, bleached by loss of organic matter and iron oxides, on top of a dark accumulation horizon with brown, reddish or black illuviated humus and/or reddish Fe compounds. Podzols occur in humid areas in the boreal and temperate zones and locally also in the tropics.
+
+ podzol
+
-
+
+
+ environmental material
+ A portion of environmental material is a fiat object part which forms the medium or part of the medium of an environmental system.
+
+ environmental material
+
-
+
+
+
-
+
+
+ chromatin
+ The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
+
+ chromatin
+
-
+
+
+
+ core promoter sequence-specific DNA binding
+ Binding to a sequence of DNA that is part of a core promoter region. The core promoter is composed of the transcription start site and binding sites for the RNA polymerase and the basal transcription machinery. The transcribed region might be described as a gene, cistron, or operon.
+
+ core promoter sequence-specific DNA binding
+
+
+
+
+
+
+
+
+
+
-
+
+
+
+ RNA-templated transcription
+ The synthesis of an RNA transcript from an RNA template.
+
+ RNA-templated transcription
+
-
+
+
+ action potential
+ A process in which membrane potential cycles through a depolarizing spike, triggered in response to depolarization above some threshold, followed by repolarization. This cycle is driven by the flow of ions through various voltage gated channels with different thresholds and ion specificities.
+
+ action potential
+
-
+
+
+ antibody-dependent cellular cytotoxicity
+ Cytolysis of target cells by natural killer cells, eosinophils, neutrophils, monocytes, or macrophages following engagement of antibodies bound to the target cells by Fc receptors on the effector cells.
+
+ antibody-dependent cellular cytotoxicity
+
-
+
+
+ type IV hypersensitivity
+ An inflammatory response driven by T cell recognition of processed soluble or cell-associated antigens leading to cytokine release and leukocyte activation.
+
+ type IV hypersensitivity
+
-
+
+
+ cytokine production
+ The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ cytokine production
+
-
+
+
+ cell killing
+ Any process in an organism that results in the killing of its own cells or those of another organism, including in some cases the death of the other organism. Killing here refers to the induction of death in one cell by another cell, not cell-autonomous death due to internal or other environmental conditions.
+
+ cell killing
+
-
+
+
+ T cell mediated cytotoxicity
+ The directed killing of a target cell by a T cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors.
+
+ T cell mediated cytotoxicity
+
-
+
+
+ adaptive immune response
+ An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
+
+ adaptive immune response
+
+
+
+
+
+
+
+
+ cytokine production involved in immune response
+ The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus contributing to an immune response, resulting in an increase in its intracellular or extracellular levels.
+
+ cytokine production involved in immune response
+
+
+
+
+
+
+
+
+
+
-
+
+
+ tolerance induction
+ A process that directly activates any of the steps required for tolerance, a physiologic state in which the immune system does not react destructively against the components of an organism that harbors it or against antigens that are introduced to it.
+
+ tolerance induction
+
-
+
+
+ B cell tolerance induction
+ A process involving any mechanism for tolerance induction in B cells.
+
+ B cell tolerance induction
+
-
+
+
+ T cell tolerance induction
+ A process involving any mechanism for tolerance induction in T cells.
+
+ T cell tolerance induction
+
-
+
+
+ hypersensitivity
+ An inflammatory response to an exogenous environmental antigen or an endogenous antigen initiated by the adaptive immune system.
+
+ hypersensitivity
+
+
+
+
+
+
+
+
+ cytokine production involved in inflammatory response
+ The synthesis or release of a cytokine following a inflammatory stimulus as part of an inflammatory response, resulting in an increase in its intracellular or extracellular levels.
+
+ cytokine production involved in inflammatory response
+
-
+
+
+ glomerular filtration
+ The process in which plasma is filtered through the glomerular membrane which consists of capillary endothelial cells, the basement membrane, and epithelial cells. The glomerular filtrate is the same as plasma except it has no significant amount of protein.
+
+ glomerular filtration
+
-
+
+
+ molecular_function
+ A molecular process that can be carried out by the action of a single macromolecular machine, usually via direct physical interactions with other molecular entities. Function in this sense denotes an action, or activity, that a gene product (or a complex) performs. These actions are described from two distinct but related perspectives: (1) biochemical activity, and (2) role as a component in a larger system/process.
+
+ molecular_function
+
+
+
+
+
+
+
+
+ antigen binding
+ Binding to an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.
+
+ antigen binding
+
-
+
+
+ catalytic activity
+ Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
+
+ catalytic activity
+
+
+
+
+
+
+
+
+ L-iditol 2-dehydrogenase activity
+ Catalysis of the reaction: L-iditol + NAD+ = L-sorbose + NADH + H+.
+
+ L-iditol 2-dehydrogenase activity
+
-
+
+
+ RNA-directed DNA polymerase activity
+ Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Catalyzes RNA-template-directed extension of the 3'- end of a DNA strand by one deoxynucleotide at a time.
+
+ RNA-directed DNA polymerase activity
+
-
+
+
+ acetylcholinesterase activity
+ Catalysis of the reaction: acetylcholine + H2O = choline + acetate.
+
+ acetylcholinesterase activity
+
+
+
+
+
+
+
+
+ acyl-CoA oxidase activity
+ Catalysis of the reaction: acyl-CoA + O2 = trans-2,3-dehydroacyl-CoA + hydrogen peroxide.
+
+ acyl-CoA oxidase activity
+
+
+
+
+
+
+
+
+ L-alanine:2-oxoglutarate aminotransferase activity
+ Catalysis of the reaction: 2-oxoglutarate + L-alanine = L-glutamate + pyruvate.
+
+ L-alanine:2-oxoglutarate aminotransferase activity
+
+
+
+
+
+
+
+
+ alkaline phosphatase activity
+ Catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.
+
+ alkaline phosphatase activity
+
+
+
+
+
+
+
+
+ L-aspartate:2-oxoglutarate aminotransferase activity
+ Catalysis of the reaction: L-aspartate + 2-oxoglutarate = oxaloacetate + L-glutamate.
+
+ L-aspartate:2-oxoglutarate aminotransferase activity
+
+
+
+
+
+
+
+
+ cholinesterase activity
+ Catalysis of the reaction: an acylcholine + H2O = choline + a carboxylic acid anion.
+
+ cholinesterase activity
+
+
+
+
+
+
+
+
+ creatine kinase activity
+ Catalysis of the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+).
+
+ creatine kinase activity
+
+
+
+
+
+
+
+
+ glutamate dehydrogenase [NAD(P)+] activity
+ Catalysis of the reaction: L-glutamate + H2O + NAD(P)+ = 2-oxoglutarate + NH3 + NAD(P)H + H+.
+
+ glutamate dehydrogenase [NAD(P)+] activity
+
-
+
+
+ glutathione transferase activity
+ Catalysis of the reaction: R-X + glutathione = H-X + R-S-glutathione. R may be an aliphatic, aromatic or heterocyclic group; X may be a sulfate, nitrile or halide group.
+
+ glutathione transferase activity
+
+
+
+
+
+
+
+
+ isocitrate dehydrogenase [NAD(P)+] activity
+ Catalysis of the reaction: isocitrate + NAD(P)+ = 2-oxoglutarate + CO2 + NAD(P)H.
+
+ isocitrate dehydrogenase [NAD(P)+] activity
+
+
+
+
+
+
+
+
+ lactate dehydrogenase activity
+ Catalysis of the reaction: lactate + NAD+ = H+ + NADH + pyruvate.
+
+ lactate dehydrogenase activity
+
+
+
+
+
+
+
+
+ ribonuclease activity
+ Catalysis of the hydrolysis of phosphodiester bonds in chains of RNA.
+
+ ribonuclease activity
+
-
+
+
+ ion channel activity
+ Enables the facilitated diffusion of an ion (by an energy-independent process) by passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism. May be either selective (it enables passage of a specific ion only) or non-selective (it enables passage of two or more ions of same charge but different size).
+
+ ion channel activity
+
-
+
+
+ cellular_component
+ A location, relative to cellular compartments and structures, occupied by a macromolecular machine when it carries out a molecular function. There are two ways in which the gene ontology describes locations of gene products: (1) relative to cellular structures (e.g., cytoplasmic side of plasma membrane) or compartments (e.g., mitochondrion), and (2) the stable macromolecular complexes of which they are parts (e.g., the ribosome).
+
+ cellular_component
+
-
+
+
+ fibrinogen complex
+ A highly soluble, elongated protein complex found in blood plasma and involved in clot formation. It is converted into fibrin monomer by the action of thrombin. In the mouse, fibrinogen is a hexamer, 46 nm long and 9 nm maximal diameter, containing two sets of nonidentical chains (alpha, beta, and gamma) linked together by disulfide bonds.
+
+ fibrinogen complex
+
-
+
+
+ chromosome
+ A structure composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information.
+
+ chromosome
+
+
+
+
+
+
+
+
+ mitochondrion
+ A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
+
+ mitochondrion
+
+
+
+
+
+
+
+
+ glucose metabolic process
+ The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.
+
+ glucose metabolic process
+
-
+
+
+ DNA replication
+ The cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by initiation proteins, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA.
+
+ DNA replication
+
-
+
+
+ DNA methylation
+ The covalent transfer of a methyl group to either N-6 of adenine or C-5 or N-4 of cytosine.
+
+ DNA methylation
+
-
+
+
+ chromatin remodeling
+ A dynamic process of chromatin reorganization resulting in changes to chromatin structure. These changes allow DNA metabolic processes such as transcriptional regulation, DNA recombination, DNA repair, and DNA replication.
+
+ chromatin remodeling
+
+
+
+
+
+
+
+
+ phagocytosis
+ A vesicle-mediated transport process that results in the engulfment of external particulate material by phagocytes and their delivery to the lysosome. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles.
+
+ phagocytosis
+
-
+
+
+ immune response
+ Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
+
+ immune response
+
-
+
+
+ cellular response to DNA damage stimulus
+ Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism.
+
+ cellular response to DNA damage stimulus
+
-
+
+
+ cell cycle
+ The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.
+
+ cell cycle
+
-
+
+
+ blood coagulation
+ The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
+
+ blood coagulation
+
+
+ biological_process
+ A biological process represents a specific objective that the organism is genetically programmed to achieve. Biological processes are often described by their outcome or ending state, e.g., the biological process of cell division results in the creation of two daughter cells (a divided cell) from a single parent cell. A biological process is accomplished by a particular set of molecular functions carried out by specific gene products (or macromolecular complexes), often in a highly regulated manner and in a particular temporal sequence.
+
+ biological_process
-
+
+
+ opsonization
+ The process in which a microorganism (or other particulate material) is rendered more susceptible to phagocytosis by coating with an opsonin, a blood serum protein such as a complement component or antibody.
+
+ opsonization
+
+
+
+
+
+
+
+
+ 5'-nucleotidase activity
+ Catalysis of the reaction: a 5'-ribonucleotide + H2O = a ribonucleoside + phosphate.
+
+ 5'-nucleotidase activity
+
-
+
+
+ cell population proliferation
+ The multiplication or reproduction of cells, resulting in the expansion of a cell population.
+
+ cell population proliferation
+
-
+
+
+ fertilization
+ The union of gametes of opposite sexes during the process of sexual reproduction to form a zygote. It involves the fusion of the gametic nuclei (karyogamy) and cytoplasm (plasmogamy).
+
+ fertilization
+
-
+
+
+ cellular process
+ Any process that is carried out at the cellular level, but not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level.
+
+ cellular process
+
-
+
+
+ gene expression
+ The process in which a gene's sequence is converted into a mature gene product (protein or RNA). This includes the production of an RNA transcript and its processing, translation and maturation for protein-coding genes.
+
+ gene expression
+
-
+
+
+ vascular endothelial growth factor production
+ The appearance of vascular endothelial growth factor production due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ vascular endothelial growth factor production
+
+
+
+
+
+
+
+
+ galactosidase activity
+ Catalysis of the hydrolysis of galactosyl compounds, substances containing a group derived from a cyclic form of galactose or a galactose derivative.
+
+ galactosidase activity
+
-
+
+
+ immunoglobulin mediated immune response
+ An immune response mediated by immunoglobulins, whether cell-bound or in solution.
+
+ immunoglobulin mediated immune response
+
+
+
+
+
+
+
+
+ amylase activity
+ Catalysis of the hydrolysis of amylose or an amylose derivative.
+
+ amylase activity
+
+
+
+
+
+
+
+
+ beta-N-acetylglucosaminidase activity
+ Catalysis of the hydrolysis of terminal non-reducing N-acetyl-D-glucosamine residues in N-acetyl-beta-D-glucosaminides.
+
+ beta-N-acetylglucosaminidase activity
+
-
+
+
+ histone modification
+ The covalent alteration of one or more amino acid residues within a histone protein.
+
+ histone modification
+
-
+
+
+ hydrolase activity, acting on ester bonds
+ Catalysis of the hydrolysis of any ester bond.
+
+ hydrolase activity, acting on ester bonds
+
-
+
+
+ immunoglobulin complex
+ A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.
+
+ immunoglobulin complex
+
-
+
+
+ B cell receptor complex
+ An immunoglobulin complex that is present in the plasma membrane of B cells and that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains and a signaling subunit, a heterodimer of the Ig-alpha and Ig-beta proteins.
+
+ B cell receptor complex
+
-
+
+
+ antigen processing and presentation
+ The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
+
+ antigen processing and presentation
+
-
+
+
+ protein domain specific binding
+ Binding to a specific domain of a protein.
+
+ protein domain specific binding
+
-
+
+
+ actin filament polymerization
+ Assembly of actin filaments by the addition of actin monomers to a filament.
+
+ actin filament polymerization
+
-
+
+
+ hemopoiesis
+ The process whose specific outcome is the progression of the myeloid and lymphoid derived organ/tissue systems of the blood and other parts of the body over time, from formation to the mature structure. The site of hemopoiesis is variable during development, but occurs primarily in bone marrow or kidney in many adult vertebrates.
+
+ hemopoiesis
+
+
+
+
+
+
+
+
+ connective tissue growth factor production
+ The appearance of connective tissue growth factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ connective tissue growth factor production
+
+
+
+
+
+
+
+
+ chemokine production
+ The appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. All chemokines possess a number of conserved cysteine residues involved in intramolecular disulfide bond formation. Some chemokines are considered pro-inflammatory and can be induced during an immune response to recruit cells of the immune system to a site of infection, while others are considered homeostatic and are involved in controlling the migration of cells during normal processes of tissue maintenance or development. Chemokines are found in all vertebrates, some viruses and some bacteria.
+
+ chemokine production
+
-
+
+
+ granulocyte macrophage colony-stimulating factor production
+ The appearance of granulocyte macrophage colony-stimulating factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ granulocyte macrophage colony-stimulating factor production
+
+
+
+
+
+
+
+
+ hepatocyte growth factor production
+ The appearance of hepatocyte growth factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ hepatocyte growth factor production
+
+
+
+
+
+
+
+
+ type I interferon production
+ The appearance of type I interferon due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.
+
+ type I interferon production
+
-
+
+
+ interferon-alpha production
+ The appearance of interferon-alpha due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interferon-alpha production
+
-
+
+
+ interferon-beta production
+ The appearance of interferon-beta due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interferon-beta production
+
-
+
+
+ interferon-gamma production
+ The appearance of interferon-gamma due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Interferon-gamma is also known as type II interferon.
+
+ interferon-gamma production
+
-
+
+
+ interleukin-1 alpha production
+ The appearance of interleukin-1 alpha due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-1 alpha production
+
-
+
+
+ interleukin-1 beta production
+ The appearance of interleukin-1 beta due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-1 beta production
+
+
+
+
+
+
+
+
+ interleukin-1 production
+ The appearance of interleukin-1 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-1 production
+
-
+
+
+ interleukin-10 production
+ The appearance of interleukin-10 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-10 production
+
+
+
+
+
+
+
+
+ interleukin-11 production
+ The appearance of interleukin-11 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-11 production
+
-
+
+
+ interleukin-12 production
+ The appearance of interleukin-12 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-12 production
+
-
+
+
+ interleukin-13 production
+ The appearance of interleukin-13 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-13 production
+
+
+
+
+
+
+
+
+ obsolete interleukin-14 production
+ OBSOLETE. The appearance of interleukin-14 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ obsolete interleukin-14 production
+
-
+
+
+ interleukin-15 production
+ The appearance of interleukin-15 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-15 production
+
-
+
+
+ interleukin-16 production
+ The appearance of interleukin-16 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-16 production
+
-
+
+
+ interleukin-17 production
+ The appearance of any member of the interleukin-17 family of cytokines due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-17 production
+
-
+
+
+ interleukin-18 production
+ The appearance of interleukin-18 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-18 production
+
+
+
+
+
+
+
+
+ interleukin-19 production
+ The appearance of interleukin-19 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-19 production
+
-
+
+
+ interleukin-2 production
+ The appearance of interleukin-2 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-2 production
+
+
+
+
+
+
+
+
+ interleukin-20 production
+ The appearance of interleukin-20 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-20 production
+
-
+
+
+ interleukin-21 production
+ The appearance of interleukin-21 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-21 production
+
-
+
+
+ interleukin-22 production
+ The appearance of interleukin-22 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-22 production
+
-
+
+
+ interleukin-23 production
+ The appearance of interleukin-23 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-23 production
+
+
+
+
+
+
+
+
+ interleukin-24 production
+ The appearance of interleukin-24 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-24 production
+
+
+
+
+
+
+
+
+ interleukin-25 production
+ The appearance of interleukin-25 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-25 production
+
+
+
+
+
+
+
+
+ interleukin-26 production
+ The appearance of interleukin-26 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-26 production
+
-
+
+
+ interleukin-27 production
+ The appearance of interleukin-27 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-27 production
+
-
+
+
+ interleukin-3 production
+ The appearance of interleukin-3 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-3 production
+
-
+
+
+ interleukin-4 production
+ The appearance of interleukin-4 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-4 production
+
-
+
+
+ interleukin-5 production
+ The appearance of interleukin-5 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-5 production
+
-
+
+
+ interleukin-6 production
+ The appearance of interleukin-6 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-6 production
+
-
+
+
+ interleukin-7 production
+ The appearance of interleukin-7 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-7 production
+
-
+
+
+ interleukin-8 production
+ The appearance of interleukin-8 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-8 production
+
-
+
+
+ interleukin-9 production
+ The appearance of interleukin-9 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-9 production
+
+
+
+
+
+
+
+
+ TRAIL production
+ The appearance of TRAIL due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ TRAIL production
+
- TNF alpha production
+
+ tumor necrosis factor production
+ The appearance of tumor necrosis factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
+ TNF alpha production
+
+ tumor necrosis factor production
@@ -3146,7 +8206,48 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
- TNF beta production
+
+ lymphotoxin A production
+ The chemical reactions and pathways resulting in the formation of the cytokine lymphotoxin A.
+ TNF beta production
+
+ lymphotoxin A production
+
+
+
+
+
+
+
+
+ transforming growth factor beta1 production
+ The appearance of transforming growth factor-beta1 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ transforming growth factor beta1 production
+
+
+
+
+
+
+
+
+ transforming growth factor beta2 production
+ The appearance of transforming growth factor-beta2 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ transforming growth factor beta2 production
+
+
+
+
+
+
+
+
+ transforming growth factor beta3 production
+ The appearance of transforming growth factor-beta3 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ transforming growth factor beta3 production
@@ -3154,101 +8255,201 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
+ protein-containing complex
A ribosome is a protein complex.
+ A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
protein complex
+
+ protein-containing complex
-
+
+
+ macromolecule localization
+ Any process in which a macromolecule is transported to, or maintained in, a specific location.
+
+ macromolecule localization
+
-
+
+
+ DNA polymerase activity
+ Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1); the synthesis of DNA from deoxyribonucleotide triphosphates in the presence of a nucleic acid template and a 3'hydroxyl group.
+
+ DNA polymerase activity
+
+
+
+
+
+
+
+
+ type III interferon production
+ The appearance of type III interferon due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Interferon lambda is the only member of the type III interferon found so far.
+
+ type III interferon production
+
-
+
+
+ chemokine (C-X-C motif) ligand 9 production
+ The appearance of chemokine (C-X-C motif) ligand 9 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ chemokine (C-X-C motif) ligand 9 production
+
-
+
+
+ helper T cell enhancement of adaptive immune response
+ Positive regulation of an adaptive immune response mediated via cytokine production by helper T cell.
+
+ helper T cell enhancement of adaptive immune response
+
-
+
+
+ helper T cell enhancement of T cell mediated immune response
+ Positive regulation of a T cell mediated immune response mediated via cytokine production by a helper T cell.
+
+ helper T cell enhancement of T cell mediated immune response
+
-
+
+
+ helper T cell enhancement of B cell mediated immune response
+ Positive regulation of a B cell mediated immune response mediated via cytokine production by a helper T cell.
+
+ helper T cell enhancement of B cell mediated immune response
+
-
+
+
+ granzyme A production
+ The appearance of granzyme A due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ granzyme A production
+
-
+
+
+ perforin production
+ The appearance of a perforin protein due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ perforin production
+
-
+
+
+ granulysin production
+ The appearance of granulysin due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ granulysin production
+
-
+
+
+ chemokine (C-C motif) ligand 20 production
+ The appearance of chemokine (C-C motif) ligand 20 (CCL20) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ chemokine (C-C motif) ligand 20 production
+
-
+
+
+ T cell proliferation
+ The expansion of a T cell population by cell division. Follows T cell activation.
+
+ T cell proliferation
+
-
+
+
+ T cell receptor complex
+ A protein complex that contains a disulfide-linked heterodimer of T cell receptor (TCR) chains, which are members of the immunoglobulin superfamily, and mediates antigen recognition, ultimately resulting in T cell activation. The TCR heterodimer is associated with the CD3 complex, which consists of the nonpolymorphic polypeptides gamma, delta, epsilon, zeta, and, in some cases, eta (an RNA splice variant of zeta) or Fc epsilon chains.
+
+ T cell receptor complex
+
-
+
+
+ T cell activation
+ The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
+
+ T cell activation
+
- antibody
- antibody
+
+ immunoglobulin complex, circulating
+ An immunoglobulin complex that is secreted into extracellular space and found in mucosal areas or other tissues or circulating in the blood or lymph. In its canonical form, a circulating immunoglobulin complex is composed of two identical heavy chains and two identical light chains, held together by disulfide bonds. Some forms of are polymers of the basic structure and contain additional components such as J-chain and the secretory component.
+ antibody
+
+ antibody
+ immunoglobulin complex, circulating
@@ -3256,6 +8457,7 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+
@@ -3267,4504 +8469,5340 @@ https://sourceforge.net/tracker/index.php?func=detail&aid=3512902&group_
+ DNA polymerase complex
+ A protein complex that possesses DNA polymerase activity and is involved in template directed synthesis of DNA.
+
+ DNA polymerase complex
+
+
+
+
+
+
+
+
+ peptide antigen binding
+ Binding to an antigen peptide.
+
+ peptide antigen binding
-
+
+
+ MHC protein complex
+ A transmembrane protein complex composed of an MHC alpha chain and, in most cases, either an MHC class II beta chain or an invariant beta2-microglobin chain, and with or without a bound peptide, lipid, or polysaccharide antigen.
+
+ MHC protein complex
+
+
+
+
+
+
+
+
+ membrane-bounded organelle
+ Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
+
+ membrane-bounded organelle
+
-
+
+
+ cytotoxic T cell degranulation
+ The regulated exocytosis of secretory granules containing preformed mediators such as perforin and granzymes by a cytotoxic T cell.
+
+ cytotoxic T cell degranulation
+
-
+
+
+ sequence-specific DNA binding
+ Binding to DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
+
+ sequence-specific DNA binding
+
-
+
+
+ regulation of DNA methylation
+ Any process that modulates the frequency, rate or extent of the covalent transfer of a methyl group to either N-6 of adenine or C-5 or N-4 of cytosine.
+
+ regulation of DNA methylation
+
-
+
+
+ macrophage migration inhibitory factor production
+ The appearance of macrophage migration inhibitory factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ macrophage migration inhibitory factor production
+
-
+
+
+ oncostatin M production
+ The appearance of oncostatin M due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ oncostatin M production
+
-
+
+
+ chemokine (C-C motif) ligand 17 production
+ The appearance of chemokine (C-C motif) ligand 17 (CCL17) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ chemokine (C-C motif) ligand 17 production
+
+
+
+
+
+
+
+
+ D-glutamyltransferase activity
+ Catalysis of the reaction: L(or D)-glutamine + D-glutamyl-peptide = NH3 + 5-glutamyl-D-glutamyl-peptide.
+
+ D-glutamyltransferase activity
+
-
+
+
+ cellular developmental process
+ A biological process whose specific outcome is the progression of a cell over time from an initial condition to a later condition.
+
+ cellular developmental process
+
-
+
+
+ response to stimulus
+ Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus and ends with a change in state or activity or the cell or organism.
+
+ response to stimulus
+
-
+
+
+ chromosome organization
+ A process that is carried out at the cellular level that results in the assembly, arrangement of constituent parts, or disassembly of chromosomes, structures composed of a very long molecule of DNA and associated proteins that carries hereditary information. This term covers covalent modifications at the molecular level as well as spatial relationships among the major components of a chromosome.
+
+ chromosome organization
+
-
+
+
+ carboxylic ester hydrolase activity
+ Catalysis of the hydrolysis of a carboxylic ester bond.
+
+ carboxylic ester hydrolase activity
+
-
+
+
+ ferritin complex
+ A protein complex that binds iron and acts as a major iron storage system. Intracellular and extracellular ferritin complexes have different ratios of two types of ferritin monomer, the L (light) chain and H (heavy) chain.
+
+ ferritin complex
+
+
+
+
+
+
+
+
+ actin polymerization-dependent cell motility
+ A process involved in the controlled movement of a bacterial cell powered by the continuous polymerization of actin at one pole of the cell.
+
+ actin polymerization-dependent cell motility
+
-
+
+
+ transforming growth factor beta production
+ The appearance of any member of the transforming growth factor-beta family of cytokines due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Transforming growth factor-beta family members include TGF-B1, TGF-B2, and TGF-B3.
+
+ transforming growth factor beta production
+
-
+
+
+ monocyte chemotactic protein-1 production
+ The appearance of monocyte chemotactic protein-1 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ monocyte chemotactic protein-1 production
+
-
+
+
+ chemokine (C-C motif) ligand 4 production
+ The appearance of chemokine (C-C motif) ligand 4 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ chemokine (C-C motif) ligand 4 production
+
-
+
+
+ macrophage inflammatory protein-1 gamma production
+ The appearance of macrophage inflammatory protein-1 gamma due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ macrophage inflammatory protein-1 gamma production
+
-
+
+
+ macrophage inflammatory protein-1 alpha production
+ The appearance of macrophage inflammatory protein 1 alpha due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ macrophage inflammatory protein-1 alpha production
+
-
+
+
+ chemokine (C-C motif) ligand 5 production
+ The appearance of chemokine (C-C motif) ligand 5 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ chemokine (C-C motif) ligand 5 production
+
-
+
+
+ chemokine (C-C motif) ligand 1 production
+ The appearance of chemokine (C-C motif) ligand 1 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ chemokine (C-C motif) ligand 1 production
+
-
+
+
+ granulocyte colony-stimulating factor production
+ The appearance of granulocyte colony-stimulating factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ granulocyte colony-stimulating factor production
+
-
+
+
+ IP-10 production
+ The appearance of IP-10 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ IP-10 production
+
-
+
+
+ granzyme B production
+ The appearance of granzyme B due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ granzyme B production
+
-
+
+
+ tumor necrosis factor superfamily cytokine production
+ The appearance of any member of the TNF superfamily due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ tumor necrosis factor superfamily cytokine production
+
-
+
+
+ IgG immunoglobulin complex
+ A protein complex composed of two identical immunoglobulin heavy chains of an IgG isotype and two identical immunoglobulin light chains, held together by disulfide bonds. An IgG immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.
+
+ IgG immunoglobulin complex
+
-
+
+
+ IgE immunoglobulin complex
+ A protein complex composed of two identical immunoglobulin heavy chains of the IgE isotype and two identical immunoglobulin light chains, held together by disulfide bonds. An IgE immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.
+
+ IgE immunoglobulin complex
+
-
+
+
+ IgA immunoglobulin complex
+ A protein complex composed of two identical immunoglobulin heavy chains of the IgA isotype and two identical immunoglobulin light chains, held together by disulfide bonds, and sometimes complexed with J chain or J chain and secretory component. An IgA immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.
+
+ IgA immunoglobulin complex
+
-
+
+
+ IgM immunoglobulin complex
+ A protein complex composed of two identical immunoglobulin heavy chains of the IgM isotype and two identical immunoglobulin light chains, held together by disulfide bonds, and in its circulating form complexed with J chain in polymeric forms. An IgM immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.
+
+ IgM immunoglobulin complex
+
-
+
+
+ chemokine (C-C motif) ligand 22 production
+ The appearance of chemokine (C-C motif) ligand 22 (CCL22) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ chemokine (C-C motif) ligand 22 production
+
-
+
+
+ tumor necrosis factor (ligand) superfamily member 11 production
+ The appearance of tumor necrosis factor superfamily member 11 (TNFSF11; RANKL) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ tumor necrosis factor (ligand) superfamily member 11 production
+
-
+
+
+ interleukin-17A production
+ The appearance of interleukin-17A due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-17A production
+
-
+
+
+ interleukin-17F production
+ The appearance of interleukin-17F due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ interleukin-17F production
+
-
+
+
+ complement-dependent cytotoxicity
+ Cell killing caused by the membrane attack complex formed following complement activation.
+
+ complement-dependent cytotoxicity
+
-
+
+
+ histamine secretion mediated by immunoglobulin
+ Histamine release triggered by the binding of an antigen to an immunoglobulin bound to the cell surface.
+
+ histamine secretion mediated by immunoglobulin
+
-
+
+
+ immune complex formation
+ The process that gives rise to an immune complex. Immune complexes are clusters of antibodies bound to antigen, to which complement may also be fixed, and which may precipitate or remain in solution. Examples are the clumping of cells such as bacteria or red blood cells in the presence of an antibody, precipitation of a toxin after an antibody binds to it, and clumping of viral particles as a result of antibody binding to the virus.
+
+ immune complex formation
+
-
+
+
+ immunoglobulin-mediated neutralization
+ The inhibition of an antigen's biological effects by antibody binding to it. An example is neutralization of diphtheria toxin by preventing its entry into human cells via the binding of antibody specific for diphtheria toxin.
+
+ immunoglobulin-mediated neutralization
+
-
+
+
+ chemokine (C-C motif) ligand 19 production
+ The appearance of chemokine (C-C motif) ligand 19 (CCL19) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ chemokine (C-C motif) ligand 19 production
+
-
+
+
+ chemokine (C-C motif) ligand 21 production
+ The appearance of chemokine (C-C motif) ligand 21 (CCL21) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ chemokine (C-C motif) ligand 21 production
+
-
+
+
+ chemokine (C-X-C motif) ligand 12 production
+ The appearance of chemokine (C-X-C motif) ligand 12 (CXCL12) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ chemokine (C-X-C motif) ligand 12 production
+
-
+
+
+ chemokine (C-X-C motif) ligand 13 production
+ The appearance of chemokine (C-X-C motif) ligand 13 (CXCL13) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ chemokine (C-X-C motif) ligand 13 production
+
-
+
+
+ chemokine (C-X-C motif) ligand 16 production
+ The appearance of chemokine (C-X-C motif) ligand 16 (CXCL16) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ chemokine (C-X-C motif) ligand 16 production
+
-
+
+
+ amphiregulin production
+ The appearance of amphiregulin due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Amphiregulin (AREG) is a ligand of the epidermal growth factor receptor (EGFR), a widely expressed transmembrane tyrosine kinase. AREG is synthesized as a membrane-anchored precursor protein that can engage in juxtacrine signaling on adjacent cells. Alternatively, after proteolytic processing by cell membrane proteases, mainly TACE/ADAM17, AREG is secreted and behaves as an autocrine or paracrine factor.
+
+ amphiregulin production
+
-
+
-
+
+
+ XCL1 production
+ The appearance of XCL1 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
+
+ XCL1 production
+
+
+
+
+
+
+
+
+ Insulin resistance
+ Increased resistance towards insulin, that is, diminished effectiveness of insulin in reducing blood glucose levels.
+
+ Insulin resistance
+
-
+
+
+ conditional specification
+
+ A directive information entity that specifies what should happen if the trigger condition is fulfilled.
+ PlanAndPlannedProcess Branch
+ OBI branch derived
+ OBI_0000349
+ conditional specification
+
-
+
+
+ measurement unit label
+ Examples of measurement unit labels are liters, inches, weight per volume.
+
+ A measurement unit label is as a label that is part of a scalar measurement datum and denotes a unit of measure.
+ 2009-03-16: provenance: a term measurement unit was
+proposed for OBI (OBI_0000176) , edited by Chris Stoeckert and
+Cristian Cocos, and subsequently moved to IAO where the objective for
+which the original term was defined was satisfied with the definition
+of this, different, term.
+ 2009-03-16: review of this term done during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify this definition please notify OBI.
+ PERSON: Alan Ruttenberg
+ PERSON: Melanie Courtot
+ measurement unit label
+
-
+
+
+ objective specification
+ In the protocol of a ChIP assay the objective specification says to identify protein and DNA interaction.
+
+ A directive information entity that describes an intended process endpoint. When part of a plan specification the concretization is realized in a planned process in which the bearer tries to effect the world so that the process endpoint is achieved.
+ 2009-03-16: original definition when imported from OBI read: "objective is an non realizable information entity which can serve as that proper part of a plan towards which the realization of the plan is directed."
+ 2014-03-31: In the example of usage ("In the protocol of a ChIP assay the objective specification says to identify protein and DNA interaction") there is a protocol which is the ChIP assay protocol. In addition to being concretized on paper, the protocol can be concretized as a realizable entity, such as a plan that inheres in a person. The objective specification is the part that says that some protein and DNA interactions are identified. This is a specification of a process endpoint: the boundary in the process before which they are not identified and after which they are. During the realization of the plan, the goal is to get to the point of having the interactions, and participants in the realization of the plan try to do that.
+ Answers the question, why did you do this experiment?
+ PERSON: Alan Ruttenberg
+ PERSON: Barry Smith
+ PERSON: Bjoern Peters
+ PERSON: Jennifer Fostel
+ goal specification
+ OBI Plan and Planned Process/Roles Branch
+ OBI_0000217
+ objective specification
+
-
+
+
+ narrative object
+ Examples of narrative objects are reports, journal articles, and patents submission.
+
+ A narrative object is an information content entity that is a set of propositions.
+ 2009-08-10 Alan Ruttenberg: Larry Hunter suggests that this be obsoleted and replaced by 'textual entity' and 'figure'. Alan restored as there are OBI dependencies and this merits further discussion
+ agree - DENRIE. Issue(alan) do we only mean text? What about a story told by mime. Does music count? (no) what about an oral report. Regarding definition, saying it is a set of propositions means we loose the idea that wording matters. Maybe adjust saying a narrative object has some relationshop to a set of propositions
+ person:Chris Stoeckert
+ OBI_0000013
+ group:OBI
+ narrative object
+
-
+
-
+
+
+ Pour the contents of flask 1 into flask 2
+
+ A directive information entity that describes an action the bearer will take.
+ Alan Ruttenberg
+ OBI Plan and Planned Process branch
+ action specification
+
-
+
-
+
+
+
+ obsolete_artifact
+ true
+
-
+
-
+
+
+ datum label
+
+ A label is a symbol that is part of some other datum and is used to either partially define the denotation of that datum or to provide a means for identifying the datum as a member of the set of data with the same label
+ http://www.golovchenko.org/cgi-bin/wnsearch?q=label#4n
+ GROUP: IAO
+ 9/22/11 BP: changed the rdfs:label for this class from 'label' to 'datum label' to convey that this class is not intended to cover all kinds of labels (stickers, radiolabels, etc.), and not even all kind of textual labels, but rather the kind of labels occuring in a datum.
+
+ datum label
+
-
+
-
+
+
+ software
+
+ Software is a plan specification composed of a series of instructions that can be
+interpreted by or directly executed by a processing unit.
+ see sourceforge tracker discussion at http://sourceforge.net/tracker/index.php?func=detail&aid=1958818&group_id=177891&atid=886178
+ PERSON: Alan Ruttenberg
+ PERSON: Bjoern Peters
+ PERSON: Chris Stoeckert
+ PERSON: Melanie Courtot
+ GROUP: OBI
+ software
+
-
-
-
-
-
+
-
+
+
+ obsolete_digital entity
+ A digital entity is an information entity which is a collection of bits that can be interpreted by a computer. Two digital entities are the same if they are bitwise identical.
+ 3/22/2009 Alan Ruttenberg, obsoleted per http://groups.google.com/group/information-ontology/browse_thread/thread/789ad4b7708d5cf4
-
-
-
-
-
-
-
+Superclass was 'digitial quality'
+ person:Chris Stoeckert
+ OBI_0000261
+ group:OBI
+
+ obsolete2_digital entity
+ true
-
+
-
+
+
+ journal article
+ Examples are articles published in the journals, Nature and Science. The content can often be cited by reference to a paper based encoding, e.g. Authors, Title of article, Journal name, date or year of publication, volume and page number.
+
+ A report that is published in a journal.
+ person:Alan Ruttenberg
+ person:Chris Stoeckert
+ OBI_0000159
+ group:OBI
+ journal article
+
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+ information carrier
+ In the case of a printed paperback novel the physicality of the ink and of the paper form part of the information bearer. The qualities of appearing black and having a certain pattern for the ink and appearing white for the paper form part of the information carrier in this case.
+
+ A quality of an information bearer that imparts the information content
+ 12/15/09: There is a concern that some ways that carry information may be processes rather than qualities, such as in a 'delayed wave carrier'.
+ 2014-03-10: We are not certain that all information carriers are qualities. There was a discussion of dropping it.
+ PERSON: Alan Ruttenberg
+ Smith, Ceusters, Ruttenberg, 2000 years of philosophy
+ information carrier
+
-
+
-
+
+
+ model number
+
+ A model number is an information content entity specifically borne by catalogs, design specifications, advertising materials, inventory systems and similar that is about manufactured objects of the same class. The model number is an alternative term for the class. The manufactered objects may or may not also bear the model number. Model numbers can be encoded in a variety of other information objects, such as bar codes, numerals, or patterns of dots.
+ manufactered items may have more than one model number, sometimes by rebranding, or because companies are sold and the products issued new model numbers
+ Person: Alan Ruttenberg
+ model number
+
-
+
-
+
+
+
+ obsolete_material_entity
+ true
+
-
+
-
+
+
+ binary digital entity
+ MS Word document, ZIP file, DICOM file, JPEG file
+ A binary digital entity is a digital entity that is encoded in a way that is not easily human readable and that contains other than text characters.
+ 3/22/2009 Alan Ruttenberg, obsoleted per http://groups.google.com/group/information-ontology/browse_thread/thread/789ad4b7708d5cf4
+Superclass was 'digital entity'
+ digital_entity
+ person:Chris Stoeckert
+ OBI_0000244
+ group:OBI
+
+ obsolete2_binary digital entity
+ true
+
-
+
-
+
+
+ The length of a ruler.
+ a unit of measure is the quality of some material entity compared to which another quality is some multiple of.
+ Alan Ruttenberg
+ Smith, Ceusters, Ruttenberg, 2000 years of philosophy
+
+ obsolete_unit of measure
+ true
+
-
+
-
+
+
+ programming language
+ R, Perl, Java
+
+ A language in which source code is written that is intended to be executed/run by a software interpreter. Programming languages are ways to write instructions that specify what to do, and sometimes, how to do it.
+ person:Alan Ruttenberg
+ person:Chris Stoeckert
+ OBI_0000058
+ group:OBI
+ programming language
+
-
+
-
+
+
+ data item
+ Data items include counts of things, analyte concentrations, and statistical summaries.
+
+ An information content entity that is intended to be a truthful statement about something (modulo, e.g., measurement precision or other systematic errors) and is constructed/acquired by a method which reliably tends to produce (approximately) truthful statements.
+ 2/2/2009 Alan and Bjoern discussing FACS run output data. This is a data item because it is about the cell population. Each element records an event and is typically further composed a set of measurment data items that record the fluorescent intensity stimulated by one of the lasers.
+ 2009-03-16: data item deliberatly ambiguous: we merged data set and datum to be one entity, not knowing how to define singular versus plural. So data item is more general than datum.
+ 2009-03-16: removed datum as alternative term as datum specifically refers to singular form, and is thus not an exact synonym.
+ 2014-03-31: See discussion at http://odontomachus.wordpress.com/2014/03/30/aboutness-objects-propositions/
+ JAR: datum -- well, this will be very tricky to define, but maybe some
+information-like stuff that might be put into a computer and that is
+meant, by someone, to denote and/or to be interpreted by some
+process... I would include lists, tables, sentences... I think I might
+defer to Barry, or to Brian Cantwell Smith
+
+JAR: A data item is an approximately justified approximately true approximate belief
+ PERSON: Alan Ruttenberg
+ PERSON: Chris Stoeckert
+ PERSON: Jonathan Rees
+ data
+ data item
+
-
+
-
+
+
+ symbol
+ a serial number such as "12324X"
+ a stop sign
+ a written proper name such as "OBI"
+
+ An information content entity that is a mark(s) or character(s) used as a conventional representation of another entity.
+ 20091104, MC: this needs work and will most probably change
+ 2014-03-31: We would like to have a deeper analysis of 'mark' and 'sign' in the future (see https://github.com/information-artifact-ontology/IAO/issues/154).
+ PERSON: James A. Overton
+ PERSON: Jonathan Rees
+ based on Oxford English Dictionary
+ symbol
+
-
+
-
+
+
+ numeral
+
+ A symbol that denotes a number.
+ PERSON: Jonathan Rees
+ numeral
+
-
+
-
+
+
+
+
+
+
+
+
+ information content entity
+ Examples of information content entites include journal articles, data, graphical layouts, and graphs.
+
+ A generically dependent continuant that is about some thing.
+ 2014-03-10: The use of "thing" is intended to be general enough to include universals and configurations (see https://groups.google.com/d/msg/information-ontology/GBxvYZCk1oc/-L6B5fSBBTQJ).
+ information_content_entity 'is_encoded_in' some digital_entity in obi before split (040907). information_content_entity 'is_encoded_in' some physical_document in obi before split (040907).
+
+Previous. An information content entity is a non-realizable information entity that 'is encoded in' some digital or physical entity.
+ PERSON: Chris Stoeckert
+ OBI_0000142
+ information content entity
+
-
+
-
+
+
+ integer numeral
+
+ A numeral that denotes an integer
+ PERSON: Jonathan Rees
+ integer numeral
+
-
+
-
+
+
-
+
-
-
-
-
-
-
-
-
-
+
+ 1
-
-
+
+ 1
+ 10 feet. 3 ml.
+
+ A scalar measurement datum is a measurement datum that is composed of two parts, numerals and a unit label.
+ 2009-03-16: we decided to keep datum singular in scalar measurement datum, as in
+this case we explicitly refer to the singular form
+ Would write this as: has_part some 'measurement unit label' and has_part some numeral and has_part exactly 2, except for the fact that this won't let us take advantage of OWL reasoning over the numbers. Instead use has measurment value property to represent the same. Use has measurement unit label (subproperty of has_part) so we can easily say that there is only one of them.
+ PERSON: Alan Ruttenberg
+ PERSON: Melanie Courtot
+ scalar measurement datum
-
+
-
+
+
+
+
+
+
+
+
+
+ An information content entity whose concretizations indicate to their bearer how to realize them in a process.
+ 2009-03-16: provenance: a term realizable information entity was proposed for OBI (OBI_0000337) , edited by the PlanAndPlannedProcess branch. Original definition was "is the specification of a process that can be concretized and realized by an actor" with alternative term "instruction".It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term.
+ 2013-05-30 Alan Ruttenberg: What differentiates a directive information entity from an information concretization is that it can have concretizations that are either qualities or realizable entities. The concretizations that are realizable entities are created when an individual chooses to take up the direction, i.e. has the intention to (try to) realize it.
+ 8/6/2009 Alan Ruttenberg: Changed label from "information entity about a realizable" after discussions at ICBO
+ Werner pushed back on calling it realizable information entity as it isn't realizable. However this name isn't right either. An example would be a recipe. The realizable entity would be a plan, but the information entity isn't about the plan, it, once concretized, *is* the plan. -Alan
+ PERSON: Alan Ruttenberg
+ PERSON: Bjoern Peters
+ directive information entity
+
-
+
-
+
+
+ time trigger
+
+ PlanAndPlannedProcess Branch
+ time trigger
+
-
+
-
+
+
+ obsolete_study interpretation
+
+ A study interpretation is a textual entity about the implications of a study result. Examples include discussion of whether a hypothesis is false, whether the study failed to address the hypothesis, and whether the study results have led to new hypotheses
+ 2009-03-16: definition was "A conclusion is a narrative object which can be published in a paper summerizing and interpreting a protocol application."
+ 2009-03-16: work has been done on this term during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify this definition please notify OBI.
+ The obsoleting of narrative object required a modest change in the definition of this term. Circularity with "interpretation... interprets" has been removed, using "about the implications" instead.
+ Lawrence Hunter
+ PERSON: Alan Ruttenberg
+ PERSON: Jennifer Fostel
+ PERSON: Melanie Courtot
+ conclusion
+ OBI_0000005
+
+ obsolete_study interpretation
+ true
+
-
+
-
+
+
+ dot plot
+ Dot plot of SSC-H and FSC-H.
+
+ A dot plot is a report graph which is a graphical representation of data where each data point is represented by a single dot placed on coordinates corresponding to data point values in particular dimensions.
+ person:Allyson Lister
+ person:Chris Stoeckert
+ OBI_0000123
+ group:OBI
+ dot plot
+
-
+
-
+
+
+ graph
+
+ A diagram that presents one or more tuples of information by mapping those tuples in to a two dimensional space in a non arbitrary way.
+ PERSON: Lawrence Hunter
+ person:Alan Ruttenberg
+ person:Allyson Lister
+ OBI_0000240
+ group:OBI
+ graph
+
-
+
-
+
+
+ text based digital entity
+ XML file, C++ source code file
+ A text based digital entity is a digital entity that is encoded so that it only contains text characters.
+ 3/22/2009 Alan Ruttenberg, obsoleted per http://groups.google.com/group/information-ontology/browse_thread/thread/789ad4b7708d5cf4
+superclass was 'digital document'
+ digital_entity
+ person:Chris Stoeckert
+ OBI_0000132
+ group:OBI
+
+ obsolete2_text based digital entity
+ true
+
-
+
-
+
+
+ rule
+ example to be added
+
+ A rule is an executable which guides, defines, restricts actions.
+ MSI
+ PRS
+ OBI_0500021
+ PRS
+ rule
+
-
+
-
+
+
+ contour plot
+ Contour plot of SSC-H, FSC-H, and FL1-H.
+
+ generically_dependent_continuants
+ person:Allyson Lister
+ person:Chris Stoeckert
+ OBI_0000246
+ group:Flow Cytometry community
+ contour plot
+
-
+
-
+
+
+ report figure
+
+ A report figure is a report display element that has some aspect of illustration, but may be a composite of figures, images, and other elements
+ I prepended the 'report ' to make it clear that we mean parts of reports here. We may want a more generic version of 'figure', in which case this would become a defined class - figure and part_of some report
+ Replaced by defined version of figure
+ person:Alan Ruttenberg
+ person:Allyson Lister
+ OBI_0000027
+ group:OBI
+
+ obsolete2_report figure
+ true
+
-
+
-
+
+
+ algorithm
+ PMID: 18378114.Genomics. 2008 Mar 28. LINKGEN: A new algorithm to process data in genetic linkage studies.
+
+ A plan specification which describes the inputs and output of mathematical functions as well as workflow of execution for achieving an predefined objective. Algorithms are realized usually by means of implementation as computer programs for execution by automata.
+ Philippe Rocca-Serra
+ PlanAndPlannedProcess Branch
+ OBI_0000270
+ adapted from discussion on OBI list (Matthew Pocock, Christian Cocos, Alan Ruttenberg)
+ algorithm
+
-
+
-
+
+
+ software interpreter
+ R program, Perl interpreter, Java virtual machine
+
+ A software interpreter is a software application that executes some specified input software.
+ Do we care? Jennifer: Yes, there was a particular version of R that had a bug and it was fixed later. That would imply that we mean specific version of an interpreter. So an instance of this would be a particular version of the interpreter
+ person:Alan Ruttenberg
+ person:Chris Stoeckert
+ OBI_0000199
+ group:OBI
+ software interpreter
+
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ curation status specification
+
+ The curation status of the term. The allowed values come from an enumerated list of predefined terms. See the specification of these instances for more detailed definitions of each enumerated value.
+ Better to represent curation as a process with parts and then relate labels to that process (in IAO meeting)
+ PERSON:Bill Bug
+ GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
+ OBI_0000266
+ curation status specification
+
-
+
-
+
+
+ density plot
+ Density plot of SSC-H and FSC-H.
+
+ A density plot is a report graph which is a graphical representation of data where the tint of a particular pixel corresponds to some kind of function corresponding the the amount of data points relativelly with their distance from the the pixel.
+ person:Allyson Lister
+ person:Chris Stoeckert
+ OBI_0000179
+ group:Flow Cytometry community
+ density plot
+
-
+
-
+
+
+ report
+ Examples of reports are gene lists and investigation reports. These are not published (journal) articles but may be included in a journal article.
+
+ A document assembled by an author for the purpose of providing information for the audience. A report is the output of a documenting process and has the objective to be consumed by a specific audience. Topic of the report is on something that has completed. A report is not a single figure. Examples of reports are journal article, patent application, grant progress report, case report (not patient record).
+ 2009-03-16: comment from Darren Natale: I am slightly uneasy with the sentence "Topic of the report is on
+something that has completed." Should it be restricted to those things
+that are completed? For example, a progress report is (usually) about
+something that definitely has *not* been completed, or may include
+(only) projections. I think the definition would not suffer if the
+whole sentence is deleted.
+ 2009-03-16: this was report of results with definition: A report is a narrative object that is a formal statement of the results of an investigation, or of any matter on which definite information is required, made by some person or body instructed or required to do so.
+ 2009-03-16: work has been done on this term during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify this definition please notify OBI.
+ 2009-08-10 Alan Ruttenberg: Larry Hunter suggests that this be obsoleted and replaced by 'document'. Alan restored as there are OBI dependencies and this merits further discussion
+ disagreement about where reports go. alan: only some gene lists are reports. Is a report all the content of some document? The example of usage suggests that a report may be part of some article. Term needs clarification
+ PERSON: Alan Ruttenberg
+ PERSON: Melanie Courtot
+ PERSON:Chris Stoeckert
+ GROUP: OBI
+ OBI_0000099
+ report
+
-
+
-
+
+
+ report element
+
+ A report element is a narrative object in which information is presented and consumed by a human being, and is part of a report. Examples of report elements are figure (dot plot), table, text portion (may include a movie or audio clip on a web page).
+ 2009-03-16: needs some more work (clarify relations).
+ 2009-03-16: was report display element with definition: A report display element is a narrative object that is part of a report. Report display elements are set off from the textual parts of a report and are typically given a label(e.g. Figure 2) which is used to refer to the element from the text. Typically the 2d layout is part of the identity of such elements.
+ 2009-03-16: work has been done on this term during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify this definition please notify OBI.
+ 2009-08-10 Alan Ruttenberg: Larry Hunter suggests that this be obsoleted and replaced by 'textual entity' and 'figure'. Alan restored as there are OBI dependencies and this merits further discussion
+ Replaced by textual entity and figure
+ There will be some issue here about whether these are defined classes. As intended these are meant to denote the parts of the report that are not textual but are typically boxed and set within the text, labelled with some identifier, and referred to in the text
+ PERSON: Alan Ruttenberg
+ PERSON: Allyson Lister
+ PERSON: Melanie Courtot
+ GROUP:OBI
+ OBI_0000001
+
+ obsolete_report element
+ true
+
-
+
-
+
+
+ binary executable
+ Binary executable is a digital entity consisting of the binary representation of machine instructions of a specific processor or they may be binary pseudocode for a virtual machine. A non-source executable file is also called an object program. It is assumed that the binary executable file contains properly-formatted computer instructions. (derived from Wikipedia, Nov 1, 2007)
+ 3/22/2009 Alan Ruttenberg, obsoleted per http://groups.google.com/group/information-ontology/browse_thread/thread/789ad4b7708d5cf4
+superclass was 'digital entity'
+ person:Jennifer Fostel
+ OBI_0000222
+ group:OBI
+
+ obsolete2_binary executable
+ true
+
-
+
-
+
+
+ source code module
+ The written source code that implements part of an algorithm. Test - if you know that it was written in a specific language, then it can be source code module. We mean here, roughly, the wording of a document such as a perl script.
+
+ A source code module is a directive information entity that specifies, using a programming language, some algorithm.
+ person:Alan Ruttenberg
+ person:Chris Stoeckert
+ OBI_0000039
+ group:OBI
+ source code module
+
-
+
-
+
+
+ report table
+
+ A report table is a report display element consisting of a matrix of cells layed out in a grid, some set of which are filled with some information content
+ 2009-08-10 Alan Ruttenberg: Larry Hunter suggests that this be obsoleted and replaced by 'textual entity table'. Alan restored as there are OBI dependencies and this merits further discussion
+ person:Alan Ruttenberg
+ person:Allyson Lister
+ OBI_0000265
+ group:OBI
+
+ obsolete_report table
+ true
+
-
+
-
+
+
+ data format specification
+
+ A data format specification is the information content borne by the document published defining the specification.
+Example: The ISO document specifying what encompasses an XML document; The instructions in a XSD file
+ 2009-03-16: provenance: term imported from OBI_0000187, which had original definition "A data format specification is a plan which organizes
+information. Example: The ISO document specifying what encompasses an
+XML document; The instructions in a XSD file"
+ PERSON: Alan Ruttenberg
+ PlanAndPlannedProcess Branch
+ OBI branch derived
+ OBI_0000187
+ data format specification
+
-
+
-
+
+
+ data set
+ Intensity values in a CEL file or from multiple CEL files comprise a data set (as opposed to the CEL files themselves).
+
+ A data item that is an aggregate of other data items of the same type that have something in common. Averages and distributions can be determined for data sets.
+ 2009/10/23 Alan Ruttenberg. The intention is that this term represent collections of like data. So this isn't for, e.g. the whole contents of a cel file, which includes parameters, metadata etc. This is more like java arrays of a certain rather specific type
+ 2014-05-05: Data sets are aggregates and thus must include two or more data items. We have chosen not to add logical axioms to make this restriction.
+ person:Allyson Lister
+ person:Chris Stoeckert
+ OBI_0000042
+ group:OBI
+ data set
+
-
+
-
+
+
+ image
+
+ An image is an affine projection to a two dimensional surface, of measurements of some quality of an entity or entities repeated at regular intervals across a spatial range, where the measurements are represented as color and luminosity on the projected on surface.
+ person:Alan Ruttenberg
+ person:Allyson
+ person:Chris Stoeckert
+ OBI_0000030
+ group:OBI
+ image
+
-
+
-
+
+
+ data about an ontology part
+ Data about an ontology part is a data item about a part of an ontology, for example a term
+ Person:Alan Ruttenberg
+ data about an ontology part
+
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ plan specification
+ PMID: 18323827.Nat Med. 2008 Mar;14(3):226.New plan proposed to help resolve conflicting medical advice.
+
+ A directive information entity with action specifications and objective specifications as parts that, when concretized, is realized in a process in which the bearer tries to achieve the objectives by taking the actions specified.
+ 2009-03-16: provenance: a term a plan was proposed for OBI (OBI_0000344) , edited by the PlanAndPlannedProcess branch. Original definition was " a plan is a specification of a process that is realized by an actor to achieve the objective specified as part of the plan". It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term.
+ 2014-03-31: A plan specification can have other parts, such as conditional specifications.
+ Alternative previous definition: a plan is a set of instructions that specify how an objective should be achieved
+ Alan Ruttenberg
+ OBI Plan and Planned Process branch
+ OBI_0000344
+ 2/3/2009 Comment from OBI review.
-
+Action specification not well enough specified.
+Conditional specification not well enough specified.
+Question whether all plan specifications have objective specifications.
-
+Request that IAO either clarify these or change definitions not to use them
+ plan specification
+
-
+
-
+
+
+ digital document
+ A digital document is a digital entity consisting of an electronic file which can be rendered into human-readable form by one or more computational applications. The digital document does not refer to the information content of the document but to an instance of the file.
+ 3/22/2009 Alan Ruttenberg, obsoleted per http://groups.google.com/group/information-ontology/browse_thread/thread/789ad4b7708d5cf4
+superclass was 'digial entity'
+ person:Jennifer Fostel
+ OBI_0000195
+ group:OBI
+
+ obsolete2_digital document
+ true
+
-
+
-
+
+
+
+
+
+
+
+
+ measurement datum
+ Examples of measurement data are the recoding of the weight of a mouse as {40,mass,"grams"}, the recording of an observation of the behavior of the mouse {,process,"agitated"}, the recording of the expression level of a gene as measured through the process of microarray experiment {3.4,luminosity,}.
+
+ A measurement datum is an information content entity that is a recording of the output of a measurement such as produced by a device.
+ 2/2/2009 is_specified_output of some assay?
+ person:Chris Stoeckert
+ OBI_0000305
+ group:OBI
+ measurement datum
+
-
+
+
+
+
+
+ _identifier is a container under information content entity for collecting types of terms to indicate a specific instance or clas of what was used or participated in an investigation. Identifiers are borne by a product or its packaging, and can be encoded in a variety of other information objects, such as bar codes, numerals, or patterns of dots.
-
+Note: everybody agreed that identifier is probably a too general term. We however felt that it would be appropriate to group "identifiying" terms under some kind of umbrella. We therefore propose to use _identifier for that purpose. As per OBI conventions, the _ prefixing identifier indicates that this is a helper class and shouldn't be considered as final.
+
+ obsolete_identifier
+ true
+
-
+
-
+
+
+ version number
+
+ A version number is an information content entity which is a sequence of characters borne by part of each of a class of manufactured products or its packaging and indicates its order within a set of other products having the same name.
+ Note: we feel that at the moment we are happy with a general version number, and that we will subclass as needed in the future. For example, see 7. genome sequence version
+ GROUP: IAO
+ version number
+
-
+
-
+
+
+ serial number
+
+ A serial number is an information content entity which is a unique sequence of characters borne by part of manufactured product or its packaging that is assigned to each individual in some class of products, and so can serve as a way to identify an individual product within the class. Serial numbers can be encoded in a variety of other information objects, such as bar codes, numerals, or patterns of dots.
+ Note: during the call there was some confusion between serial number and model number. We agreed that it would be very helpful for all those terms to have example of usages - please add if you have any :-)
+ GROUP: IAO
+ serial number
+
-
+
-
+
+
+ lot number
+
+ A lot number is an information content entity which is an identical sequence of character borne by part of manufactured product or its packaging for each instances of a product class in a discrete batch of an item. Lot numbers are usually assigned to each separate production run of an item. Manufacturing as a lot might be due to a variety of reasons, for example, a single process during which many individuals are made from the same portion of source material. Lot numbers can be encoded in a pattern of other information objects, such as bar codes, numerals, or patterns of dots.
+ GROUP: IAO
+ batch number
+ lot number
+
-
-
-
-
+
+
+
+
+ A settings datum is a datum that denotes some configuration of an instrument.
+ 2/3/2009 Feedback from OBI
-
+This should be a "setting specification". There is a question of whether it is information about a realizable or not.
-
+Pro other specification are about realizables.
+Cons sometimes specifies a quality which is not a realizable.
+ Alan grouped these in placeholder for the moment. Name by analogy to measurement datum.
+ setting datum
+
-
+
-
+
+
+ 3/22/2009 Alan Ruttenberg, obsoleted per http://groups.google.com/group/information-ontology/browse_thread/thread/789ad4b7708d5cf4
+ Need to rework digital entity. Digital quality was suggested by Barry.
+
+ obsolete_digital quality
+ true
+
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ conclusion textual entity
+ that fucoidan has a small statistically significant effect on AT3 level but no useful clinical effect as in-vivo anticoagulant, a paraphrase of part of the last paragraph of the discussion section of the paper 'Pilot clinical study to evaluate the anticoagulant activity of fucoidan', by Lowenthal et. al.PMID:19696660
+
+ A textual entity that expresses the results of reasoning about a problem, for instance as typically found towards the end of scientific papers.
+ 2009/09/28 Alan Ruttenberg. Fucoidan-use-case
+ 2009/10/23 Alan Ruttenberg: We need to work on the definition still
+ Person:Alan Ruttenberg
+ conclusion textual entity
+
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ material information bearer
+ A page of a paperback novel with writing on it. The paper itself is a material information bearer, the pattern of ink is the information carrier.
+ a brain
+ a hard drive
+
+ A material entity in which a concretization of an information content entity inheres.
+ GROUP: IAO
+ material information bearer
+
-
+
-
+
+
+ histogram
+
+ A histogram is a report graph which is a statistical description of a
+distribution in terms of occurrence frequencies of different event classes.
+ PERSON:Chris Stoeckert
+ PERSON:James Malone
+ PERSON:Melanie Courtot
+ GROUP:OBI
+ histogram
+
-
+
-
+
+
+ heatmap
+
+ A heatmap is a report graph which is a graphical representation of data
+where the values taken by a variable(s) are shown as colors in a
+two-dimensional map.
+ PERSON:Chris Stoeckert
+ PERSON:James Malone
+ PERSON:Melanie Courtot
+ GROUP:OBI
+ heatmap
+
-
+
-
+
+
+ Venn diagram
+
+ A Venn diagram is a report graph showing all hypothetically possible
+logical relations between a finite collection of sets.
+ PERSON:Chris Stoeckert
+ PERSON:James Malone
+ PERSON:Melanie Courtot
+ WEB: http://en.wikipedia.org/wiki/Venn_diagram
+ Venn diagram
+
-
+
-
- human being
+
+
+ obsolete_survival curve
+
+ A survival curve is a report graph which is a graphical representation of data where the percentage of survival is plotted as a function of time.
+ PERSON:Chris Stoeckert
+ PERSON:James Malone
+ PERSON:Melanie Courtot
+ WEB: http://www.graphpad.com/www/book/survive.htm
+
+ obsolete_survival curve
+ true
-
+
-
+
+
+ dendrogram
+ Dendrograms are often used in computational biology to
+illustrate the clustering of genes.
+
+ A dendrogram is a report graph which is a tree diagram
+frequently used to illustrate the arrangement of the clusters produced by a
+clustering algorithm.
+ PERSON:Chris Stoeckert
+ PERSON:James Malone
+ PERSON:Melanie Courtot
+ WEB: http://en.wikipedia.org/wiki/Dendrogram
+ dendrogram
+
-
+
-
-
- role of being consumer safety officer
- Consumer safety officer; Consumer Safety Officer Positions at FDA http://69.20.19.211/jobs/cso.htm
- Person charged with serving as CSO, FDA official who coordinates the review
-
- the role of a human being that is realized by enforcing regulations to ensure consumer safety
- Jennifer Fostel
- Person:Helen Parkinson
- OBI, CDISC
- role of being consumer safety officer
+
+
+ scatter plot
+ Comparison of gene expression values in two samples can be displayed in a scatter plot
+
+ A scatterplot is a graph which uses Cartesian coordinates to display values for two variables for a set of data. The data is displayed as a collection of points, each having the value of one variable determining the position on the horizontal axis and the value of the other variable determining the position on the vertical axis.
+ PERSON:Chris Stoeckert
+ PERSON:James Malone
+ PERSON:Melanie Courtot
+ scattergraph
+ WEB: http://en.wikipedia.org/wiki/Scatterplot
+ scatter plot
-
+
-
-
- fluorescent reporter intensity
-
- A measurement datum that represents the output of a scanner measuring the intensity value for each fluorescent reporter.
- person:Chris Stoeckert
- group:OBI
- From the DT branch: This term and definition were originally submitted by the community to our branch, but we thought they best fit DENRIE. However we see several issues with this. First of all the name 'probe' might not be used in OBI. Instead we have a 'reporter' role. Also, albeit the term 'probe intensity' is often used in communities such as the microarray one, the name 'probe' is ambiguous (some use it to refer to what's on the array, some use it to refer to what's hybed to the array). Furthermore, this concept could possibly be encompassed by combining different OBI terms, such as the roles of analyte, detector and reporter (you need something hybed to a probe on the array to get an intensity) and maybe a more general term for 'measuring intensities'. We need to find the right balance between what is consistent with OBI and combinations of its terms and what is user-friendly. Finally, note that 'intensity' is already in the OBI .owl file and is also in PATO. Why didn't OBI import it from PATO? This might be a problem.
- fluorescent reporter intensity
+
+
+
+ A photograph is created by projecting an image onto a photosensitive surface such as a chemically treated plate or film, CCD receptor, etc.
+ PERSON:Alan Ruttenberg
+ PERSON:Joanne Luciano
+ PERSON:Melanie Courtot
+ WEB: http://en.wiktionary.org/wiki/photograph
+ photograph
-
+
-
+
-
-
-
+
+
+
-
-
+
+
+
+
+
+
+
-
-
+
+
- planned process
- Injecting mice with a vaccine in order to test its efficacy
-
- A process that realizes a plan which is the concretization of a plan specification.
- 'Plan' includes a future direction sense. That can be problematic if plans are changed during their execution. There are however implicit contingencies for protocols that an agent has in his mind that can be considered part of the plan, even if the agent didn't have them in mind before. Therefore, a planned process can diverge from what the agent would have said the plan was before executing it, by adjusting to problems encountered during execution (e.g. choosing another reagent with equivalent properties, if the originally planned one has run out.)
- We are only considering successfully completed planned processes. A plan may be modified, and details added during execution. For a given planned process, the associated realized plan specification is the one encompassing all changes made during execution. This means that all processes in which an agent acts towards achieving some
-objectives is a planned process.
- Bjoern Peters
- branch derived
- 6/11/9: Edited at workshop. Used to include: is initiated by an agent
- This class merges the previously separated objective driven process and planned process, as they the separation proved hard to maintain. (1/22/09, branch call)
- planned process
+
+ photographic print
+
+ A photographic print is a material entity upon which a photograph generically depends.
+ PERSON:Alan Ruttenberg
+ PERSON:Melanie Courtot
+ photographic print
-
+
-
-
- regulator role
- Fact sheet - Regulating the companies The role of the regulator. Ofwat is the economic regulator of the water and sewerage industry in England and Wales. http://www.ofwat.gov.uk/aptrix/ofwat/publish.nsf/Content/roleofregulator_factsheet170805
-
- a regulatory role involved with making and/or enforcing relevant legislation and governmental orders
- Person:Jennifer Fostel
- regulator
- OBI
- regulator role
+
+
+
+
+
+
+
+
+
+
+
+
+
+ obsolescence reason specification
+
+ The reason for which a term has been deprecated. The allowed values come from an enumerated list of predefined terms. See the specification of these instances for more detailed definitions of each enumerated value.
+ The creation of this class has been inspired in part by Werner Ceusters' paper, Applying evolutionary terminology auditing to the Gene Ontology.
+ PERSON: Alan Ruttenberg
+ PERSON: Melanie Courtot
+ obsolescence reason specification
-
+
-
-
- biological feature identification objective
+
+
+ textual entity
+ Words, sentences, paragraphs, and the written (non-figure) parts of publications are all textual entities
- Biological_feature_identification_objective is an objective role carried out by the proposition defining the aim of a study designed to examine or characterize a particular biological feature.
- Jennifer Fostel
- biological feature identification objective
+ A textual entity is a part of a manifestation (FRBR sense), a generically dependent continuant whose concretizations are patterns of glyphs intended to be interpreted as words, formulas, etc.
+ AR, (IAO call 2009-09-01): a document as a whole is not typically a textual entity, because it has pictures in it - rather there are parts of it that are textual entities. Examples: The title, paragraph 2 sentence 7, etc.
+ MC, 2009-09-14 (following IAO call 2009-09-01): textual entities live at the FRBR (http://en.wikipedia.org/wiki/Functional_Requirements_for_Bibliographic_Records) manifestation level. Everything is significant: line break, pdf and html versions of same document are different textual entities.
+ PERSON: Lawrence Hunter
+ text
+ textual entity
-
+
-
-
- regulation-assigned role
- Approval letter
-
- Regulation-assigned role is a regulatory role defined by legislation or governmental orders
- Person: Jennifer Fostel
- regulation-assigned role
+
+
+
+
+
+
+
+
+ citation
+ Verspoor, K., Cohen, KB., Hunter, L. Textual characteristics of traditional and Open Access scientific journals are similar, BMC Bioinformatics 2009, 10:183.
+
+ A textual entity intended to identify a particular publication.
+ PERSON: Lawrence Hunter
+ citation
-
+
-
-
- regulatory role
- Regulatory agency, Ethics committee, Approval letter; example: Browse these EPA Regulatory Role subtopics http://www.epa.gov/ebtpages/enviregulatoryrole.html Feb 29, 2008
-
- a role which inheres in material entities and is realized in the processes of making, enforcing or being defined by legislation or orders issued by a governmental body.
- GROUP: Role branch
- OBI, CDISC
- govt agents responsible for creating regulations; proxies for enforcing regulations. CDISC definition: regulatory authorities. Bodies having the power to regulate. NOTE: In the ICH GCP guideline the term includes the authorities that review submitted clinical data and those that conduct inspections. These bodies are sometimes referred to as competent
- regulatory role
+
+
+ author identification
+ L. Hunter
+
+ A textual entity intended to identify a particular author
+ PERSON: Lawrence Hunter
+ author identification
-
+
-
-
- material supplier role
- Jackson Labs is an organization which provide mice as experimental material
-
- a role realized through the process of supplying materials such as animal subjects, reagents or other materials used in an investigation.
- Supplier role is a special kind of service, e.g. biobank
- PERSON:Jennifer Fostel
- material provider role
- supplier
- material supplier role
+
+
+ institutional identification
+ University of Colorado Denver School of Medicine
+
+ A textual entity intended to identify a particular institution
+ PERSON: Lawrence Hunter
+ institutional identification
-
+
-
-
- contract research organization role
-
- a worker role of carrying out the study according to the protocol document or study plan delivered by the PI, under the control of the study director. This role cannot make decisions about the study execution
- Person: Jennifer Fostel
- contract research organization
- contract research organization role
+
+
+
+
+
+
+
+
+ caption
+ Figure 1: A system diagram describing the modules of the Hanalyzer. Reading methods (green) take external sources of knowledge (blue) and extract information from them, either by parsing structured data or biomedical language processing to extract information from unstructured data. Reading modules are responsible for tracking the provenance of all knowledge. Reasoning methods (yellow) enrich the knowledge that results from reading by, for example, noting two genes that are annotated to the same ontology term or database entry. All knowledge sources, read or reasoned, are assigned a reliability score, and all are combined using that score into a knowledge network (orange) that represents the integration of all sorts of relationship between a pair of genes and a combined reliability score. A data network (also orange) is created from experimental results to be analyzed. The reporting modules (pink) integrate the data and knowledge networks, producing visualizations that can be queried with the associated drill-down tool.
+
+ A textual entity that describes a figure
+ PERSON: Lawrence Hunter
+ caption
-
+
-
-
- list-mode data file
- An example of a list-mode data file is a file following list-mode Flow Cytometry Standard (FCS) format. Since FCS files can be in histogram mode or list-mode we have to specify which data format specifically. List-mode format in the overwhelming (even universal) option used.
+
+
+ document title
+ Textual characteristics of traditional and Open Access scientific journals are similar
- A list-mode data file is a binary digital entity where events are stored sequentially, parameter by parameter.
- One example of usage is in the context of flow cytometry, however is not restricted to this community and is more widely used, e.g. by imaging people.
- person:Chris Stoeckert
- group:Flow Cytometry community
- list-mode data file
+ A textual entity that names a document
+ PERSON: Lawrence Hunter
+ document title
-
+
-
-
-
-
-
-
-
-
- classified data set
+
+
+ table
+ | T F
+--+-----
+T | T F
+F | F F
- A data set that is produced as the output of a class prediction data transformation and consists of a data set with assigned class labels.
- PERSON: James Malone
- PERSON: Monnie McGee
- data set with assigned class labels
- classified data set
+ A textual entity that contains a two-dimensional arrangement of texts repeated at regular intervals across a spatial range, such that the spatial relationships among the constituent texts expresses propositions
+ PERSON: Lawrence Hunter
+ table
-
+
-
-
+
+
+ table of abbreviations
+ IAO information artifact ontology
+OBI ontology of biomedical investiations
+GO gene ontology
+
+ A table where the constituent texts are abbreviations and their expansions
+ PERSON: Lawrence Hunter
+ table of abbreviations
+
+
+
+
+
+
+
+
+ figure
+ Any picture, diagram or table
+
+ An information content entity consisting of a two dimensional arrangement of information content entities such that the arrangement itself is about something.
+ PERSON: Lawrence Hunter
+ figure
+
+
+
+
+
+
+
+
+ diagram
+ A molecular structure ribbon cartoon showing helices, turns and sheets and their relations to each other in space.
+
+ A figure that expresses one or more propositions
+ PERSON: Lawrence Hunter
+ diagram
+
+
+
+
+
+
+
+
+ document
+ A journal article, patent application, laboratory notebook, or a book
+
+ A collection of information content entities intended to be understood together as a whole
+ PERSON: Lawrence Hunter
+ document
+
+
+
+
+
+
+
+
+ publication
+ A journal article or book
+
+ A document that has been accepted by a publisher
+ PERSON: Lawrence Hunter
+ publication
+
+
+
+
+
+
+
+
-
-
+
+
- reference substance role
- Calibration standard, positive control substance, vehicle Good Laboratory Practices: Questions and Answers - Test Control and Reference Substance Characterization http://www.epa.gov/enforcement/monitoring/programs/fifra/glpqanda-character.html
+ publication about an investigation
+ Most scientific journal articles
- a role inhering in a material entity that is realized when characteristics or responses elicited by the substance are used for comparison or reference.
- Person:Jennifer Fostel
- reference substance
- OBI
- reference substance role
+ A publication that is about an investigation
+ PERSON: Lawrence Hunter
+ scientific publication
+ publication about an investigation
-
+
-
-
- cytological stain role
- haemotoxylin is a general purpose nuclear stain extracted from the wood of the logwood tree WEB: http://en.wikipedia.org/wiki/Haematoxylin
+
+
+ patent
+ US Patent 6,449,603
- A dye role that is realized when the stain is used to colour cells and or cellular components for the purposes of visualization
- Person:Helen Parkinson
- Person:Jennifer Fostel
- cytological stain
- cytological stain role
+ A document that has been accepted by a patent authority
+ PERSON: Lawrence Hunter
+ patent
-
+
-
-
+
+
-
-
+
+
+ document part
+ An abstract, introduction, method or results section.
+
+ An information content entity that is part of a document.
+ PERSON: Lawrence Hunter
+ document part
+
+
+
+
+
+
+
+
-
-
+
+
- centrifuge pellet role
- Definition of pellet :the material concentrated at the bottom of a centrifuge tube after centrifugation. http://www.everythingbio.com/glos/definition.php?word=pellet
-
- pellet role is a role which inheres in a material entity and is realized by a material separation process using gravitational force generated by a centrifuge in which the material bearing the pellet role is the heavier or heaviest component of the output material..
- GROUP: Role branch
- OBI
- 9Mar09 after discussion with process branch changed definition to include use of centrifuge;
- centrifuge pellet role
+ abstract
+ The profusion of high-throughput instruments and the explosion of new results in the scientific literature, particularly in molecular biomedicine, is both a blessing and a curse to the bench researcher. Even knowledgeable and experienced scientists can benefit from computational tools that help navigate this vast and rapidly evolving terrain. In this paper, we describe a novel computational approach to this challenge, a knowledge-based system that combines reading, reasoning and reporting methods to facilitate analysis of experimental data. Reading methods extract information from external resources, either by parsing structured data or biomedical language processing to extract information from unstructured data, and track knowledge provenance. Reasoning methods enrich the knowledge that results from reading by, for example, noting two genes that are annotated to the same ontology term or database entry. Reasoning is also used to combine all sources into a knowledge network that represents the integration of all sorts of relationships between a pair of genes, and to calculate a combined reliability score. Reporting methods combine the knowledge network with a congruent network constructed from experimental data and visualize the combined network in a tool that facilitates the knowledge-based analysis of that data.
+
+ A summary of the entire document that is substantially smaller than the document it summarizes. It is about the document it summarizes.
+ PERSON: Lawrence Hunter
+ abstract
-
+
-
-
- clinical research coordinator role
-
- a worker role comprised of handling the administrative duties of a trial or study.
- Person:Jennifer Fostel
- clinical research coordinator
- clinical research coordinator role
+
+
+
+
+
+
+
+
+ introduction to a publication about an investigation
+ Section labelled 'introduction' of a typical scientific journal article
+
+ A part of a publication about an investigation that is about the objective specification (why the investigation is being done)
+ PERSON: Lawrence Hunter
+ background
+ introduction
+ introduction to a publication about an investigation
-
+
-
-
+
+
-
-
+
+
+ methods section
+ The section labelled 'Methods' or 'Materials and Methods' in a typical scientific journal article.
+
+ A part of a publication about an investigation that is about the study design of the investigation
+ PERSON: Lawrence Hunter
+ experimental
+ experimental procedures
+ experimental section
+ methods
+ methods section
+
+
+
+
+
+
+
+
-
-
+
+
- supernatant role
- Precipitation is the formation of a solid in a solution during a chemical reaction. When the reaction occurs, the solid formed is called the precipitate, and the liquid remaining above the solid is called the supernate. Wikipedia
+ results section
+ The section labelled 'results' in a typical scientific journal article
- supernatant role is a role which inheres in a material entity and is realized by a material separation process using gravitational force in which the material bearing the supernatant role is the liquid component of the output material.
- GROUP: Role branch
- OBI
- supernatant role
+ A part of a publication about an investigation that is about a study design execution
+ PERSON: Lawrence Hunter
+ results
+ results section
-
+
-
-
+
+
+ discussion section of a publication about an investigation
+
+ A part of a publication about an investigation that is about the study interpretation of the investigation
+ PERSON: Lawrence Hunter
+ discussion
+ discussion section
+ discussion section of a publication about an investigation
+
+
+
+
+
+
+
+
-
+
+ references section
+ The list of citations found at the end of a scientific publication, grant proposal or patent application, sometimes called "literature cited" or "bibliography"
+
+ A part of a document that has citations as parts
+ PERSON: Lawrence Hunter
+ references section
+
+
+
+
+
+
+
+
-
-
-
-
-
-
-
-
-
-
-
-
+
+
- chromatography column
-
- Chromatography column in chemistry is a tube and contents (typically glass) used to purify individual chemical compounds from mixtures of compounds. It is often used for preparative applications on scales from micrograms up to kilograms.
- Frank Gibson
- http://en.wikipedia.org/wiki/Column_chromatography
- open tracker https://sourceforge.net/tracker/index.php?func=detail&aid=2881353&group_id=177891&atid=886178
- chromatography column
+ author list
+ Lawrence Hunter and Kevin Brettonel Cohen
+
+ A part of a document that enumerates the authors of the document
+ PERSON: Lawrence Hunter
+ author list
-
+
-
-
+
+
-
-
+
+
- drug role
- http://www.answers.com/topic/drug
- 1. A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication.
- 2. Such a substance as recognized or defined by the U.S. Food, Drug, and Cosmetic Act.
+ institution list
+ The University of Colorado Denver School of Medicine and the University of Colorado Boulder.
- a role borne by a molecular entity and is realized in a process of absorption by an organism alters, or effects (or is assumed to effect) a function(s) which inhere in an organism
- Role Branch
- drug
- OBI, CDISC
- drug role
+ A part of a document that has parts that are institution identifications associated with the authors of the document
+ PERSON: Lawrence Hunter
+ institution list
-
+
-
-
+
+
+ author contributions section
+ LH conceived of the hypothesis, designed the study and contributed to the writing of the manuscript. KBC executed the experiments, analyzed the data, and contributed to the writing of the manuscript.
+
+ A part of a publication that is about the specific contributions of each author
+ PERSON: Lawrence Hunter
+ author contributions
+ contributions by the authors
+ author contributions section
+
+
+
+
+
+
+
+
+ acknowledgements section
+ The authors wish to thank Alan Ruttenberg for his constructive comments about an earlier draft of this manuscript
+
+ Part of a publication that is about the contributions of people or institutions other than the authors.
+ PERSON: Lawrence Hunter
+ acknowledgements
+ acknowledgments
+ acknowledgements section
+
+
+
+
+
+
+
+
-
-
+
+
- pump valve switch
-
- A pump valve switch is a cardinal part of a liquid chromatography instrument that controls the flow.
- FG:I would assume this should be a pump valve control switch and it would not be specific to a liquid chromatography instrument
- OBI Instrument branch
- OBI
- pump valve switch
+ footnote
+ The referent in the text is usually indicated by a special typographic character such as * or a superscripted number, which is also used to indicate the footnote that refers to that text.
+
+ A part of a document that is about a specific other part of the document. Usually footnotes are spatially segregated from the rest of the document.
+ PERSON: Lawrence Hunter
+ endnote
+ footnote
-
+
-
-
- xenotransplantation
+
+
+ supplementary material to a document
+
+ A part of a document that is segregated from the rest of the document due to its size
+ PERSON: Lawrence Hunter
+ additional information
+ appendix
+ supplemental information
+ supplementary material
+ supporting information
+ supplementary material to a document
+
+
+
+
+
+
+
+
+ table of contents
- is the transplantation of living cells, tissues or \norgans from one species to another such as from pigs to humans
- PlanAndPlannedProcess Branch
- OBI branch derived
- xenotransplantation
+ A table that relates document parts to specific locations in a document (usually page numbers). This is also a document part (subsumption there should be inferred).
+ PERSON: Lawrence Hunter
+ table of contents
-
+
-
-
- physical document
- a book is a physical document
-
- A physical document is an object serving as a record of information by means of symbolic marks.
- PERSON: Bjoern Peters
- GROUP: OBI
- physical document
+
+
+ table of figures
+
+ A table that relates figures in a document to specific locations in that document (usually page numbers). This is also a document part (subsumption there should be inferred).
+ PERSON: Lawrence Hunter
+ table of figures
-
+
-
-
- waiting
+
+
+ running title
- not actively doing anything to a material for a duration of time.
- PERSON:Alan Ruttenberg
- OBI branch derived
- BP: I have doubts about the utility of this.
- We need a better handling/modeling of time (January 2008)
- waiting
+ A shorter version of a document title
+ PERSON: Lawrence Hunter
+ running title
-
+
-
-
-
-
-
-
-
-
-
-
-
-
- processed material
- Examples include gel matrices, filter paper, parafilm and buffer solutions, mass spectrometer, tissue samples
-
- Is a material entity that is created or changed during material processing.
- PERSON: Alan Ruttenberg
- processed material
+
+
+ copyright section
+ This work is licensed under a Creative Commons Attribution-Share Alike 3.0 United States License.
+
+ A document part that describes legal restrictions on making or distributing copies of the document
+ PERSON: Lawrence Hunter
+ copyright section
-
+
-
-
+
+
-
-
+
+
-
-
+
+ 1
+
+ A cartesian spatial coordinate datum is a representation of a point in a spatial region, in which equal changes in the magnitude of a coordinate value denote length qualities with the same magnitude
+ 2009-08-18 Alan Ruttenberg - question to BFO list about whether the BFO sense of the lower dimensional regions is that they are always part of actual space (the three dimensional sort) http://groups.google.com/group/bfo-discuss/browse_thread/thread/9d04e717e39fb617
+ Alan Ruttenberg
+ AR notes: We need to discuss whether it should include site.
+ cartesian spatial coordinate datum
+ http://groups.google.com/group/bfo-discuss/browse_thread/thread/9d04e717e39fb617
+
+
+
+
+
+
+
+
-
-
+
+
+
+
+
+
+
+
+
+
+
+
-
-
+
+ 1
- chromatography device
-
- A device that facilitates the separation of mixtures. The function of a chromatography device involves passing a mixture dissolved in a "mobile phase" through a stationary phase, which separates the analyte to be measured from other molecules in the mixture and allows it to be isolated.
- Frank Gibson
- chromatography instrument
- http://en.wikipedia.org/wiki/Chromatography
- open tracker https://sourceforge.net/tracker/index.php?func=detail&aid=2881353&group_id=177891&atid=886178
- chromatography device
+
+ A cartesion spatial coordinate datum that uses one value to specify a position along a one dimensional spatial region
+ Alan Ruttenberg
+ one dimensional cartesian spatial coordinate datum
-
+
-
-
-
-
-
-
-
-
+
+
-
-
+
+
+
+
+
+
+
+
+
+
+
+
-
-
+
+ 1
-
-
+
+ 1
- mass spectrometer
- LCQ Fleet Ion Trap MSn manufactured by thermo fisher scientific
-
- A mass spectrometer is an instrument which is used to measure the mass to charge ratio of ions. All mass spectrometers consist of three basic parts: an ion source, a mass analyzer, and a detector system. The stages within the mass spectrometer are: 1. Production of ions from the sample 2. Separation of ions with different masses 3. Detection of the number of ions of each mass produced 4.Collection of data to generate the mass spectrum
- Frank Gibson
- http://en.wikipedia.org/wiki/Mass_spectrometry
- mass spectrometer
-
-
-
-
-
-
-
-
- A platform is an object_aggregate that is the set of instruments and software needed to perform a process. definition_source: OBI.
- OBI Instrument branch
- OBI Instrument branch
-
- obsolete_platform
- true
+ A cartesion spatial coordinate datum that uses two values to specify a position within a two dimensional spatial region
+ Alan Ruttenberg
+ two dimensional cartesian spatial coordinate datum
-
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
+
+
+
+
-
-
+
+ 1
-
-
+
+ 1
-
-
+
+ 1
- liquid chromatography mass spectrometry platform
- A liquid chromatography mass spectrometry platform is a platform that is the collection of instrument, software and reagents needed to perform a liquid chromatography mass spectrometry protocol. definition_source: OBI.
- OBI instrument branch
- OBI Instrument branch
- liquid chromatography mass spectrometry platform
+ A cartesion spatial coordinate datum that uses three values to specify a position within a three dimensional spatial region
+ Alan Ruttenberg
+ three dimensional cartesian spatial coordinate datum
-
+
-
-
+
+
-
-
+
+
-
-
+
+
- microarray platform
- A microarray platform is a platform that contains the instruments, software and reagents needed to perform a microarray protocol. definition_source: OBI.
- OBI Instrument branch
- OBI Instrument branch
- microarray platform
+ A scalar measurement datum that is the result of measurement of length quality
+ Alan Ruttenberg
+ length measurement datum
-
+
-
-
- ratio of collected to emitted light
- 10%
-
- A measurement datum measuring the amount of light collected s compared to the total amount of emitted light in the detector component of a flow cytometer instrument. The datum has a qualitative role
- person:Chris Stoeckert
- person:Kevin Clancy
- Submitted by the Flow Cytometry community in DigitalEntity-FlowCytometry-2007-03-30.txt
- ratio of collected to emitted light
+
+
+
+
+
+
+
+
+
+
+
+ denotator type
+ The Basic Formal Ontology ontology makes a distinction between Universals and defined classes, where the formal are "natural kinds" and the latter arbitrary collections of entities.
+ A denotator type indicates how a term should be interpreted from an ontological perspective.
+ Alan Ruttenberg
+ Barry Smith, Werner Ceusters
+ denotator type
-
+
-
-
- software optimization objective
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
- Software_optimization is a software_testing_objective role describing a study designed to identify the best software or parameters of the software.
- Jennifer Fostel
- software optimization objective
+ A scalar measurement datum that is the result of measurement of mass quality
+ 2009/09/28 Alan Ruttenberg. Fucoidan-use-case
+ Person:Alan Ruttenberg
+ mass measurement datum
-
+
-
-
- notified body role
- The role of notified bodies presentation: http://ec.europa.eu/enterprise/electr_equipment/emc/revision/notified_bodies.pdf
+
+
+ hypothesis textual entity
+ that fucoidan has a small statistically significant effect on AT3 level but no useful clinical effect as in-vivo anticoagulant, a paraphrase of part of the last paragraph of the discussion section of the paper 'Pilot clinical study to evaluate the anticoagulant activity of fucoidan', by Lowenthal et. al.PMID:19696660
- Notified body is regulator of consumables and medical devices charged by the Competent Authority with verifying compliance of medical devices (not drugs) with the applicable Essential Requirements stated in the Medical Device Directive
- Notified Body (NB). A private institution charged by the Competent Authority with verifying compliance of medical devices (not drugs) with the applicable Essential Requirements stated in the Medical Device Directive. This process, called Conformity Assessment, has EU-wide validity once completed by the NB.
- Person: Jennifer Fostel
- notified body
- OBI, CDISC
- notified body role
+ A textual entity that expresses an assertion that is intended to be tested.
+ 2009/09/28 Alan Ruttenberg. Fucoidan-use-case
+ Person:Alan Ruttenberg
+ hypothesis textual entity
-
+
-
-
- allotransplantation
-
- is the transplantation of organs between members of the same species.
- PlanAndPlannedProcess Branch
- OBI branch derived
- allotransplantation
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ A scalar measurement datum that is the result of measuring a temporal interval
+ 2009/09/28 Alan Ruttenberg. Fucoidan-use-case
+ Person:Alan Ruttenberg
+ time measurement datum
-
+
-
-
+
+
-
-
+
+
- gamma counter
- A Geiger counter
-
- A processed material which measures gamma radiation
- Frank Gibson
- http://en.wikipedia.org/wiki/Gamma_counter
- gamma counter
+
+ A textual entity that is used as directive to deliver something to a person, or organization
+ 2010-05-24 Alan Ruttenberg. Use label for the string representation. See issue https://github.com/information-artifact-ontology/IAO/issues/59
+ postal address
-
+
-
-
- trial monitor role
+
+
+ email address
- a responsible party involved in planning, overseeing the conduct of a study or study component, and interpreting data from a study
- Person:Jennifer Fostel
- trial monitor
- CDISC definition: Person employed by the sponsor or CRO who is responsible for determining that a trial is being conducted in accordance with the protocol and GCP guidance. NOTE: A monitor's duties may include, but are not limited to, helping to plan and initiate a trial, assessing the conduct of trials, and assisting in data analysis, interpretation and extrapolation. Clinical Research Associate: Primary representative of the sponsor; monitors progress of investigator sites participating in a clinical study.
- trial monitor role
+ Alan Ruttenberg 1/3/2012 - Provisional id, see issue at https://github.com/information-artifact-ontology/IAO/issues/130&thanks=130&ts=1325636583
+ Person:Alan Ruttenberg
+ Person:Chris Stoeckart
+ email address
-
+
-
-
-
-
-
-
-
-
- positive reference substance role
- MMS mutagen
-
- a reference role in which the characteristics or responses elicited by the substance playing the reference substance role are used to establish a "100%" response
- Person: Jennifer Fostel
- positive reference substance
- positive reference substance role
+
+
+ author role
+
+ A role inhering in a person or organization that is realized when the bearer participates in the work which is the basis of the document, in the writing of the document, and signs it with their name.
+ PERSON: Alan Ruttenberg
+ PERSON: Melanie Courtot
+ author role
-
+
-
-
- polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether
- PMID: 30799. J Histochem Cytochem. 1978 Sep;26(9):696-712. Acid lipase: a histochemical and biochemical study using triton X100-naphtyl palmitate micelles.
-
- triton X100 is a chemical entity which belongs to the group of The pluronics which are triblock copolymers of ethylene oxide and propylene oxide. Triton x-100 is_used_as detergent due to its non-ionic surfactant properties
- Philippe Rocca-Serra
- adapted from Wikipedia before possible import from CHEBI
- polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ A planned process in which journal articles are read or processed and data items are extracted, typically for further analysis or indexing
+ Person:Alan Ruttenberg
+ data item extraction from journal article
-
+
-
+
+
-
-
+
+
-
-
+
+
+ Recording the current temperature in a laboratory notebook. Writing a journal article. Updating a patient record in a database.
+
+ A planned process in which a document is created or added to by including the specified input in it.
+ 6/11/9: Edited at OBI workshop. We need to be able identify a child form of information artifact which corresponds to something enduring (not brain like). This used to be restricted to physical document or digital entity as the output, but that excludes e.g. an audio cassette tape
+ Bjoern Peters
+ wikipedia http://en.wikipedia.org/wiki/Documenting
+ documenting
+
+
+
+
+
+
+
+
+ line graph
+
+ A line graph is a type of graph created by connecting a series of data
+points together with a line.
+ PERSON:Chris Stoeckert
+ PERSON:Melanie Courtot
+ line chart
+ GROUP:OBI
+ WEB: http://en.wikipedia.org/wiki/Line_chart
+ line graph
+
+
+
+
+
+
+
+
-
-
+
+
-
-
-
-
-
-
-
-
-
-
-
-
+
+
- investigation
- Lung cancer investigation using expression profiling, a stem cell transplant investigation, biobanking is not an investigation, though it may be part of an investigation
-
- a planned process that consists of parts: planning, study design execution, documentation and which produce conclusion(s).
- Bjoern Peters
- OBI branch derived
- Could add specific objective specification
- Following OBI call November 2012,26th: it was decided there was no need for adding "achieves objective of drawing conclusion" as existing relations were providing equivalent ability. this note closes the issue and validates the class definition to be part of the OBI core
-editor = PRS
- study
- investigation
+ A new pubmed ID being created for a journal article, and the associated pubmed record containing information to the journal article. A license plate number registered at the DMV to be belonging to a specific vehicle and owner. Placing a barcode on a product and entering information in a database that this barcode is assigned.
+
+ A planned process in which a new CRID is created, associated with an entity, and stored in the CRID registry thereby registering it as being associated with some entity
+ 2014-05-05: It is the CRID registry that assigns CRIDs, not the users of the registry.
+ Person:Alan Ruttenberg
+ Person:Bjoern Peters
+ Person:Melanie Courtot
+ assigning a CRID
+ assigning a centrally registered identifier
-
+
-
-
+
+
-
-
+
+
-
-
+
+
- evaluant role
- When a specimen of blood is assayed for glucose concentration, the blood has the evaluant role. When measuring the mass of a mouse, the evaluant is the mouse. When measuring the time of DNA replication, the evaluant is the DNA. When measuring the intensity of light on a surface, the evaluant is the light source.
-
- a role that inheres in a material entity that is realized in an assay in which data is generated about the bearer of the evaluant role
- Role call - 17nov-08: JF and MC think an evaluant role is always specified input of a process. Even in the case where we have an assay taking blood as evaluant and outputting blood, the blood is not the specified output at the end of the assay (the concentration of glucose in the blood is)
- examples of features that could be described in an evaluant: quality.... e.g. "contains 10 pg/ml IL2", or "no glucose detected")
- GROUP: Role Branch
- OBI
- Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term.
- evaluant role
+
+
+
+
+
+
+ Articles in Pubmed are reviewed by curators who add MESH terms to the Pubmed records in order to categorize them better and improve the ability to search for them.
+
+ A planned process in which a CRID registry associates an information content entity with a CRID symbol
+ PERSON:Alan Ruttenberg
+ associating information with a CRID in the CRID registry
+ associating information with a centrally registered identifier in its registry
-
+
-
-
- reporting party role
- Person who prepares microarray data in MAGE-TAB format and submits to a database, such as ArrayExpress.
- The first section has been pre-designated as the 'Reporting Party' section and should be filled with the Reporting Party's personal information. http://www.mercedsheriff.com/SelfReporting.htm
-
- a study personnel role played by a party who reports the outcome of a study component
- MO:submitter mapped to this term. So, alternative term 'submitter' was added.
- Jennifer Fostel
- reporting party
- submitter
- OBI
- reporting party role
+
+
+ a planned process with the objective to establish a system that allows to refer to specific entities of a certain kind and store information about them, by establishing a CRID registry and plan specifications for the process of 1) assigning a CRID and 2) looking up a CRID.
+ MC, 20101124: deprecated following discussion at IAO call 20101124. Term was deemed not necessary - no use case for now.
+
+ obsolete_establishing a CRID registry
+ true
-
+
-
-
-
-
-
-
-
-
+
+
-
-
+
+
+ The sentence "The article has Pubmed ID 12345." contains a CRID that has two parts: one part is the CRID symbol, which is '12345'; the other part denotes the CRID registry, which is Pubmed.
+
+ A symbol that is part of a CRID and that is sufficient to look up a record from the CRID's registry.
+ PERSON: Alan Ruttenberg
+ PERSON: Bill Hogan
+ PERSON: Bjoern Peters
+ PERSON: Melanie Courtot
+ CRID symbol
+ Original proposal from Bjoern, discussions at IAO calls
+ centrally registered identifier symbol
+
+
+
+
+
+
+
+
-
-
-
-
-
-
-
-
-
-
-
-
+
+
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
+
+
-
-
-
- assay
- Assay the wavelength of light emitted by excited Neon atoms. Count of geese flying over a house.
-
- A planned process with the objective to produce information about the material entity that is the evaluant, by physically examining it or its proxies.
- 12/3/12: BP: the reference to the 'physical examination' is included to point out that a prediction is not an assay, as that does not require physical examiniation.
- PlanAndPlannedProcess Branch
- measuring
- scientific observation
- OBI branch derived
- study assay
- any method
- assay
+ The sentence "The article has Pubmed ID 12345." contains a CRID that has two parts: one part is the CRID symbol, which is '12345'; the other part denotes the CRID registry, which is Pubmed.
+
+ An information content entity that consists of a CRID symbol and additional information about the CRID registry to which it belongs.
+ 2014-05-05: In defining this term we take no position on what the CRID denotes. In particular do not assume it denotes a *record* in the CRID registry (since the registry might not have 'records').
+ Alan, IAO call 20101124: potentially the CRID denotes the instance it was associated with during creation.
+
+ Note, IAO call 20101124: URIs are not always CRID, as not centrally registered. We acknowledge that CRID is a subset of a larger identifier class, but this subset fulfills our current needs. OBI PURLs are CRID as they are registered with OCLC. UPCs (Universal Product Codes from AC Nielsen)are not CRID as they are not centrally registered.
+ PERSON: Alan Ruttenberg
+ PERSON: Bill Hogan
+ PERSON: Bjoern Peters
+ PERSON: Melanie Courtot
+ CRID
+ Original proposal from Bjoern, discussions at IAO calls
+ centrally registered identifier
-
+
-
-
- quantitative confidence value
-
- A data item which is used to indicate the degree of uncertainty about a measurement.
- person:Chris Stoeckert
- group:OBI
- quantitative confidence value
+
+
+ PubMed is a CRID registry. It has a dataset of PubMed identifiers associated with journal articles.
+
+ A CRID registry is a dataset of CRID records, each consisting of a CRID symbol and additional information which was recorded in the dataset through a assigning a centrally registered identifier process.
+ PERSON: Alan Ruttenberg
+ PERSON: Bill Hogan
+ PERSON: Bjoern Peters
+ PERSON: Melanie Courtot
+ CRID registry
+ Original proposal from Bjoern, discussions at IAO calls
+ centrally registered identifier registry
-
+
-
-
+
+
-
-
+
+
- sample preparation for assay
-
- A sample_preparation_for_assay is a protocol_application including material_enrollments and biomaterial_transformations. definition_source: OBI.
- PlanAndPlannedProcess Branch
- study
- OBI branch derived
- sample preparation for assay
+
+
+
+
+
+
+
+
+
+
+
+
+ Going to the PubMed website and entering a PubMed ID in order to retrieve the Pubmed information associated with that ID.
+
+ A planned process in which a request to a CRID registry is made to return the information associated with a CRID symbol
+ PERSON: Alan Ruttenberg
+ PERSON: Bill Hogan
+ PERSON: Bjoern Peters
+ PERSON: Melanie Courtot
+ looking up a CRID
+ looking up a centrally registered identifier
-
+
-
-
- diagnosis textual entity
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
- diagnosis is an assessment of a disease or injury, its likely prognosis and treatment.
- Jennifer Fostel
- diagnosis textual entity
+ time stamped measurement datum
-
+
-
-
- unplanned occurrence effecting an investigation
- Earthquake that destroys the lab, an outside investigator discovering an adverse effect of the reagants used
+
+
+
+
+
+
+
+
+ pmid:20604925 - time-lapse live cell microscopy
- a process which is external in origin to the investigation that has an impact on the outcome.
- PERSON: Bjoern Peters
- OBI
- unplanned occurrence effecting an investigation
+ A data set that is an aggregate of data recording some measurement at a number of time points. The time series data set is an ordered list of pairs of time measurement data and the corresponding measurement data acquired at that time.
+ Alan Ruttenberg
+ experimental time series
+ time sampled measurement data set
-
+
-
-
- eMedical record
+
+
+ written name
+ "Bill Clinton"
+ "The Eiffel Tower"
+ "United States of America"
- An eMedical record is a digital document derived from a computer system used primarily for patient care in a clinical setting. Not required to be compliant with requirements of 21 CFR Part 11.
- person:Jennifer Fostel
- article-without-pmid-or-doi:CDISCglossary
- eMedical record
-
-
-
-
-
-
-
-
- culture medium
- A growth medium or culture medium is a substance in which microorganisms or cells can grow. Wikipedia, growth medium, Feb 29, 2008
-
- a processed material that provides the needed nourishment for microorganisms or cells grown in vitro.
- changed from a role to a processed material based on on Aug 22, 2011 dev call. Details see the tracker item: http://sourceforge.net/tracker/?func=detail&aid=3325270&group_id=177891&atid=886178
-Modification made by JZ.
- Person: Jennifer Fostel, Jie Zheng
- OBI
- culture medium
+ A textual entity that denotes a particular in reality.
+ PERSON: Bill Hogan
+ https://github.com/information-artifact-ontology/IAO/issues/114
+ The qualifier "written" is to set it apart from spoken names. Also, note the restrictions to particulars. We are not naming universals. We could however, be naming, attributive collections which are particulars, so "All people located in the boundaries of the city of Little Rock, AR on June 18, 2011 at 9:50a CDT" would be a name.
+ written name
-
+
-
-
- electronic case report tabulation
-
- An electronic case report tabulation is a digital document containing tabular data about multiple trial participants which is part of a clinical regulatory submission. An eCRT has the property that it can be audited and compliant with requirements of 21 CFR Part 11 and has format suited to review by regulators.
- person:Jennifer Fostel
- CDISC glossary
- electronic case report tabulation
+
+
+
+ A software method (also called subroutine, subprogram, procedure, method, function, or routine) is software designed to execute a specific task.
+ PERSON: Melanie Courtot
+ PERSON: Michel Dumontier
+ https://github.com/information-artifact-ontology/IAO/issues/80
+ software method
-
+
-
-
- polystyrene tube
- Polystyrene tubes can be used to contain tissue culture cells during centrifgation
-
- A polystyrene tube is a test tube made of polystyrene
- PERSON: Chris Stoeckert
- PERSON: Chris Stoeckert
- polystyrene tube
+
+
+
+ A software module is software composed of a collection of software methods.
+ PERSON: Melanei Courtot
+ PERSON: Michel Dumontier
+ https://github.com/information-artifact-ontology/IAO/issues/80
+ software module
-
-
-
-
- reagent role
- Buffer, dye, a catalyst, a solvating agent.
-
- A role inhering in a biological or chemical entity that is intended to be applied in a scientific technique to participate (or have molecular components that participate) in a chemical reaction that facilitates the generation of data about some entity distinct from the bearer, or the generation of some specified material output distinct from the bearer.
- PERSON:Matthew Brush
- reagent
- PERSON:Matthew Brush
- Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term.
-
-May 28 2013. Updated definition taken from ReO based on discussions initiated in Philly 2011 workshop. Former defnition described a narrower view of reagents in chemistry that restricts bearers of the role to be chemical entities ("a role played by a molecular entity used to produce a chemical reaction to detect, measure, or produce other substances"). Updated definition allows for broader view of reagents in the domain of biomedical research to include larger materials that have parts that participate chemically in a molecular reaction or interaction.
-
- (copied from ReO)
-Reagents are distinguished from instruments or devices that also participate in scientific techniques by the fact that reagents are chemical or biological in nature and necessarily participate in or have parts that participate in some chemical interaction or reaction during their intended participation in some technique. By contrast, instruments do not participate in a chemical reaction/interaction during the technique.
-
-Reagents are distinguished from study subjects/evaluants in that study subjects and evaluants are that about which conclusions are drawn and knowledge is sought in an investigation - while reagents, by definition, are not. It should be noted, however, that reagent and study subject/evaluant roles can be borne by instances of the same type of material entity - but a given instance will realize only one of these roles in the execution of a given assay or technique. For example, taq polymerase can bear a reagent role or an evaluant role. In a DNA sequencing assay aimed at generating sequence data about some plasmid, the reagent role of the taq polymerase is realized. In an assay to evaluate the quality of the taq polymerase itself, the evaluant/study subject role of the taq is realized, but not the reagent role since the taq is the subject about which data is generated.
+
-In regard to the statement that reagents are 'distinct' from the specified outputs of a technique, note that a reagent may be incorporated into a material output of a technique, as long as the IDENTITY of this output is distinct from that of the bearer of the reagent role. For example, dNTPs input into a PCR are reagents that become part of the material output of this technique, but this output has a new identity (ie that of a 'nucleic acid molecule') that is distinct from the identity of the dNTPs that comprise it. Similarly, a biotin molecule input into a cell labeling technique are reagents that become part of the specified output, but the identity of the output is that of some modified cell specimen which shares identity with the input unmodified cell specimen, and not with the biotin label. Thus, we see that an important criteria of 'reagent-ness' is that it is a facilitator, and not the primary focus of an investigation or material processing technique (ie not the specified subject/evaluant about which knowledge is sought, or the specified output material of the technique).
- reagent role
+
+
+
+ A software library is software composed of a collection of software modules and/or software methods in a form that can be statically or dynamically linked to some software application.
+ PERSON: Melanie Courtot
+ PERSON: Michel Dumontier
+ https://github.com/information-artifact-ontology/IAO/issues/80
+ software library
-
+
-
-
- role of regulator of chemical manufacturer
- EPA; John Mollison is the registrar of chemical products in Tasmania, the body that administers the Act that regulates chemical use in that State. http://www.abc.net.au/rn/science/earth/stories/s1160346.htm
-
- a regulator involved with making and enforcing legislation and governmental orders relevant to chemical manufacture
- Person: Jennifer Fostel
- regulator of chemical manufacture
- OBI
- role of regulator of chemical manufacturer
+
+
+
+ A software application is software that can be directly executed by some processing unit.
+ PERSON: Melanie Courtot
+ PERSON: Michel Dumontier
+ https://github.com/information-artifact-ontology/IAO/issues/80
+ software application
-
+
-
-
- detector reagent role
+
+
- a role which inheres in a molecular entity and is realized by the process of recording or registering a stimulus.
- 19feb2009. not clear we need this term. originally if came from microarrays -- the probes on the array are termed detectors in some instances
- One that detects, especially a mechanical, electrical, or chemical device that automatically identifies and records or registers a stimulus, such as an environmental change in pressure or temperature, an electric signal, or radiation from a radioactive material. http://www.answers.com/topic/detector 19feb2009
- detector reagent role
+ A software script is software whose instructions can be executed using a software interpreter.
+ PERSON: Melanie Courtot
+ PERSON: Michel Dumontier
+ https://github.com/information-artifact-ontology/IAO/issues/80
+ software script
-
+
-
-
- role of certified IRB professional
- CIP= Certified IRB Professional; http://acronyms.thefreedictionary.com/Certified+IRB+Professional
-
- a role of which inheres in a Homo sapiens and realized during administration and oversight of the daily activities of Institutional Review Boards (IRBs) in the USA
- Person:Helen Parkinson
- Person:Jennifer Fostel
- certified IRB professional
- WEB: http://en.wikipedia.org/wiki/Certified_IRB_Professional
- role of certified IRB professional
+
+
+ abbreviation textual entity
+ From Shiba et al. Acta Neuropathol Commun. 2013; 1: 45. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893467/):
+
+BAC: Bacterial artificial chromosome; CR: Calretinin; GFAP: Glial fibrillary acidic protein; MAP: Microtubule-associated protein; MRI: Magnetic resonance imaging; NSC: Neural stem cell; PDA: Patent ductus arteriosus; PMG: Polymicrogyria; PNH: Periventricular nodular heterotopia; VSD: Ventricular septal defect.
+ A textual entity listing abbreviations and their expansions that are used in a document.
+ PERSON: Bill Baumgartner
+
+ abbreviation textual entity
-
+
-
-
+
+
-
-
+
+
- patient role
- a hospitalized person; a person with controlled diabetes; the patient's role http://www.fertilityjourney.com/testingAndDiagnosis/theRightDoctor/thePatientsRole/index.asp?C=55245395146924652778
-
- a role which inheres in a person and is realized by the process of being under the care of a physician or health care provider
- GROUP:Role Branch
- patient
- OBI, CDISC
- CDISC definition: patient. Person under a physician's care for a particular disease or condition. NOTE: A subject in a clinical trial is not necessarily a patient, but a patient in a clinical trial is a subject. See also subject, trial subject, healthy volunteer. Often used interchangeably
- patient role
+ abbreviations section
+ The section labelled 'abbreviations' in a typical scientific journal article.
+ A part of a document where abbreviations and their long-forms used within the document are listed.
+ PERSON: Bill Baumgartner
+ abbreviations
+ abbreviations list
+ abbreviations used
+ list of abbreviations
+ list of abbreviations used
+
+ abbreviations section
-
+
-
-
-
-
-
-
-
-
+
+
-
-
+
+
+ author information section
+ The section labelled 'author information' in a typical scientific journal article, e.g. in Takon. Ann Gen Psychiatry. 2011; 10: 25. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204268/)
+ A part of a document about the authors that provides biographical information and may discuss how the authors' professional experiences are relevant to the work described in the document.
+ PERSON: Bill Baumgartner
+ author information
+ authors’ information
+
+ author information section
+
+
+
+
+
+
+
+
+ author information textual entity
+ From Takon. Ann Gen Psychiatry. 2011; 10: 25. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204268/):
+
+IT [the author] is the lead paediatrician for ADHD services in East Hertfordshire, UK, where she runs a weekly joint ADHD clinic with the Child and Adolescent psychiatrist and works within an ADHD specialist team. IT also sees children with other neurodisability issues who may have comorbid ADHD, where the presentation may be more complex and challenging to manage. IT has vast experience in managing children with complex ADHD. She has 18 years of experience in paediatrics and also has extensive experience in the use of psychopharmacologic agents in managing children with ADHD.
+ A textual entity expression information about an author of a document. This information may include biographical information and may discuss how the authors' professional experiences are relevant to the work described in the document.
+ PERSON: Bill Baumgartner
+
+ author information textual entity
+
+
+
+
+
+
+
+
-
-
+
+
-
- material processing
- A cell lysis, production of a cloning vector, creating a buffer.
-
- A planned process which results in physical changes in a specified input material
- PERSON: Bjoern Peters
- PERSON: Frank Gibson
- PERSON: Jennifer Fostel
- PERSON: Melanie Courtot
- PERSON: Philippe Rocca Serra
- material transformation
- OBI branch derived
- material processing
+ author summary section
+ The section labelled 'synopsis' in a typical scientific journal article, e.g. in Pendse et al. BMC Genomics. 2013; 14: 136. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608171/)
+ A part of a document, distinct from the abstract, that describes the significance and broader context of the document content. The author summary is often written in a non-technical manner and is aimed at both scientists and non-scientist readers.
+ PERSON: Bill Baumgartner
+ author summary
+ summary
+ synopsis
+ Article submission guidelines for PLoS Genetics (http://journals.plos.org/plosgenetics/s/submission-guidelines)
+
+ author summary section
-
+
-
-
- protocol testing objective
-
- Protocol_testing_objective is a methodology_testing_objective role describing a study designed to examine the effects of using different protocols.
- Jennifer Fostel
- protocol testing objective
+
+
+ author summary textual entity
+ From Pendse et al. BMC Genomics. 2013; 14: 136. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608171/):
+
+
+The search for genetic risk factors for common human diseases often relies on the use of linkage and association studies to establish correlation between genomic markers and disease risk. These studies require additional functional evaluation of candidate genes, including their possible interaction with diet and environment. The number of candidate genes is typically large and the development of appropriate genetic tools in mammalian systems is slow. By contrast, large-scale genetic screens, using widely available genetic tools, are routinely conducted in the fruit fly Drosophila melanogaster. In this study, we used Drosophila to screen candidate genes identified in human genome-wide scans as associated with risk of metabolic abnormalities such as type 2 diabetes. We show that a number of human candidate genes have fly orthologs that play an important role in Drosophila tolerance to high dietary sucrose. We further explored some of the specific metabolic abnormalities that can result when these genes’ activities are reduced in flies, focusing on a gene we call dHHEX (CG7056), the fly ortholog of human HHEX.
+ A textual entity, distinct from the abstract, that describes the significance and broader context of the document content. The author summary is often written in a non-technical manner and is aimed at both scientists and non-scientist readers, e.g as described in the article submission guidelines for PLoS Genetics (http://journals.plos.org/plosgenetics/s/submission-guidelines).
+ PERSON: Bill Baumgartner
+ Article submission guidelines for PLoS Genetics (http://journals.plos.org/plosgenetics/s/submission-guidelines).
+
+ author summary textual entity
-
+
-
-
+
+
-
-
+
+
- study subject role
- Human subjects in a clinical trial, rats in a toxicogenomics study, tissue cutlures subjected to drug tests, fish observed in an ecotoxicology study.
-Parasite example: people are infected with a parasite which is then extracted; the particpant under investigation could be the parasite, the people, or a population of which the people are members, depending on the nature of the study.
-Lake example: a lake could realize this role in an investigation that assays pollution levels in samples of water taken from the lake.
-
- A role that is realized through the execution of a study design in which the bearer of the role participates and in which data about that bearer is collected.
- A participant can realize both "specimen role" and "participant under investigation role" at the same time. However "participant under investigation role" is distinct from "specimen role", since a specimen could somehow be involved in an investigation without being the thing that is under investigation.
- GROUP: Role Branch
- OBI
- Following OBI call November 2012,26th:
-
-1. it was decided there was no need for moving the children class and making them siblings of study subject role.
-2. it also settles the disambiguation about 'study subject'. This is about the individual participating in the investigation/study, Not the 'topic' (as in 'toxicity study') of the investigation/study
-
-This note closes the issue and validates the class definition to be part of the OBI core
-editor = PRS
-
- participant under investigation role
+ availability section
+ The section labelled 'availability and requirements' in a typical scientific journal article, e.g. Qi et al. BMC Bioinformatics. 2014; 15: 11. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897912/).
+ A part of a document about a resource described in the document, e.g. software, that describes where and/or how that resource can be obtained.
+ PERSON: Bill Baumgartner
+ availability
+
+ availability section
-
+
-
-
- Rat 1A; first enrolled patient to receive treatment
-
- First subject treated role is a study subject role borne by the subject realized in the application of the process specified in intervention study design with no previous study subject realizing the role prior in the study
- Role Branch
- OBI
-
- obsolete_role of being first subject treated
- true
+
+
+ availability textual entity
+ From Qi et al. BMC Bioinformatics. 2014; 15: 11. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897912/):
+
+Project home page:http://krux.googlecode.com
+ A textual entity expressing the location of a resource, e.g. software, or the manner in which a resource can be obtained.
+ PERSON: Bill Baumgartner
+
+ availability textual entity
-
+
-
-
- measured expression level
- Examples are quantified data from an expression microarray experiment, PCR measurements, etc.
-
- A measurement datum that is the outcome of the quantification of an assay for the activity of a gene, or the number of RNA transcripts.
- person:Chris Stoeckert
- OBI Data Transformation branch
- measured expression level
+
+
+
+
+
+
+
+
+ case report section
+ The section labelled 'case report' in a typical scientific journal article, e.g. in Taglia et al. Acta Myol. 2012 Dec; 31(3): 201–203. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631801/)
+ A part of a document about the medical history of a specific patient as it relates to the topic of the document.
+ PERSON: Bill Baumgartner
+ case presentation
+ case report
+
+ case report section
-
+
-
-
- responsible party role
- he THERAPIST has the ability to print a separate statement for the patient and each responsible party. http://www.beaverlog.com/therapist/ez_support/billing/responsible_party_statements.htm
-
- a study personnel role played by a party who is accountable for the execution of a study component and can make decisions about the conduct of the study
- Person: Jennifer Fostel
- responsible party
- OBI
- responsible party role
+
+
+ case report textual entity
+ Excerpt from Taglia et al. Acta Myol. 2012 Dec; 31(3): 201–203. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631801/):
+
+The patient is a 50-year-old man. His medical history was not contributory. At the age of 37 years, he complained of persistent fatigue and dyspnoea even for modest efforts and oedema of lower limbs. The patient was examined at the department of internal medicine of the local hospital, and hospitalised with a diagnosis of dilated cardiomyopathy probably consequence of a myocarditis process. Soon after he was transferred to the cardiologic department of the regional hospital, and pharmacologically treated for heart failure and pulmonary hypertension.
+ A textual entity that expresses a detailed account of a portion of the medical history for a specific patient.
+ PERSON: Bill Baumgartner
+
+ case report textual entity
-
+
-
-
- principal investigator role
-
- a responsible party role played by a person responsible for the overall conduct of a study
- Person: Jennifer Fostel
- principal investigator
- CDISC definition: A person responsible for the conduct of the clinical trial at a trial site. If a trial is conducted by a team of individuals at a trial site, the investigator is the responsible leader of the team and may be called the principal investigator. 2. The individual principal investigator. 2. The individual under whose immediate direction the test article is administered or dispensed to, or used involving, a subject, or, in the event of an investigation conducted by a team of individuals, is See also sponsor-investigator.; Leiter der klinischen Prufung.Under the German Drug Law, the physician who is head of the clinical investigation (CDISC): coordinating investigator (CDISC) (also study coordinator, MUSC); sponsor-investigator. An individual who both initiates and conducts, alone or with others, a clinical trial, and under whose immediate direction the investigational product is administered to, dispensed to, or used by a subject.NOTE: The term does not include any person other than an individual, hence not a corporation, agency (CDISC)
- principal investigator role
+
+
+
+
+
+
+
+
+ conclusion section
+ The section labelled 'conclusion' in a typical scientific journal article.
+ A part of a document used to summarize the findings discussed in the document. The conclusion section is typically found near the end of a document.
+ PERSON: Bill Baumgartner
+ concluding remarks
+ conclusion
+ conclusions
+ findings
+ summary
+
+ conclusion section
-
+
-
-
+
+
-
-
+
+
- transplantation
-
- a protocol application to replace an organ or tissue of an organism
- PlanAndPlannedProcess Branch
- OBI branch derived
- transplantation
+ conflict of interest section
+ The section labelled 'conflict of interest statement' in a typical scientific journal article.
+ A part of a document used to declare any competing interests regarding the authors and/or funding organization for the work described in the document.
+ PERSON: Bill Baumgartner
+ competing interests
+ conflict of interest
+ conflict of interest statement
+ declaration of competing interests
+ disclosure of potential conflicts of interest
+
+ conflict of interest section
-
+
-
-
- 1983 Sci. Amer. Jan. 58/2 Plasmids are routinely used as vectors for introducing foreign DNA into bacteria.
- Some epidemiological aspects and vector role of tick infestation on layers in the Faisalabad district (Pakistan). http://journals.cambridge.org/action/displayAbstract;jsessionid=0373164489D00868AEEF2C556EB4FD29.tomcat1?fromPage=online&aid=624280
-
- a biological vector role is a material to be added role that is realized by the process of transmitting material to the organism that is the target of the transmission.
- GROUP: Role Branch
- OBI and Wikipedia
-
- obsolete biological vector role
- true
+
+
+ conflict of interest statement
+ SD [an author] is a Merck employee and Merck is the sponsor of this study. [Taken from 'Effects of obstructive sleep apnoea risk on postoperative respiratory complications: protocol for a hospital-based registry study' Shin et al. 2016 (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735131/)]
+ A textual entity that expresses a situation involving one or more of the authors, or the funding source of a document whereby the authors or funding source stand to potentially gain (typically financially) from the results reported in the document.
+ PERSON: Bill Baumgartner
+
+ conflict of interest textual entity
-
+
-
-
- pH indicator dye role
- bromophenol blue has a pH indicator dye role
- phenol red in RPMI; pH=4 indicator dye (also carries reference role)
-
- the role of a dye that is realized when the dye is used in an experiment to measure the pH in a material entity
- Person: Jennifer Fostel
- Person:Helen Parkinson
- pH indicator dye
- pH indicator dye role
+
+
+
+
+
+
+
+
+ consent section
+ The section labelled 'consent' in a typical scientific journal article, e.g. Shiba et al. Acta Neuropathol Commun. 2013; 1: 45. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893467/)
+ A part of a document about the consent process that was used to enroll patients in a study.
+ PERSON: Bill Baumgartner
+ consent
+
+ consent section
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- specimen role
- liver section; a portion of a culture of cells; a nemotode or other animal once no longer a subject (generally killed); portion of blood from a patient.
-
- a role borne by a material entity that is gained during a specimen collection process and that can be realized by use of the specimen in an investigation
- 22Jun09. The definition includes whole organisms, and can include a human. The link between specimen role and study subject role has been removed. A specimen taken as part of a case study is not considered to be a population representative, while a specimen taken as representing a population, e.g. person taken from a cohort, blood specimen taken from an animal) would be considered a population representative and would also bear material sample role.
- Note: definition is in specimen creation objective which is defined as an objective to obtain and store a material entity for potential use as an input during an investigation.
- blood taken from animal: animal continues in study, whereas blood has role specimen.
-something taken from study subject, leaves the study and becomes the specimen.
- parasite example
-- when parasite in people we study people, people are subjects and parasites are specimen
-- when parasite extracted, they become subject in the following study
-specimen can later be subject.
- GROUP: Role Branch
- OBI
-
- specimen role
+
+
+ consent textual entity
+ From Shiba et al. Acta Neuropathol Commun. 2013; 1: 45. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893467/):
+
+Written informed consent was obtained from the patient’s parents for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in chief of this journal.
+ A textual entity that documents the consenting process used to enroll patients in a study.
+ PERSON: Bill Baumgartner
+
+ consent textual entity
-
+
-
-
- sequence feature identification objective
-
- Sequence_feature_identification_objective is a biological_feature_identification_objective role describing a study designed to examine or characterize molecular features exhibited at the level of a macromolecular sequence, e.g. nucleic acid, protein, polysaccharide.
- Jennifer Fostel
- sequence feature identification objective
+
+
+
+
+
+
+
+
+ ethical approval section
+ The section labelled 'ethical approval' in a typical scientific journal article.
+ A part of a document about the governance body responsible for approving the work discussed in a document on an ethical basis.
+ PERSON: Bill Baumgartner
+ ethical approval
+
+ ethical approval section
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- intervention design
- PMID: 18208636.Br J Nutr. 2008 Jan 22;:1-11.Effect of vitamin D supplementation on bone and vitamin D status among Pakistani immigrants in Denmark: a randomised double-blinded placebo-controlled intervention study.
-
- An intervention design is a study design in which a controlled process applied to the subjects (the intervention) serves as the independent variable manipulated by the experimentalist. The treatment (perturbation or intervention) defined can be defined as a combination of values taken by independent variable manipulated by the experimentalists are applied to the recruited subjects assigned (possibly by applying specific methods) to treatment groups. The specificity of intervention design is the fact that independent variables are being manipulated and a response of the biological system is evaluated via response variables as monitored by possibly a series of assays.
- Philppe Rocca-Serra
- OBI branch derived
- intervention design
+
+
+
+
+
+
+
+
+ ethical approval textual entity
+ From McLean et al. Br J Gen Pract. 2014 Jul; 64(624): e440–e447 (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073730/):
+
+The NHS National Research Ethics Service had previously approved the use of these anonymised data for research purposes and this analysis did not require independent review.
+ A textual entity that documents the ethical approval of some study design.
+ PERSON: Bill Baumgartner
+
+ ethical approval textual entity
-
+
-
-
- worker role
- Public sector workers in states that run their own OSHA programs are covered by those states. http://www.osha.gov/as/opa/worker/index.html
-
- a personnel role played by a party who executes a component of the study plan; this can occur before, during, after or outside the study timeline
- "executes the study plan" includes the suppliers and manufacturers of reagents and other materials used in the study
- Person:Jennifer Fostel
- worker
- OBI
- worker role
+
+
+
+
+
+
+
+
+ figures section
+ The section labelled 'figures' in a typical scientific journal article.
+ A part of a document that contains one or more figures.
+ PERSON: Bill Baumgartner
+ figures
+
+ figures section
-
+
-
-
-
- An assay where the output data is a datum with one of two values denoting success and failure.
- PlanAndPlannedProcess Branch
- OBI branch derived
- Bernoulli trial
+
+
+
+
+
+
+
+
+ funding source declaration section
+ The section labelled 'funding' in a typical scientific journal article.
+ A part of a document used to detail information regarding the source of funding used in support of the generation of the document content.
+ PERSON: Bill Baumgartner
+ funding
+ funding information
+ funding sources
+ funding statement
+ funding/support
+ source of funding
+ sources of funding
+
+ funding source declaration section
-
+
-
-
- gene list
- Gene lists may arise from analysis to determine differentially expressed genes, may be collected from the literature for involvement in a particular process or pathway (e.g., inflammation), or may be the input for gene set enrichment analysis.
-
- A data set of the names or identifiers of genes that are the outcome of an analysis or have been put together for the purpose of an analysis.
- person:Chris Stoeckert
- group:OBI
- kind of report. (alan) need to be careful to distinguish from output of a data transformation or calculation. A gene list is a report when it is published as such? Relates to question of whether report is a whole, or whether it can be a part of some other narrative object.
- gene list
+
+
+ funding souce declaration textual entity
+ From Stephan et al. Accid Anal Prev. 2011 May; 43(3): 1062–1067. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062852/):
+
+This study was supported by the International Collaborative Research Grants Scheme with joint grants from the Wellcome Trust UK (GR071587MA) and the Australian NHMRC (268055). The funding sources played no role in study design, data collection, analysis or interpretation, writing the report, or the decision to submit the paper for publication.
+ A textual entity documenting the source of funding that supported some study.
+ PERSON: Bill Baumgartner
+
+ funding source declaration textual entity
-
+
-
-
- number of particles in subset
- 500, 200, 0
-
- A measurement datum measuring the number of subjects in a defined subset in a flow cytometer instrument. The datum has a qualitative role
- person:Kevin Clancy
- Submitted by the Flow Cytometry community in DigitalEntity-FlowCytometry-2007-03-30.txt
- number of particles in subset
+
+
+
+
+
+
+
+
+ future directions section
+ The section labelled 'future directions' in a typical scientific journal article.
+ A part of a document detailing extensions of the described work that may be implemented at some future point in time.
+ PERSON: Bill Baumgartner
+ future challenges
+ future considerations
+ future developments
+ future directions
+ future outlook
+ future perspectives
+ future plans
+ future prospects
+ future research
+ future research directions
+ future studies
+ future work
+
+ future directions section
-
+
-
-
- number of lost events electronic
- 74, 0, 14 events lost due to data acquisition electronic coincidence.
-
- A measurement datum measuring the number of analysis events lost due to errors in data acquisition electronic coincidence in a flow cytometer instrument. The datum has a qualitative role.
- person:Kevin Clancy
- Submitted by the Flow Cytometry community in DigitalEntity-FlowCytometry-2007-03-30.txt
- number of lost events electronic
+
+
+ future directions textual entity
+ Excerpt from Wang and Li. Acta Pharmacol Sin. 2016 Jan; 37(1): 25–33. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722976/):
+
+In the future, several questions will need to be resolved regarding the physiological assembly of KCNQ channels and their functional implications in complex neural circuits. First, we still lack sufficiently selective inhibitors and activators among the KCNQ family members.
+ A textual entity expressing ideas regarding future work relevant to work described in a document that could be done.
+ PERSON: Bill Baumgartner
+
+ future directions textual entity
-
+
-
-
+
+
-
-
+
+
- calibration substance role
- pH buffer used to calibrate a pH meter bears a calibration substance role
-
- A reference substance role that is realized when characteristics or responses elicited by the bearer are used to ensure an instrument is within protocol specification of accuracy or performance
- Jennifer Fostel
- calibration substance role
+ genome announcement section
+ The section labelled 'genome announcement' in a typical scientific journal article, e.g. in Kim et al. J Bacteriol. 2011 Oct; 193(19): 5537. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187466/)
+ A document part announcing the publication of a novel draft genome sequence.
+ PERSON: Bill Baumgartner
+ genome announcement
+
+ genome announcement section
-
+
-
-
- molecular feature identification objective
-
- Molecular_feature_identification_objective is a biological_feature_identification_objective role describing a study designed to examine or characterize molecular features of a biological system, e.g. expression profiling, copy number of molecular components, epigenetic modifications.
- Jennifer Fostel
- molecular feature identification objective
+
+
+ genome announcement textual entity
+ Excerpt from Kim et al. J Bacteriol. 2011 Oct; 193(19): 5537. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187466/):
+
+Here we report the genome sequence of Lactobacillus malefermentans KCTC 3548, which we obtained using a whole-genome shotgun strategy (4) with Roche 454 GS (FLX Titanium) pyrosequencing (257,559 reads totaling ∼89.8 Mb; ∼45-fold coverage of the genome) at the Genome Resource Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB).
+ A textual entity that describes the generation and public release of a novel, draft genome sequence.
+ PERSON: Bill Baumgartner
+
+ genome announcement textual entity
-
+
-
-
- hardware testing objective
-
- Hardware_testing_objective is a methodology_testing_objective role describing a study designed to examine the effects of using different hardware, e.g. scanner.
- Jennifer Fostel
- hardware testing objective
+
+
+ keyword textual entity
+ From: Fu and Lin. Identification of gene-oriented exon orthology between human and mouse. BMC Genomics. 2012; 13(Suppl 1): S10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303729/):
+
+Exon orthology; alternative splicing; exon duplication; intron-exon structure.
+ A textual entity listing keywords indicating the major theme(s) of a document.
+ PERSON: Bill Baumgartner
+
+ keyword textual entity
-
+
-
-
+
+
-
-
+
+
- incubator
- Incubators are used in microbiology for culturing (growing) bacteria and other microorganisms. Incubators in tissue culture rooms are used for culturing stem cells, lymphocytes, skin fibroblasts and other types of cells
-
- A device in which environmental conditions (light, photoperiod, temperature, humidity, etc.) can be controlled
- Frank Gibson
- http://www.medterms.com/script/main/art.asp?articlekey=18426
- incubator
+ keywords section
+ The section labelled 'keywords' in a typical scientific journal article.
+ A part of a document where keywords selected by the author to categorize the major theme(s) of a document are listed.
+ PERSON: Bill Baumgartner
+ keywords
+
+ keywords section
-
+
-
-
-
- Label role is a role which inheres in a material entity and which is realized in a detection of label assay
- Role Branch
- label
- OBI
-
-
- obsolete_label role
- true
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ study limitations section
+ The section labelled 'limitations' in a typical scientific journal article.
+ A part of a document about biases or short comings related to the study design and execution.
+ PERSON: Bill Baumgartner
+ limitations
+ study limitations
+ Author guidelines published by The Society for Academic Emergency Medicine. (http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1553-2712/homepage/ForAuthors.html)
+
+ study limitations section
-
+
-
-
- baseline participant role
- Subject at time = 0; subject before a stress test.
-
- a reference participant role which is realized by making the reference to qualities at the start of the study or intervention
- Person: Jennifer Fostel
- baseline participant
- baseline participant role
+
+
+ study limitations textual entity
+ Excerpt from the Limitations section of Fermann et al 2015, Acad Emerg Med. 2015 Mar; 22(3): 299–307 (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405051/).
+
+Owing to the nature of a post hoc study, any significant values must be interpreted with caution. In the current analysis, no multiple testing was conducted and p-values remain unadjusted. Moreover, a selection bias arising from the randomized open-label design of the original EINSTEIN PE study cannot be ruled out.
+ A textual entity addressing a shortcoming or bias of a study design or execution.
+ PERSON: Bill Baumgartner
+ Author guidelines published by The Society for Academic Emergency Medicine. (http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1553-2712/homepage/ForAuthors.html)
+
+ study limitations textual entity
-
+
-
-
- role of independent data monitoring committee
-
- a trial monitor role charged recommending whether to continue, modify, or end the trial
- Person: Jennifer Fostel
- independent data monitoring committee
- role of independent data monitoring committee
+
+
+ materials section
+ The section labelled 'materials' in a typical scientific journal article, e.g. Nguyen et al. BMC Bioinformatics. 2010; 11: 279. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889936/)
+ A part of a document about the materials required to reproduce the content of the document.
+ PERSON: Bill Baumgartner
+ materials
+
+ materials section
-
+
-
-
- pathologist role
-
- a worker role of being responsible for making the histopathology diagnoses associated with data from a study; this activity occurs outside the study timeline
- Person:Jennifer Fostel
- Pathologist
- pathologist role
+
+
+ notes section
+ The section labelled 'notes' in a typical scientific journal article, e.g. McLean et al. Br J Gen Pract. 2014 Jul; 64(624): e440–e447 (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073730/):
+ A part of a document containing typically short notes about the document itself and/or the authors. Often the notes section contains subsections related to funding, competing interests, ethical approval, etc.
+ PERSON: Bill Baumgartner
+ footnotes
+ notes
+
+ notes section
-
+
-
-
+
+
-
-
+
+
- supernatant collection system harvesting frame
-
- A device that is designed for collecting 90% of the supernatant in a microplate well and separating the living cell with no stress, eliminating centrifugation and other similar techniques. It can be used in a variety of release assays with different radioactive isotopes, such as Cr51 or I125.
- Daniel Schober
- google
- supernatant collection system harvesting frame
+ patients section
+ The section labelled 'patients' in a typical scientific journal article, e.g. in Citak et al. Acta Orthop. 2013 Jun; 84(3): 326–327. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715825/)
+ A part of a document about the patients that participated in a study.
+ PERSON: Bill Baumgartner
+
+ patients section
-
+
-
-
-
-
-
-
-
-
- filter paper
-
- A device manufacture with the intent to provide a porous unsized paper used for filtering.
- Frank Gibson
- sep:00107
- filter paper
+
+
+ patients textual entity
+ Excerpt from Citak et al. Acta Orthop. 2013 Jun; 84(3): 326–327. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715825/):
+
+Between January 1996 and February 2012, we treated 4 patients with interprosthetic femoral fractures (3 of them women) (Figure 2) using a custom-made interposition device (Waldemar Link GmbH, Hamburg, Germany) (Figure 1). Mean age was 74 (59–86) years. The fractures occurred mean 18 (13–28) years after primary THA and mean 14 (10–17) years after primary TKA. At the latest follow-up, after mean 8 (0.5–16) years, revision surgery with a total femur replacement was required in 1 case due to aseptic loosening. No other complications requiring revision surgery occurred.
+ A textual entity expressing information regarding the patients used in a study.
+ PERSON: Bill Baumgartner
+
+ patients textual entity
-
+
-
-
-
-
-
-
-
-
-
-
-
- 2
-
-
-
-
+
+
-
-
+
+
+ pre-publication history section
+ The section labelled 'pre-publication history' in a typical scientific journal article, e.g. in Xiao et al. BMC Anesthesiol. 2013; 13: 33. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016475/)
+ A part of the document about the publication history of a document. This section typically details dates of document submission to a journal and dates of any re-submissions as well as reviewer comments and responses to reviewers by the authors.
+ PERSON: Bill Baumgartner
+ notice of republication
+ pre-publication history
+
+ pre-publication history section
+
+
+
+
+
+
+
+
+ pre-publication history textual entity
+ From Xiao et al. BMC Anesthesiol. 2013; 13: 33. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016475/):
+
+The pre-publication history for this paper can be accessed here:
+http://www.biomedcentral.com/1471-2253/13/33/prepub
+ A textual entity that expresses the pre-publication history (submission dates, reviewer comments, etc) for a document, often including a hyperlink to a web page detailing the information.
+ PERSON: Bill Baumgartner
+
+ pre-publication history textual entity
+
+
+
+
+
+
+
+
-
-
+
+
+ related work section
+ The section labelled 'related work' in a typical scientific journal article, e.g. Žitnik and Zupan. Bioinformatics. 2015 Jun 15; 31(12): i230–i239. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542780/)
+ A part of a document about work in other publications that is relevant to the content of the document.
+ PERSON: Bill Baumgartner
+ related literature
+ related work
+
+ related work section
+
+
+
+
+
+
+
+
+ related work textual entity
+ Excerpt from Žitnik and Zupan. Bioinformatics. 2015 Jun 15; 31(12): i230–i239. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542780/):
+
+Our work presented here is similar in spirit to our recently developed methodology for data fusion via collective matrix factorization (Žitnik and Zupan, 2015).
+
+
+ A textual entity that discusses work from other publications and expresses their relevancy to the content of a document.
+ PERSON: Bill Baumgartner
+
+ related work textual entity
+
+
+
+
+
+
+
+
-
-
+
+
- cell co-culturing
- Culturing cytotoxic T-lymphocytes together with target cells in order to study lysis of the target cells. See chromium_release_assay
-
- A material combination in which cell cultures of two or more different types are are combined and allowed to culture as one.
- PlanAndPlannedProcess Branch
- OBI branch derived
- cell co-culturing
+ requirements section
+ The section labelled 'availability and requirements' in a typical scientific journal article, e.g. Qi et al. BMC Bioinformatics. 2014; 15: 11. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897912/).
+ A part of a document about a resource described in the document, e.g. software, that describes the requirements necessary to use the resource, e.g. operating systems, hardware, etc. in the case of a software resource.
+ PERSON: Bill Baumgartner
+ requirements
+
+ requirements section
-
+
-
-
- role of Institutional Review Board
- An institutional review board/independent ethics committee (IRB/IEC) (also known as ethical review board) is a group that has been formally designated to approve, monitor, and review biomedical and behavioral research involving humans with the alleged aim to protect the rights and welfare of the subjects. Wikipedia March 2008
- Animal protocol review board
-
- the role of a organization that is realized by members reviewing study designs for their agreement with regulations
- Person:Helen Parkinson
- Person:Jennifer Fostel
- Internal Review Board
- OBI, CDISC
- CDISC definition: institutional review board; independent ethics committee (IEC). An independent body (a review board or a committee, institutional, regional, national, or supranational) constituted of medical/scientific professionals and non-scientific members, whose responsibility it is to ensure the protection of the rights, safety and well-being of human subjects involved in a trial.
- role of Institutional Review Board
+
+
+ requirements textual entity
+ From Qi et al. BMC Bioinformatics. 2014; 15: 11. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897912/):
+
+• Operating systems: Platform independent
+
+• Programming language: Matlab, R, Python
+
+• Other requirements: None
+
+• License: GNU GPL v3
+
+• Any restrictions to use by non-academics: None
+ A textual entity that expresses the requirements necessary to use a resource, e.g. software.
+ PERSON: Bill Baumgartner
+
+ requirements textual entity
-
+
-
-
- eSource document
-
- an eSource document is a digital document consisting of a logical collection of Source data and other eSource documents that can be presented in an ordered way and capture the time of completion, change, and any signatures
- person:Jennifer Fostel
- article-without-pmid-or-doi:CDISCglossary
- eSource document
+
+
+ statistical analysis textual entity
+ From Mondo et al. Cardiovasc J Afr. 2013 Mar; 24(2): 28–33. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734881/):
+
+Data were captured into EPI-DATA (version 3.1), cleaned and then exported to Stata version 10 for analysis. Continuous variables were summarised as mean (± standard deviation) and median (inter-quartile range), and presented in the tables. Categorical data were analysed using frequency and percentages, and results are presented in frequency tables and bar charts. Test of significance (p-value) was determined using the chi-square test. A p-value of less than 0.05 was considered significant.
+ A textual entity documenting statistical analysis tools and techniques employed.
+ PERSON: Bill Baumgartner
+
+ statistical analysis textual entity
-
+
-
-
- crossover population role
-
- a role realized when a participant serves as reference to itself
- Person: Jennifer Fostel
- crossover population
- crossover population role
+
+
+
+
+
+
+
+
+ statistical analysis section
+ The section labelled 'statistical analysis' in a typical scientific journal article, e.g. Mondo et al. Cardiovasc J Afr. 2013 Mar; 24(2): 28–33. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734881/)
+ A part of the document used to describe the statistical methodologies employed in the work presented in the document.
+ PERSON: Bill Baumgartner
+ statistical analysis
+
+ statistical analysis section
-
+
-
-
- complete nutrient role
- Rat chow; RPMI medium + serum; use example: CNS17 (Complete Nutrient System) Grow 3-2-4, http://www.kalyx.com/store/proddetail.cfm/ItemID/552307/CategoryID/12000/SubCatID/2755/file.htm
-
- A nutrient role that inheres in a material entity and is realized in the use of that material entity by an organism to provide all needed nourishment.
- Person: Jennifer Fostel
- complete nutrient
- complete nutrient role
+
+
+
+
+
+
+
+
+ tables section
+ The section labelled 'tables' in a typical scientific journal article.
+ A part of a document that contains one or more tables.
+ PERSON: Bill Baumgartner
+ tables
+
+ tables section
-
+
-
-
- radiolabel role
-
- a molecular label role which inheres in a material entity which is realized by the process of radioactivity detection
- Jennifer Fostel
- radiolabel
- radiolabel role
+
+
+ An identifier that denotes some postal delivery route, some aggregate of postal delivery routes or a geographical region and was created for the purpose of sorting and delivering mail.
+ Mathias Brochhausen
+ postal code
-
+
-
-
+
+
+ A plan specification that if realized, is realized by the delivery of mail to some facility or mailbox within some geographical region.
+ Mathias Brochhausen
+ Postal delivery route
+
+
+
+
+
+
+
+
+ A postal code that is used in the United States for the purpose of sorting and delivering mail, and that denotes some postal delivery route or some aggregate of postal delivery routes.
+ Mathias Brochhausen
+ ZIP code
+ zone improvement plan code
+
+
+
+
+
+
+
+
-
-
+
+
-
-
+
+
- cDNA library
- PMID:6110205. collection of cDNA derived from mouse splenocytes.
-
- Mixed population of cDNAs (complementaryDNA) made from mRNA from a defined source, usually a specific cell type. This term should be associated only to nucleic acid interactors not to their proteins product. For instance in 2h screening use living cells (MI:0349) as sample process.
-
-ALT DEF (PRS):: a cDNA library is a collection of host cells, typically E.Coli cells but not exclusively. modified by transfer of plasmid DNA molecule used as vector containing a fragment or totality of cDNA molecule (the insert) . cDNA library may have an array of role and applications.
- PERSON: Luisa Montecchi
- PERSON: Philippe Rocca-Serra
- GROUP: PSI
- PRS: 22022008. class moved under population,
-modification of definition and replacement of biomaterials in previous definition with 'material'
-addition of has_role restriction
- clonal cDNA library
+ database extract, transform, and load process
+ A planned process which takes as input a database and fills another database by extracting concretizations of information entities from the first, transforming them, and loading the transformed concretizations into the second.
+ Alan Ruttenberg 12/21/16: Maybe this definition instead: A planned process which takes as input a database and copies concretizations from the first, optionally transforms then copies the result to the second
+ Alan Ruttenberg 12/21/16: We don't define database in IAO, currently, as the bare word is ambiguous. Reasonable interpretations of the word might be the material entity, an information structure, an information content entity. However this definition commits, at least, to there being some material thing which bear concretizations of information entities and that there are new concretizations created during the process. We consider the ETL process in terms of information entities rather than the concretizations. No committment is made as to whether the specified output.
+ PERSON:Alan Ruttenberg
+ ETL
+ WEB:https://en.wikipedia.org/wiki/Extract,_transform,_load
+
+
+ database extract, transform, and load process
+
-
+
-
+
- electronic case report form
-
- An electronic case report form is a digital document used to record all of the protocol required information to be reported for each trial subject. An eCRF has the property that it can be audited and compliant with requirements of 21 CFR Part 11.
- person:Jennifer Fostel
- CDISC glossary
- electronic case report form
+ identifier
+ An identifier is an information content entity that is the outcome of a dubbing process and is used to refer to one instance of entity shared by a group of people to refer to that individual entity.
+
+ identifier
-
+
-
-
- placebo role
- Pill consisting of inert materials
-
- a negative reference substance is a reference role in which the substance playing the reference substance role is physically similar in appearance to the test substance
- Person:Jennifer Fostel
- placebo
- CDISC definition placebo. A pharmaceutical preparation that does not contain the investigational agent. In blinded studies, it is generally prepared to be physically indistinguishable from the preparation containing the investigational product.
- placebo role
+
+
+ ontology module
+ I have placed this under 'data about an ontology part', but this can be discussed. I think this is OK if 'part' is interpreted reflexively, as an ontology module is the whole ontology rather than part of it.
+ ontology file
+ This class and it's subclasses are applied to OWL ontologies. Using an rdf:type triple will result in problems with OWL-DL. I propose that dcterms:type is instead used to connect an ontology URI with a class from this hierarchy. The class hierarchy is not disjoint, so multiple assertions can be made about a single ontology.
+ ontology module
-
+
-
-
- autotransplantation
-
- is the transplantation of tissue from one part of \nthe body to another in the same individual. )
- PlanAndPlannedProcess Branch
- OBI branch derived
- autotransplantation
+
+
+ base ontology module
+ An ontology module that comprises only of asserted axioms local to the ontology, excludes import directives, and excludes axioms or declarations from external ontologies.
+ base ontology module
+
-
+
-
-
- parameter threshold
- 0.01, 0.03
-
- A measurement datum measuring the minimal signal that must be detected to generate an electrical event, as compared to the maximal detected signal in a flow cytometer instrument. The datum has a qualitative role
- person:Kevin Clancy
- Submitted by the Flow Cytometry community in DigitalEntity-FlowCytometry-2007-03-30.txt
- parameter threshold
+
+
+ editors ontology module
+ An ontology module that is intended to be directly edited, typically managed in source control, and typically not intended for direct consumption by end-users.
+ source ontology module
+ editors ontology module
-
+
-
-
- study group role
- The group of randomized participants that are assigned to a treatment arm of the trial
-
- a study population role where the bearer is a population of material entities and the role is realized in the implementation of a study design wherein the entities bearing the study population role are observed or subjected to intervention according to the study design and are biological replicates, i.e. they receive the same treatment under the protocol
- Jennifer Fostel
- study group population
- study group role
+
+
+ main release ontology module
+ An ontology module that is intended to be the primary release product and the one consumed by the majority of tools.
+ TODO: Add logical axioms that state that a main release ontology module is derived from (directly or indirectly) an editors module
+ main release ontology module
-
+
-
-
- p-value
- PMID:19696660
-in contrast to the in-vivo data AT-III increased significantly from
-113.5% at baseline to 117% after 4 days (n = 10, P-value= 0.02; Table 2).
-
- A quantitative confidence value that represents the probability of obtaining a result at least as extreme as that actually obtained, assuming that the actual value was the result of chance alone.
- May be outside the scope of OBI long term, is needed so is retained
- PERSON:Chris Stoeckert
- WEB: http://en.wikipedia.org/wiki/P-value
- p-value
+
+
+ bridge ontology module
+ An ontology module that consists entirely of axioms that connect or bridge two distinct ontology modules. For example, the Uberon-to-ZFA bridge module.
+ bridge ontology module
+
-
+
-
-
- population
- PMID12564891. Environ Sci Technol. 2003 Jan 15;37(2):223-8. Effects of historic PCB exposures on the reproductive success of the Hudson River striped bass population.
-
- a population is a collection of individuals from the same taxonomic class living, counted or sampled at a particular site or in a particular area
- 1/28/2013, BP, on the call it was raised that we may want to switch to an external ontology for all populatin terms:
-http://code.google.com/p/popcomm-ontology/
- PERSON: Philippe Rocca-Serra
- adapted from Oxford English Dictionnary
- rem1: collection somehow always involve a selection process
- population
+
+
+ import ontology module
+ A subset ontology module that is intended to be imported from another ontology.
+ TODO: add axioms that indicate this is the output of a module extraction process.
+ import file
+ import ontology module
+
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- Determining the binding of epitope-specific nanobody cAb-HuL5 to wild type human lysozyme by chemical shift perturbations in NMR spectra (Erwin De Genst, J Phys Chem B 2013).
- A 3D molecular structure determination assay that uses magnetic properties of atomic nuclei to determine the 3D structure and dynamics of molecules in the input sample.
- IEDB
- PlanAndPlannedProcess Branch
- IEDB
- NMR 3D molecular structure determination assay
+
+
+ subset ontology module
+ An ontology module that is extracted from a main ontology module and includes only a subset of entities or axioms.
+ ontology slim
+ subset ontology
+ subset ontology module
+
+
-
+
-
-
-
-
-
-
-
-
-
- An assay that produces a picture of an entity.
- PlanAndPlannedProcess Branch
- OBI branch derived
- imaging assay
+
+
+ curation subset ontology module
+ A subset ontology that is intended as a whitelist for curators using the ontology. Such a subset will exclude classes that curators should not use for curation.
+ curation subset ontology module
-
+
-
-
- protocol optimization objective
-
- Protocol_optimization is a protocol_testing_objective role describing a study designed to identify the best protocol. This may be carried out by comparing different protocols or by modifying the parameters used within a single protocol.
- Jennifer Fostel
- protocol optimization objective
+
+
+ analysis ontology module
+ An ontology module that is intended for usage in analysis or discovery applications.
+ analysis subset ontology module
-
+
-
-
- role of pathology review board
-
- a worker role comprised of providing a confirmed and consensus diagnosis for histopathology results obtained during the investigation
- Person: Jennifer Fostel
- pathology review board
- role of pathology review board
+
+
+ single layer ontology module
+ A subset ontology that is largely comprised of a single layer or strata in an ontology class hierarchy. The purpose is typically for rolling up for visualization. The classes in the layer need not be disjoint.
+ ribbon subset
+ single layer subset ontology module
-
+
-
-
-
-
-
-
-
-
- microtiter plate
- A microtiter plate with 6, 24, 96, 384 or 1536 sample wells used in the enzyme-linked immunosorbent assay (ELISA)
-
- A microtiter_plate is a flat plate with multiple wells used as small test tubes.
- Melanie Courtot
- microplate
- http://en.wikipedia.org/wiki/Microtiter_plate
- microtiter plate
+
+
+ exclusion subset ontology module
+ A subset of an ontology that is intended to be excluded for some purpose. For example, a blacklist of classes.
+ antislim
+ exclusion subset ontology module
-
+
-
-
- role of impartial witness
- According to GCP , an impartial witness should be present for an
-illiterate subject. PharmPK Discussion, http://www.boomer.org/pkin/PK06/PK2006253.html
-
- a role which inheres in a Homo sapiens and is realized during a clinical trial - the impartial witness is independent of the trial and cannot be unfairly influenced by people involved with the trial
- impartial witness. A person, who is independent of the trial, who cannot be unfairly influenced by people involved with the trial, who attends the informed consent process if the subject or the subject's legally acceptable representative cannot read, and who
- Person: Helen Parkinson
- Person: Jennifer Fostel
- impartial witness
- role of impartial witness
+
+
+ external import ontology module
+ An imported ontology module that is derived from an external ontology. Derivation methods include the OWLAPI SLME approach.
+ external import
+ external import ontology module
-
+
-
-
- Yang et al, Int J Clin Exp Pathol. 2015; 8(3): 2746–275 PMID:26045780. Cells were lysed and sonicated to shear DNA to lengths between 200-1000 bp. The sample was then incubated with antibodies against Acety-H3 to immunoprecipitate protein-DNA complexes using protein A agarose beads. The isolated protein-DNA complexes were treated with proteinase K digestion to remove histones. QPCR was then performed using primers specific for TGF-β1, MMP-9 and PI3K promoters at 95°C for 5 min, followed by 40 cycles at 95 °C for 20 s, 58°C for 20 s, and 72°C for 20 s. Each QPCR reaction was repeated in triplicate. QPCR was followed by a melt curve analysis to determine the reaction specificity. The relative gene expression was calculated using 2-ΔΔCt method.
- An immunoprecipitation in which chromatin (i.e. packaged DNA which can include protein and RNA complexes) is cut into short regions, reversibly cross linked, and antibodies or tags are used to select for pieces of chromatin with desired characteristics.
- Bjoern Peters, Randi Vita, James A. Overton
- ChIP
- OBI
- chromatin immunoprecipitation
+
+
+ species subset ontology module
+ A subset ontology that is crafted to either include or exclude a taxonomic grouping of species.
+ taxon subset
+ species subset ontology module
+
-
+
-
-
- biological replicate role
- A member of a dose-time group; a patient in a given arm of a trial
-
- a reference participant role realized by equivalent treatment of participants
- Person:Jennifer Fostel
- biological replicate
- OBI
- biological replicate role
+
+
+ reasoned ontology module
+ An ontology module that contains axioms generated by a reasoner. The generated axioms are typically direct SubClassOf axioms, but other possibilities are available.
+ reasoned ontology module
+
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- Placing the evaluant input material close to a scintillation counter which emits light upon being hit with alpha/beta/gamma radiation and counting the frequency of light blasts to determine the radioactivity of the input material.
- An assay that measures the amount of radiation in the radioactive spectrum (alpha, beta or gamma rays) emitted from an input material.
- IEDB
- PlanAndPlannedProcess Branch
- IEDB
- radioactivity detection
+
+
+ generated ontology module
+ An ontology module that is automatically generated, for example via a SPARQL query or via template and a CSV.
+ TODO: Add axioms (using PROV-O?) that indicate this is the output-of some reasoning process
+ generated ontology module
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- investigation agent role
- The person perform microarray experiments and submit microarray results (including raw data, processed data) with experiment description to ArrayExpress.
-
- A role borne by an entity and that is realized in a process that is part of an investigation in which an objective is achieved. These processes include, among others: planning, overseeing, funding, reviewing.
- Implementing a study means carrying out or performing the study and providing reagents or other materials used in the study and other tasks without which the study would not happen.
- Philly2013: Historically, this role would have been borne only by humans or organizations. However, we now also want to enable representing investigations run by robot scientists such as ADAM (King et al, Science, 2009)
- GROUP: Role Branch
- investigator
- OBI
- Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term.
- study person role
- Philly2013: Historically, this role would have been borne only by humans or organizations. However, we now also want to enable investigations run by robot scientists such as ADAM (King et al, Science, 2009)
- investigation agent role
+
+
+ template generated ontology module
+ An ontology module that is automatically generated from a template specification and fillers for slots in that template.
+ template generated ontology module
+
+
+
-
+
-
-
-
-
-
-
-
-
- nutrient role
- Luria broth; vitamin A; A nutrient is a substance used in an organism's metabolism which must be taken in from the environment. Wikipedia.
-
- a role that inheres in a material entity and is realized in the use of that material entity by an organism when it is used in that organism's metabolism and provides nourishment.
- GROUP: Role branch
- nutrient
- Wikipedia, feb 29, 2008
- 19 Feb 2009; old def: A nutrient role is a role played by a substance used in an organism's metabolism which is taken in from the environment and provides nourishment.
- nutrient role
+
+
+ taxonomic bridge ontology module
+ taxonomic bridge ontology module
-
+
-
-
- Escaped rat; human who moved to another city. Rat which escapes part way through a study; a human study participant who moved to another city before the study was completed (and stopped participating in the study)
-
- Dropout is a study subject role borne by an entity realized by a process of leaving the study earlier than the protocol specified and where the bearer of the dropout role had been borne study subject role prior to bearing dropout role.
- Role Branch
- OBI
-
- obsolete_dropout role
- true
+
+
+ ontology module subsetted by expressivity
+ ontology module subsetted by expressivity
-
+
-
-
-
- a worker role of providing medical care either within or outside the study timeline
- Person:Jennifer Fostel
- health care provider
-
- obsolete health care provider role
- true
+
+
+ obo basic subset ontology module
+ A subset ontology that is designed for basic applications to continue to make certain simplifying assumptions; many of these simplifying assumptions were based on the initial version of the Gene Ontology, and have become enshrined in many popular and useful tools such as term enrichment tools.
+
+Examples of such assumptions include: traversing the ontology graph ignoring relationship types using a naive algorithm will not lead to cycles (i.e. the ontology is a DAG); every referenced term is declared in the ontology (i.e. there are no dangling clauses).
+
+An ontology is OBO Basic if and only if it has the following characteristics:
+DAG
+Unidirectional
+No Dangling Clauses
+Fully Asserted
+Fully Labeled
+No equivalence axioms
+Singly labeled edges
+No qualifier lists
+No disjointness axioms
+No owl-axioms header
+No imports
+ obo basic subset ontology module
+
-
+
-
-
- methodology testing objective
-
- Methodology_testing_objective is an objective role carried out by a proposition defining the aim of the study is to examine the effect of using different methodologies.
- Jennifer Fostel
- methodology testing objective
+
+
+ ontology module subsetted by OWL profile
+ ontology module subsetted by OWL profile
-
+
-
-
- analytical cytology data file
- FCS file, ACS file, foo.fcs, foo.asc
-
- A digital entity intended to capture data in analytical cytology domain.
- person:Chris Stoeckert
- group:Flow Cytometry community
- analytical cytology data file
+
+
+ EL++ ontology module
+ EL++ ontology module
-
+
-
-
- proxy respondent role
-
- Proxy respondent is a worker role of describing patient's symptoms or condition to medical personnel
- Jennifer Fostel
- proxy respondent
- proxy respondent role
+
+
+ pathogenic disposition
+ A disposition to initiate processes that result in a disorder.
+
+ pathogenic disposition
-
+
-
-
- fluorescence compensation matrix
- ((1.053096, -0.22476), (-0.24877, 1.053096))
-
- A fluorescence compensation matrix is a square matrix which is used as the left multiplier of the vector of fluorescence values while performing digital fluorescence compensation. Also, fluorescence compensation matrix is the inverse of the fluorescence spillover matrix.
- person:Chris Stoeckert
- group:Flow Cytometry community
- fluorescence compensation matrix
+
+
+ pathogen
+ A material entity with a pathogenic disposition.
+
+ pathogen
-
+
-
-
-
-
-
-
-
-
- negative reference substance role
- Saline solution
-
- a reference role in which the characteristics or responses elicited by the substance playing the reference substance role are used to establish a "no effect" response
- Person: Jennifer Fostel
- negative reference substance
- negative reference substance role
+
+
+ antibacterial
+ A material entity bearing an antibacterial disposition.
+
+ antibacterial
-
+
-
-
- role of legally acceptable representative
- Parent of minor patient; Definition of legally acceptable representative
-An individual or juridicial or other body authorized under applicable law to consent, on behalf of a prospective subject, to the subject`s participation in the clinical trial. http://www.geneed.com/website/catalog/glossary_search.php?id=2134&search_term=legally%20acceptable%20representative&select=TRUE
-
- a role which inheres in a human or organization who are able subject to applicable law to consent, on behalf of a prospective subject, to the subject`s participation in as clinical trial.
- legally acceptable representative. An individual or juridical or other body authorized under applicable law to consent, on behalf of a prospective subject, to the subject's participation in the clinical trial. [ICH, E6 Glossary]
- Person: Jennifer Fostel
- Person:Helen Parkinson
- legally acceptable representative
- OBI, CDISC
- role of legally acceptable representative
+
+
+ infection
+ A part of an extended organism that itself has as part a population of one or more infectious agents and that (1) exists as a result of processes initiated by members of the infectious agent population and is (2) clinically abnormal in virtue of the presence of this infectious agent population, or (3) has a disposition to bring clinical abnormality to immunocompetent organisms of the same Species as the host (the organism corresponding to the extended organism) through transmission of a member or offspring of a member of the infectious agent population.
+
+ infection
-
+
-
-
- investigation results report
-
- An investigation report is a report on the results of an investigation.
- person:Chris Stoeckert
- group:OBI
- investigation results report
+
+
+ human pathogenicity disposition
+ A disposition to initiate processes that result in a disorder in a human organism.
+
+ human pathogenicity disposition
-
+
-
-
- cellular feature identification objective
-
- Cellular_feature_identification_objective is a biological_feature_identification_objective role describing a study designed to examine or characterize a biological feature monitored at the cellular level, e.g. stage of cell cycle, stage of differentiation.
- Jennifer Fostel
- cellular feature identification objective
+
+
+ Mus musculus
+ house mouse
+ mouse
+
+ Mus musculus
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- reference subject role
- Saline treated rat; one of three identically-treated subjects
-
- a reference subject role which inheres in an organism or entity of organismal origin so that the characteristics or responses of the participant playing the reference participant role are used for comparison or reference
- Jennifer Fostel
- reference participant
- OBI
- reference subject role
+
+
+ Rattus norvegicus
+ Norway rat
+ brown rat
+ rat
+ rats
+
+ Rattus norvegicus
-
+
-
-
- vital dye role
- typtan blue has a vital dye
-
- A dye role that is realized when used to detect live cells in an experiment
- 2009-11-10. Tracker: https://sourceforge.net/tracker/?func=detail&aid=2893048&group_id=177891&atid=886178
- Person: Helen Parkinson
- Person: Jennifer Fostel
- vital dye
- vital dye role
+
+
+ Viruses
+
+ Viruses
-
+
-
-
- 115 patients received ipilimumab and blinded medication
- Inert pill shaped like aspirin tablet
-
- Is a role which inheres in a material entity which is manufactured to be similar in appearance to a test material entity in e.g. a clinical trial to prevent participants from detecting which is the active and inactive substance
- Jennifer Fostel
- Person:Helen Parkinson
-
- obsolete_blinded medication role
- true
+
+
+ Herpesviridae
+
+ Herpesviridae
-
+
-
-
- sub-investigator role
-
- a worker role authorized to make study-related decisions and carry out tasks related to the study; this role occurs during the study timeline
- Person: Jennifer Fostel
- sub-investigator
- CDISC definition: Sub-investigator. Any member of the clinical trial team designated and supervised by the investigator at a trial site to perform critical trial-related procedures and/or to make important trial-related decisions (e.g., associates, residents, research fellows) [ICH] See associates, residents, research fellows
- sub-investigator role
+
+
+ Cytomegalovirus
+
+ Cytomegalovirus
-
+
-
-
- data encoding
- storage of measurement results from an assay into a text file, such as
-
- a documenting process to encode an information entity into a digital document
- PlanAndPlannedProcess Branch
- OBI branch derived
- We (protocol application branch) placed this term because it kept getting bounced from data transformation and DENRIE
- data encoding
+
+
+ Human gammaherpesvirus 4
+ Epstein Barr virus
+ Epstein-Barr virus
+ Epstein-Barr virus EBV
+ Human herpesvirus 4
+ Human herpesvirus type 4
+
+ Human gammaherpesvirus 4
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- enzymatic cleavage
- Polymorphism R62W results in resistance of CD23 to enzymatic cleavage in cultured cells. Genes Immun. 2007 Apr;8(3):215-23. Epub 2007 Feb 15. PMID: 17301828
-
- a material processing that digests the fraction of input material that is susceptible to that enzyme
- PlanAndPlannedProcess Branch
- OBI branch derived
- enzymatic cleavage
+
+
+ Hepatitis B virus
+ Human hepatitis B virus
+ hepatitis B virus (HBV)
+ hepatitis B virus HBV
+ hepatitis B virus, HBV
+ human hepatitis B virus HBV
+
+ Hepatitis B virus
-
+
-
-
- hardware optimization objective
-
- Hardware_optimization is a hardware_testing_objective describing a study designed to identify the best hardware.
- Jennifer Fostel
- hardware optimization objective
+
+
+ Hepacivirus C
+ Hepatitis C virus
+ hepatitis C virus HCV
+ human hepatitis C virus
+ human hepatitis C virus HCV
+ human hepatitis virus C HCV
+ post-transfusion hepatitis non A non B virus
+
+ Hepacivirus C
-
+
-
-
-
- Place holder class, Utility class to gather the defined classes
- Susanna Sansone
- OBI Biomaterial derived
-
- obsolete_defined_material
- true
+
+
+ Lentivirus
+ Lentivirinae
+
+ Lentivirus
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- trial statistician role
-
- a worker role that analyzes data obtained during a trial or study; this role occurs after the trial or study is completed or terminated.
- Person:Jennifer Fostel
- trial statistician
- CDISC definition: trial statistician. A statistician who has a combination of education/training and experience sufficient to implement the principles in the ICH E9 guidance and who is responsible for the statistical aspects of the trial. [ICH E9]
- trial statistician role
+
+
+ Human immunodeficiency virus 1
+ human immunodeficiency virus 1 HIV-1
+ human immunodeficiency virus HIV-1
+ human immunodeficiency virus type 1 HIV 1
+ human immunodeficiency virus type 1 HIV1
+ human immunodeficiency virus type 1, HIV-1
+ human immunodeficiency virus type I HIV-1
+ human immunodeficiency virus type-1 HIV-1
+ human immunodeficiency virus-1 HIV-1
+
+ Human immunodeficiency virus 1
-
+
-
-
- standard error
-
- A quantitative confidence value which is the standard deviations of the sample in a frequency distribution, obtained by dividing the standard deviation by the total number of cases in the frequency distribution.
- person:Chris Stoeckert
- group:OBI
- see P-Value
- standard error
+
+
+ Human immunodeficiency virus 2
+ HIV type 2
+ Human immunodeficiency virus type 2
+ Human immunodeficiency virus-2
+ human immunodeficiency virus type 2 HIV-2
+ human immunodeficiency virus type 2, HIV-2
+
+ Human immunodeficiency virus 2
-
+
-
-
-
-
-
-
-
-
- antigen role
-
- Antigen is a role played by material which when introduced into an immune-competent organism causes an immune response
- An antigen is a substance that prompts the generation of antibodies and can cause an immune response. Wikipedia http://en.wikipedia.org/wiki/Antigen. In the strict sense, immunogens are those substances that elicit a response from the immune system, whereas antigens are defined as substances that bind to specific antibodies. Not all antigens produce an immunogenic response, but all immunogens are antigens
- Role Branch
- OBI
- 9Mar09 waiting for discussion with immunology terms
- antigen role
+
+
+ Euteleostomi
+ bony vertebrates
+
+ Euteleostomi
-
+
-
-
- software testing objective
-
- Software_testing_objective is a hardware_optimization role describing a study designed to examine the effects of using different software or software parameters, e.g. data processing software.
- Jennifer Fostel
- software testing objective
+
+
+ Ecdysozoa
+
+ Ecdysozoa
-
+
-
-
- sponsor role
-
- a responsible party role involved with any of the following activities: initiating, managing and funding a study
- Person: Jennifer Fostel
- sponsor
- CDISC definition: sponsor. 1. An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical trial. 2. A corporation or agency whose employees conduct the investigation is considered a sponsor; employees are considered investigators
- sponsor role
+
+
+ Treponema pallidum
+
+ Treponema pallidum
-
+
-
-
- organization
- PMID: 16353909.AAPS J. 2005 Sep 22;7(2):E274-80. Review. The joint food and agriculture organization of the United Nations/World Health Organization Expert Committee on Food Additives and its role in the evaluation of the safety of veterinary drug residues in foods.
-
- An entity that can bear roles, has members, and has a set of organization rules. Members of organizations are either organizations themselves or individual people. Members can bear specific organization member roles that are determined in the organization rules. The organization rules also determine how decisions are made on behalf of the organization by the organization members.
- BP: The definition summarizes long email discussions on the OBI developer, roles, biomaterial and denrie branches. It leaves open if an organization is a material entity or a dependent continuant, as no consensus was reached on that. The current placement as material is therefore temporary, in order to move forward with development. Here is the entire email summary, on which the definition is based:
+
+
+ Pancrustacea
+
+ Pancrustacea
+
+
-1) there are organization_member_roles (president, treasurer, branch
-editor), with individual persons as bearers
-2) there are organization_roles (employer, owner, vendor, patent holder)
+
-3) an organization has a charter / rules / bylaws, which specify what roles
-there are, how they should be realized, and how to modify the
-charter/rules/bylaws themselves.
+
+
+ Bacteria
+ eubacteria
+
+ Bacteria
+
+
-It is debatable what the organization itself is (some kind of dependent
-continuant or an aggregate of people). This also determines who/what the
-bearer of organization_roles' are. My personal favorite is still to define
-organization as a kind of 'legal entity', but thinking it through leads to
-all kinds of questions that are clearly outside the scope of OBI.
-Interestingly enough, it does not seem to matter much where we place
-organization itself, as long as we can subclass it (University, Corporation,
-Government Agency, Hospital), instantiate it (Affymetrix, NCBI, NIH, ISO,
-W3C, University of Oklahoma), and have it play roles.
+
-This leads to my proposal: We define organization through the statements 1 -
-3 above, but without an 'is a' statement for now. We can leave it in its
-current place in the is_a hierarchy (material entity) or move it up to
-'continuant'. We leave further clarifications to BFO, and close this issue
-for now.
- PERSON: Alan Ruttenberg
- PERSON: Bjoern Peters
- PERSON: Philippe Rocca-Serra
- PERSON: Susanna Sansone
- GROUP: OBI
- organization
+
+
+ Archaea
+
+ Archaea
-
+
-
-
- feed role
- Purina rat chow; cited use: Control; F = feed (rat chow); W = water; F. g. = feed-ginger concentrate. www.academicjournals.org/AJB/PDF/pdf2007/19Sep/Egwurugwu%20et%20al.pdf - Feb 29, 2008
-
- a role that inheres in a material entity and is realized in the use of that material entity by lab animal to provide all needed nourishment.
- Person: Jennifer Fostel
- feed
- OBI
- feed role
+
+
+ Riboviria
+ RNA viruses
+ RNA viruses and viroids
+
+ Riboviria
-
+
-
-
- technical replicate role
- Aliquots of a tissue subjected to parallel assays
-
- technical replicate role is realized when two portions from one evaluant are used in replicate runs of an assay
- Person: Jennifer Fostel
- technical replicate
- technical replicate role
+
+
+ Revtraviricetes
+
+ Revtraviricetes
-
+
-
-
- dye role
-
- A molecular label role which inheres in a material entity and which is realized in the process of detecting a molecular dye that imparts color to some material of interest.
- Jennifer Fostel
- dye
- A substance used to color materials www.answers.com/topic/dye 19feb09
- dye role
+
+
+ Eukaryota
+ eucaryotes
+ eukaryotes
+
+ Eukaryota
-
+
-
-
- cluster
- Cluster of the lymphocytes population.
-
- A data set which is a subset of data that are a similar to each other in some way.
- person:Allyson
- person:Chris Stoeckert
- group:OBI
- cluster
+
+
+ Euarchontoglires
+
+ Euarchontoglires
-
+
-
-
- cohort role
- In statistics and demography, a cohort is a group of subjects - most often humans from a given population - defined by experiencing an event (typically birth) in a particular time span. Wikipedia "cohort", Feb 29 2008
-
- a cohort role is a biological replicate role played by a group of study participants who share a common characteristic of interest to the study.
- Jennifer Fostel
- WEB:http://www.sceoc.com/glossaryofterms/ # a group of individuals having a statistical factor (as age or class membership) in common in a demographic study, such as a cohort of students.
- WEB:http://www.thebody.org/content/treat/art2612.html # a group of individuals in a study who share a demographic, clinical, or other statistical characteristic (eg, age, study site).
- WEB:http://www.uhhospitals.org/tabid/591/Default.aspx # A cohort is a group of people with a common characteristic that is studied over a period of time as part of a scientific or medical investigation.
- cohort role
+
+
+ Tetrapoda
+ tetrapods
+
+ Tetrapoda
-
+
-
-
-
-
-
-
-
-
- artificially induced nucleic acid hybridization
- www.ornl.gov/sci/techresources/Human_Genome/publicat/97pr/09gloss.html, http://www.accessexcellence.org/RC/VL/GG/nucleic.html, http://omrf.ouhsc.edu/~frank/HYBNOTES.html. http://en.wikipedia.org/wiki/Nucleic_acid_hybridization,http://www.pnas.org/cgi/reprint/46/8/1044.pdf
-
- Is a material transformation in which strands of nucleic acids that are (somewhat) complementary form a double-stranded molecule. Has input at least two single stranded molecules of nucleic acid molecules.
- PlanAndPlannedProcess Branch
- OBI branch derived
- artificially induced nucleic acid hybridization
+
+
+ Amniota
+ amniotes
+
+ Amniota
-
+
-
-
-
-
-
-
-
-
- DNA extraction
-
- A DNA extraction is a nucleic acid extraction where the desired output material is DNA.
- PlanAndPlannedProcess Branch
- OBI branch derived
- DNA extraction
+
+
+ Opisthokonta
+
+ Opisthokonta
-
+
-
-
- plan
- The plan of researcher X to perform an experiment according to a protocol.
-
- A plan is a realizable entity that is the inheres in a bearer who is committed to realizing it as a planned process.
- This class is included to make clear how the plan specification, the plan, and the planned process relate. OBI will however only subclass and work under the 'plan specification', and 'planned process' class, as we want to avoid to get deep into discussions of 'intend' etc.
- AR, BP, JM, MC, PRS
- branch derived
- plan
+
+
+ Metazoa
+ metazoans
+ multicellular animals
+
+ Metazoa
-
+
-
-
- Patterns of benzylpiperazine/trifluoromethylphenylpiperazine party pill use and adverse effects in a population sample in New Zealand. Drug Alcohol Rev. 2008 Mar 31:1-7. PMID: 18608458
-
- A sample population is an object aggregate that is selected from the population, e.g. the fish in the net that were sampled from the lake, the people that responded to the call for volunteers.
- PERSON: Jennifer Fostel
- PERSON: Philippe Rocca-Serra
- recruited population
- GROUP: OBI Biomaterial Branch
-
- obsolete_sample population
- true
+
+
+ Bilateria
+
+ Bilateria
-
+
-
-
- organism feature identification objective
-
- Organism_feature_identification_objective is a biological_feature_identification_objective role describing a study designed to examine or characterize a biological feature monitored at the level of the organism, e.g. height, weight, stage of development, stage of life cycle.
- Jennifer Fostel
- organism feature identification objective
+
+
+ Arabidopsis thaliana
+ mouse-ear cress
+ thale cress
+ thale-cress
+
+ Arabidopsis thaliana
-
+
-
-
- number of lost events computer
- 0, 125, 787 events lost due to computer busy.
-
- A measurement datum recording the number of measurement events lost due to overloading of the analysis chip in a flow cytometer instrument. The datum has a qualitative role
- person:Kevin Clancy
- Submitted by the Flow Cytometry community in DigitalEntity-FlowCytometry-2007-03-30.txt
- number of lost events computer
+
+
+ HIV-1 group O
+
+ HIV-1 group O
-
+
-
-
- protocol
- PCR protocol, has objective specification, amplify DNA fragment of interest, and has action specification describes the amounts of experimental reagents used (e..g. buffers, dNTPS, enzyme), and the temperature and cycle time settings for running the PCR.
-
- A plan specification which has sufficient level of detail and quantitative information to communicate it between investigation agents, so that different investigation agents will reliably be able to independently reproduce the process.
- PlanAndPlannedProcess Branch
- OBI branch derived + wikipedia (http://en.wikipedia.org/wiki/Protocol_%28natural_sciences%29)
- study protocol
- protocol
+
+
+ Murinae
+
+ Murinae
-
+
-
-
- role of regulator of consumables and medical devices
- FDA, EMEA; http://www.fda.gov/; The International Conference of Drug Regulatory Authorities (ICDRAs) provide drug regulatory authorities of WHO Member States with a forum to meet and discuss ways to strengthen collaboration.http://www.who.int/medicines/areas/quality_safety/regulation_legislation/icdra/en/index.html
-
- a regulator involved with making and enforcing legislation and governmental orders relevant to the development, testing, manufacture and use of food, drugs and medical devices
- Person: Jennifer Fostel
- drug regulatoy authority
- OBI, CDISC
- role of regulator of consumables and medical devices
+
+
+ Mammalia
+ mammals
+
+ Mammalia
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- adding a material entity into a target
- Injecting a drug into a mouse. Adding IL-2 to a cell culture. Adding NaCl into water.
-
- is a process with the objective to place a material entity bearing the 'material to be added role' into a material bearing the 'target of material addition role'.
- Class was renamed from 'administering substance', as this is commonly used only for additions into organisms.
- BP
- branch derived
- adding a material entity into a target
+
+
+ Dictyostelium discoideum
+
+ Dictyostelium discoideum
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- analyte role
- Glucose in blood (measured in an assay to determine the concentration of glucose).
-
- A measurand role borne by a molecular entity or an atom and realized in an analyte assay which achieves the objective to measure the magnitude/concentration/amount of the analyte in the entity bearing evaluant role.
- interestingly, an analyte is still an analyte even if it is not detected. for this reason it does not bear a specified input role
- pH (technically the inverse log of [H+]) may be considered a quality; this remains to be tested.
- qualities such as weight, color are not assayed but measured, so they do not fall into this category.
- GROUP: Role Branch
- OBI
- Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term.
- analyte role
+
+
+ Ascomycota
+ ascomycetes
+ sac fungi
+
+ Ascomycota
-
+
-
-
-
-
-
-
-
-
- disease stage
- Stage II breast cancer, The timepoint of recovery from a disease
-
- a part of an occurrence of a disease process which is associated with position in the normal progression of the disease
- PERSON: Bjoern peters
- disease stage
+
+
+ Schizosaccharomyces pombe
+ fission yeast
+
+ Schizosaccharomyces pombe
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- intraperitoneal injection
-
- is the injection of a material entity (bearing the administered substance role) into the peritoneum (bearing the target role) of an organism using a syringe
- BP
- intraperitoneal injection
+
+
+ Saccharomyces cerevisiae
+ S. cerevisiae
+ baker's yeast
+ brewer's yeast
+
+ Saccharomyces cerevisiae
-
+
-
-
-
-
-
-
-
-
- precipitate
- Physicochemical properties and antibacterial activity of the precipitate of vancomycin and ceftazidime: implications in the management of endophthalmitis. Retina. 2008 Feb;28(2):320-5. PMID: 18301038
-
- a precipitate is a material entity which is output of a precipitation process
- PERSON: Philippe Rocca-Serra
- precipited material
- GROUP: OBI Biomaterial Branch
- precipitate
+
+
+ Neurospora
+
+ Neurospora
-
+
-
-
-
- An assay that determines interactions between proteins, such as protein-protein binding.
- protein-protein interaction detection assay
+
+
+ Plasmodium
+
+ Plasmodium
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- Transcription factor binding site identification in yeast: a comparison of high-density oligonucleotide and PCR-based microarray platforms.
-
- An assay tthat determines DNA regions specifically recognized by proteins that function as transcription factors
- Philippe Rocca-Serra
- TF binding
- OBI
- https://sourceforge.net/p/obi/obi-terms/767/
- transcription factor binding site assay
+
+
+ Caenorhabditis elegans
+
+ Caenorhabditis elegans
-
+
-
-
- Enrollment of patients in a study. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum. 2008 May 15;59(5):721-9. PMID: 18438902
-
- enrollment is a process of identifying a set of objects for further use in an investigation based on a set of criteria or rules
- Bjoern Peters
- IEDB
-
- obsolete_enrollment
- true
+
+
+ Arthropoda
+ arthropods
+
+ Arthropoda
-
+
-
-
- adverse event trigger
-
- revisit?
- PERSON:Alan Ruttenberg
- OBI branch derived
- adverse event trigger
+
+
+ Daphnia
+ common water fleas
+
+ Daphnia
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- eluate
- Raman spectroscopic detection of haemoproteins in the eluate from high-performance liquid chromatography. J Chromatogr. 1983 Jan 7;254:285-8. PMID: 6298263
-
- a eluate is a material entity which results from an elution, e.g. from a chromatography column. it has as part a material entity with role mobile phase
- need to add restriction to indicate: has_part some (material entity has_role mobile phase)
-need to add mobile phase as role
- PERSON: Philippe Rocca-Serra
- eluted material
- OBI Bionaterial
- eluate
+
+
+ Diptera
+ flies
+
+ Diptera
-
+
-
-
- material to be added role
- drug added to a buffer contained in a tube; substance injected into an animal;
-
- material to be added role is a protocol participant role realized by a material which is added into a material bearing the target of material addition role in a material addition process
- Role Branch
- OBI
- 9 March 09 from discussion with PA branch
- material to be added role
+
+
+ Culicidae
+ mosquitos
+
+ Culicidae
-
+
-
-
-
- is the serous membrane that forms the lining of the abdominal cavity
-
- obsolete_peritoneum
- true
+
+
+ saccharomyceta
+
+ saccharomyceta
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- interpreting data
- Concluding that a gene is upregulated in a tissue sample based on the band intensity in a western blot. Concluding that a patient has a infection based on measurement of an elevated body temperature and reported headache. Concluding that there were problems in an investigation because data from PCR and microarray are conflicting. Concluding that 'defects in gene XYZ cause cancer due to improper DNA repair' based on data from experiments in that study that gene XYZ is involved in DNA repair, and the conclusion of a previous study that cancer patients have an increased number of mutations in this gene.
-
- A planned process in which data gathered in an investigation is evaluated in the context of existing knowledge with the objective to generate more general conclusions or to conclude that the data does not allow one to draw general conclusion
- PERSON: Bjoern Peters
- PERSON: Jennifer Fostel
- Bjoern Peters
- drawing a conclusion based on data
+
+
+ Drosophila melanogaster
+ fruit fly
+
+ Drosophila melanogaster
-
+
-
-
-
-
-
-
-
-
-
-
-
-
- planning
- The process of a scientist thinking about and deciding what reagents to use as part of a protocol for an experiment. Note that the scientist could be human or a "robot scientist" executing software.
-
- a process of creating or modifying a plan specification
- 7/18/2011 BP: planning used to itself be a planned process. Barry Smith pointed out that this would lead to an infinite regression, as there would have to be a plan to conduct a planning process, which in itself would be the result of planning etc. Therefore, the restrictions on 'planning' were loosened to allow for informal processes that result in an 'ad hoc plan '. This required changing from 'has_specified_output some plan specifiction' to 'has_participant some plan specification'.
- Bjoern Peters
- Bjoern Peters
- Plans and Planned Processes Branch
- planning
+
+
+ Vertebrata <vertebrates>
+ Vertebrata
+ vertebrates
+
+ Vertebrata <vertebrates>
-
+
-
-
- Recording the current temperature in a laboratory notebook. Writing a journal article. Updating a patient record in a database.
-
- Bjoern Peters
- wikipedia http://en.wikipedia.org/wiki/Documenting
-
-
- obsolete_documenting
- true
+
+
+ Danio rerio
+ leopard danio
+ zebra danio
+ zebra fish
+ zebrafish
+
+ Danio rerio
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- histological sample preparation
-
- histological sample preparation is the preparation of an input tissue via slicing and labeling to make tissue microstructure of interest visible in a future histology assay
- PERSON:Bjoern Peters
- OBI branch derived
- histological sample preparation
+
+
+ Xenopus <genus>
+ Xenopus
+
+ Xenopus <genus>
-
-
-
-
- inductive reasoning
- Based on the observation that all lung cancer patients treated with aspirin in our clinical trial survived longer than the control group, we conclude by inductive reasining that aspirin has a therapeutic effect on lung cancer.
-
- a interpreting data that is used to ascribe properties or relations to types based on an observation instance (i.e., on a number of observations or experiences); or to formulate laws based on limited observations of recurring phenomenal patterns.
- BP: 10/22/122: After changing the parent class to drawing a conclusion *based on data* it is no longer clear that this class is needed; minimally it needs a better definition to distinguish it.
-
-Proposal is to obsolete.
+
-
- Bjoern Peters
- wikipedia: http://en.wikipedia.org/wiki/Inductive_reasoning
- inductive reasoning
+
+
+ Gallus gallus
+ Gallus domesticus
+ bantam
+ chicken
+ chickens
+
+ Gallus gallus
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- mass analyzer
- The mass analyzer of the Voyager-DE(tm) STR Biospectrometry Workstation
-
- A Mass analyzer is a device that separates ions according to their mass-to-charge ratio. All mass spectrometers are based on dynamics of charged particles in electric and magnetic fields in vacuum where the two laws of Lorentz force law and Newton's second law of motion apply.
- Frank Gibson
- PERSON: Daniel Schober
- http://en.wikipedia.org/wiki/Mass_spectrometry#Mass_analyzer
- mass analyzer
+
+
+ Homo sapiens
+ human
+ human being
+
+ Homo sapiens
-
+
-
-
- hypothesis driven investigation
-
- is an investigation with the goal to test one or more hypothesis
- PlanAndPlannedProcess Branch
- OBI branch derived
- hypothesis driven investigation
+
+
+ Rodentia
+ rodent
+
+ Rodentia
-
+
-
-
- hypothesis generating investigation
-
- is an investigation in which data is generated and analyzed with the purpose of generating new hypothesis
- PlanAndPlannedProcess Branch
- OBI branch derived
- hypothesis generating investigation
+
+
+ role of being consumer safety officer
+ Consumer safety officer; Consumer Safety Officer Positions at FDA http://69.20.19.211/jobs/cso.htm
+ Person charged with serving as CSO, FDA official who coordinates the review
+
+ the role of a human being that is realized by enforcing regulations to ensure consumer safety
+ Jennifer Fostel
+ Person:Helen Parkinson
+ OBI, CDISC
+ role of being consumer safety officer
-
+
-
-
-
-
-
-
-
-
- ion source
- The ion source of a Voyager-DE??? STR Biospectrometry Workstation
-
- An ion source is a device that is part of a mass spectrometer that ionizes the material under analysis. The ions are then transported by magnetic or electric fields to the mass analyzer. Techniques for ionization have been key to determining what types of samples can be analyzed by mass spectrometry. Electron ionization and chemical ionization are used for gases and vapors. In chemical ionization sources, the material is ionized by chemical ion-molecule reactions during collisions in the source. Two techniques often used with liquid and solid biological samples include electrospray ionization (due to John Fenn PMID 2675315.) and matrix-assisted laser desorption/ionization (MALDI, due to M. Karas and F. Hillenkamp (Measuring Mass: From Positive Rays to Proteins by Michael A. Grayson (Editor) (ISBN 0-941901-31-9))).
- Frank Gibson
- http://en.wikipedia.org/wiki/Mass_spectrometry#Ion_source
- ion source
+
+
+ fluorescent reporter intensity
+
+ A measurement datum that represents the output of a scanner measuring the intensity value for each fluorescent reporter.
+ person:Chris Stoeckert
+ group:OBI
+ From the DT branch: This term and definition were originally submitted by the community to our branch, but we thought they best fit DENRIE. However we see several issues with this. First of all the name 'probe' might not be used in OBI. Instead we have a 'reporter' role. Also, albeit the term 'probe intensity' is often used in communities such as the microarray one, the name 'probe' is ambiguous (some use it to refer to what's on the array, some use it to refer to what's hybed to the array). Furthermore, this concept could possibly be encompassed by combining different OBI terms, such as the roles of analyte, detector and reporter (you need something hybed to a probe on the array to get an intensity) and maybe a more general term for 'measuring intensities'. We need to find the right balance between what is consistent with OBI and combinations of its terms and what is user-friendly. Finally, note that 'intensity' is already in the OBI .owl file and is also in PATO. Why didn't OBI import it from PATO? This might be a problem.
+ fluorescent reporter intensity
-
+
-
-
-
+
+
-
-
+
+
+
+
+
+
+
-
- ion detector
- The ion detector of the Voyager-DE(tm) STR Biospectrometry Workstation
+
+
+ planned process
+ planned process
+ Injecting mice with a vaccine in order to test its efficacy
- An ion detector is a device that measures and records the charge induced or current produced when an ion passes by or hits a surface. Example: In a scanning instrument the signal produced in the detector during the course of the scan versus where the instrument is in the scan (at what m/Q) will produce a mass spectrum, a record of ions as a function of m/Q.
- Frank Gibson
- http://en.wikipedia.org/wiki/Mass_spectrometry#Detector
- ion detector
+ A process that realizes a plan which is the concretization of a plan specification.
+ 'Plan' includes a future direction sense. That can be problematic if plans are changed during their execution. There are however implicit contingencies for protocols that an agent has in his mind that can be considered part of the plan, even if the agent didn't have them in mind before. Therefore, a planned process can diverge from what the agent would have said the plan was before executing it, by adjusting to problems encountered during execution (e.g. choosing another reagent with equivalent properties, if the originally planned one has run out.)
+ We are only considering successfully completed planned processes. A plan may be modified, and details added during execution. For a given planned process, the associated realized plan specification is the one encompassing all changes made during execution. This means that all processes in which an agent acts towards achieving some
+objectives is a planned process.
+ Bjoern Peters
+ branch derived
+ 6/11/9: Edited at workshop. Used to include: is initiated by an agent
+ This class merges the previously separated objective driven process and planned process, as they the separation proved hard to maintain. (1/22/09, branch call)
+
+ planned process
-
+
-
-
-
-
-
-
-
-
- Metabolite profiling of human colon carcinoma - deregulation of TCA cycle and amino acid turnover. Mol Cancer. 2008 Sep 18;7(1):72. PMID: 18799019
+
+
+ regulator role
+ Fact sheet - Regulating the companies The role of the regulator. Ofwat is the economic regulator of the water and sewerage industry in England and Wales. http://www.ofwat.gov.uk/aptrix/ofwat/publish.nsf/Content/roleofregulator_factsheet170805
- An assay that detects and identifies chemical entities resulting from biochemical and cellular metabolism
- Philippe Rocca-Serra
- metabolite assay
- metabolomic assay
- OBI
- metabolite profiling assay
+ a regulatory role involved with making and/or enforcing relevant legislation and governmental orders
+ Person:Jennifer Fostel
+ regulator
+ OBI
+ regulator role
-
+
-
-
- light emission function
-
- A light emission function is an excitation function to excite a material to a specific excitation state that it emits light.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- light emission function
+
+
+ biological feature identification objective
+
+ Biological_feature_identification_objective is an objective role carried out by the proposition defining the aim of a study designed to examine or characterize a particular biological feature.
+ Jennifer Fostel
+ biological feature identification objective
-
+
-
-
- record function
-
- A record function is a function that registers or collects information in a particular format on a particular recording medium. For example on paper or a digital representation
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- record function
+
+
+ regulation-assigned role
+ Approval letter
+
+ Regulation-assigned role is a regulatory role defined by legislation or governmental orders
+ Person: Jennifer Fostel
+ regulation-assigned role
-
+
-
-
- magnify function
-
- A magnify function is a function to increase the size of a transmitted object image through the precise arrangement of energy diffraction elements along an imaging path.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- magnify function
+
+
+ regulatory role
+ Regulatory agency, Ethics committee, Approval letter; example: Browse these EPA Regulatory Role subtopics http://www.epa.gov/ebtpages/enviregulatoryrole.html Feb 29, 2008
+
+ a role which inheres in material entities and is realized in the processes of making, enforcing or being defined by legislation or orders issued by a governmental body.
+ GROUP: Role branch
+ OBI, CDISC
+ govt agents responsible for creating regulations; proxies for enforcing regulations. CDISC definition: regulatory authorities. Bodies having the power to regulate. NOTE: In the ICH GCP guideline the term includes the authorities that review submitted clinical data and those that conduct inspections. These bodies are sometimes referred to as competent
+ regulatory role
-
+
-
-
- contain function
- A syringe, a beaker
-
- A contain function is a function to constrain a material entities location in space
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- contain function
+
+
+ material supplier role
+ Jackson Labs is an organization which provide mice as experimental material
+
+ a role realized through the process of supplying materials such as animal subjects, reagents or other materials used in an investigation.
+ Supplier role is a special kind of service, e.g. biobank
+ PERSON:Jennifer Fostel
+ material provider role
+ supplier
+ material supplier role
-
+
-
-
- heat function
-
- A heat function is a function that increases the internal kinetic energy of a material
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- heat function
+
+
+ contract research organization role
+
+ a worker role of carrying out the study according to the protocol document or study plan delivered by the PI, under the control of the study director. This role cannot make decisions about the study execution
+ Person: Jennifer Fostel
+ contract research organization
+ contract research organization role
-
+
-
-
- material separation function
-
- A material separation function is a function that increases the resolution between two or more material entities. The to distinction between the entities is usually based on some associated physical quality.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- material separation function
+
+
+ list-mode data file
+ An example of a list-mode data file is a file following list-mode Flow Cytometry Standard (FCS) format. Since FCS files can be in histogram mode or list-mode we have to specify which data format specifically. List-mode format in the overwhelming (even universal) option used.
+
+ A list-mode data file is a binary digital entity where events are stored sequentially, parameter by parameter.
+ One example of usage is in the context of flow cytometry, however is not restricted to this community and is more widely used, e.g. by imaging people.
+ person:Chris Stoeckert
+ group:Flow Cytometry community
+ list-mode data file
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
-
-
+
+
-
- ionize process
- Electrospray ionization in mass spectrometry
-
- a physical process of converting an atom or molecule into an ion by adding or removing charged particles such as electrons or other ions. This excludes chemical processes of dissociation.
- 2009-11-10. Tracker: http://en.wikipedia.org/wiki/Ionize
- Person:Bjoern Peters
- ionize process
-
-
-
-
-
-
-
-
- excitation function
-
- A excitation function is a function to inject energy by bombarding a material with energetic particles (e.g., photons) thereby imbuing internal material components such as electrons with additional energy. These internal, 'excited' particles may lead to the rupturing of covalent chemical bonds or may quickly relax back to there unexcited state with an exponential time course thereby locally emitting energy in the form of photons.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- excitation function
+
+
+ classified data set
+
+ A data set that is produced as the output of a class prediction data transformation and consists of a data set with assigned class labels.
+ PERSON: James Malone
+ PERSON: Monnie McGee
+ data set with assigned class labels
+ classified data set
-
+
-
-
- freeze function
-
- A freeze function is a function to decrease the internal kinetic energy of a material below the freezing point of that type of material.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- freeze function
+
+
+
+
+
+
+
+
+ reference substance role
+ Calibration standard, positive control substance, vehicle Good Laboratory Practices: Questions and Answers - Test Control and Reference Substance Characterization http://www.epa.gov/enforcement/monitoring/programs/fifra/glpqanda-character.html
+
+ a role inhering in a material entity that is realized when characteristics or responses elicited by the substance are used for comparison or reference.
+ Person:Jennifer Fostel
+ reference substance
+ OBI
+ reference substance role
-
+
-
-
- synthesizing function
-
- A synthesizing function is a function to assemble new output materials from distinct input materials. The output materials typically consist of chemically distinct monomeric objects or object aggregate polymers.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- synthesizing function
+
+
+ cytological stain role
+ haemotoxylin is a general purpose nuclear stain extracted from the wood of the logwood tree WEB: http://en.wikipedia.org/wiki/Haematoxylin
+
+ A dye role that is realized when the stain is used to colour cells and or cellular components for the purposes of visualization
+ Person:Helen Parkinson
+ Person:Jennifer Fostel
+ cytological stain
+ cytological stain role
-
+
-
-
- perturb function
-
- A perturb function is a function that disrupts the normal function of a system induced through either internal or external means. External means of perturbation include: (1) displacement fields in the physical sense - e.g., temperature change, osmotic shock, pressure change; (2) application of small molecules such as drugs or toxins to perturb the function of specific pathways or application of surfactants to perturb the normal function of plasma membrane. Internal means of perturbation include: (1) manipulation of gene function via gene knockout or transcript knockdown via RNAi; (2) directed genetic mutation leading to minimal aa alterations that interfere with peptide function.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- http://en.wikipedia.org/wiki/Perturbation_biology
- perturb function
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ centrifuge pellet role
+ Definition of pellet :the material concentrated at the bottom of a centrifuge tube after centrifugation. http://www.everythingbio.com/glos/definition.php?word=pellet
+
+ pellet role is a role which inheres in a material entity and is realized by a material separation process using gravitational force generated by a centrifuge in which the material bearing the pellet role is the heavier or heaviest component of the output material..
+ GROUP: Role branch
+ OBI
+ 9Mar09 after discussion with process branch changed definition to include use of centrifuge;
+ centrifuge pellet role
-
+
-
-
- filter function
-
- A filter function is a function to prevent the flow of certain entities based on a quality or qualities of the entity while allowing entities which have different qualities to pass through
- Frank Gibson
- filter function
+
+
+ clinical research coordinator role
+
+ a worker role comprised of handling the administrative duties of a trial or study.
+ Person:Jennifer Fostel
+ clinical research coordinator
+ clinical research coordinator role
-
+
-
-
- mechanical function
-
- A mechanical function is a function that is realised via mechanical work (through an certain amount of energy transferred by some force).
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- http://en.wikipedia.org/wiki/Mechanical_work
- mechanical function
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ supernatant role
+ Precipitation is the formation of a solid in a solution during a chemical reaction. When the reaction occurs, the solid formed is called the precipitate, and the liquid remaining above the solid is called the supernate. Wikipedia
+
+ supernatant role is a role which inheres in a material entity and is realized by a material separation process using gravitational force in which the material bearing the supernatant role is the liquid component of the output material.
+ GROUP: Role branch
+ OBI
+ supernatant role
-
+
-
-
- gas filter function
-
- A gas filter function is a filter function which prevents the flow of solid objects, defined by specific qualities, in a gas-solid mixture
- Frank Gibson
- gas filter function
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ chromatography column
+
+ Chromatography column in chemistry is a tube and contents (typically glass) used to purify individual chemical compounds from mixtures of compounds. It is often used for preparative applications on scales from micrograms up to kilograms.
+ Frank Gibson
+ http://en.wikipedia.org/wiki/Column_chromatography
+ open tracker https://sourceforge.net/tracker/index.php?func=detail&aid=2881353&group_id=177891&atid=886178
+ chromatography column
-
+
-
-
- liquid filter function
-
- A liquid filter function is a filter function which prevents the flow of solid objects, defined by specific qualities, in a liquid-solid mixture
- Frank Gibson
- liquid filter function
+
+
+
+
+
+
+
+
+ drug role
+ http://www.answers.com/topic/drug
+ 1. A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication.
+ 2. Such a substance as recognized or defined by the U.S. Food, Drug, and Cosmetic Act.
+
+ a role borne by a molecular entity and is realized in a process of absorption by an organism alters, or effects (or is assumed to effect) a function(s) which inhere in an organism
+ Role Branch
+ drug
+ OBI, CDISC
+ drug role
-
+
-
-
- transfer function
-
- A transfer function is a function to displace a material from one location to another.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- transfer function
+
+
+
+
+
+
+
+
+ pump valve switch
+
+ A pump valve switch is a cardinal part of a liquid chromatography instrument that controls the flow.
+ FG:I would assume this should be a pump valve control switch and it would not be specific to a liquid chromatography instrument
+ OBI Instrument branch
+ OBI
+ pump valve switch
-
+
-
-
- electricity supply function
- the function of supplying current during a neuroscience experiment.
-
- An electricity supply function is an energy supply function to transfer electricity from one source to another, typically a consumer of the electricity or as a stimulus during a neuroscience experiment.
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- power supply
- electricity supply function
+
+
+ xenotransplantation
+
+ is the transplantation of living cells, tissues or \norgans from one species to another such as from pigs to humans
+ PlanAndPlannedProcess Branch
+ OBI branch derived
+ xenotransplantation
-
+
-
-
- ionization function
- The ion source in amass spectrometer
-
- An ionization function is a function to physically convert an atom or molecule into an ion by adding or removing charged particles such as electrons or other ions.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- http://en.wikipedia.org/wiki/Ionization
- ionization function
+
+
+ physical document
+ a book is a physical document
+
+ A physical document is an object serving as a record of information by means of symbolic marks.
+ PERSON: Bjoern Peters
+ GROUP: OBI
+ physical document
-
+
-
-
- cool function
-
- A cool function is a function to decrease the internal kinetic energy of a material below the initial kinetic energy of that type of material.
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- cool function
+
+
+ waiting
+
+ not actively doing anything to a material for a duration of time.
+ PERSON:Alan Ruttenberg
+ OBI branch derived
+ BP: I have doubts about the utility of this.
+ We need a better handling/modeling of time (January 2008)
+ waiting
-
+
-
-
- connection function
- An electricity cable
+
+
+
+
+
+
+
+
+
+
+
+
+ processed material
+ Examples include gel matrices, filter paper, parafilm and buffer solutions, mass spectrometer, tissue samples
- A connection function is a function to couple two or more flow channels so that material or signals can be transported from one set of channels to another.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- connection function
+ Is a material entity that is created or changed during material processing.
+ PERSON: Alan Ruttenberg
+ processed material
-
+
-
+
@@ -7775,7 +13813,7 @@ Proposal is to obsolete.
-
+
@@ -7784,1419 +13822,945 @@ Proposal is to obsolete.
- isoelectric focusing device
+
+
+
+
+
+
+ chromatography device
- An isoelectric focusing device is a device in which isoelectric focusing can be performed. An isoelectric focussing device had the function to contain and control the contained environment and transfer electrical energy from a power supply to a separation medium and the charged material to be separated.
- Frank Gibson
- isoelectric focusing unit
- sep:00097
- isoelectric focusing device
+ A device that facilitates the separation of mixtures. The function of a chromatography device involves passing a mixture dissolved in a "mobile phase" through a stationary phase, which separates the analyte to be measured from other molecules in the mixture and allows it to be isolated.
+ Frank Gibson
+ chromatography instrument
+ http://en.wikipedia.org/wiki/Chromatography
+ open tracker https://sourceforge.net/tracker/index.php?func=detail&aid=2881353&group_id=177891&atid=886178
+ chromatography device
-
+
-
+
-
-
+
+
-
-
+
+
- thermostatic circulator
-
- A thermostatic circulator is a device which cools or heats a circulating liquid. It has the function to contain control the contained environment and transfer energy from or to the circulating liquid
- Frank Gibson
- sep:00098
- thermostatic circulator
-
-
-
-
-
-
-
-
- energy supply function
-
- An energy supply function is a function to supply or transfer energy from an energy source to a consumer of the energy
- Frank Gibson
- energy supply function
-
-
-
-
-
-
-
-
-
+
-
-
+
+
- information processor function
+ mass spectrometer
+ LCQ Fleet Ion Trap MSn manufactured by thermo fisher scientific
- An information processor function is a function that converts information from one form to another, by a lossless process or an extraction process.
- Frank Gibson
- data processor function
- information processor function
+ A mass spectrometer is an instrument which is used to measure the mass to charge ratio of ions. All mass spectrometers consist of three basic parts: an ion source, a mass analyzer, and a detector system. The stages within the mass spectrometer are: 1. Production of ions from the sample 2. Separation of ions with different masses 3. Detection of the number of ions of each mass produced 4.Collection of data to generate the mass spectrum
+ Frank Gibson
+ http://en.wikipedia.org/wiki/Mass_spectrometry
+ mass spectrometer
-
+
-
-
- signal conversion function
-
- A signal conversion function is an information processor function which transforms a signal into another type of signal. For example an analog-to-digital_converter, Ac/Ac converter, a synapse converts electrical action potentials into an intermediate chemical signal. The post synapse converts it back into an electric one passed on to the axon.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- transduction function
- signal conversion function
+
+
+ obsolete_platform
+
+ A platform is an object_aggregate that is the set of instruments and software needed to perform a process. definition_source: OBI.
+ OBI Instrument branch
+ OBI Instrument branch
+
+ obsolete_platform
+ true
-
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
+
+
+
+
+
+
- blot module
+ liquid chromatography mass spectrometry platform
- A blot module is a device which has the function to conatin and facilitate the material transfer process blotting to be realised
- Frank Gibson
- sep:00092
- blot module
-
-
-
-
-
-
-
-
- signal amplification function
-
- A signal amplification function is a signal conversion function to inject energy into an input signal so as to produce an output signal with increased differential magnitude while also seeking to minimize increases in the signal to noise ratio. For example, to produce a 0.1 KW output signal from a 1 mW RMS input signal.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- signal amplification function
+ A liquid chromatography mass spectrometry platform is a platform that is the collection of instrument, software and reagents needed to perform a liquid chromatography mass spectrometry protocol. definition_source: OBI.
+ OBI instrument branch
+ OBI Instrument branch
+ liquid chromatography mass spectrometry platform
-
+
-
-
+
+
-
-
+
+
-
-
+
+
- image acquisition function
-
- An image acquisition function is a function to acquire an image of a material
- Frank Gibson
- image acquisition function
+ microarray platform
+
+ A microarray platform is a platform that contains the instruments, software and reagents needed to perform a microarray protocol. definition_source: OBI.
+ OBI Instrument branch
+ OBI Instrument branch
+ microarray platform
-
+
-
-
-
-
-
-
-
-
-
-
-
-
- image acquisition device
-
- An image creation device is a device which captures a digitized image of an object
- Frank Gibson
- image acquisition device
- sep:00096
- image creation device
-
-
-
-
-
-
-
-
- solid support function
- Taped, glued, pinned, dried or molecularly bonded to a solid support
-
- A solid support function is a function of a device on which an entity is kept in a defined position and prevented in its movement
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- solid support function
+
+
+ ratio of collected to emitted light
+ 10%
+
+ A measurement datum measuring the amount of light collected s compared to the total amount of emitted light in the detector component of a flow cytometer instrument. The datum has a qualitative role
+ person:Chris Stoeckert
+ person:Kevin Clancy
+ Submitted by the Flow Cytometry community in DigitalEntity-FlowCytometry-2007-03-30.txt
+ ratio of collected to emitted light
-
+
-
-
- display function
-
- A display function is a function to present information by translating that information through some lookup process into visual form.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- display function
+
+
+ software optimization objective
+
+ Software_optimization is a software_testing_objective role describing a study designed to identify the best software or parameters of the software.
+ Jennifer Fostel
+ software optimization objective
-
+
-
-
- environment control function
-
- An environmental control function is a function that regulates a contained environment within specified parameter ranges. For example the control of light exposure, humidity and temperature.
- Bill Bug
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- environment control function
+
+
+ notified body role
+ The role of notified bodies presentation: http://ec.europa.eu/enterprise/electr_equipment/emc/revision/notified_bodies.pdf
+
+ Notified body is regulator of consumables and medical devices charged by the Competent Authority with verifying compliance of medical devices (not drugs) with the applicable Essential Requirements stated in the Medical Device Directive
+ Notified Body (NB). A private institution charged by the Competent Authority with verifying compliance of medical devices (not drugs) with the applicable Essential Requirements stated in the Medical Device Directive. This process, called Conformity Assessment, has EU-wide validity once completed by the NB.
+ Person: Jennifer Fostel
+ notified body
+ OBI, CDISC
+ notified body role
-
+
-
-
- sort function
-
- A sort function is a function to distinguish material components based on some associated physical quality or entity and to partition the separate components into distinct fractions according to a defined order.
- Daniel Schober
- Frank Gibson
- Melanie Courtot
- sort function
+
+
+ allotransplantation
+
+ is the transplantation of organs between members of the same species.
+ PlanAndPlannedProcess Branch
+ OBI branch derived
+ allotransplantation
-
+
-
+
-
-
-
-
-
-
-
+
- gel dryer
-
- A gel dryer is a device which has the function to contain and to control the contained environment to facilitate the drying of gels
- Frank Gibson
- sep:00094
- gel dryer
+ gamma counter
+ A Geiger counter
+
+ A processed material which measures gamma radiation
+ Frank Gibson
+ http://en.wikipedia.org/wiki/Gamma_counter
+ gamma counter
-
+
-
-
+
+
+ trial monitor role
+
+ a responsible party involved in planning, overseeing the conduct of a study or study component, and interpreting data from a study
+ Person:Jennifer Fostel
+ trial monitor
+ CDISC definition: Person employed by the sponsor or CRO who is responsible for determining that a trial is being conducted in accordance with the protocol and GCP guidance. NOTE: A monitor's duties may include, but are not limited to, helping to plan and initiate a trial, assessing the conduct of trials, and assisting in data analysis, interpretation and extrapolation. Clinical Research Associate: Primary representative of the sponsor; monitors progress of investigator sites participating in a clinical study.
+ trial monitor role
+
+
+
+
+
+
+
+
-
+
- primer role
+ positive reference substance role
+ MMS mutagen
- a complementary nucleotide probe role which inheres in nucleic acid molecular entity and is realized by the use of the entity bearing the role to initiate chain elongation.
- (cell and molecular biology) A short strand of RNA that is synthesized along single-stranded DNA during replication, initiating DNA polymerase-catalyzed synthesis of the complementary strand. http://www.answers.com/topic/rna-primer
- primer role
+ a reference role in which the characteristics or responses elicited by the substance playing the reference substance role are used to establish a "100%" response
+ Person: Jennifer Fostel
+ positive reference substance
+ positive reference substance role
-
+
-
-
-
-
-
-
-
-
-
-
-
-
- PCR product
- PCR products are the results of amplifcation process. Detection of a PCR products is used to detect DNA and RNA.
-
- is double stranded DNA that is the specified output of a polymerase chain reaction
- We are using PCR and not the written out words, as this is the most common used.
- GROUP: OBI BIomaterial Branch
- GROUP: OBI BIomaterial Branch
- PCR product
+
+
+ polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether
+ PMID: 30799. J Histochem Cytochem. 1978 Sep;26(9):696-712. Acid lipase: a histochemical and biochemical study using triton X100-naphtyl palmitate micelles.
+
+ triton X100 is a chemical entity which belongs to the group of The pluronics which are triblock copolymers of ethylene oxide and propylene oxide. Triton x-100 is_used_as detergent due to its non-ionic surfactant properties
+ Philippe Rocca-Serra
+ adapted from Wikipedia before possible import from CHEBI
+ polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether
-
+
-
-
+
+
-
-
+
+
- viral RNA extraction
- The AccuPrepTM Viral RNA Extraction Kit is designed for the rapid and convenient extraction of viral RNA from cell-free samples as serum, plasma, CSF, urine, etc - http://www.biokits.com/moreinfos.html?id=2703
-
- The extraction of RNA from an input material that specifically isolates viral RNA
- Person:Bjoern Peters
- viral RNA extraction
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ investigation
+ Lung cancer investigation using expression profiling, a stem cell transplant investigation, biobanking is not an investigation, though it may be part of an investigation
+
+ a planned process that consists of parts: planning, study design execution, documentation and which produce conclusion(s).
+ Bjoern Peters
+ OBI branch derived
+ Could add specific objective specification
+ Following OBI call November 2012,26th: it was decided there was no need for adding "achieves objective of drawing conclusion" as existing relations were providing equivalent ability. this note closes the issue and validates the class definition to be part of the OBI core
+editor = PRS
+
+ study
+ investigation
-
+
-
-
+
+
-
+
-
+
- nucleic acid template role
- a model or standard for making comparisons; wordnet.princeton.edu/perl/webwn 19 feb 2009
-
- a reference substance role which inheres in nucleic acid material entity and is realized in the process of using the nucleic acid bearing the template role as a reference during synthesis of a reverse copy.
- nucleic acid template role
+ evaluant role
+ When a specimen of blood is assayed for glucose concentration, the blood has the evaluant role. When measuring the mass of a mouse, the evaluant is the mouse. When measuring the time of DNA replication, the evaluant is the DNA. When measuring the intensity of light on a surface, the evaluant is the light source.
+
+ a role that inheres in a material entity that is realized in an assay in which data is generated about the bearer of the evaluant role
+ Role call - 17nov-08: JF and MC think an evaluant role is always specified input of a process. Even in the case where we have an assay taking blood as evaluant and outputting blood, the blood is not the specified output at the end of the assay (the concentration of glucose in the blood is)
+ examples of features that could be described in an evaluant: quality.... e.g. "contains 10 pg/ml IL2", or "no glucose detected")
+ GROUP: Role Branch
+ OBI
+ Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term.
+ evaluant role
-
+
-
-
-
-
-
-
-
-
-
-
-
-
- recombinant plasmid
+
+
+ reporting party role
+ Person who prepares microarray data in MAGE-TAB format and submits to a database, such as ArrayExpress.
+ The first section has been pre-designated as the 'Reporting Party' section and should be filled with the Reporting Party's personal information. http://www.mercedsheriff.com/SelfReporting.htm
- a plasmid in which extraneous DNA has been inserted.
- PERSON: Bjoern Peters
- PERSON: Kevin Clancy
- PERSON: Melanie Courtot
- GROUP: OBI Biomaterial Branch
- recombinant plasmid
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- cloning vector role
- pBluescript plays the role of a cloning vector
-
- A material to be added role played by a small, self-replicating DNA or RNA molecule - usually a plasmid or chromosome - and realized in a process whereby foreign DNA or RNA is inserted into the vector during the process of cloning.
- JZ: related tracker: https://sourceforge.net/p/obi/obi-terms/102/
- PERSON: Helen Parkinson
- cloning vector role
+ a study personnel role played by a party who reports the outcome of a study component
+ MO:submitter mapped to this term. So, alternative term 'submitter' was added.
+ Jennifer Fostel
+ reporting party
+ submitter
+ OBI
+ reporting party role
-
+
-
-
-
-
-
-
-
-
-
+
+
-
-
+
+
-
+
+
-
-
+
+
- cell cycle synchronization
- Elimination of serum from the culture medium for about 24 hours results in the accumulation of cells at G1 phase. This effect of nutritional deprivation can be restored by their addition by which time the cell synchrony occurs.
-
- a process with the objective to obtain a cell culture in which all cells are in the same stage of the cell cycle
- OBI PA
- Bjoern Peters and Nicole Washington
- cell cycle synchronization
-
-
-
-
-
-
-
-
-
+
-
+
-
-
+
+
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
- polymerase chain reaction
- Opisthorchis viverrini: Detection by polymerase chain reaction (PCR) in human stool samples. Exp Parasitol. 2008 Sep 9. PMID: 18805413
-
- PCR is the process in which a DNA polymerase is used to amplify a piece of DNA by in vitro enzymatic replication. As PCR progresses, the DNA thus generated is itself used as a template for replication. This sets in motion a chain reaction in which the DNA template is exponentially amplified.
- OBI Plan
- PCR
- adapted from wikipedai
- polymerase chain reaction
+
+
+
+ assay
+ Assay the wavelength of light emitted by excited Neon atoms. Count of geese flying over a house.
+
+ A planned process with the objective to produce information about the material entity that is the evaluant, by physically examining it or its proxies.
+ 12/3/12: BP: the reference to the 'physical examination' is included to point out that a prediction is not an assay, as that does not require physical examiniation.
+ PlanAndPlannedProcess Branch
+ measuring
+ scientific observation
+ OBI branch derived
+ study assay
+ any method
+ assay
-
+
-
-
- cloning insert role
-
- cloning insert role is a role which inheres in DNA or RNA and is realized by the process of being inserted into a cloning vector in a cloning process.
- Feb 20, 2009. from Wikipedia: cloning of any DNA fragment essentially involves four steps: DNA fragmentation with restriction endonucleases, ligation of DNA fragments to a vector, transfection, and screening/selection. There are multiple processes involved, it is not just "cloning process"
- GROUP: Role branch
- OBII and Wikipedia
- cloning insert role
+
+
+ quantitative confidence value
+
+ A data item which is used to indicate the degree of uncertainty about a measurement.
+ person:Chris Stoeckert
+ group:OBI
+ quantitative confidence value
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
+
+
- Measuring glucose concentration in blood from a mouse. See Figure 2 of the 2016 OBI paper, PMID: 27128319.
-
- An assay that determines the concentration of glucose molecules in a blood serum sample
- Bjoern Peters
- OBI
- measuring glucose concentration in blood serum assay
+ sample preparation for assay
+
+ A sample_preparation_for_assay is a protocol_application including material_enrollments and biomaterial_transformations. definition_source: OBI.
+ PlanAndPlannedProcess Branch
+ study
+ OBI branch derived
+ sample preparation for assay
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- reverse transcriptase
-
- enzyme and has_function some GO:0003964 (RNA-directed DNA polymerase
-activity)
- person:Melanie Courtot
- group:OBI
- reverse transcriptase
+
+
+ diagnosis textual entity
+
+ diagnosis is an assessment of a disease or injury, its likely prognosis and treatment.
+ Jennifer Fostel
+ diagnosis textual entity
-
+
-
-
- A trypsinized suspension of cells
-
- A material entity that has undergone a process of digestion with trypsin
- Person:Bjoern Peters
-
- obsolete_trypsinized material
- true
+
+
+ unplanned occurrence effecting an investigation
+ Earthquake that destroys the lab, an outside investigator discovering an adverse effect of the reagants used
+
+ a process which is external in origin to the investigation that has an impact on the outcome.
+ PERSON: Bjoern Peters
+ OBI
+ unplanned occurrence effecting an investigation
-
+
-
-
-
-
-
-
-
-
- syringe
- Accuracy of oral liquid measuring devices: comparison of dosing cup and oral dosing syringe.Ann Pharmacother. 2008 Jan;42(1):46-52. Epub 2007 Dec 4. PMID: 18056832
-
- A processed material which is used to introduce or draw fluids from a material entity. A syringe is made of a piston and body. the movement of the piston in the body determines the amount/volume of fluid to inject or draw
- Philippe Rocca-Serra
- OBI Instrument adapted from Wikipedia
- syringe
+
+
+ eMedical record
+
+ An eMedical record is a digital document derived from a computer system used primarily for patient care in a clinical setting. Not required to be compliant with requirements of 21 CFR Part 11.
+ person:Jennifer Fostel
+ article-without-pmid-or-doi:CDISCglossary
+ eMedical record
-
+
-
+
-
-
-
-
-
-
- extract
- Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxygenase-2 -1195G>a polymorphism reveal risk of oral cancer. Cancer Res. 2008 Oct 15;68(20):8489-98. PMID: 18922923
-
- an extract is a material entity which results from an extraction process
- PERSON: Philippe Rocca-Serra
- extracted material
- GROUP: OBI Biomatrial Branch
- extract
+ culture medium
+ A growth medium or culture medium is a substance in which microorganisms or cells can grow. Wikipedia, growth medium, Feb 29, 2008
+
+ a processed material that provides the needed nourishment for microorganisms or cells grown in vitro.
+ changed from a role to a processed material based on on Aug 22, 2011 dev call. Details see the tracker item: http://sourceforge.net/tracker/?func=detail&aid=3325270&group_id=177891&atid=886178
+Modification made by JZ.
+ Person: Jennifer Fostel, Jie Zheng
+ OBI
+ culture medium
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- Whole genome transcription profiling of Anaplasma phagocytophilum in human and tick host cells by tiling array analysis. BMC Genomics. 2008 Jul 31;9:364. PMID: 18671858
+
+
+ electronic case report tabulation
- An assay that determines gene expression and transcription activity using ribonucleic acids collected from a material entity.
- This term should encompass transcription and post-transcription, but before translation into protein. So 'gene expression' itself is too broad, and we use 'transcription profiling identification objective' to constrain the scope of this term.
- Philippe Rocca-Serra
- gene expression profiling
- transcription profiling
- OBI
- transcription profiling assay
+ An electronic case report tabulation is a digital document containing tabular data about multiple trial participants which is part of a clinical regulatory submission. An eCRT has the property that it can be audited and compliant with requirements of 21 CFR Part 11 and has format suited to review by regulators.
+ person:Jennifer Fostel
+ CDISC glossary
+ electronic case report tabulation
-
+
-
-
- averaging objective
- A mean calculation which has averaging objective is a descriptive statistics calculation in which the mean is calculated by taking the sum of all of the observations in a data set divided by the total number of observations. It gives a measure of the 'center of gravity' for the data set. It is also known as the first moment.
+
+
+ polystyrene tube
+ Polystyrene tubes can be used to contain tissue culture cells during centrifgation
- An averaging objective is a data transformation objective where the aim is to perform mean calculations on the input of the data transformation.
- Elisabetta Manduchi
- James Malone
- PERSON: Elisabetta Manduchi
- averaging objective
+ A polystyrene tube is a test tube made of polystyrene
+ PERSON: Chris Stoeckert
+ PERSON: Chris Stoeckert
+ polystyrene tube
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- injection
- Multiple Small-Dose Injections Can Reduce the Passage of Sclerosant Foam into Deep Veins During Foam Sclerotherapy for Varicose Veins. Eur J Vasc Endovasc Surg. 2008 Oct 13. PMID: 18922712
+
+
+ reagent role
+ Buffer, dye, a catalyst, a solvating agent.
- injection is process which aims at introducing a compound or a mixture into a material entity (either biological entity or instrument) by relying on devices such as syringe or injector connection, attached or forced into a vascular system (veins of an organism or tubes of a machine) or in a tissue.
- Philippe Rocca-Serra
- OBI Biomaterial
- injection
+ A role inhering in a biological or chemical entity that is intended to be applied in a scientific technique to participate (or have molecular components that participate) in a chemical reaction that facilitates the generation of data about some entity distinct from the bearer, or the generation of some specified material output distinct from the bearer.
+ PERSON:Matthew Brush
+ reagent
+ PERSON:Matthew Brush
+ Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term.
+
+May 28 2013. Updated definition taken from ReO based on discussions initiated in Philly 2011 workshop. Former defnition described a narrower view of reagents in chemistry that restricts bearers of the role to be chemical entities ("a role played by a molecular entity used to produce a chemical reaction to detect, measure, or produce other substances"). Updated definition allows for broader view of reagents in the domain of biomedical research to include larger materials that have parts that participate chemically in a molecular reaction or interaction.
+
+ (copied from ReO)
+Reagents are distinguished from instruments or devices that also participate in scientific techniques by the fact that reagents are chemical or biological in nature and necessarily participate in or have parts that participate in some chemical interaction or reaction during their intended participation in some technique. By contrast, instruments do not participate in a chemical reaction/interaction during the technique.
+
+Reagents are distinguished from study subjects/evaluants in that study subjects and evaluants are that about which conclusions are drawn and knowledge is sought in an investigation - while reagents, by definition, are not. It should be noted, however, that reagent and study subject/evaluant roles can be borne by instances of the same type of material entity - but a given instance will realize only one of these roles in the execution of a given assay or technique. For example, taq polymerase can bear a reagent role or an evaluant role. In a DNA sequencing assay aimed at generating sequence data about some plasmid, the reagent role of the taq polymerase is realized. In an assay to evaluate the quality of the taq polymerase itself, the evaluant/study subject role of the taq is realized, but not the reagent role since the taq is the subject about which data is generated.
+
+In regard to the statement that reagents are 'distinct' from the specified outputs of a technique, note that a reagent may be incorporated into a material output of a technique, as long as the IDENTITY of this output is distinct from that of the bearer of the reagent role. For example, dNTPs input into a PCR are reagents that become part of the material output of this technique, but this output has a new identity (ie that of a 'nucleic acid molecule') that is distinct from the identity of the dNTPs that comprise it. Similarly, a biotin molecule input into a cell labeling technique are reagents that become part of the specified output, but the identity of the output is that of some modified cell specimen which shares identity with the input unmodified cell specimen, and not with the biotin label. Thus, we see that an important criteria of 'reagent-ness' is that it is a facilitator, and not the primary focus of an investigation or material processing technique (ie not the specified subject/evaluant about which knowledge is sought, or the specified output material of the technique).
+ reagent role
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- enzyme
-
- (protein or rna) or has_part (protein or rna) and
-has_function some GO:0003824 (catalytic activity)
- MC: known issue: enzyme doesn't classify under material entity for now as it isn't stated that anything
-that has_part some material entity is a material entity. If we add as equivalent classes to material entity has_part some material entity and part_of some material entity (each one in his own necessary and sufficient block) Pellet in P3 doesn't classify any more.
- person: Melanie Courtot
- GROUP:OBI
- enzyme
+
+
+ role of regulator of chemical manufacturer
+ EPA; John Mollison is the registrar of chemical products in Tasmania, the body that administers the Act that regulates chemical use in that State. http://www.abc.net.au/rn/science/earth/stories/s1160346.htm
+
+ a regulator involved with making and enforcing legislation and governmental orders relevant to chemical manufacture
+ Person: Jennifer Fostel
+ regulator of chemical manufacture
+ OBI
+ role of regulator of chemical manufacturer
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- intraperitoneal administration
- Rats were injected intraperitoneally with either rrIL-6 (250 ng/0.5 ml) or equal-volume sterile saline twice within an interval of 24 h
+
+
+ detector reagent role
- The administration of a substance into the peritoneum of an organism
- Person:Bjoern Peters
- intraperitoneal administration
+ a role which inheres in a molecular entity and is realized by the process of recording or registering a stimulus.
+ 19feb2009. not clear we need this term. originally if came from microarrays -- the probes on the array are termed detectors in some instances
+ One that detects, especially a mechanical, electrical, or chemical device that automatically identifies and records or registers a stimulus, such as an environmental change in pressure or temperature, an electric signal, or radiation from a radioactive material. http://www.answers.com/topic/detector 19feb2009
+ detector reagent role
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- plasmid
-
- plasmid = DNA and has_quality circular and has_function
-(is_realized_as some gene expression) GO:0010467
- person:Melanie Courtot
- group:OBI
- plasmid
+
+
+ role of certified IRB professional
+ CIP= Certified IRB Professional; http://acronyms.thefreedictionary.com/Certified+IRB+Professional
+
+ a role of which inheres in a Homo sapiens and realized during administration and oversight of the daily activities of Institutional Review Boards (IRBs) in the USA
+ Person:Helen Parkinson
+ Person:Jennifer Fostel
+ certified IRB professional
+ WEB: http://en.wikipedia.org/wiki/Certified_IRB_Professional
+ role of certified IRB professional
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
-
-
+
+
- injection into organ section
- Staining a specimen of human lung tissue with hematoxylin and eosin in order as a preparative step in histology
-
- A process in which an input substance is injected into a organ section.
- Person:Bjoern Peters
- injection into organ section
+ patient role
+ a hospitalized person; a person with controlled diabetes; the patient's role http://www.fertilityjourney.com/testingAndDiagnosis/theRightDoctor/thePatientsRole/index.asp?C=55245395146924652778
+
+ a role which inheres in a person and is realized by the process of being under the care of a physician or health care provider
+ GROUP:Role Branch
+ patient
+ OBI, CDISC
+ CDISC definition: patient. Person under a physician's care for a particular disease or condition. NOTE: A subject in a clinical trial is not necessarily a patient, but a patient in a clinical trial is a subject. See also subject, trial subject, healthy volunteer. Often used interchangeably
+ patient role
-
+
-
-
+
+
+
+
+
+
+
+
-
-
+
+
-
-
+
+
- polyacrylamide gel
- Assessing CMT cell line stability by two dimensional polyacrylamide gel electrophoresis and mass spectrometry based proteome analysis. J Proteomics. 2008 Jul 21;71(2):160-7. PMID: 18617143
-
- a material entity resulting from the polymerization of acrylamide with TEMED in some buffer solution
- PERSON: Jie Zheng
- PERSON: Philippe Rocca-Serra
- GROUP: OBI Biomaterial Branch
- polyacrylamide gel
+
+ material processing
+ A cell lysis, production of a cloning vector, creating a buffer.
+
+ A planned process which results in physical changes in a specified input material
+ PERSON: Bjoern Peters
+ PERSON: Frank Gibson
+ PERSON: Jennifer Fostel
+ PERSON: Melanie Courtot
+ PERSON: Philippe Rocca Serra
+ material transformation
+ OBI branch derived
+ material processing
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
+ protocol testing objective
+
+ Protocol_testing_objective is a methodology_testing_objective role describing a study designed to examine the effects of using different protocols.
+ Jennifer Fostel
+ protocol testing objective
+
+
+
+
+
+
+
+
-
-
+
+
- genotyping using an Affymetrix chip
-
- An assay with the objective to determine a sequence feature of DNA
- Bjoern Peters
- Philippe Rocca-Serra
- OBI
- DNA sequence feature detection assay
+ study subject role
+ Human subjects in a clinical trial, rats in a toxicogenomics study, tissue cutlures subjected to drug tests, fish observed in an ecotoxicology study.
+Parasite example: people are infected with a parasite which is then extracted; the particpant under investigation could be the parasite, the people, or a population of which the people are members, depending on the nature of the study.
+Lake example: a lake could realize this role in an investigation that assays pollution levels in samples of water taken from the lake.
+
+ A role that is realized through the execution of a study design in which the bearer of the role participates and in which data about that bearer is collected.
+ A participant can realize both "specimen role" and "participant under investigation role" at the same time. However "participant under investigation role" is distinct from "specimen role", since a specimen could somehow be involved in an investigation without being the thing that is under investigation.
+ GROUP: Role Branch
+ OBI
+ Following OBI call November 2012,26th:
+
+1. it was decided there was no need for moving the children class and making them siblings of study subject role.
+2. it also settles the disambiguation about 'study subject'. This is about the individual participating in the investigation/study, Not the 'topic' (as in 'toxicity study') of the investigation/study
+
+This note closes the issue and validates the class definition to be part of the OBI core
+editor = PRS
+
+ participant under investigation role
-
+
-
-
- adding material objective
- creating a mouse infected with LCM virus
-
- is the specification of an objective to add a material into a target material. The adding is asymmetric in the sense that the target material largely retains its identity
- BP
- adding material objective
+
+
+ obsolete_role of being first subject treated
+ Rat 1A; first enrolled patient to receive treatment
+
+ First subject treated role is a study subject role borne by the subject realized in the application of the process specified in intervention study design with no previous study subject realizing the role prior in the study
+ Role Branch
+ OBI
+
+ obsolete_role of being first subject treated
+ true
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry. Clin Chem. 2008 Jan;54(1):86-92. Epub 2007 Nov 2.PMID: 17981923
+
+
+ measured expression level
+ Examples are quantified data from an expression microarray experiment, PCR measurements, etc.
- An assay which generates data about a genotype from a specimen of genomic DNA. A variety of techniques and instruments can be used to produce information about sequence variation at particular genomic positions.
- Philippe Rocca-Serra
- SNP analysis
- genotype profiling
- OBI Biomaterial
- genotyping assay
+ A measurement datum that is the outcome of the quantification of an assay for the activity of a gene, or the number of RNA transcripts.
+ person:Chris Stoeckert
+ OBI Data Transformation branch
+ measured expression level
-
+
-
-
-
-
-
-
-
-
- needle
- Ovarian carcinoma presenting with axillary lymph node metastasis: A case diagnosed by fine-needle aspiration and brief review of the literature. Diagn Cytopathol. 2008 Oct 16. PMID: 18925569
+
+
+ responsible party role
+ he THERAPIST has the ability to print a separate statement for the patient and each responsible party. http://www.beaverlog.com/therapist/ez_support/billing/responsible_party_statements.htm
- A needle is a sharp, hollow device used to penetrate tissue or soft material. When attached to a syringe. it allows delivery of a specific volume of liquid or gaseous mixture.
- Philippe Rocca-Serra
- OBI Instrument
- needle
+ a study personnel role played by a party who is accountable for the execution of a study component and can make decisions about the conduct of the study
+ Person: Jennifer Fostel
+ responsible party
+ OBI
+ responsible party role
-
+
-
-
- analyte measurement objective
- The objective to measure the concentration of glucose in a blood sample
-
- an assay objective to determine the presence or concentration of an analyte in the evaluant
- PERSON: Bjoern Peters
- PPPB branch
- analyte measurement objective
+
+
+ principal investigator role
+
+ a responsible party role played by a person responsible for the overall conduct of a study
+ Person: Jennifer Fostel
+ principal investigator
+ CDISC definition: A person responsible for the conduct of the clinical trial at a trial site. If a trial is conducted by a team of individuals at a trial site, the investigator is the responsible leader of the team and may be called the principal investigator. 2. The individual principal investigator. 2. The individual under whose immediate direction the test article is administered or dispensed to, or used involving, a subject, or, in the event of an investigation conducted by a team of individuals, is See also sponsor-investigator.; Leiter der klinischen Prufung.Under the German Drug Law, the physician who is head of the clinical investigation (CDISC): coordinating investigator (CDISC) (also study coordinator, MUSC); sponsor-investigator. An individual who both initiates and conducts, alone or with others, a clinical trial, and under whose immediate direction the investigational product is administered to, dispensed to, or used by a subject.NOTE: The term does not include any person other than an individual, hence not a corporation, agency (CDISC)
+ principal investigator role
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
-
+
- Capturing genomic signatures of DNA sequence variation using a standard anonymous microarray platform. Nucleic Acids Res. 2006;34(18):e121. PMID: 17000641
-
- An assay that measures changes (expansion, amplification, deletion, mutation) in the sequence of a DNA molecule.
- Philippe Rocca-Serra
- OBI Biomaterial
- DNA sequence variation detection assay
+ transplantation
+
+ a protocol application to replace an organ or tissue of an organism
+ PlanAndPlannedProcess Branch
+ OBI branch derived
+ transplantation
-
+
-
-
-
-
-
-
-
-
- agarose gel
- Performance comparison of capillary and agarose gel electrophoresis for the identification and characterization of monoclonal immunoglobulins. Am J Clin Pathol. 2008 Mar;129(3):451-8. PMID: 18285269
+
+
+ obsolete biological vector role
+ 1983 Sci. Amer. Jan. 58/2 Plasmids are routinely used as vectors for introducing foreign DNA into bacteria.
+ Some epidemiological aspects and vector role of tick infestation on layers in the Faisalabad district (Pakistan). http://journals.cambridge.org/action/displayAbstract;jsessionid=0373164489D00868AEEF2C556EB4FD29.tomcat1?fromPage=online&aid=624280
- a material entity resulting from the polymerization of agarose after heating agarose suspended in some buffer solution
- PERSON: Philippe Rocca-Serra
- GROUP: OBI Biomaterial Branch
- agarose gel
-
-
-
-
-
-
-
-
- assay objective
- the objective to determine the weight of a mouse.
-
- an objective specification to determine a specified type of information about an evaluated entity (the material entity bearing evaluant role)
- PPPB branch
- PPPB branch
- assay objective
+ a biological vector role is a material to be added role that is realized by the process of transmitting material to the organism that is the target of the transmission.
+ GROUP: Role Branch
+ OBI and Wikipedia
+
+ obsolete biological vector role
+ true
-
+
-
-
- Alan Ruttenberg's heart
-
- The heart is a muscular organ found in all vertebrates that is responsible for pumping blood throughout the blood vessels by repeated, rhythmic contractions
- Person:Bjoern Peters
- http://en.wikipedia.org/wiki/Heart
-
- obsolete_heart
- true
+
+
+ pH indicator dye role
+ bromophenol blue has a pH indicator dye role
+ phenol red in RPMI; pH=4 indicator dye (also carries reference role)
+
+ the role of a dye that is realized when the dye is used in an experiment to measure the pH in a material entity
+ Person: Jennifer Fostel
+ Person:Helen Parkinson
+ pH indicator dye
+ pH indicator dye role
-
+
-
-
-
-
-
-
-
-
+
+
-
-
+
+
+
+
+
+
+
+
+
+
+
+
- example of usage: In lab test for blood glucose, the test is the assay, the blood bears evaluant_role and glucose bears the analyte role. The evaluant is considered an input to the assay and the information entity that records the measurement of glucose concentration the output
+ specimen role
+ liver section; a portion of a culture of cells; a nemotode or other animal once no longer a subject (generally killed); portion of blood from a patient.
- An assay with the objective to capture information about the presence, concentration, or amount of an analyte in an evaluant.
- Alan Ruttenberg
- Bjoern Peters
- Helen Parkinson
- Philippe Rocca-Serra
- Alan Ruttenberg
- Bjoern Peters
- Helen Parkinson
- OBI Planned process branch
- Philippe Rocca-Serra
- analyte assay
+ a role borne by a material entity that is gained during a specimen collection process and that can be realized by use of the specimen in an investigation
+ 22Jun09. The definition includes whole organisms, and can include a human. The link between specimen role and study subject role has been removed. A specimen taken as part of a case study is not considered to be a population representative, while a specimen taken as representing a population, e.g. person taken from a cohort, blood specimen taken from an animal) would be considered a population representative and would also bear material sample role.
+ Note: definition is in specimen creation objective which is defined as an objective to obtain and store a material entity for potential use as an input during an investigation.
+ blood taken from animal: animal continues in study, whereas blood has role specimen.
+something taken from study subject, leaves the study and becomes the specimen.
+ parasite example
+- when parasite in people we study people, people are subjects and parasites are specimen
+- when parasite extracted, they become subject in the following study
+specimen can later be subject.
+ GROUP: Role Branch
+ OBI
+
+ specimen role
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- target of material addition role
- peritoneum of an animal receiving an interperitoneal injection; solution in a tube receiving additional material; location of absorbed material following a dermal application.
-
- target of material addition role is a role realized by an entity into which a material is added in a material addition process
- From Branch discussion with BP, AR, MC -- there is a need for the recipient to interact with the administered material. for example, a tooth receiving a filling was not considered to be a target role.
- GROUP: Role Branch
- OBI
- target of material addition role
+
+
+ sequence feature identification objective
+
+ Sequence_feature_identification_objective is a biological_feature_identification_objective role describing a study designed to examine or characterize molecular features exhibited at the level of a macromolecular sequence, e.g. nucleic acid, protein, polysaccharide.
+ Jennifer Fostel
+ sequence feature identification objective
-
+
-
-
-
+
+
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
-
+
-
-
+
+
@@ -9204,1884 +14768,1801 @@ that has_part some material entity is a material entity. If we add as equivalent
-
-
-
-
-
-
-
- The patients was weighed and mass was determined to be 47 kilograms
+
+ intervention design
+ PMID: 18208636.Br J Nutr. 2008 Jan 22;:1-11.Effect of vitamin D supplementation on bone and vitamin D status among Pakistani immigrants in Denmark: a randomised double-blinded placebo-controlled intervention study.
+
+ An intervention design is a study design in which a controlled process applied to the subjects (the intervention) serves as the independent variable manipulated by the experimentalist. The treatment (perturbation or intervention) defined can be defined as a combination of values taken by independent variable manipulated by the experimentalists are applied to the recruited subjects assigned (possibly by applying specific methods) to treatment groups. The specificity of intervention design is the fact that independent variables are being manipulated and a response of the biological system is evaluated via response variables as monitored by possibly a series of assays.
+ Philppe Rocca-Serra
+ OBI branch derived
+ intervention design
+
+
+
+
+
+
+
+
+ worker role
+ Public sector workers in states that run their own OSHA programs are covered by those states. http://www.osha.gov/as/opa/worker/index.html
- An assay that determines the mass of an evaluant
- Helen Parkinson
- OBI
- mass measurement assay
+ a personnel role played by a party who executes a component of the study plan; this can occur before, during, after or outside the study timeline
+ "executes the study plan" includes the suppliers and manufacturers of reagents and other materials used in the study
+ Person:Jennifer Fostel
+ worker
+ OBI
+ worker role
-
+
-
-
- DNA cleavage assay for the identification of topoisomerase I inhibitors. Nat Protoc. 2008;3(11):1736-50. PMID: 18927559
-
- a process by which the identity (what a thing is) of a material entity is established within a certain confidence interval
- Philippe Rocca-Serra
-
- obsolete_identification
- true
+
+
+ Bernoulli trial
+
+ An assay where the output data is a datum with one of two values denoting success and failure.
+ PlanAndPlannedProcess Branch
+ OBI branch derived
+ Bernoulli trial
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- An electrophysiology recording assay where the recording location of the electrode is intracellular
- Frank Gibson
- Frank Gibson
- intra cellular electrophysiology recording assay
+
+
+ gene list
+ Gene lists may arise from analysis to determine differentially expressed genes, may be collected from the literature for involvement in a particular process or pathway (e.g., inflammation), or may be the input for gene set enrichment analysis.
+
+ A data set of the names or identifiers of genes that are the outcome of an analysis or have been put together for the purpose of an analysis.
+ person:Chris Stoeckert
+ group:OBI
+ kind of report. (alan) need to be careful to distinguish from output of a data transformation or calculation. A gene list is a report when it is published as such? Relates to question of whether report is a whole, or whether it can be a part of some other narrative object.
+ gene list
-
+
-
-
- packed column
+
+
+ number of particles in subset
+ 500, 200, 0
- A packed column is a chromatography column where the particles of the solid stationary phase or the support coated with a liquid stationary phase may fill the whole inside volume of the tube.
- PERSON:Daniel Schober
- WEB:<http:www.iupac.org/publications/pac/1993/pdf/6504x0819.pdf>
- http://msi-ontology.sourceforge.net/ontology/CHROM.owl#msi_01218
- packed column
+ A measurement datum measuring the number of subjects in a defined subset in a flow cytometer instrument. The datum has a qualitative role
+ person:Kevin Clancy
+ Submitted by the Flow Cytometry community in DigitalEntity-FlowCytometry-2007-03-30.txt
+ number of particles in subset
-
+
-
-
- example of subclass: normalized data set - A normalized data set is a data set that is produced as the output of a normalization data transformation.
-
- This is only a placeholder for defined classes, as are its siblings _defined_material and _defined protocol application. Its children should be defined classes constructed as output of a process.
- PERSON: Alan Ruttenberg
- PERSON: James Malone
- PERSON: Melanie Courtot
-
- obsolete_defined_output
- true
+
+
+ number of lost events electronic
+ 74, 0, 14 events lost due to data acquisition electronic coincidence.
+
+ A measurement datum measuring the number of analysis events lost due to errors in data acquisition electronic coincidence in a flow cytometer instrument. The datum has a qualitative role.
+ person:Kevin Clancy
+ Submitted by the Flow Cytometry community in DigitalEntity-FlowCytometry-2007-03-30.txt
+ number of lost events electronic
-
+
-
-
-
-
-
-
-
-
-
-
-
-
- regulatory agency
- The US Environmental Protection Agency
+
+
+
+
+
+
+
+
+ calibration substance role
+ pH buffer used to calibrate a pH meter bears a calibration substance role
- A regulatory agency is a organization that has responsibility over or for the legislation (acts and regulations) for a given sector of the government.
- GROUP: OBI Biomaterial Branch
- WEB: en.wikipedia.org/wiki/Regulator
- regulatory agency
+ A reference substance role that is realized when characteristics or responses elicited by the bearer are used to ensure an instrument is within protocol specification of accuracy or performance
+ Jennifer Fostel
+ calibration substance role
-
+
-
-
-
-
-
-
-
-
- normalized data set
-
- A data set that is produced as the output of a normalization data transformation.
- PERSON: James Malone
- PERSON: Melanie Courtot
- normalized data set
+
+
+ molecular feature identification objective
+
+ Molecular_feature_identification_objective is a biological_feature_identification_objective role describing a study designed to examine or characterize molecular features of a biological system, e.g. expression profiling, copy number of molecular components, epigenetic modifications.
+ Jennifer Fostel
+ molecular feature identification objective
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- measure function
- A glucometer measures blood glucose concentration, the glucometer has a measure function.
-
- Measure function is a function that is borne by a processed material and realized in a process in which information about some entity is expressed relative to some reference.
- PERSON: Daniel Schober
- PERSON: Helen Parkinson
- PERSON: Melanie Courtot
- PERSON:Frank Gibson
- measure function
+
+
+ hardware testing objective
+
+ Hardware_testing_objective is a methodology_testing_objective role describing a study designed to examine the effects of using different hardware, e.g. scanner.
+ Jennifer Fostel
+ hardware testing objective
-
+
-
-
-
-
-
-
-
-
+
+
-
-
-
-
-
-
-
+
+
- The recording of a spike train in the caudate nucleus of a monkey where the electrodes are extra cellular, i.e. not in the neuron
+ incubator
+ Incubators are used in microbiology for culturing (growing) bacteria and other microorganisms. Incubators in tissue culture rooms are used for culturing stem cells, lymphocytes, skin fibroblasts and other types of cells
- An electrophysiology recording assay where the recording location of the electrode is extracellular
- Frank Gibson
- Helen Parkinson
- Frank Gibson
- extracellular electrophysiology recording assay
+ A device in which environmental conditions (light, photoperiod, temperature, humidity, etc.) can be controlled
+ Frank Gibson
+ http://www.medterms.com/script/main/art.asp?articlekey=18426
+ incubator
-
+
-
-
-
-
-
-
-
-
- consume data function
-
- Process data function is a function that is borne by in a material entity by virtue of its structure. When realized the material entity consumes data.
- PERSON: Daniel Schober
- PERSON: Frank Gibson
- PERSON: Melanie Courtot
- consume data function
+
+
+ obsolete_label role
+
+ Label role is a role which inheres in a material entity and which is realized in a detection of label assay
+ Role Branch
+ label
+ OBI
+
+
+ obsolete_label role
+ true
-
+
-
-
- material transformation objective
- The objective to create a mouse infected with LCM virus. The objective to create a defined solution of PBS.
-
- an objective specifiction that creates an specific output object from input materials.
- PERSON: Bjoern Peters
- PERSON: Frank Gibson
- PERSON: Jennifer Fostel
- PERSON: Melanie Courtot
- PERSON: Philippe Rocca-Serra
- artifact creation objective
- GROUP: OBI PlanAndPlannedProcess Branch
- material transformation objective
+
+
+ baseline participant role
+ Subject at time = 0; subject before a stress test.
+
+ a reference participant role which is realized by making the reference to qualities at the start of the study or intervention
+ Person: Jennifer Fostel
+ baseline participant
+ baseline participant role
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- manufacturing
-
- Manufacturing is a process with the intent to produce a processed material which will have a function for future use. A person or organization (having manufacturer role) is a participant in this process
- Manufacturing implies reproducibility and responsibility AR
- This includes a single scientist making a processed material for personal use.
- PERSON: Bjoern Peters
- PERSON: Frank Gibson
- PERSON: Jennifer Fostel
- PERSON: Melanie Courtot
- PERSON: Philippe Rocca-Serra
- GROUP: OBI PlanAndPlannedProcess Branch
- manufacturing
+
+
+ role of independent data monitoring committee
+
+ a trial monitor role charged recommending whether to continue, modify, or end the trial
+ Person: Jennifer Fostel
+ independent data monitoring committee
+ role of independent data monitoring committee
-
+
-
-
- manufacturing objective
-
- is the objective to manufacture a material of a certain function (device)
- PERSON: Bjoern Peters
- PERSON: Frank Gibson
- PERSON: Jennifer Fostel
- PERSON: Melanie Courtot
- PERSON: Philippe Rocca-Serra
- GROUP: OBI PlanAndPlannedProcess Branch
- manufacturing objective
+
+
+ pathologist role
+
+ a worker role of being responsible for making the histopathology diagnoses associated with data from a study; this activity occurs outside the study timeline
+ Person:Jennifer Fostel
+ Pathologist
+ pathologist role
-
+
-
+
-
+
- column chromatography detector
-
- There is a wide range of detectors available for both GC and LC each having their own particular areas of application. In general the more catholic the response, the less sensitive the detector and the most sensitive detectors are those that have a specific response. The performance of all detectors should be properly specified so that the user can determine which is most suitable for a specific application. Such specifications are also essential to compare the performance of different detectors supplied by alternative instrument manufactures. Detector specifications should be presented in a standard form and in standard units, so that detectors can be compared that function on widely different principles.
- PERSON:Daniel Schober
- WEB:<http://www.chromatography-online.org/Principles/Basic-Chromatograph/Detector/rs56.html>
- http://msi-ontology.sourceforge.net/ontology/CHROM.owl#msi_01077
- chromatography detector, defined class/xps
- column chromatography detector
-
-
-
-
-
-
-
-
- Bruker autosampler
-
- A Bruker autosampler is an autosampler made by Bruker.
- PERSON:Daniel Schober
- GROUP:<http://msi-ontology.sourceforge.net>
- http://msi-ontology.sourceforge.net/ontology/NMR.owl#msi_400209
- Bruker autosampler
-
-
-
-
-
-
-
-
- organic acid column
-
- An organic acid column is a chromatography column which enables (reversed-phase) separation of hydrophilic aliphatic and aromatic organic acids with UV detection. Organic acid columns allow retention of polar and apolar organic acids and are hydrolysis resistant.
- PERSON:Daniel Schober
- GROUP:<http://msi-ontology.sourceforge.net>
- http://msi-ontology.sourceforge.net/ontology/CHROM.owl#msi_01099
- organic acid column
-
-
-
-
-
-
-
-
- thermal conductivity detector
-
- The most commonly used detector in preparative GC is the thermal conductivity detector (hot wire detector). Even this detector, however, is often too sensitive and has too high a flow impedance. Under such circumstances, the procedure mentioned above must be employed. The eluent from the preparative column is split and a small portion diverted through the detector (sometimes with further dilution with carrier gas to reduce sensitivity).
- PERSON:Daniel Schober
- TCD, hot wire detector
- WEB:<http://www.chromatography-online.org/Preparative/Apparatus/Detectors/rs27.html>
- http://msi-ontology.sourceforge.net/ontology/CHROM.owl#msi_01084
- thermal conductivity detector
-
-
-
-
-
-
-
-
- Bruker US 2 NMR magnet
-
- An actively-shielded superconducting magnet from Bruker that combines Bruker BioSpin's advanced, proprietary UltraShield active shielding and UltraStabilized sub-cooling technologies. This shielded and stabilized (US2) magnet system delivers high sensitivity and spectral dispersion.
- PERSON:Daniel Schober
- WEB:<http://www.bruker-biospin.com/nmr_magnets_950us2.html>
- http://msi-ontology.sourceforge.net/ontology/NMR.owl#msi_400189
- NMR instrument
- Bruker US 2 NMR magnet
-
-
-
-
-
-
-
-
- protein column
+ supernatant collection system harvesting frame
- A protein column is a chromatography column used for the separation of complex protein mixtures. Protein columns enable sample desalting, followed by chromatographic separation or fractionation of complex protein samples, e.g. immunodepleted serum or plasma proteins.
- PERSON:Daniel Schober
- GROUP:<http://msi-ontology.sourceforge.net>
- http://msi-ontology.sourceforge.net/ontology/CHROM.owl#msi_01238
- refactor as defined class
- protein column
+ A device that is designed for collecting 90% of the supernatant in a microplate well and separating the living cell with no stress, eliminating centrifugation and other similar techniques. It can be used in a variety of release assays with different radioactive isotopes, such as Cr51 or I125.
+ Daniel Schober
+ google
+ supernatant collection system harvesting frame
-
+
-
-
- solvent mixer
+
+
+
+
+
+
+
+
+ filter paper
- A liquid chromatography device that mixes different solvents, e.g. under high pressure and in differrent volumes ranging from 5 ml to 5 L capacity. Powerful magnetic mixers provide vigorous agitation required for high pressure reaction chemistry.
- PERSON:Daniel Schober
- GROUP:<http://msi-ontology.sourceforge.net>
- http://msi-ontology.sourceforge.net/ontology/CHROM.owl#msi_01072
- check on definition !
- solvent mixer
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-